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INTRAOPERATIVE RADIOFREQUENCY 
ABLATION COMBINED OR NOT WITH 
RESECTION TO TREAT UNRESECTABLE 
COLORECTAL METASTASES. RESULTS 
OF THE MULTICENTRIC PHASE 2 
STUDY: ARF2003
S. Evrard1, M. Rivoire2, J-P. Arnaud3, A. Ayav4, 
A. S. Cuhna5, J-M. Regimbeau6, S. Mathoulin1 and 
C. Bellera1
1Institut Bergonié, Bordeaux, France; 2Centre Léon Bérard, 
Lyon, France; 3CHU Angers, Angers, France; 4CHU 
Nancy, Nancy, France; 5CHU Bordeaux, Bordeaux, 
France; 6CHU Amiens, Amiens, France
Background: Only few patients suffering from colorectal 
metastases (CRM) can have surgery and thus hope for a 40% 
5-year survival rate. Adding intra-operative radiofrequency 
ablation (IRFA) to resection may improve the effi cacy of 
surgery.
Aims: The primary objective was to evaluate the effi cacy of 
IRFA combined or not with resection in terms of 3-month 
complete hepatic response (CHR) in patients with unresect-
able CRM. Secondary endpoints were overall survival (OS), 
disease-free survival (DFS), morbidity and quality of life.
Methods: A phase 2 study (NTC 00210106) based on a 
Simon’s two-stage design was conducted in 6 university 
French hospitals. Number of subjects estimated was 53, with 
19 for the 1st stage. At the end of the 1st stage, 12 CHR were 
required to continue recruiting. At the end of 2nd stage, 37 
CHR would be required to claim effi cacy.
Results: Mean age 60.5 years; 7 had RFA alone (14%), 43 
had RFA & resections (86%), 3 could not be treated (5.7%). 
Median number of CRM was 5 (1–13). All had chemother-
apy pre-op and 21 post-op (42%). The median follow-up was 
15 months. One patient died of septic shock. Global morbid-
ity (Dindo Clavien) was 40%, but grade 2 and more was only 
20%, none were reoperated on. 40 patients had CHR (75.5%; 
IC95% = [63.9; 87.1]);). One-year OS and EFS rates were 
94.2% and 26.9% respectively. 5 years OS was 35.4% and 3 
years EFS was 5.6.
Discussion: Our results suggest that IRFA combined or not 
to resection may be effi cient in treating unresectable diseases 
despite their more aggressive pattern. This corroborates the 
EORTCC CLOCC Trial fi ndings which demonstrated IRFA 
superiority upon chemotherapy alone. IRFA combined with 
resection is now considered in Europe to be a curative treat-
ment of CR mets as it is considered to be so in an EORTC 
study to be launched.
PP2
DISTAL PANCREATIC RESECTION FOR 
ADENOCARCINOMA: NO MORE PLACE 
FOR NIHILISM
F. Paye, J. R. Delpero, P. Bachellier and 
Association Française de Chirurgie AFC
1Digestive Surgery Hôpital Saint Antoine, Paris, France; 
2Oncologic Surgery Institut Paoli Calmettes, Marseille, 
France; 3Hepatobiliary Surgery CHU Hautepierre, 
Stasbourg, France; 4Association Française de Chirurgie 
(AFC), Paris, France
Background, aims: In 1996, our association reported a 
postoperative mortality of 9% with no 5 years survivor after 
left pancreatic resections for pancreatic adenocarcinoma. In 
order to precise the current results of distal pancreatectomy 
for adenocarcinoma, a new multicentric retrospective was 
conducted by the French Association of Surgery gathering 
the distal pancreatectomies performed for pancreatic adeno-
carcinoma between 2004 and 2009.
Patients and methods: All pathological reports of distal 
pancreatectomies perfomed by 36 participating centers were 
reviewed to include only pancreatic adenocarcinomas. Thus, 
271 distal pancreatic resection for adenocarcinoma were 
selected and studied. Neoadjuvant treatment was performed 
by chemo-or chemoradio-therapy in 40 patients. Pancreatic 
resection was preceded by explorative coelioscopy in 30 
patients. Extended resection to adjacent viscera and venous 
resection of mesenterico-portal axis were performed respec-
tively in 77 and 33 cases. Adjuvant chemo- or chemoradio-
therapy was administered to 77% of patients
Results: Post-operative mortality was 1.8%. Post operative 
morbidity was 47% signifi cantly increased by preoperative 
diabetes. 15% of patients underwent perioperative transfu-
sions, 27% developed pancreatic fi stula that were signifi -
cantly related to obesity (BMI > 30). According to Clavien’s 
classifi cation, 35% had a class III or more postoperative 
complication and 7% needed reoperation. Resection was 
classifi ed by pathologist as R0 in 206 cases. Global survival 
rates at 3 and 5 years were 44% and 24%, signifi cantly better 
in women and altered by perioperative transfusion and addi-
tional visceral resection in univariate analysis. Nodal status, 
tumor size and arterial involvement were signifi cantly cor-
related with survival by multivariate analysis. Three years 
recurrence free survival was 27%.
Conclusion: Better patient’s selection, standardization of 
surgical procedures and larger use of adjuvant treatments are 
likely responsible for the dramatic improvement of the 
results of surgical resection of distal pancreatic adenocarci-
noma observed in the largest available multicentric study.
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PP3
USEFULNESS OF THE LYMPH NODE 
STATUS CHARACTERISTICS TO DEFINE 
THE REPRESENTATIVE MINIMAL 
NUMBER OF LYMPH NODES TO BE 
RESECTED DURING 
PANCREATICODUODENECTOMY FOR 
DUCTAL CARCINOMA OF THE 
PANCREAS
P. Bachellier1, Elie. Oussoultzoglou1, F. Paye2 and 
J. R. Delpero3
1Centre de Chirurgie Viscérale et de Transplantation – 
Hopital de Hautepierre – Université de Strasbourg, 
Strasbourg, France; 2Service de Chirurgie Digestive – 
Hopital Saint Antoine – UPMC Paris 6, Paris, France; 
3Département de Chirurgie – Institut Paoli Calmettes, 
Marseille, France
Aim: To analyse the pathological characteristics of the 
lymph node status and defi ne the extent of lymphade-
nectomy after pancreaticoduodenectomy (PD) for ductal 
adenocarcinoma.
Methods: A multicentric retrospective french study col-
lected the data of 1325 patients who underwent PD for pan-
creatic ductal adenocarcinoma between 2004 and 2009. A 
log-rank test was used to determine the prognostic impact of 
each characteristics of the lymph nodes status on survival.
Results: A standard PD was performed in 771 patients. A 
mesenterico-portal axis resection was associated in 360 
patients. The mean number of retrieved lymph node was 19 
± 11 (median 17). In 901 patients lymph nodes were invaded 
on the fi nal pathological assessment. Among these patients 
the mean number of positive lymph node was 3.8 ± 3.8 
(median 3). Logistic regression analysis showed that young 
patients (<70 years), with ASA score 1 or 2, operated in high 
volume centers (>20 patients/year), undergoing PD with 
additional mesenterico-portal resection and without pylorus 
preservation were signifi cantly associated with higher 
number of retrieved lymph nodes without an increase of the 
morbidity and mortality rates. Overall and disease-free sur-
vival rates were 78% and 55% at 1-year and 41% and 25% 
at 3-year respectively. Univariate analysis of prognostic 
factors for survival demonstrated that positive lymph node 
status, the ratio of positive/total retrieved lymph nodes >0.15 
(6th), and total number of retrieved lymph node <10 were 
associated with poor outcome. Considering the mean number 
of positive lymph node and the ratio of positive/total retrieved 
lymph node, the minimal number of retrieved lymph node 
that may infl uence survival should include at least 24 lymph 
nodes.
Conclusion: PD for pancreatic cancer can provide long-
term survival even in patients with positive lymph node 
status. This study suggests that lymphadenectomy should 
include at least 24 lymph nodes.
PP4
HUMAN HEPATOMA CELL LINE 
HEPARG BASED BIOARTIFICIAL LIVER 
THERAPY INCREASES SURVIVAL TIME 
IN RATS WITH ACUTE LIVER FAILURE
G. Nibourg, T. van der Hoeven, A. Maas, M. Ackermans, 
R. O. Elferink, R. Chamuleau, R. Hoekstra and 
T. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Background: Bioartifi cial livers (BALs) should bridge liver 
failure patients to liver transplantation or liver regeneration. 
BALs comprise a bioreactor loaded with cells, and their 
effi cacy heavily relies on the functionality of the cells 
applied. In this study, we evaluated the potential of the 
human hepatoma cell line HepaRG for BAL application.
Methods: HepaRG cells were cultured in laboratory scale 
AMC-BALs (n = 6) for 14 days and analyzed for growth 
characteristics, expression of various hepatic genes, and liver 
specifi c functionality. Next, HepaRG BALs were tested for 
effi cacy in a rat model of acute liver failure (ALF; n = 6), 
induced surgically by liver ischemia. Control rats were 
treated with an empty BAL. The pimary endpoint was sur-
vival time, and secondary endpoints were progression of 
hepatic encephalopathy (clinical score), plasma ammonia 
levels, renal function (plasma creatinine), and bleeding ten-
dency (hemoglobin and intra-abdominal blood loss).
Results: Total protein content demonstrated a stable culture 
of HepaRG cells in the BAL for 14 days. Histological inspec-
tion revealed liver-like tissue with polarized cells throughout 
the bioreactor. Expression levels of hepatic genes remained 
stable or increased by BAL culture. Ammonia elimination 
and urea production reached 52% and 10% of the rate 
of a primary porcine hepatocyte BAL. For lactate consump-
tion this level was 62%. Detoxifi cation function and syn-
thetic function, as tested by the production rates of 
6β-hydroxytestosterone and apolipoprotein A-1 reached 22% 
and 192% of primary human hepatocyte cultures. HepaRG 
BAL treatment of ALF rats increased survival time with 47% 
from 9.7 to 14.3 hours (p = 0.002). In addition, HepaRG BAL 
treatment signifi cantly and substantially slowed down the 
progression of hepatic encephalopathy and renal dysfunc-
tion, ammonia accumulation (28%) and bleeding tendency.
Conclusion: Utilization of HepaRG cells as a biocompo-
nent in the AMC-BAL results in a BAL with high hepatic 
functionality that proves effi cacy in a rat model of ALF.
PP5
WHAT WOULD HAPPEN IF WE 
TRANSPLANT A RESECTABLE 
HEPATOCELLULAR CARCINOMA 
RATHER THAN RESECT? A MARKOV 
MODEL SIMULATION
A. Cucchetti, M. Cescon, G. Ercolani, M. C. Morelli, 
M. Ravaioli, M. Del Gaudio, P. Di Gioia, V. Bertuzzo, 
E. Peri and A. D. Pinna
Liver and Multiorgan Transplant Unit – University of 
Bologna, Bologna, Italy
Background: Primary transplantation offers longer life-
expectancy in comparison to hepatic resection for hepatocel-
lular carcinoma (HCC); however, the improved diagnostic 
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and interventional techniques have greatly improved the sur-
vival after partial hepatectomy. Aim of the study was to 
compare the observed survival of transplantable patients sub-
mitted to resection to their predicted survival in case of liver 
transplantation.
Methods: Clinical data and survivals of 123 transplantable 
patients (within Milan criteria) resected for HCC were 
reviewed and their predicted survival after listing for liver 
transplantation was calculated using a Markov model simu-
lation based on literature data or estimated from the United 
Network for Organ Sharing (UNOS) database.
Results: The mean observed 5-years life-expectancy after 
resection (33.7 ± 18.9 months) was signifi cantly lower than 
the predicted life-expectancy in case of listing for transplan-
tation (37.4 ± 12.1 months; P = 0.030). The gain in life-
expectancy was higher in patients negative for hepatitis C 
(HCV) serology (P = 0.043), with MELD score ≥9 (P = 
0.002) and with UNOS-TNM T2 tumors (P = 0.012). Life-
expectancy of T1 patients was slightly higher after resection 
than after listing (P = 0.061). In the worst case scenario of 
HCV-positive patients and MELD <9 the mean observed 
5-years life-expectancy after resection (37.1 ± 18.1 months) 
was slightly higher than the predicted survival after listing 
(35.4 ± 12.3 months) even if not statistically signifi cant 
(P = 0.350).
Conclusions: Survival after hepatic resection can be similar 
than that after transplantation in T1 patients and HCV-
positive patients with well compensated cirrhosis.
PP6
IMPROVED LIVER REGENERATION 
AND FUNCTIONAL RECOVERY AFTER 
PARTIAL HEPATECTOMY OF FATTY 
LIVERS TREATED WITH OMEGA-3 
FATTY ACIDS IN RATS
H. Marsman, W. de Graaf, M. Heger, F. ten Kate, 
R. Bennink and T. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Introduction: Hepatic steatosis is an important risk factor 
for postoperative morbidity and mortality after major hepa-
tectomy. Omega3-fatty acids (FA) have shown to inhibit 
experimental steatosis. The aim of this study was to examine 
reduction of steatosis and the consequent effect on liver 
regeneration in an experimental steatosis model in rats.
Methods: Liver steatosis was induced in rats by 3 wk 
methione/choline-defi cient diet (MCDD). Regenerative and 
functional recovery following partial hepatectomy were 
measured by 99mTc-mebrofenin hepatobiliairy scintigraphy 
(HBS). Firstly, HBS measurements before, after steatosis 
induction and following 2 wk daily oral omega3-FA 
(Omega3-group) or NaCl (saline-group) administration were 
performed and compared with control rats (N = 6/group). 
Secondly, HBS was performed in Omega3, saline and control 
rats, 1, 2, 3 and 5 days after 70%-partial hepatectomy (N = 
7/group). Hepatocellular damage and proliferation (Ki-67 
staining), anti-oxidative capacity and Kupffer cell activation 
(hepatic TNF-alpha) were assessed.
Results: Histologically severe (>66%) steatosis (saline-
group) was reduced by Omega3-FA to mild (<33%) steatosis. 
HBS-uptake in the saline-group was >2.0 fold impaired, as 
compared to control, but improved signifi cantly (P < 0.05) 
following omega3-FA treatment. Posthepatectomy, hepato-
cellular damage (ASAT/ALAT) and bilirubin levels were 
decreased in Omega3-group at day 1, 2 and 3, as compared 
to the saline-group. HBS-uptake and regenerated liver mass 
were signifi cantly improved as compared to saline-group at 
day 1 and 3 (P < 0.05). Posthepatectomy proliferation peak 
response was delayed in saline rats until day 2, as compared 
to day 1 in Omega3 and control rats. Anti-oxidative capacity 
was signifi cantly improved (P < 0.05) by omega3-FA treat-
ment, as compared to the saline group, before and 1, and 3 
days posthepatectomy. Kupffer cell activation was lowered 
in Omega3 rats before and 1 day posthepatectomy, as com-
pared to saline-group.
Conclusion: Omega3-FA treatment effectively reduced 
severe steatosis resulting in improved liver regeneration and 
functional recovery following partial hepatectomy.
PP7
SINGLE CENTRE EXPERIENCE WITH 
ONE THOUSAND CONSECUTIVE 
PANCREATICODUODENECTOMIES: HAS 
ANYTHING CHANGED?
M. Sofi a, S. Aroori, J. Isaac, P. Muisan, S. Bramhall, 
D. Mirza, D. Mayer and J. Buckels
Liver Unit, Queen Elizabeth Hospital, Birmingham, United 
Kingdom
Introduction: The post-operative morbidity and mortality 
and has decreased signifi cantly following pancreaticoduode-
nectomy (PD) since it was fi rst performed by Whipple in 
1940s. The aim of this study was to analyse our experience 
with 1000 consecutive PDs performed over 23 years.
Methods: This is a retrospective analysis of prospectively 
collected data of 1000 consecutive patients who underwent 
PD between January 1987 and June 2010. For the purpose 
of this study patients were divided into two groups: period 
1- patients who had PD between 1987 and 1999 and period 
2 – patients who had PD between January 2000 and June 
2010. The two groups were compared to fi nd out if there 
were any differences in terms of: age distribution, co-
morbidities, indications for PD, type of PD, hospital stay, 
post-operative morbidity and mortality, fi nal histology, 
resection status and overall survival.
Results: A total of 244 patients underwent PD during period 
1 and 756 patients during period 2. The mean age of patients 
was signifi cantly higher during period 2, 64.2 ± 10.9 vs. 57.9 
± 13.7 years, p < 0.0001. Furthermore, more patients with 
co-morbidities were considered for PD during period 2: 
57.8% vs. 28.2%, p = 0.0001. The percentage of patients who 
had PD for suspected malignancy and subsequent histology 
showed benign disease has decreased signifi cantly during 
second time period, 20.5% vs. 13.6%, p = 0.002. The number 
of patients who underwent Pylorus-preserving PD has 
increased from 64% in period 1 to 88.4% during period 2, 
p = 0.000. The percentage of patients who underwent portal 
vein resection has increased signifi cantly (0.8% vs. 11.5%, 
p = 0.0001) during period 2. The overall morbidity has 
increased during period 2: 40.7 vs.29%, p = 0.03. The median 
length of hospital stay has decreased from 12 (range: 2–150) 
to 10 days (3–181, p = 0.000), during period 2 and at the 
same time the median intensive care unit stay has increased 
from 2 (1–29) to 6.5 days (1–55, p = 0.000) during period 2.
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There was no signifi cant reduction in the 30 (5.7% vs. 6.6%, 
p = 0.6) and 90-day mortality (9.9%) during period 2 com-
pared to period 1. Histology data did not reveal any signifi cant 
difference in the mean size of the tumour and positive resec-
tion margin status between two time periods. However, the 
lymph node (LN) yield was signifi cantly higher during period 
2: mean number of LNs 18.6 ± 7.2 vs.14.5 ± 5.4, p = 0.009. 
The median survival for all cancers together was 20 (95% CI: 
16.7–23.8) months during period 2 compared to 17.6 (95% CI: 
13.8–21.4, p = 0.49) months during period 1. There was an 
improvement in the median survival of patients with ampul-
lary carcinoma during period 2 (59.8 vs. 32.7 months, p = 
0.43) but there was no difference in the median survival of 
patients with pancreatic head adenocarcinoma between both 
time periods (14.3 vs.13 months, p = 0.85).
Conclusion: Older and sicker patients were considered for 
PD during the last decade. There was a signifi cant reduction 
in length of hospital stay despite an increase in the post-
operative morbidity. There was no signifi cant improvement 
in overall mortality during last decade. We also did not 
observe any improvement in the median survival of patients 
with pancreatic head cancers during last decade.
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EARLY LAPAROSCOPIC 
CHOLECYSTECTOMY IMPROVES 
OUTCOMES AFTER ENDOSCOPIC 
SPHINCTEROTOMY FOR 
CHOLEDOCHOCYSTOLITHIASIS
J. S. Reinders1, A. Goud1, R. Timmer1, P. Kruyt2, 
B. Witteman2, N. Smakman3, R. Breumelhof3, 
S. Donkervoort4, J. Jansen4, J. Heisterkamp5, M. Grubben5, 
B. van Ramshorst1 and D. Boerma1
1St. Antonius Hospital, Nieuwegein, Netherlands; 2Hospital 
Gelderse Vallei, Ede, Netherlands; 3Diakonessenhuis, 
Utrecht, Netherlands; 4Onze Lieve Vrouwe Gasthuis, 
Amsterdam, Netherlands; 5St. Elisabeth Hospital, Tilburg, 
Netherlands
Patients with choledochocystolithiasis generally undergo 
endoscopic sphincterotomy (ES) followed by laparoscopic 
cholecystectomy (LC). Nowadays many patients are being 
scheduled for surgery, for practical reasons, between 6–8 
weeks after ES. There is a high conversion rate of elective 
LC after ES, and patients can develop recurrent biliary events 
during the waiting period. We investigated whether the 
timing of surgery infl uences outcome.
We performed a randomized clinical trial of patients with 
choledochocystolithiasis who underwent successful ES. 
Patients were randomly assigned to groups that received 
early LC [ELC] (within 72 hours after ES, n = 49) or delayed 
LC [DLC] (after 6–8 weeks, n = 47), based on an expected 
difference in conversion rate of 5% vs 25%, respectively. 
Conversion rate, biliary events during follow-up, duration 
and diffi culty of laparoscopic cholecystectomy, postopera-
tive morbidity and hospital stay were scored. Analysis was 
performed on Intention-to-treat principle.
Groups were comparable in age, sex, and comorbidity. 
There was no difference between groups in conversion rate 
(4.3% in early versus 8.7% in delayed group) nor were there 
differences in operating time and/or diffi culty or hospital 
stay. During the waiting period for LC, 17 patients in the 
DLC group (36.2%) developed recurrent biliary events com-
pared with 1 patient in the ELC group (P < .001, LR = 
20.623).
In a randomized trial to evaluate timing of LC after ES, 
recurrent biliary events occurred in 36.2% of patients whose 
LC was delayed for 6–8 weeks. Early LC (i.e. within 72 
hours) appears to be safe and might prevent the majority of 
biliary events in this period following sphincterotomy.
PP9
EXTERNAL PANCREATIC DUCT 
STENT DECREASES PANCREATIC 
FISTULA RATE AFTER 
PANCREATICODUODENECTOMY: 
PROSPECTIVE MULTICENTER 
RANDOMIZED TRIAL
P. Pessaux1,9, A. Sauvanet2,9, C. Mariette3,9, F. Paye4,9, 
F. Muscari5,9, A. S. Cunha6,9, B. Sastre7,9 and J-P. Arnaud8,9
1Hôpital de Hautepierre – Université de Strasbourg, 
Strasbourg, France; 2Hôpital Beaujon – Université Paris 
VII, Clichy, France; 3Hôpital Claude Huriez – Université 
de Lille, Lille, France; 4Hôpital Saint-antoine- UPMC 
Paris VI, Paris, France; 5Hôpital Rangueil – Université de 
Toulouse, Toulouse, France; 6Hôpital Haut Levêque – 
Université de Bordeaux, Bordeaux, France; 7Hôpital 
Timone – Université de Marseille, Marseille, France; 
8Hôpital universitaire d’Angers – Université d’Angers, 
Angers, France; 9Fédération de Recherche en Chirurgie 
(FRENCH), Colombe, France
Introduction: Pancreatic fi stula (PF) is a leading cause of 
morbidity and mortality after pancreaticoduodenectomy 
(PD). The aim of this multicenter prospective randomized 
trial was to compare the results of PD with an external drain-
age stent versus no stent.
Methods: Between 2006 to 2009, 158 patients who under-
went PD were randomized intraoperatively to either receive 
an external stent inserted across the anastomosis to drain the 
pancreatic duct (n = 77) or no stent (n = 81). The criteria of 
inclusion were soft pancreas and a diameter of wirsung 
<3 mm. The primary study end point was PF rate defi ned as 
amylase-rich fl uid (amylase concentration >3 times the upper 
limit of normal serum amylase level) collected from the 
peripancreatic drains after postoperative day 3. CT scan was 
routinely done on day 7.
Results: The 2 groups were comparable concerning demo-
graphic data, underlying pathologies, presenting symptoms, 
presence of comorbid illness, and proportion of patients with 
preoperative biliary drainage. Mortality, morbidity and PF 
rates were 3.8%, 51.8% and 34.2%, respectively. Stented 
group had a signifi cantly lower overall PF (26% vs 42%; p 
= 0.034), morbidity (41.5% vs 61.7%; p = 0.01), and delayed 
gastric emptying (7.8% vs 27.2%; p = 0.001) rates compared 
with nonstented group. Radiologic or surgical intervention 
for PF was required in 9 patients in the stented group and 12 
patients in the nonstented group. There were no signifi cant 
differences in mortality rate (3.7% vs 3.9%; p = 0.37) and in 
hospital stay (22 vs 26 days; p = 0.11).
Conclusion: External drainage of pancreatic duct with a 
stent reduced.
PF and overall morbidity rates after PD in high risk 
patients (soft pancreatic texture and a nondilated pancreatic 
duct).
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OPTIMIZING STEATOTIC LIVERS FOR 
TRANSPLANTATION USING A CELL 
PENETRATING HEME OXYGENASE 
PROTEIN
S. Livingstone, K. Savage, L. Murray, T. Lee and I. Alwayn
Dalhousie University, Halifax, Nova Scotia, Canada
Objective: The development of a cell penetrating heme 
oxygenase 1 (HO1) protein for treatment steatotic livers 
ex vivo prior to transplantation to potentially improve their 
resistance to reperfusion injury.
Methods: Cell penetrating enhanced green fl uorescent 
protein (CPP-EGFP) and HO1 (CPP-HO1) clones were gen-
erated by PCR amplifi cation of EGFP and HO1 cDNA using 
primers containing the sequence for an upstream cell pene-
trating peptide (CPP). PCR products were cloned into an 
expression vector; the resultant clones transformed into E. 
coli; and protein synthesis induced with Isopropyl β-D-1-
thiogalactopyranoside (IPTG). Proteins were purifi ed using 
nickel agarose columns and identifi ed by western blot analy-
sis. HO1 function was confi rmed by spectrophotometric 
quantifi cation of bilirubin production by CPP-HO1 treated 
HEK293T cells supplemented with hemin, biliverdin reduc-
tase and the necessary cofactors. Cell penetrating ability was 
confi rmed by immunohistochemical and fl uorescence micro-
scopic analysis of treated cells for the presence of intracel-
lular CPP-EGFP and CPP-HO1.
Results: Sequence analysis confi rmed the successful gen-
eration of CPP-EGFP and CPP-HO1 clones. Induction of 
protein expression resulted in a colour change of the media 
and bacterial pellet of CPP-HO1 expressing E. coli from 
beige to green, due to production of biliverdin. Western blot 
analysis confi rmed the successful purifi cation of both CPP-
EGFP and CPP-HO1. CPP-EGFP and CPP-HO1 were found 
to effi ciently penetrate hepatoma cells in vitro. CPP-HO1 
was found to penetrate HEK293Tcells, and extracts from 
treated cells catalyzed the breakdown of heme into bilirubin, 
whereas untreated cells did not.
Conclusions: We have successfully generated a functional 
heme oxygenase protein that is able to penetrate cells in vitro. 
Further work will determine if 1) CPP-HO1 can provide 
cellular protection in an in vitro model of ischemia/reperfu-
sion injury 2) if CPP-HO1 is able to penetrate the hepato-
cytes of ex vivo treated livers and 3) whether the treatment 
of steatotic livers with CPP-HO1 protects these livers from 
reperfusion injury.
PP11
RANDOMIZED CONTROLLED TRIAL 
ANALYZING THE EFFECT OF 15 OR 30 
MINUTES INTERMITTENT PRINGLE 
MANOEUVRE ON HEPATOCELLULAR 
DAMAGE DURING LIVER SURGERY 
IN MAN
M. van den Broek, J. Bloemen, S. Dello, M. van de Poll, 
S. O. Damink and C. Dejong
Maastricht University Medical Centre, Maastricht, 
Netherlands
Aminotransferases are commonly used to assess the optimal 
duration of ischemic intervals during intermittent Pringle 
manoeuvre (IPM). However, they might not be responsive 
enough to detect small differences in hepatocellular damage. 
Liver fatty acid-binding protein (L-FABP) is a more sensitive 
marker. This randomized controlled trial aimed to compare 
hepatocellular injury refl ected by L-FABP in patients under-
going liver resection with IPM using either 15 or 30 minutes 
ischemic intervals.
Twenty patients requiring IPM during liver surgery were 
randomly assigned to 15 (15IPM) or 30 (30IPM) minutes 
ischemic intervals. Ten patients without the need for IPM 
(noIPM) served as controls. Blood samples from the radial 
artery, portal and hepatic vein were collected according to a 
fi xed protocol. Primary endpoint was hepatocellular injury 
during and after liver surgery refl ected by L-FABP. Between 
and within group comparisons were performed using area 
under the curve (AUC) and repeated measures two-way 
ANOVA.
The 15IPM and 30IPM group had similar characteristics. 
Aminotransferases did not signifi cantly differ between the 
15IPM and 30IPM group at any time point. L-FABP levels 
rose up to 1853 ± 708 ng/mL in the 15IPM and 3662 ± 
1355 ng/mL in the 30IPM group after fi nishing liver transec-
tion and decreased rapidly thereafter. There were no signifi -
cant differences between the 15IPM and 30IPM group in 
cumulative L-FABP level (p = 0.378) or L-FABP level at any 
time point (p = 0.149). NoIPM resulted in signifi cantly lower 
cumulative L-FABP and ALAT levels (p = 0.019 and p = 
0.049). Blood loss, remnant liver function and postoperative 
morbidity were comparable.
To conclude, this study provides novel data showing 
that 30IPM induced similar hepatocellular injury refl ected 
by the sensitive marker L-FABP compared with 15IPM. 
The present study confi rms the results of earlier trials, 
suggesting that IPM with 30 minutes ischemic intervals 
may be used if pedicle clamping during liver surgery is 
required.
PP12
POST FREY PROCEDURE QUALITY OF 
LIFE IN SOUTH AFRICANS WITH 
CHRONIC PANCREATITIS
C. Y. Jeppe1, P. J. Bekker2, J. Omoshoro-Jones3 and 
M. D. Smith3
1SA Department of Health, Johannesburg, South Africa; 
2SA Medical Research Council, Johannesburg, South 
Africa; 3University of the Witwatersrand, Johannesburg, 
South Africa
Background: The reliability and validity of the European 
Organisation for Research and Treatment of Cancer’s quality 
of life (QoL) questionnaire (QLQ-C30, version 3) in clinical 
studies of patients with chronic pancreatitis (CP) before and 
after the local resection and lateral pancreatico-jejunostomy 
(LR-LPJ) or Frey procedure was endorsed in 1995. This 
procedure was performed for symptomatic and/or compli-
cated chronic pancreatitis. The poor socio-economic condi-
tions from which the indigent South African presents may 
infl uence the long term outcome after this procedure
Objectives: To compare pre- and post-LR-LPJ outcomes 
using the QLQ-C30 and to compare it to a locally developed 
structured interview.
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Methods: A prospective, observational, long term study was 
conducted. Consecutive adult patients with a confi rmed diag-
nosis of painful and/or complicated CP undergoing the pro-
cedure were included.
Results: 112 LR-LPJ procedures were performed between 
March 1995 and February 2009. Sixty fi ve participants 
answered the QLQ-C30 and were interviewed at follow ups 
(months of follow up: mean: 23.9, range: 0.5–141). Fifty two 
of these answered both instruments within 6 months after 
surgery, 32 before and after the surgery. Post LR-LPJ there 
were signifi cant improvements in QLQ global health status: 
(26.6 points, p < 0.001, n = 31), and emotional (15.4 points, 
p = 0.015, n = 32) and social (21 points, p = 0.0005, n = 32) 
functioning, but not with physical functioning (0.85 points, 
p = 0.85, n = 32). Their improvement in role functioning was 
clinically relevant but not signifi cant (15.16 points, p = 0.11) 
and cognitive functioning was neither clinically relevant 
(improved 8.32 points) nor signifi cant (p = 0.25).
Mean functional scale scores improved post-operatively in 
the 32 (11.88 points, p = 0.01). There was a clinically rele-
vant improvement in most symptom scales of the QLQ-C30. 
Pre- and post-surgical mean symptom scale scores improved 
by 17.27 points (p = 0.0001, n = 32). There were no signifi -
cant differences in the means of the functional (1.43 points, 
p = 0.62) and symptom (3.4 points, p = 0.24) scale scores 
between post-operative (≤6 months) and fi nal (minimum of 
6 months) visits (n = 52). There was poor agreement between 
the QLQ-C30 pain score and the visual analogue scale for 
pain of the interview: Pearson’s correlation coeffi cient, r = 
0.5333 and poor correlation between the former and the pain 
intensity of the latter using Spearman’s correlation coeffi -
cient, r = 0.5228. When evaluating the two instruments of 
measure with respect to similar domains the outcomes were 
concurrent (oql: p = 0.0004; rf: p = 0.0247; ssnv: p ≤ 0.0001; 
ssal: p = 0.0006).
Conclusion: Signifi cant improvements in most domains of 
the QLQ-C30 post operatively were found. For patients (n = 
32) with QLQ-C30 measurements preoperatively the 
improvement to last visit was signifi cant for mean functional 
and symptom scale scores, while for patients (n = 52) with 
QLQ-C30 measurements post operatively but within 6 
months improvement to last visit was not signifi cant, sug-
gesting that benefi ts were mostly made manifest within 6 
months. Apart from pain there was concurrence between 
some parameters of the QLQ-C30 and the structured 
interview.
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PANCREATIC ADENOCARCINOMAS 
ARISING ON THE BACKGROUND OF 
PANCREATIC CYSTIC DISEASE HAVE A 
BETTER OUTCOME THAN POOR 
OUTCOME
G. Morris-Stiff, G. Lentz, S. Chalikonda and M. Walsh
Cleveland Clinic, Cleveland, Ohio, United States
Background: Pancreatic adenocarinoma has a poor progno-
sis with a reported 5-year survival of <5%, however, this 
general fi gure does not differentiate ductal adenocarcinoma 
from adenocarcinomas arising within a background of pan-
creatic cystic disease.
Aims: To report long-term survival rates in patients with 
ductal adenocarcinoma and compare them to carcinomas 
arising in cystic disease and to those originating from the 
endocrine pancreas.
Methods: Frequency and follow-up data was obtained from 
The National Cancer Institute’s Surveillance, Epidemiology, 
End Results (SEER) database for the period 1973–2006. The 
survival of patients with ductal adenocarcinoma (ICD 
[International classifi cation of disease] codes: 8010, 8140–
8147, 8500) were compared to: adenocarcinoma in IPMN 
(ICD: 8453); mucinous cystadenocarcinoma (ICD: 8470–
8471); endocrine/islet cell carcinoma (8240–8249, 8150–
8157); and mucinous adenocarcinoma 8480–8481). 
Carcinomas classifi ed as malignant neoplasms and those 
of other histopathological subtypes were excluded.
Results: During the period February 1998 to December 
2008, 127,295 patients were identifi ed of which 111,714 
were within the remit of the study. Adequate data to perform 
survival analysis was available for 92,911 cases.5-yr Survival 
for carcinomas arising in IPMN carcinomas (44%) and muci-
nous cystadenocarcinomas (34.1%) were superior to that of 
standard adenocarcinomas (2.3%) or mucinous adenocarci-
nomas (2.8%) [p < 0.001] for each, with survival of carcino-
mas of endocrine origin being similar to that of cystic lesion 
carcinomas (36.7%) [p = 0.38].
Conclusions: It is evident that survival of patients with car-
cinoma arising in this setting is superior and thus all patients 
with a mucinous cystic neoplasm should be referred for a 
surgical opinion.
O2
SOLID PSEUDOPAPILLARY TUMORS OF 
THE PANCREAS
M. Frost, J. Krige, E. Panieri and P. Bornman
Department of Surgery, University of Cape Town Health 
Sciences Faculty, Cape Town, South Africa
Introduction: Solid Pseudopapillary tumors (SPT) of the 
pancreas are rare, low grade malignant, but curable tumors 
that occur almost exclusively in young women. The clinical 
characteristics and surgical strategy in 20 patients with SPT 
of the pancreas are discussed.
Methods: We report a retrospective review of 20 patients 
with SPT from patients treated over a 30 year period. An 
evaluation of each case with respect to age, sex, presenting 
symptoms and signs, type of operation, histology and tumor 
markers, post-operative complications and follow up was 
performed.
Results: All 20 patients were female. The average age 
was 24.6 years (range 13–51). Fifteen patients presented 
with abdominal pain and 14 patients had a palpable 
abdominal mass on examination. Of the 20 patients, fi ve 
had a pylorus preserving pancreaticoduodenectomy and 
the remainder were excised locally or required a central 
or distal pancreatectomy. One patient had two liver 
metastases that were resected in addition to the pancreatic 
primary. One patient died of multisystem organ failure. 
Other signifi cant complications included bleeding (two) 
requiring reoperation and intraabdominal fl uid collections 
requiring percutaneous drainage (three) or operation 
(one). Nineeen patients were alive and well at follow up with 
an average follow up of 4.7 years (range 8 months to 15 
years).
Conclusion: Solid pseudopapillary tumors of the pancreas 
are uncommon, but should be considered in the differential 
diagnosis of a young female with a cystic mass of the pan-
creas. Despite the indolent biological behavior of SPT, most 
patients required a major pancreatic resection. Surgery is 
curative regardless of the size or location of the tumor. 
Metastases are rare, as is recurrence after complete surgical 
resection.
O3
NATIONWIDE IMPROVEMENT OF 
ENDOCRINE PANCREATIC CANCER 
SURVIVAL IN THE NETHERLANDS
I. de Hingh1, S. van de Akker2, E. de Vries2, S. Nienhuijs1, 
O. Visser3, B. Kiemeney4 and V. Lemmens5
1Catharina-hospital, Eindhoven, Netherlands; 2Erasmus 
University Medical Centre, Rotterdam, Netherlands; 
3Comprehensive Cancer Center Amsterdam, Amsterdam, 
Netherlands; 4University Medical Centre Nijmegen, 
Nijmegen, Netherlands; 5Comprehensive Cancer Center 
South, Eindhoven, Netherlands
Background: Endocrine pancreatic cancer distinguishes 
itself from the adenocarcinoma in a less remarkable tendency 
for rapid dissemination and insidious infi ltration. As it has a 
very low incidence, data on treatment patterns and survival 
trends derived from a population based registry are preferred. 
We have reviewed these trends at a national level in the 
Netherlands.
Methods: From the nationwide Netherlands Cancer 
Registry, trends in incidence, treatment and relative survival 
were analysed for the period 1989–2008.
Results: A total of 690 patients with endocrine pancreatic 
cancer were included. The incidence increased from 0.1 to 
0.3 per 100.000 inhabitants (European Standardised Rate) 
over the 20-year study period. Distribution between genders 
was equal; age-peaks were at sixth and seventh decade. One 
third of the patients underwent a resection, infrequently (3%) 
with adjuvant chemotherapy, and 17% received palliative 
chemotherapy. These rates did not change over time. Relative 
survival rates increased from 71% to 82% at 6 months, from 
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68% to 76% at 1 year and 50% to 62% at 3 years. Five-year 
survival increased from 40% to 50%; among patients who 
underwent surgery it increased from 69% to 83%.
Conclusion: The incidence of endocrine pancreatic cancer 
increased over time. Although treatment patterns did not 
change, relative survival improved. Explanatory factors 
could be improved imaging resolution and refi nements of 
surgical techniques and perioperative care. The ongoing 
implementation of centralisation of pancreatic cancer surgery 
in the Netherlands may result in further improvement.
O4
MULTI-VISCERAL EN BLOC 
PANCREATIC RESECTIONS FOR 
MALIGNANT TUMOURS
M. A. Hilal2, M. McPhail1,2, W. E. Ghoul2, F. Di Fabio2, 
C. Johnson2, N. Pearce2 and P. Swan2
1Imperial College London, London, United Kingdom; 
2Southampton General Hospital, Southampton, United 
Kingdom
Introduction: Neuroendocrine tumours involving multiple 
organs can achieve useful symptomatic palliation with mul-
tivisceral resection but other tumour histologies are less well 
studied, and multivisceral resection of (even non-pancreatic) 
adenocarcinomas is rarely undertaken.
Methods: 59 patients (39 male: 20 female, mean age 62 
(95% CI 58–64) years underwent multi-visceral en bloc 
resections for malignant tumours involving the pancreas. 
9 patients had gastrointestinal stromal tumours (GIST), 
20 NET, 10 abdominal adenocarcinoma and 21 other 
histologies.
Results: A median of 2 (range 1–7) additional organs were 
resected, with a median duration of operation of 5 (2.5–9.5) 
hours and 1 (0.2–12) L blood loss. There was no difference 
in duration, blood loss, number of organs resected, major 
complication rate or total postoperative/critical care stay 
among the 4 groups. 22 patients experienced a major com-
plication with 2 postoperative deaths. Median follow up was 
12 months (range 1–177) months, 16 patients have died (12 
of recurrent disease) and 19 patients are alive with recurrent 
disease. Median survival was 37 months (higher in the NET 
group, median survival not attained vs GIST (32 months) vs 
adenocarcinomas (12) and others (32 months), p = 0.005 
Kaplan-Meier method) with 24 months median disease free 
survival (p = 0.680 among groups). No determinants of 
recurrence were found on multivariate Cox regression but 
survival was less likely in patients with adenocarcinomas 
(HR 4.4, p = 0.016) and with rising number of organs 
resected (HR 1.4, p = 0.029, overall p < 0.001). Receiver-
Operating Curve analysis did not detect a suitable limit of 
number of resected organs to predict poor 6 or 12 month 
mortality.
Conclusion: En bloc multi-visceral resection for selected 
locally advanced malignancy involving the pancreas is tech-
nically feasible with acceptable disease-free and overall sur-
vival. In this series outcome was best in patients with NET 
and with a low en bloc organ count. Adenocarcinomas had 
the poorest survival and are poor candidate histologies for 
multivisceral resection. An unacceptable upper limit of addi-
tional organs to remove remains to be determined.
O5
CENTRALIZATION OF 
PANCREATICODUODENECTOMY IN 
THE NETHERLANDS: TRENDS AND 
IMPACT ON MORTALITY
R. F. de Wilde1,2, M. G. Besselink1, I. H. B. Rinkes1, 
C. H. Van Eijck3, C. H. Dejong4, R. J. Porte5, 
D. J. Gouma6, O. R. Busch6 and Q. Molenaar1
1University Medical Center Utrecht, Utrecht, Netherlands; 
2Sol Goldman Pancreatic Cancer Research Center Johns 
Hopkins Hospital, Baltimore, United States; 3Erasmus 
Medical Center, Rotterdam, Netherlands; 4Maastricht 
University Medical Center, Maastricht, Netherlands; 
5University Medical Center Groningen, Groningen, 
Netherlands; 6Academic Medical Center, Amsterdam, 
Netherlands
Introduction: Mortality after pancreaticoduodenectomy 
(PD) may be reduced by nationwide centralization of this 
complex procedure to high volume centres. In the Netherlands, 
the fi rst initiative to centralize PD dates back to 1997. 
Evaluation of this process in 1999 and 2005 showed no 
change in referral patterns or decrease in mortality. We evalu-
ated the current state of centralization and mortality of PD 
in the Netherlands in the period 2004–2009.
Methods: Data were retrieved from the independent, nation-
wide registry (Kiwa Prismant Utrecht, Netherlands) for 
ICD-9 code 5-526 (pancreaticoduodenectomy, including 
Whipple). Hospitals were categorized by number of annually 
performed PDs based on previously published data: <5, 
5–10, 11–16 and >16 PDs.
Results: Number of PDs per hospital and associated mortal-
ity in the period 2004–2009 were evaluated. In 2004, 
295 PDs were performed by 48 hospitals compared to 
343 PDs by 30 hospitals in 2009. The number of hospitals 
performing <5 PDs decreased from 23 to 8, as did the 
number of hospitals performing 5–10 PDs, from 17 to 7. 
Hospitals performing 11–16 PDs increased from 6 to 10 and 
likewise hospitals >16 PDs, from 2 to 5. Hospitals meeting 
the recommended number of at least 11 PDs performed 
40.3% of the PDs in 2004 compared to 81.9% in 2009. PD 
associated mortality decreased from 11.5% in 2004 to 6.4% 
in 2009 (p = 0.03). Average mortality during the 6-year 
period for categorized hospitals performing <5, 5–10, 11–16 
or >16 PDs (2009 volume) was respectively 14.2%, 8.3%, 
7.4% and 5.4% (p < 0.001).
Conclusion: Centralization for PD in the Netherlands is 
succeeding and is associated with a reduction in postopera-
tive mortality. Current efforts to further stimulate centraliza-
tion and improve outcome include a new nationwide study 
group for pancreatic cancer, regional hospital network agree-
ments and involvement of both the ministry of Health and 
insurance companies.
10 Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
O6
NO NATIONWIDE IMPROVEMENT OF 
LONGER-TERM PANCREATIC CANCER 
SURVIVAL IN THE NETHERLANDS
S. Nienhuijs1, S. van de Akker2, E. de Vries2, I. de Hingh1, 
O. Visser3, B. Kiemeney4 and V. Lemmens5
1Catharina-hospital, Eindhoven, Netherlands; 2Erasmus 
University Medical Centre, Rotterdam, Netherlands; 
3Comprehensive Cancer Center Amsterdam, Amsterdam, 
Netherlands; 4University Medical Centre Nijmegen, 
Nijmegen, Netherlands; 5Comprehensive Cancer Center 
South, Eindhoven, Netherlands
Background: Pancreatic cancer remains an important 
health issue as, of all cancer types, it has one of the lowest 
survival rates. We described treatment patterns and survival 
trends at a national level in the Netherlands.
Methods: From the nationwide Netherlands Cancer 
Registry, trends in incidence, treatment and survival were 
analysed for the period 1989–2008.
Results: A total of 30.025 patients with pancreatic cancer 
were included. The incidence remained stable at about 9 per 
100.000 inhabitants (European Standardised Rate) over the 
20-year study period, being slightly higher for males. 
Resection rates increased from 8% in 1989 to 12% in 2008 
(p < 0.0001). Adjuvant chemotherapy rates increased from 
0% in 1998, to 12% in 2006, and to 27% in 2008 (p < 
0.0001). Palliative chemotherapy rates increased from 5% in 
1989 to 18% in 2008 (p < 0.0001). Relative survival rates 
did not change over time; besides a minimal increase at 3 
months from 53% to 55%, these remained 34% at 6 months, 
and 4.5% at 3 years. Among patients who underwent tumour 
resection, relative survival increased from 82% to 93% at 3 
months, from 72% to 84% at 6 months, and from 51% to 
63% at 1 year after diagnosis. However, no improvement was 
seen after 3 years (23%).
Conclusion: An increase in resection and adjuvant chemo-
therapy rates did not yet translate into improvements in 
longer-term survival. The ongoing implementation of cen-
tralisation of pancreatic cancer surgery in the Netherlands 
may impact future results.
O7
LONG-TERM SURVIVAL AFTER 
PANCREATODUODENECTOMY FOR 
PANCREATIC HEAD CARCINOMA
Y. van Gestel1, V. Lemmens1 and I. de Hingh2
1Comprehensive Cancer Center, Eindhoven, Netherlands; 
2Catharina Hospital, Eindhoven, Netherlands
Background: Cancer of the pancreatic head is one of the 
most lethal types of cancer with a poor prognosis even after 
curative resection. The aim of this study was to determine 
long-term survival after pancreatoduodenectomy for cancer 
of the pancreatic head and to determine clinicopathologic 
features of long-term survivors.
Methods: Between 1985 and 2004, a total of 1612 patients 
were diagnosed with cancer of the pancreatic head in the 
southern part of the Netherlands. Long-term survival was 
defi ned as ≥5 years survival after cancer diagnosis. Follow-up 
was at least 5 years or until death.
Results: Of the 1612 patients with pancreatic cancer, 233 
(14%) underwent surgical resection. The 5-year survival rate 
of these surgical patients was 7.3% (n = 17), including 10 
patients (4.3%) who survived longer than 10 years. Mean age 
of the 17 long-term survivors was 65 ± 9 years and 53% were 
men. No differences in patient and tumor characteristics were 
observed between the patients who underwent pancreatic 
resection who were still alive after 5 years (n = 17) and those 
who died within 5 year follow-up (n = 216). Notably, 3 out 
of 17 (18%) patients who underwent resection and survived 
during 5 years after diagnosis had tumor stage T3-4, 2 
patients (12%) had a poorly differentiated tumor grade and 
2 patients (12%) were diagnosed with positive local regional 
lymph node metastasis.
Conclusions: The results of our study confi rm that patients 
with pancreatic head carcinoma have poor prognosis. 
However 5 year survival after pancreatic resection is possible 
even in patients with an advanced T stage, poorly differenti-
ated tumor grade and positive local regional lymph node 
metastasis.
O8
LESSONS LEARNED FROM OUR PAST: 
IMPROVED CARE AND OUTCOME FOR 
PATIENTS WITH PANCREATIC CANCER 
IN THE SOUTH OF THE NETHERLANDS 
AFTER CENTRALISATION OF 
SURGICAL TREATMENT
V. Lemmens1,2, J. W. Coebergh1,2, K. Bosscha3, 
G. van der Schelling4, S. Brenninkmeijer5 and I. De Hingh6
1Eindhoven Cancer Registry, Comprehensive Cancer 
Centre South, Eindhoven, Netherlands; 2Department of 
Public Health, Erasmus University Medical Centre, 
Rotterdam, Netherlands; 3Jeroen Bosch Hospital, 
‘sHertogenbosch, Netherlands; 4Amphia Hospital, Breda, 
Netherlands; 5TweeSteden Hospital, Tilburg, Netherlands; 
6Catharina Hospital, Eindhoven, Netherlands
Introduction: Boosted by high postoperative mortality, 
pancreatic surgery was centralised in the south of the 
Netherlands, a region characterised by the absence of 
academic centres. The impact of this initiative was 
investigated.
Methods: All patients diagnosed in the Eindhoven Cancer 
Registry area in the periods 1995–2000 (pre-centralisation) 
and 2005–2008 (implementation of centralisation agree-
ments) with primary cancer of the pancreatic head or duct, 
extrahepatic bile ducts, ampulla of Vater, and duodenum 
were included (N = 2129). Resection proportions, in-hospital 
mortality, and 2-year survival were analyzed. Multivariable 
regression analyses were used to discriminate independent 
risk factors for death, including changes in treatment 
patterns.
Results: Resection rates increased from 19% to 30% (p < 
0.0001). The number of hospitals performing resections 
decreased from 8 to 3, the annual number of resections per 
hospital increased from 2 to 16. In-hospital mortality rates 
dropped from 24% to 4% (p < 0.0001), reaching 0% in 2008. 
Two-year survival after surgery increased from 38% to 49% 
(p = 0.001). Two-year survival irrespective of treatment 
increased from 10% to 16% (p < 0.0001). It did not improve 
in the non-surgery group. After adjustment for relevant 
patient- and tumour factors, patients undergoing surgery after 
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centralisation exhibited a lower death risk (hazard ratio 0.70, 
confi dence limits 0.51–0.97). Changes in surgical referral 
patterns seemed to explain the improvements.
Conclusions: High quality of care can be achieved in 
non-academic regional hospitals through collaboration. 
Centralisation should no longer be regarded as a threat by 
general hospitals but as a chance to improve outcome for 
patients suffering from pancreatic cancer.
O9
PROLYL HYDROXYLASE-2 (PHD2) – A 
NEW TUMOR SUPPRESSOR GENE IN 
PANCREATIC CANCER
Y. Su2,3, N. Giese3, E. Metzen1, M. Büchler3, A. Kornberg4, 
H. Friess4 and P. Büchler4
1Institute of Physiology, University Hospital of Essen, 
Essen, Germany; 2Department of Surgery, Zhongda 
Hospital, Nanjng Southeast University, Nanjing, China; 
3Department of General Surgery, University of Heidelberg, 
Heidelberg, Germany; 4Klinikum rechts der Isar, 
Technische Universität München, München, Germany
Purpose: Pancreatic cancer is one of the most common and 
poorly treated tumors. In search for new therapeutic 
approaches the oxygen sensors prolyl-hydroxylases (PHD) 
are potential targets. PHD2 is considered as the key oxygen 
sensor regulating hypoxia-inducible factor (HIF). Currently, 
there is confl icting evidence to the exact role of PHD2 in 
tumorigenesis. The aim of this study was to investigate the 
PHD2 in pancreatic cancer growth and progression.
Experimental design: PHD2 expression was analyzed by 
quantitative real-time polymerase chain reaction and immu-
nohistochemistry in human tissue specimens and cell lines. 
Knockdown of PHD2 was done by siRNA and overexpres-
sion was achieved by stable cDNA transfection. In vivo a 
orthotopic murine model was used. Angiogenic cytokines 
were determined by ELISAs and invasion was studied with 
Matrigel assays.
Results: PHD2 expression is not substantially altered in 
cancer tissues and their metastases. Lymh node negativ 
tissues had higher levels of PHD2 than nodal positive speci-
mens. PHD2 is hypoxia inducible in pancreatic cancer cell 
lines and regulates cell growth via downregulation of Cyclin 
D1 in the case of PHD2 suppression and via upregulation of 
p21 in the case of PHD2 overexpression. In vivo PHD2 
causes tumor growth retardation and reduced tumor invasion 
by inhibition of angiogenesis. This observation is caused by 
suppression of angiogenic cytokines and tumor invasion.
Conclusions: The present study indicates that PHD2 plays 
an important role in pancreatic tumorigenesis. In sum PHD2 
may function as a tumor suppressor gene in pancreatic cancer 
and therefore, might defi ne a potential target for treatment of 
pancreatic cancer.
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O10
GENERATION OF INSULIN PRODUCING 
CELLS FROM NON HUMAN PRIMATE 
MONOCYTES DERIVED FROM AN 
OPTIMIZED PROTOCOL FOR THE 
GENERATION OF HUMAN NEO-ISLET 
CELLS
O. Harder1, D. Kahn2, D. Bröring1, F. Fändrich1 and 
M. Schulze1
1Department of Surgery, University of Schleswig Holstein, 
Campus kiel, Kiel, Germany; 2Department of Surgery, 
University of Cape Town, Groote Schuur Hospital, Cape 
Town, Germany
According to a previously published protocol for the genera-
tion of Insulin-producing cells from human monocytes we 
now analyzed wether the addition of 4 different growth 
factors could optimize Insulin production.Secondly we tried 
to generate these cells from non-human primate monocytes 
either blood or spleen derived.As a preliminary experiment 
for a large animal model of induced diabetes and potential 
autologous treatment we generated Insulin producing cells 
from a complete spleen after splenectomy of a live baboon 
(Papio anubis).
Methods: Human monocytes were treated according to a 
published Protocol (Ruhnke et al., Gastroenterology 2005) 
to dedifferenciate into PCMO (Programmable cells of mono-
cytic origin).In addition to the previously published differ-
entiation protocoll PCMO’s then received treatment with 
either activin a, betacellulin, exendin 3 or 4. Cells were 
analyzed according to the expression of Insulin, PDX-1, 
C-peptide, Glut-2 and insulin content.After identifying the 
optimal protocoll, we isolated monocytes from baboon blood 
and repeated the protocol. Furthermore a fully grown female 
baboon was anethetized and unterwent median laparotomy 
with subsequent splenectomy. Spleen monocytes were dif-
ferentiated and analyzed in the same manner and calculated 
in number and volume for potential further in vivo autolo-
gous application.
Results: Insulin content of human neo-islets was highest 
when cells were treated with activin a addition. Insulin 
content was 13,000 μU/1 Million cells.This protocoll was 
used fro the differentiation of primate monocytes. Surprisingly 
we could generate Insulin producing neo-islets cells form 
primate monocytes despite using only human growth factors 
and serum.Expresson of Insulin, PDX-1, C-peptide and 
Glut-2 was comparable to that of human neo-islets. Total 
insilin content of activin a treated baboon monocytes was 
comparable to that of human neo-Islets with appr. 
16,000 μU/1Million cells.
Conclusions: We could show that Insulin producing cells 
could be generated from baboon monocytes with human 
growth factors. The amount generated from one spleen could 
be enough to cure a 40 kg baboon from an experimentally 
induced diabetes in an autologous cell transplant setting.
O11
POST ERCP PERFORATIONS: IS THERE 
A PLACE FOR SELECTIVE 
MANAGEMENT?
R. Miller, N. Musenkis, E. Melzer, O. Lifshitz and 
E. Mavor
Kaplan Medical Center, Rehovot, Israel
Background: Duodenal perforation is a rare complication 
of endoscopic retrograde cholangiopancreatography (ERCP). 
It is associated with signifi cant morbidity and mortality. The 
aim of this study was to evaluate the management and 
outcome of these perforations considering the type of injury 
and method of treatment – conservative vs surgical.
Patients and methods: Between January 1995 and 
September 2010, a total of 1638 ERCP procedures were 
performed in our hospital endoscopy unit. 29 duodenal 
perforations (1.7%) were identifi ed and reviewed.
Results: Patients’ median age was 72.9 years. 19 patients 
had ductal stone disease. In twenty-three cases the diagnosis 
of perforation was made within 24 hours following the pro-
cedure. 16 patients were treated surgically and 13 conserva-
tively. Of the surgically treated patients, ten were operated 
on immediately following diagnosis. Overall mortality was 
31%. Delay of operation and/or inappropriate procedures 
were identifi ed in 8 out of the nine mortality cases. Two out 
of four patients with type I (lateral duodenal) perforations 
who had early surgery survived. Ten patients were diagnosed 
as type II (peri-Vaterian) injury. Of them, 3 patients were 
operated on immediately and survived; out of the seven 
patients managed initially conservatively four had died. Only 
two patients out of seven with type III (bile duct) injury 
failed conservative management and all fi ve patients with 
type IV (retroperitoneal air) perforations survived without an 
operation. Most patients that survived surgical treatment had 
complex duodenal diversion procedures.
Conclusions: Early diagnosis is a crucial factor in the man-
agement of ERCP related duodenal perforations. Most of 
type III and type IV injuries can be managed conservatively. 
Retroperitoneal fl uid on CT, delay in diagnosis and failure 
of conservative treatment requiring surgical intervention are 
associated with poor outcome. Early aggressive surgery may 
improve outcome in type I and type II injuries. Duodenal 
diversion should be the procedure of choice.
O12
POSSIBLE MORTALITY REDUCTION OF 
ENDOSCOPIC SPHINCTEROTOMY 
DURING ERCP: A POPULATION BASED 
CASE-CONTROL STUDY
C. Strömberg1,2, U. Arnelo1,2, L. Enochsson1,2, M. Löhr1,2 
and M. Nilsson1,2
1CLINTEC Karolinska Institutet, Stockholm, Sweden; 
2Department of Surgery, Gastrocentrum, Karolinska 
University Hospital, Stockholm, Sweden
Background and aims: Endoscopic retrograde cholangio-
pancreatography (ERCP) is widely used also in young 
patients but ERCP and endoscopic sphincterotomy in par-
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ticular have been reported to suffer from an increased com-
plication rate and mortality. The aims of this study were to 
calculate mortality and to identify risk factors for death 
within 90 days after ERCP for non-malignant disease.
Methods: From the Swedish Hospital Discharge Registry 
we identifi ed all individuals in Stockholm County who had 
undergone in-patient ERCP 1990–2003. Among these indi-
viduals, we excluded those recorded in the Swedish Cancer 
Registry as having a diagnosis of malignancy in the liver, 
pancreas or bile ducts. Cases were defi ned as patients who 
had died within 90 days of the procedure and were identifi ed 
by cross-linkage to the Causes of Death Registry. Controls 
were randomly sampled from the same cohort. The medical 
records were studied to discern risk factors for death after 
ERCP.
Results: The mortality was 1.6%. Advanced age, severe 
comorbidity, high complexity of the procedure and the 
occurrence of a complication were associated to death within 
90 days whereas a previous cholecystectomy or the simulta-
neous performance of an endoscopic sphincterotomy reduced 
the risk.
Conclusions: Old age and comorbidity are the main risk 
factors for death after ERCP but a complex procedure or the 
occurrence of a complication also seems to increase short 
term mortality. The performance of a sphincterotomy may 
reduce the risk of death, possibly by facilitating adequate 
drainage. Previous cholecystectomy may also decrease the 
risk of dying after ERCP.
O13
PERCUTANEOUS DRAINAGE VS. 
EMERGENCY CHOLECYSTECTOMY 
FOR THE TREATMENT OF ACUTE 
CHOLECYSTITIS IN CRITICALLY ILL 
PATIENTS – DOES IT MATTER?
E. Melloul1, A. Denys2, N. Demartines1, J-M. Calmes1 and 
M. Schäfer1
1Department of Visceral surgery, Centre Hospitalier 
Universitaire Vaudois, University Hospital, Lausanne, 
Switzerland; 2Department of Interventionnal Radiology, 
Centre Hospitalier Universitaire Vaudois, University 
Hospital, Lausanne, Switzerland
Aim of the study: To compare percutaneous drainage of the 
gallbladder (PD) to emergency cholecystectomy (EC) in a 
well defi ned patient group with sepsis related to acute calcu-
lous/acalculous cholecystitis (ACC/AAC).
Methods: Between 2001 and 2007, all consecutive patients 
of our ICU treated either by PD or EC were retrospectively 
analyzed. Cases were collected from a prospective database. 
PD was performed by a transhepatic route; and EC by open 
or laparoscopic approach. Patients’ general condition and 
organ dysfunction were assessed by two validated scoring 
systems (SAPS II and SOFA, respectively). Morbidity, mor-
tality and long term outcome were systematically reviewed 
and analyzed in both groups.
Results: Forty-two patients with a median age of 65.5 years 
(range 32–94) were included. 45% underwent EC (n = 10 
laparoscopy, n = 9 open) and 55% PD (n = 23). Both patient 
groups were similar regarding preoperative characteristics. 
PD and EC were successful in 91% and 100% of patients, 
respectively. Organ dysfunctions were similarly improved by 
the third postoperative/drainage days. Despite PD, 2 patients 
required EC due to gangrenous cholecystitis. Conversion rate 
after laparoscopy was 20%.
Overall morbidity was 8.7% after PD and 47% after EC 
(p = 0.011). Major morbidity was 0% after PD and 21% after 
EC (p = 0.034). Mortality rate was not different (13% after 
PD and 16% after EC, p = 1.0) and always related to patients’ 
pre-existing disease. Hospital and ICU stays were not differ-
ent. Recurrent symptoms (17%) occurred only after ACC in 
the PD group.
Conclusions: In high-risk patients, PD and EC are both 
effi cient in the resolution of acute cholecystitis sepsis. 
However, EC is associated with a higher procedure-related 
morbidity and the laparoscopic approach is not always pos-
sible. Percutaneous drainage represents a valuable interven-
tion, but secondary cholecystectomy is mandatory in cases 
of acute calculous cholecystitis.
O14
LOWER RATE OF MAJOR BILE DUCT 
INJURY AND INCREASED 
INTRAOPERATIVE MANAGEMENT OF 
COMMON BILE DUCT STONES AFTER 
IMPLEMENTATION OF ROUTINE 
INTRAOPERATIVE 
CHOLANGIOGRAPHY
K. T. Buddingh1, R. K. Weersma2, R. A. J. Savenije1, 
G. M. Van Dam1 and V. B. Nieuwenhuijs1
1University Medical Centre Groningen, Department of 
Surgery, Groningen, Netherlands; 2University Medical 
Centre Groningen, Department of Gastroenterology and 
Hepatology, Groningen, Netherlands
Introduction: Our university medical centre is the only 
centre in the Netherlands that has adopted a policy of routine 
intraoperative cholangiography (IOC) during cholecystec-
tomy. The aim of this study was to describe the rate of bile 
duct injury (BDI) and the management of common bile duct 
stones before and after implementation of routine IOC.
Method: Medical records were reviewed of all patients 
undergoing cholecystectomy in 3 years prior to implementa-
tion of routine IOC and 3 years thereafter.
Results: 421 patients underwent cholecystectomy with 
selective IOC, 435 patients with routine IOC. The two groups 
were similar in age, gender, co-morbidity, indication for 
surgery and surgical approach. IOC was attempted in 5.9% 
in the selective IOC group and 59.8% in the routine IOC 
group (p < 0.001).
The rate of major BDI was 1.9% in the selective IOC 
group and 0% in the routine IOC group (p = 0.004). The 
injuries comprised fi ve type B and three type D injuries 
according to the Amsterdam classifi cation. The rate of minor 
BDI did not differ signifi cantly between the two groups.
More CBD stones were detected in the routine IOC group 
(4.8% versus 1.0%, p = 0.001) and they were managed intra-
operatively more frequently (2.8% versus 0.7%, p = 0.023). 
There was also a trend towards fewer preoperative and post-
operative ERCPs and other interventions for CBD stones in 
the routine IOC group (19.1% versus 24.2%, p = 0.067).
Conclusions: Implementation of a routine IOC policy was 
followed by fewer major bile duct injuries and higher rates 
of intra-operative CBD stone management.
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O15
FACTORS AFFECTING THE OUTCOME 
AFTER REPAIR OF BILE DUCT INJURIES
D. Subar1, A. Sultana2, A. Kausar1, D. Sherlock1, 
G. Poston2, A. Wu2 and D. O’Reilly1
1North Manchester General Hospital, Manchester, United 
Kingdom; 2Aintree Hospital, Liverpool, United Kingdom
Aim: The incidence of bile duct injuries is reported to be 
between 0.3–0.6%. The long term outcome of these patients 
after repair varies signifi cantly. The aim of this study was to 
assess factors affecting the outcome of repair following bile 
duct injuries.
Method: This is a retrospective study of bile duct injuries 
referred to two HpB units over the last 30 years. Clinical 
outcome was assessed according to Terblanche classifi cation. 
Factors considered were the specialty of the operating 
surgeon doing the repair, time to repair, the presence of 
vascular injury and type of repair.
Results: There were 82 patients with a median age of 47 
years (range 20–77). The male: female ratio was 20:62. The 
follow-up period ranges from 0.5–30 years. 58% of patients 
operated on by HpB surgeons had no signifi cant post-
operative complications (Terblanche I and II) whereas it was 
only 11% for non-HpB surgeons. Repairs done within 24 
hours or between 7–90 days had a signifi cant incidence of 
poor outcomes (73% and 67% respectively Terblanche III 
and IV). 83% of patients with associated vascular injury had 
Terblanche III and IV outcomes.
Conclusion: Bile duct injuries result in signifi cant and 
sometimes recurrent post-repair sequelae. These complica-
tions can occur long after the initial injury and repair. It is 
important that repair of these injuries are undertaken by a 
specialist HpB surgeon and that these patients have life long 
follow-up.
O16
LONG TERM OUTCOMES OF BILE-
DUCT INJURY AND VASCULO-BILIARY 
INJURY FOLLOWING LAPAROSCOPIC 
CHOLECYSTECTOMY
R. Jones, A. Al-Sarireh, G. Sarno, S. Fenwick, H. Malik 
and G. Poston
Department of Hepatobiliary Surgery, Aintree University 
Hospital NHS Foundation Trust, Liverpool, United 
Kingdom
Background: Bile duct injury is a serious complication of 
cholecystectomy. Associated vascular injuries are not uncom-
mon. Because of hepatic arterial infl ow disruption, the man-
agement strategy may be challenging. This study aims to 
evaluate the impact of bile duct injury (BDI) and vasculo-
biliary injury (VBI) on long-term outcome.
Methods: All patients referred to our unit between 1992–
2009 for BDI or VBI were recorded. Outcomes were evalu-
ated by retrospective note review.
Results: 63 patients were referred during the study period, 
with a median age of 53 years (20–82). 18 patients (29%) 
had sustained VBI and 45 (71%) had BDI. 30 patients (48%) 
suffered septic complications before referral to the specialist 
unit. Overall postoperative in-hospital morbidity rate was 
18%. 26 patients (41%) suffered long-term biliary complica-
tions over a median follow-up of 89 (3–204) months, with 9 
patients (14%) requiring surgical re-intervention [3 (33%) 
with BDI and 6 (67%) with VBI, P = 0.006]. Worse outcomes 
were associated with VBI, sepsis, attempted repair by 
primary surgeon, and postoperative morbidity. VBI and 
sepsis were independent risk factors for treatment failure 
[Hazard ratio (95% Confi dence interval) = 7.73 (2.74–21.79) 
P < 0.001; 4.99 (1.66–14.00) P = 0.004 respectively]. 
Excellent/good outcomes were achieved in 45 patients 
(71%) after defi nitive surgical repair.
Conclusion: Cholecystectomy remains a potentially dan-
gerous operation. Most non-specialist surgeons have little 
training in the appropriate technique for repair of iatrogenic 
BDI, and few are aware of the risk of concomitant VBI. 
Outcome following biliary repair is worse in patients with 
concomitant VBI and sepsis. Careful assessment is required 
of all potential biliary or vasculo-biliary injuries and prompt 
referral to a specialist centre is mandatory.
O17
SPECIALIST SURGERY FOR 
IATROGENIC BILE DUCT INJURY 
RESULTS IN ACCEPTABLE LONG-TERM 
QUALITY OF LIFE
J. Terrace, R. McMurray, H. Paterson, O. J. Garden and 
R. Parks
University of Edinburgh, Edinburgh, United Kingdom
Introduction: Specialist management of laparoscopic cho-
lecystectomy (LC)-associated bile duct injury (BDI) results 
in improved clinical outcomes. However, patient morbidity 
after BDI repair is poorly understood, as confl icting data 
exist regarding quality of life (QOL) outcomes. This study 
aimed to quantify long-term quality QOL following surgery 
for BDI.
Methods: Prospectively collected data from patients 
referred following LC over 22 years to a specialist institution 
were compared with matched controls that underwent either 
uncomplicated LC (ULC) or laparoscopic converted to open 
cholecystectomy (LOC) at the same centre. Late morbidity 
outcome was assessed using the validated SF-36 and GIQOL 
patient QOL questionnaires.
Results: 148 patients with BDI were referred and of the 95 
contacted, 50 (53%) responded; 38 (76%) female; median 
age of 55 (29–76) years; median follow-up 83 (13–229) 
months. Classifi cation of BDI was most frequently E2 and 
92% underwent hepatico-jejunostomy. Of 107 matched ULC 
and 92 matched LOC patients, 69 (64%) and 49 (53%) 
responded, respectively. Both QOL measures demonstrated 
that outcomes were signifi cantly worse in BDI patients com-
pared with ULC (p ≤ 0.0006). However, only the mild 
symptom domain of the GIQOL questionnaire showed a dif-
ference (p = 0.007) in QOL between BDI and LOC patients. 
QOL was signifi cantly worse when comparing LOC with 
ULC patients in all but 2 questionnaire domains (p ≤ 0.0005).
Conclusions: Although patient morbidity is impaired when 
uncomplicated laparoscopic surgery is not possible, special-
ist BDI repair results in a similar outcome to that observed 
with open biliary surgery. Therefore the type of open biliary 
surgery may be less important than the open approach itself 
in infl uencing long-term quality of life.
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O18
SURVIVAL AFTER RADIOFREQUENCY 
OF STAGE III PANCREATIC 
CARCINOMA: A WIND OF CHANGE?
R. Girelli1, A. Giardino1, I. Frigerio1, R. Salvia2,1, 
S. Partelli1 and C. Bassi1,2
1HPB Unit, Pederzoli Clinic, Peschiera Del GARDA, Italy; 
2Surgical and Gastroenterological Department, University 
Of Verona, Verona, Italy
Background and aim: Radiofrequency ablation (RFA) is a 
widely accepted treatment for different solid tumours but 
experiences in pancreatic cancer are very limited. In our 
recent paper we demonstrated feasibility and safety of RFA 
in locally advanced (Stage III) pancreatic cancer (LAPC). 
Aim of the present study is to evaluate survival after RFA+ 
chemo-radiotherapy.
Patients and methods: Only pts with histologically proven 
LAPC were consecutively enrolled. RFA was carried out 
during laparotomy. CT scan was performed at discharge and 
follow up was planned at 1-3-6-12 months. Overall survival 
(OS) and disease specifi c survival (DSS) were analysed. 
Results: Between February 2007 and December 2008, 50 
patients with LAPC underwent RFA and were enrolled for a 
12 months follow up. Male/female ratio was 25/25 with a 
median age of 61, Tumor was located in the head or uncinate 
process in 30/50 pts and in body-tail in 20/50 pts. Thirty 
eight pts received RFA as up front treatment while 12 pts 
received different associations of chemo-radiotherapy before 
RFA (3 pts only Ch, 7 pts Ch+RT, 2 pts Ch+ RT+ locore-
gional Ch). Palliative surgery was associated to RFA in 
30 pts. After RFA, 37 pts received different association of 
postoperative chemo-radiotheraphy.
At a medium follow up of 15 months, 24 pts are alive 
(49%). In all, 34 pts had recurrence of disease and 20 of them 
eventually died of disease. The 1-,2-year overall survival was 
67% and 45% respectively with a median survival of 20 
months. The 1-,2-year disease specifi c survival was 74% and 
51% respectively with a median survival of 28 months. The 
6-,12-months progression free survival was 62% and 24% 
respectively with a median of 10 months. No statistically 
signifi cant difference on survival was found according to the 
timing of RFA (up front treatment o after neoadjuvant 
therapy) or the tumor site.
Conclusions: LAPC is a very aggressive entity and the 
results of chemo and/or radiotherapy are so far disappoint-
ing. The apparent positive impact on survival achieved by 
RFA associated to chemo and/or radiotherapy is tempting. 
RFA should be considered as part of a new multimodal treat-
ment but further randomised studies are urgently needed.
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O19
SINGLE-CENTRE COMPARATIVE STUDY 
OF LAPAROSCOPIC VERSUS OPEN 
RIGHT HEMI-HEPATECTOMY
M. A. Hilal, F. Di Fabio, M. J. Teng, J. N. Primrose, 
N. W. Pearce and P. Swan
Southampton University Hospitals NHS Trust, 
Hepatobiliary-Pancreatic and Laparoscopic Surgical Unit, 
Southampton, Hampshire, United Kingdom
Background: Laparoscopy for minor liver resection has 
now become an accepted alternative to conventional open 
liver surgery. However, the expansion of major laparoscopic 
liver resection is still limited due to the well-recognised 
technical diffi culties and to the lack of clinical data compar-
ing the open and laparoscopic approaches.
Methods: This case-control study was undertaken over a 
4-year period (2006–09) in a high-volume liver unit. Patients 
requiring right hepatectomy in whom the procedure appeared 
possible via either open or laparoscopic surgery were identi-
fi ed by the hepato-biliary multidisciplinary team. Patients 
under the care of two surgeons (MAH, NWP) routinely 
underwent laparoscopic resection and those under the care 
of the other surgeon (JNP) underwent open resection. Patients 
in the open-surgery group were matched according to sex, 
age and liver disease and compared with the laparoscopic 
group for operative details, hospital stay, short- and mid-term 
postoperative outcomes.
Results: Seventy patients were included in the comparative 
analysis: 36 patients underwent totally laparoscopic right 
hepatectomy (LRH) and 34 open right hepatectomy (ORH). 
Operative time was longer for LRH (median 300 min vs. 
180 min for ORH, p < 0.0001). Intensive care unit (median 
2 days for LRH vs. 4 for ORH, p < 0.0001) and postoperative 
length of stay (5 days for LRH vs. 9 for ORH, p < 0.0001) 
were shorter for LRH. Four laparoscopic cases were 
converted to open surgery. No signifi cant difference in 
complications and mortality was observed between LRH and 
ORH. Among patients with colorectal liver metastases, R0 
resection was obtained in 20/21 (95%) cases after LRH, and 
in 20/25 (80%) after ORH (p = 0.198). Mid-term overall 
survival did not signifi cantly differ between the laparoscopic 
and the open group.
Conclusions: LRH can be a safe, effective, and oncologi-
cally effi cient alternative to open resection in selected cases. 
Extensive experience in hepatic and laparoscopic surgery is 
required.
O20
THE ORANGE II-TRIAL: AN 
INTERNATIONAL MULTICENTRE RCT 
COMPARING OPEN VERSUS 
LAPAROSCOPIC LEFT LATERAL 
HEPATIC SECTIONECTOMY IN AN 
ERAS-PROGRAMME
R. M. van Dam1, E. W. Wong-Lun-Hing1, 
J. R. van der Vorst1, M. H. A. Bemelmans1, 
J. H. M. B. Stoot1, S. W. M. O. Damink1, K. Lassen2, 
G. J. P. van Breukelen1 and C. H. C. Dejong1
1Maastricht UMC, Maastricht, Netherlands; 2University of 
Northern Norway Hospital, Tromso, Norway
Background: The optimization of postoperative recovery 
by laparoscopic surgery and enhanced recovery programmes 
has been introduced into liver surgery recently. Therefore, 
this is the subject of the international multicentre randomised 
controlled ORANGE II-trial: open versus laparoscopic 
surgery within an enhanced recovery programme.
Objectives: The added value of laparoscopy compared to 
open liver surgery in left lateral liver sectionectomy within 
an ERAS programme in terms of functional recovery, hospi-
tal length of stay and postoperative morbidity has never been 
studied in a randomized controlled setting.
Methods: Patients eligible for left lateral hepatic sectionec-
tomy (LLS) will be recruited at the outpatient clinic. The 
experimental design produces two randomization arms open 
LLS (a) laparoscopic LLS (b). Two additional non random-
ized arms will be based on surgeons/patients that have a 
preference for the laparoscopic LLS (c), or that have a prefer-
ence for the open LLS (d). The two primary endpoints of the 
ORANGE II trial to be analysed are functional recovery and 
the total postoperative length of hospital stay. Secondary 
outcomes of this trial are readmission percentage, morbidity, 
quality of life, body image and cosmesis, hospital and soci-
etal costs during 1 year and the long term incidence of inci-
sional hernias. We assume that in patients undergoing LLS 
the LOS can be reduced by 2 days. We have chosen to imple-
ment interim analysis by Snappin’s method. This method 
enables us to detect 1 day reduction in hospital length of stay 
(N = 2 × 160, power 90% and α = 0.05) or a 2 day reduction 
with a smaller sample size(N = 2 × 40), with the extra benefi t 
to stop the trial for non-signifi cance or futility reasons at 
interim analysis.
Discussion: The ORANGE-II trial is a multicentre RCT that 
will provide evidence on the merits of laparoscopic surgery 
in patients undergoing a left lateral hepatic sectionectomy 
within an enhanced recovery programme.
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O21
THE EFFECTS OF PROLONGED 
PNEUMOPERITONEUM ON HEPATIC 
FUNCTION DURING LAPAROSCOPIC 
SURGERY: A PILOT STUDY
L. T. Hoekstra, A. T. Ruys, D. M. J. Milstein, 
G. van Samkar, M. I. van Berge Henegouwen and 
T. M. van Gulik
Department of Surgery, Academic Medical Center, 
Amsterdam, Netherlands
Background: The percentage of laparoscopically per-
formed hepatic resections is increasing. Anatomic liver 
resections using laparoscopy, however, may require pro-
longed operation time. Pneumoperitoneum (PP) during 
laparoscopic surgery produces increased intra-abdominal 
pressure with compression of intra-abdominal organs and 
potential microcirculatory changes in the liver.
Objective: To assess the effect of prolonged pneumoperito-
neum on liver function in a porcine animal model.
Methods: Five female pigs with a mean weight of 45.6 ± 
6.6 kg were used in this pilot study. The pigs underwent 
laparoscopic intra-abdominal insuffl ation with CO2 gas 
(14–25 mm Hg) for 6 hours followed by a recovery period 
of 2 hours. Aminotransferases were measured to assess liver 
injury. Liver function was determined by R15 (indocyanine 
green retention rate 15 min after administration). Hepatic 
hemodynamics were measured by simultaneous refl ectance 
spectrophotometry (StO2 and rHb) and laser Doppler (blood 
fl ow and fl ow velocity) using Oxygen-to-See (O2C).
Results: The central venous pressure and blood pressures 
increased during insuffl ation, whereas no other changes in 
central hemodynamic parameters were observed. Liver 
enzyme levels did not change. R15 values decreased as a 
result of increased blood fl ow to the liver during PP (median 
5.6 ± 1.6% vs 3.0 ± 1.3%; P < 0.01) and the recovery phase 
(median 1.3 ± 0.7%; P < 0.001). A signifi cant difference 
(P < 0.05) was observed in fl ow velocity.
Conclusion: Our results demonstrate that liver function did 
not change during prolonged PP. There was an improvement 
in liver blood fl ow after 6 hours of PP. Consequently, the 
liver sustains no additional damage because of PP during 
laparoscopic surgery. The clinical relevance of the present 
study is high since patients with liver failure may undergo 
prolonged laparoscopic (hepatic) surgery.
O22
ENDOTHELIN-1 AS MODULATOR OF 
ACUTE PHASE SHEAR STRESS 
RESPONSE IN LIVER SURGERY: 
IMPLICATIONS IN HEPATIC 
HEMODYNAMICS AND POSTOPERATIVE 
LIVER FAILURE. A PROSPECTIVE 
CLINICAL STUDY
F. Ratti, F. Cipriani, M. Catena, M. Paganelli, R. Finazzi, 
L. Aldrighetti, G. Ferla and C. Pulitanò
Dipartimento di Chirurgia Generale e Specialistica – Liver 
Unit. IRCCS H San Raffaele, Università Vita-Salute San 
Raffaele, Milano, Italy
Background: Endothelin-1 (ET-1) plays an important regu-
latory role in hepatic microcirculation and is implicated in 
the pathogenesis of liver fi brosis and cirrhosis, mediated by 
sinusoidal constriction. ET-1 is produced not only by the 
liver during ischemia-reperfusion, but also by splanchnic 
district in response to splanchnic venous congestion that 
occurs during portal fl ow occlusion and is implicated in the 
pathogenesis of the ‘small for size syndrome’. Actually the 
most common and used criteria to predict PLF is the ‘50-50 
Criteria’ (PT and bilirubin) on POD5. Aim of the study is to 
measure the concentration of ET-1 in portal and peripheral 
blood in patients undergoing liver resection and to analyze 
the correlation with pre-, intra-and post-surgery variables to 
understand what is the actual reliability of ET-1 as a predictor 
of PLF.
Materials and methods: Between January 2009 and April 
2009, 52 patients with primary or secondary liver tumors 
entered this study at the Liver Unit, IRCCS H San Raffaele. 
Serum ET-1, AST, ALT, bilirubin and PT were measured 
before surgery and in the fi rst, second and fi fth postoperative 
day in all patients. In 22 patients blood samples were col-
lected from the portal vein at the time of laparotomy and 
after resection to determine the levels of portal ET-1. Pearson 
coeffi cient was used to analyze the correlation between bio-
chemical parameters and ET-1.
Results: ET-1 levels were not correlated signifi cantly with 
the presence of preexisting liver disease, histology, intraop-
erative transfusion requirements, use of portal clamping and 
postoperative complications. The levels of portal ET-1at the 
end of liver resection showed a signifi cant correlation with 
the PT and bilirubin level on POD 5 (p = 0.01). The serum 
ET-1 measured in POD 2 was signifi cantly correlated with 
the PT (p = 0.02) and total bilirubin (p = 0.01) of POD5.
Conclusion: The results suggest that ET-1 is associated with 
portal and serum markers of liver failure and can be used as 
an early predictor.
O23
SAFETY OF CUMULATIVE TIME OF 
INTERMITTENT PRINGLE MANEUVER 
EXCEEDING 120 MIN IN LIVER 
RESECTION
F. Procopio, M. Donadon, M. Marconi, D. Del Fabbro, 
A. Palmisano, M. Montorsi and G. Torzilli
Liver Surgery Unit; 3rd Department of Surgery, University 
of Milan School of Medicine, IRCCS Istituto Clinico 
Humanitas, Rozzano, Milan, Italy
Background: Intermittent Pringle’s maneuver is widely 
used to limit blood loss during hepatectomy, without an 
established time-limit. However, many authors claims its 
danger for patients’ outcome. We check the short term 
outcome of a consecutive cohort of patients who underwent 
hepatectomy with intermittent clamping exceeding 120 
minutes.
Material and methods: Among 426 consecutive patients 
who underwent hepatectomy 72 having intermittent Pringle 
maneuver exceeding 120 minutes were analysed. There were 
53 men and 19 women. Mean age was 63 years (range 
29–85). Background liver was cirrhotic in 25 patients, stea-
totic in 34 and normal in 13. Mean cumulative clamping time 
was 161 minutes (range 121–348).
Results: The overall morbidity rate was 31% (22/72). 
Transient liver failure occurred in 5 patients (7%). 
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Postoperative mortality was nil. Major hepatectomy was 4 
(5.6%). Mean number of lesions removed was 6 per patient 
(range 1–49). Mean operative blood loss was 477 ml (range 
50–1500) and blood transfusion rate was 25% (18/72). Mean 
postoperative AST, ALT, serum total bilirubin levels were 
58 UI/L, 136 UI/L and 2.1 mg/dL on 7th pod. Mean hospital 
stay was 13 days (range 5–49).
Conclusions: This series shows how intermittent clamping 
is safe even once exceeds 120 minutes and in that allows 
extensive liver resection performed at once.
O24
NONOPERATIVE MANAGEMENT OF 
LIVER GUNSHOT INJURIES
P. Navsaria1, A. Nicol1, J. Krige2 and S. Edu1
1Trauma Center, Groote Schuur Hospital and University of 
Cape Town, Cape Town, South Africa; 2Surgical 
Gastroenterology, Groote Schuur Hospital, University of 
Cape Town, Cape Town, South Africa
Background: Nonoperative management (NOM) of liver 
gunshot injuries is yet to gain universal acceptance. The aim 
of this study was to assess the feasibility and safety of selec-
tive nonoperative management in liver gunshot injuries.
Patients and methods: Prospective, protocol-driven study, 
which included all liver gunshot injuries admitted to a level 
I-type trauma center, over a 4-year period. Patients with 
hemodynamic instability, peritonitis, or an unevaluable 
abdomen underwent an immediate laparotomy. Patients who 
were Hemodynamically stable and had no signs of gener-
alised peritonitis with either a missile trajectory traversing 
right upper quadrant and/or localised RUQ tenderness under-
went CT scan evaluation to detect the presence of a liver 
injury. In the absence of CT scan fi ndings suggestive of 
hollow a viscus injury, the patients were observed with serial 
clinical examinations. Outcome parameters included sur-
vival, complications, need for delayed laparotomy, and 
length of hospital stay.
Results: During the study period, there were 194 patients 
with gunshot injuries to the liver: 132 (68%) patients met the 
criteria for immediate operation and 62 (32%) patients were 
selected for nonoperative management of their liver injury. 
The mean injury severity score was 19.6 (range 4–34). The 
liver injury grading was: grade II-21(33.9%), grade III-
10(16.1%), grade IV-25(40.3%) and grade V-6(9.7%). 
Associated injuries related to the same missile causing the 
liver injury were: kidney (14), diaphragm (44), lung contu-
sion (40), haemo/pneuomothorax (43) and rib fractures (21). 
Only two patients required a total of 6 u packed cell transfu-
sion. Complications included: failed abdomen observation 
(5), liver abscess (2), biliary fi stula (1), retained haemothorax 
(4), and nosocomial pneumonia (5). The mean hospital stay 
was 7.1 (range 3–20) days. There was no mortality.
Conclusion: The nonoperative management of appropri-
ately selected patients with liver gunshot injuries is highly 
feasible, safe and effective, regardless of the severity of liver 
injury.
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SURGICAL RANDOMISED TRIALS IN 
PUBMED JOURNALS IN 1999 AND 2009: 
SYSTEMATIC REVIEW OF VOLUME AND 
METHODOLOGY
U. A. Ali1, P. C. van der Sluis1, I. A. Habaga1, Y. Issa2, 
H. G. Gooszen2, A. Algra1 and M. G. Besselink1
1University Medical Center Utrecht, Utrecht, Netherlands; 
2University Medical Center St. Radboud, Nijmegen, 
Netherlands
Background: Randomised controlled trials are essential for 
evidence-based decision making in surgery. It has repeatedly 
been suggested that surgical trials are both scarce and of 
mediocre methodological quality. Our aim was to assess the 
volume and methodological quality of surgical trials in 1999 
and 2009.
Methods: We used the Cochrane Highly Sensitive Search 
Strategy to identify randomised surgical trials published in 
the last 6 months of both 1999 and 2009 in PubMed. We 
screened 10,711 abstracts and appraised general and geo-
graphical characteristics from the included full-text papers. 
Methodological quality of all included trials was evaluated 
according to a seven-item list adapted from the Cochrane 
tool for assessing risk of bias. Trials were designated as ‘high 
quality’ when four selected items were fulfi lled: adequate 
generation of allocation, concealment of allocation, inten-
tion-to-treat analysis, and adequate handling of dropouts.
Results: A total of 265 surgical trials were included, 100 in 
1999 and 165 in 2009 (65% increase). Gastro-intestinal 
surgery was the leading speciality area for surgical trials with 
a doubling of the numbers of RCTs since 1999 (from 44 in 
1999 to 88 in 2009). Geographically, the number of trials 
from the UK (14 vs 13) and USA (29 vs 24) remained 
unchanged, whereas the number of European (57 vs 72) and 
especially Australasian (12 vs 59) trials increased. In 2009, 
trial reports more frequently reported on the primary outcome 
of the study (51% in 1999 vs 64% in 2009), sample size 
calculation (37% vs 52%) and adequate generation of alloca-
tion (30% vs 44%). The number of high-quality trials 
increased slightly from 4% to 7% (NS).
Conclusion: Although the volume and the methodological 
quality of surgical trials have improved in the previous 
decade, only a minority of trials fulfi lled the criteria for ‘high 
quality’. There is a clear need for structured education, 
improved research infrastructure and enforced adherence to 
existing guidelines on randomised trials.
O26
ISOLATED HEPATIC PERFUSION (IHP) 
FOR METASTATIS OF OCULAR 
MALIGNANT MELANOMA
P. Lindner, M. Rizell, J. Mattson, C. Cahlin, L. Hafstrom 
and R. Olofsson
1Transplant Institute, Sahlgrenska University Hospital, 
Gothenburg, Sweden; 2Department of Surgery, Sahlgrenska 
University Hospital, Gothenburg, Sweden
Background: The incidence of ocular malignant melanoma 
is about 10 per million, which in Sweden gives 80 new cases 
yearly. In 5 years about 25% of these patients will develop 
isolated liver metastases. There is no effective treatment; 
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systemic chemotherapy only results in limited tumor response 
and no prolongation of survival. Isolated hepatic perfusion 
(IHP) is an effective regional treatment option and this study 
reports our single centre experience over the last 5 years.
Material and methods: A veno-venous bypass is placed 
between the iliacal vein and the axillary vein. The liver is 
fully mobilized and a catheter is placed retrohepatically in 
the inferior caval vein, which is then clamped above and 
below the liver. An arterial catheter is placed in the hepatic 
artery and the two catheters are then connected to a heart-
lung machine. In this isolated system melphalan (1 mg/kg 
bodyweight) is added and the liver is perfused for 60 minutes. 
Thereafter the liver is fl ushed and the catheters are removed. 
Between 2005 and 2010, 22 patients, 12 females and 10 
males with a median age of 59 have been treated.
Results: At radiological evalutaion three to 6 months post 
treatment complete response was seen in nine patients (41%), 
partial response in 10 patients (45%), stable disease in two 
patients (9%) and progressive disease in one patients (5%). 
This gives a total response of 86% with a median survival 
of 21 months. No treatment related mortality occurred and 
the post operative period was uneventful for 17 patients. 
Three patients had major complications, one patient with a 
perforated duodenal ulcer and two patients with respiratory 
insuffi ciency. Two patients with minor complications, includ-
ing one wound infection and a pleural effusion.
Conclusion: In patients with ocular melanoma metastasis 
confi ned to the liver IHP is a treatment option with high 
response rates and well tolerable surgical morbidity.
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ARGENTINE SURVEY TO SURGICAL 
MANAGEMENT OF LIVER HYDATIDOSIS 
IN 1412 PATIENTS
M. A. Secchi1, R. Pettinari2, C. Mercapide3, R. Bracco4, 
C. Castilla5, E. Cassone6, P. Sisco7, O. Andriani8, L. Rossi9, 
J. Grondona10, L. Quadrelli1, R. Cabral2, N. R. Leon1 and 
C. Ledesma3
1Department of Surgery, Hospital Italiano Garibaldi and 
Medical School IUNIR, Rosario, Argentina; 2Department 
of Surgery, Hospital Regional, C. Rivadavia, Argentina; 
3Department of Surgery, Hospital Artemides Zatti, Viedma, 
Argentina; 4Department of Surgery, Hospital Interzonal, 
Mar del Plata, Argentina; 5Department of Surgery, 
Hospital General San Martin, La Plata, Argentina; 
6Department of Surgery, Hospital Central de mendoza, 
Mendoza, Argentina; 7Department of Surgery, Hospital 
Pirovano, Buenos Aires, Argentina; 8Department of 
Surgery, Fundacion Favaloro, Buenos Aires, Argentina; 
9Department of Surgery, Clinica Modelo de Rufi no, Sante 
Fe, Argentina; 10Department of Surgery, Centro Medico de 
San Isidro, Buenos Aires, Argentina
Background: The management of hydatid liver disease 
(HLD) includes various nonsurgical and surgical treatment 
options.
Methods: The purpose of the present longitudinal 
study(national survey) was to report the changes in surgical 
management and the consequent outcome of HLD patients 
in 10 referral surgical centres in Argentina from 1975 to 
2007. The study result analysis was divided into two study 
periods (1975–1990 and 1991–2007).
Results: A total of 1412 patients underwent radical (Group 
1: 396 patients), conservative (Group 2: 748 patients) or 
combined (Group 3: 536 interventions in 268 patients) surgi-
cal procedures. The overall mortality and complication rate 
(Clavien I–IV) was 1.8 and 39% respectively. The complica-
tion rate was signifi cantly lower in Group 1 (26%) compared 
with Group 2 (45%) and Group 3 (42%) There was a signifi -
cant decrease in mortality (2.3 vs. 1%), complication (42 vs. 
34%) and early reoperation (12 vs. 6%) rates between the 
fi rst study part (918 patients) and the second study part (494 
patients). During a median follow-up of 7 years, there was a 
signifi cant decrease in the fi rst part of this study in the late 
reoperation rate (8.4–3%) and in disease recurrence (9–1.6%).
Conclusion: This large national survey, observational mul-
ticentre series shows a signifi cant improvement in surgical 
management of HLD in Argentina, with a decrease in mortal-
ity, morbidity, early and late reoperation and recurrence rates. 
A recent trend was observed in favour of an earlier diagnosis, 
less complicated clinical presentation and recent use of mini-
mally invasive approaches.
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
FREE PAPERS 4
O28
MALIGNANT BILIARY OBSTRUCTION: A 
PROSPECTIVE RANDOMISED TRIAL 
COMPARING PLASTIC AND METAL 
STENTS FOR PALLIATION OF 
SYMPTOMATIC JAUNDICE
M. Bernon, J. Shaw, J. Krige and P. Bornman
Department of Surgery, University of Cape Town Health 
Sciences Faculty, Cape Town, South Africa
Background: Both plastic and self expanding metal stents 
(SEMS) have been used to relieve jaundice in patients with 
advanced malignant biliary obstruction. This study compared 
the clinical effi cacy of plastic versus metal biliary stents.
Materials and methods: In a prospective randomised con-
trolled trial 22 patients with malignant common bile duct 
obstruction not amenable to curative resection were offered 
palliative stenting from November 2008 to March 2010 and 
were followed-up until death. Data were collected prospec-
tive. We compared patient survival and stent patency rates.
Results: 12 patients received 10 Fr plastic stents and 10 
patients received expandable metal stents. Mean duration of 
hospital stay after stenting for both groups was 2 days (range 
1–2 days). Jaundice was relieved in all patients. Two patients 
with metal stents required subsequent intervention at 8 and 
21 days: one stent blocked due to a bile duct stone and 
another migrated proximally and was replaced. Plastic stents 
in 6 patients blocked at a mean of 7 months (range 3–18 
months) In the metal stent group 2 patients required re-
admission twice to hospital (total 32 days) compared to the 
plastic group in which 5 patients required a total of 36 days 
in hospital. Mean survival was 173 days compared to 192 
days.
Conclusion: Plastic 10 Fr biliary stents blocked more fre-
quently were replaced more often and required more hospital 
admissions but with similar total number of days in hospital 
after placement compared to SEMS. These preliminary data 
suggest only a marginal advantage for palliative metal 
stenting.
O29
FAST-TRACK PROTOCOL FOR 
PANCREATIC SURGERY: A SINGLE-
CENTER EXPERIENCE
P. Di Sebastiano1, L. Festa1, A. De Bonis1, A. Ciuffreda2, 
M. R. Valvano4, A. Andriulli3 and F. F. di Mola1
1Dept of Surgery, IRCCS Casa Sollievo della Soffrenza 
Hospital, San Giovanni Rotondo, Italy; 2Dept of 
Anaesthesiology, IRCCS Casa Sollievo della Soffrenza 
Hospital, San Giovanni Rotondo, Italy; 3Unit of 
Gastroenterology, IRCCS Casa Sollievo della Soffrenza 
Hospital, San Giovanni Rotondo, Italy; 4Unit of 
Biostatistics, IRCCS – Casa Sollievo della Sofferenza 
Hospital, San Giovanni Rotondo, Italy
Introduction: The concept of fast-track surgery allowing 
accelerated postoperative recovery is accepted in colorectal 
surgery, but effi cacy data are only preliminary for patients 
undergoing major pancreatic surgery. We aimed to evaluate 
the impact of a modifi ed fast-track protocol in a high-volume 
center for patients with pancreatic disorders.
Methods: Between February 2005 and January 2010, 154 
subjects had resective pancreatic surgery and were enrolled 
in the program. Essential features of the program were no 
preanaesthetic medication, upper and lower air-warming 
device, avoidance of excessive i.v. fl uids perioperatively, 
effective control of pain, early reinstitution of oral feeding, 
immediate mobilization and restoration of bowel function 
following surgery.
Outcome measures were postoperative complications, such 
as pancreatic fi stula, delayed gastric emptying, biliary leak, 
intra-abdominal abscess, postpancreatectomy hemorrhage, 
acute pancreatitis, wound infection, 30-day mortality, post-
operative hospital stay, and readmission rates.
Results: On average, patients were discharged on postop-
erative day 10 (range 6–69), with a 30-day readmission rate 
of 6%. Percentage of patients with at least one complication 
was 39%. Pancreatic anastomotic leakage occurred in eight 
of 107 pancreatico-jejunostomies, and biliary leak in three 
of 115 biliary jejunostomies. Postoperative hemorrhage 
occurred in ten (6.4%) patients and wound infection in nine 
(5.8%) cases. In-hospital mortality was 1.9%. Fast-track 
parameters, such as normal food and fi rst stool, correlated 
signifi cantly with early discharge (<0.05). Multivariate anal-
ysis, lack of jaundice and resumption of normal diet by the 
5th postoperative day were independent factors of early 
discharge.
Conclusion: Fast-tack programs are feasible, easy, and also 
applicable for patients undergoing major surgery such as 
pancreatic resection.
O30
AN IMMEDIATE 5 DAYS 
POSTOPERATIVE ANTIBIOTHERAPY 
COURSE DECREASES THE RATE OF 
INFECTIOUS COMPLICATIONS AFTER 
PANCREATICODUODENECTOMY (PD) IN 
CASE OF BILE CONTAMINATION
I. Sourrouille1, B. Blanc1, B. Frédéric2, S. Dokmak1, 
B. Aussilhou1, C. Paugam-Burtz3, J. Belghiti1 and 
A. Sauvanet1
1Departments of HBP Surgery – AP-HP, Clichy, France; 
2Departments of Bacteriology – AP-HP, Clichy, France; 
3Departments of Anaesthesiology – AP-HP, Clichy, France
Background: Bile contamination increases the rate of post-
operative infectious complications after PD, especially in 
case of unadapted antibioprophylaxis (ABP).
Objective: To evaluate the consequences of a immediate 5 
days postoperative antibiotherapy (ATB) course on post-
operative outcomes after PD in case of bile contamination.
Methods: From 2004 to 2009, 90 patients with peroperative 
positive bile culture (M/F = 52/38, mean age = 62 years) 
underwent PD for malignant ampulloma (n = 37) or cephalic 
pancreatic adenocarcinoma (n = 53), following endoscopic 
sphincterotomy or biliary endoprothesis (n = 63). These 
patients received an immediate postoperative ATB associat-
ing gentamicin (n = 90) with piperacilline+tazobactam (n = 
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28) or ticarcilline+clavulanic acid (n = 62). This 5 days ATB 
was adapted to antibiogram on postoperative day 2. 
Postoperative outcomes of these patients were compared to 
those of an historic group of 27 PD with infected bile who 
only received a Cefoxitin peroperative ABP.
Results: Postoperative mortality (ABT = 1.1% vs ABP = 
3.7, NS), overall morbidity (70% vs 81%, NS) or rate of 
grade B/C pancreatic fi stula (17% vs 15%, NS) did not differ 
between the 2 groups. The rate of infectious complications 
(30% vs 67%, p = 0.001) was lower in the ABT group, as 
well as the median length of hospital stay (21 days [11–69] 
vs 33 days [13–69], p = 0.03). Decrease in infectious com-
plications include reduce rate of wound infection (3% vs 
26%, p = 0.01), intraabdominal abscess (6% vs 22%, p = 
0.025), septicemia (7% vs 30%, p = 0.04), and urinary infec-
tion (3% vs 14%, p = 0.02). The use of a curative antibio-
therapy for more than 7 days for any infectious complication 
was less frequent in the ABT group (22% vs 45%, p = 0.04).
Conclusions: In case of positive bile culture, an immediate 
5 days postoperative ABT course secondarily adapted to the 
antibiogramm of the peroperative bile culture decreases the 
rate of infectious complications and the lengh of stay after 
PD. The long term impact of bacterial ecology remains to be 
evaluated.
O31
CRYSTALLOID FLUID RESTRICTION 
DURING PANCREATIC SURGERY HAS 
NO MEASURABLE EFFECT ON 
DELAYED GASTRIC EMPTYING AND 
OTHER COMPLICATIONS: THE 
RESULTS OF A DOUBLE-BLINDED 
PROSPECTIVE TRIAL (EPOR)
G. van Samkar1, O. Busch2, R. Bennink3, W. Eshuis2, 
T. van Gulik2, M. Dijkgraaf4, B. Preckel1, S. de Hert1, 
D. Gouma2 and M. Hollmann1
1Anesthesiology Dept, University of Amsterdam, 
Amsterdam, Netherlands; 2Surgery Dept, AMC, University 
of Amsterdam, Amsterdam, Netherlands; 3Nuclear 
Medicine, AMC, Amsterdam, Netherlands; 4Clinical 
Epidemiology, AMC, Amsterdam, Netherlands
Introduction: A number of recent studies have shown ben-
efi cial effects of perioperative fl uid restriction during intra-
abdominal surgery on various outcome parameters including 
complications, recovery of gastrointestinal function and 
duration of hospital stay. Our aim was to investigate whether 
intraoperative crystalloid fl uid restriction in pancreatic 
surgery would have a benefi cial effect on postoperative com-
plications. The main endpoint was delayed gastric emptying 
(DGE), measured 7 days postoperatively by Technetium 
scan, as this is the most common complication. Secondary 
endpoints were postoperative complications, weight gain and 
duration of hospital stay.
Methods: The study was approved by the Ethics board. 
After written informed consent, 66 patients were random-
ized, and 50 patients completed the full protocol. 26 patients 
were subjected to a restricted (R) fl uid protocol (5 ml/kg/hr) 
and 24 patients to a standard (S) fl uid protocol (10 ml/kg/hr), 
Ringers Lactate, during the operation. Postoperative fl uid 
was set at 2.5 liters/24 h in both groups. 33 pancreatoduode-
nectomies (PD) and 17 double bypass (DBP) operations were 
performed. All patients underwent preoperative and postop-
erative gastric emptying scintigraphy.
Results: DGE occurred in 12 out of 26 patients in the R 
group and in 11 out of 24 patients in the S group. The time 
to empty half of the stomach contents (T½) was 194 min (CI 
95% 133–254) in the S group, and 170 min (CI 95% 110–
222) in the R group, with a P value of 0.543 (NS). 
Complications, weight gain and duration of hospital stay 
were comparable in both groups.
Conclusion: Our results do not support the hypothesis of a 
benefi cial effect of crystalloid fl uid restriction during pancre-
atic surgery on DGE incidence or clinical outcome.
O32
DO RISK FACTORS FOR PANCREATIC 
FISTULA REALLY EXIST? A FOURTEEN 
YEAR SINGLE INSTITUTION 
EXPERIENCE
M. Inama, G. Butturini, G. Malleo, A. Cavallini, 
D. Tamburrino, C. Bassi and P. Pederzoli
General Surgery Departement, Medical Univarsity of 
Verona, Verona, Italy
Context: Distal Pancreatectomy (DP) is the surgical proce-
dure of choice for pancreatic tumors in the body-tail of the 
pancreas. Even though in high volume centers the mortality 
is less than 2%, morbidity remains high. Pancreatic Fistula 
(PF) is the most important clinical complication and its inci-
dence is around 30%. The optimal management of pancreatic 
remnant during DP is still unknown.
Aim: We retrospectively reviewed our 14-year experience 
(January 1996 to December 2009) with distal pancreatecto-
mies to fi nd parameters potentially associated with pancre-
atic fi stula. The International Study Group for Pancreatic 
Fistula classifi cation was used. Pre- and post-operative 
details were analyzed using uni- and multivariate models.
Results: 515 DP were performed at author’s institution. Of 
these 463 were distal pancreatectomy with splenectomy 
(DPS) and 52 were spleen-preserving distal pancreatectomy 
(SPDP). Indications for surgery were ductal adenocarcinoma 
(19.5%), cystic lesions (42.7%), endocrine neoplasms (24.8), 
and other conditions (including chronic pancreatitis, pseudo-
cyst, trauma, 13%). The pancreatic remnant was sutured in 
50% of cases, stapled alone 47% and both stapled and 
sutured in 3%. Median operative time was 228 minutes (IQR 
180–265). The median hospital stay was 12 days (IQR 
10–15). The overall morbidity rate was 51%. PF developed 
in 24.4% of patients. At the univariate and multivariate anal-
ysis, no risk factors for PF emerged.
Conclusions: Our experience demonstrated that manage-
ment of the pancreatic remnant (stapler, manual suture, mul-
tivisceral resection) does not infl uence pancreatic fi stula after 
distal pancreatectomy.
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IMPACT OF PERI-OPERATIVE 
COMPLICATIONS FOLLOWING 
PANCREATICODUODENECTOMY FOR 
PANCREAS DUCTAL 
ADENOCARCINOMA ON LONG-TERM 
SURVIVAL
R. Lochan, S. Robinson, M. Jacob, D. Manas, S. White, 
R. Charnley, J. French and B. Jaques
Hepato-pancreato-Biliary Surgery unit, Freeman Hospital, 
Newcastle upon Tyne, United Kingdom
Background and aim: Complications following pancreatic 
resections are a signifi cant source of morbidity and may 
affect hospital stay. Patients with severe complication require 
further intervention. We sought to ascertain whether signifi -
cant complication following pancreaticoduodenectomy for 
ductal adenocarcinoma impacts on long term survival.
Methods: Our unit is a tertiary referral centre for all hepato-
pancreato-biliary surgery and performs over 100 elective 
pancreatic resections annually. We have retrospectively 
examined patients undergoing Whipple’s resection from 
2002–2009. Post-operative complications were graded 
according to Clavien and pancreatic leaks were graded 
as per the International Study Group on Pancreatic Fistula 
(ISGPF) classifi cation.
Results: Over the study period; in total 486 pancreaticoduo-
denectomies were performed; 190 (39%) of which were for 
pancreas ductal cancer. The complication rate for all was 
32.7% (159/486), of which Clavien grade 1 comprised 16.4% 
(26/159), grade 2 = 42.1% (67/159), grade 3 = 18.2% 
(29/159), grade 4 = 17% (27/159). There were 8 periopera-
tive deaths; mortality = 1.6%. The overall pancreatic fi stula 
rate was 17.5% (85/486) with ISGPF Grade A = 23.5% 
(20/85), Grade B = 42.4% (36/85) and Grade C = 34.1% 
(29/85). After censoring for perioperative mortality, in the 
pancreatic ductal adenocarcinoma subgroup, the complica-
tion rate was 24.7% (46/186). Of these, 15.2% (7/46) were 
Clavien grade 3 or 4 and/or ISGPF Grade C which we have 
defi ned as signifi cant complication. Median (95% CI) sur-
vival for ductal cancers was 25.54 (20.39–30.70), Kaplan 
Meier (Univariate) analysis did not reveal any signifi cant 
relationship between occurrence of complications including 
the occurrence of a pancreatic leak and long-term survival 
(p = 0.199).
Conclusions: Post-operative complication and mortality 
rates in our series of patients are at comparable levels to other 
high-volume centres cross the world. The occurrence of a 
serious post-operative complication does not appear to 
adversely infl uence long-term survival for patients with 
pancreatic ductal adenocarcinoma.
O34
MANAGEMENT OF POST 
PANCREATECTOMY HEMMORHAGE: 
DOES THE PERFORMANCE OF A 
PANCREATICOGASTROSTOMY 
INSTEAD OF A 
PANCREATICOJEJUNOSTOMY 
IMPROVE OUTCOMES BY BETTER 
ENDOSCOPIC ACCESSIBILITY?
F. Klein1, A. Eckardt2, W. Veltzke-Schlieker2, A. Andreou1, 
P. Warnick1, M. Bahra1, P. Neuhaus1 and M. Glanemann1
1Department of General, Visceral, and Transplantation 
Surgery, Charité Campus Virchow, Universitätsmedizin, 
Berlin, Germany; 2Clinic for Hepatology and 
Gastroenterology, Charité Campus Virchow, 
Universitätsmedizin, Berlin, Germany
Background: Post pancreatectomy hemorrhage (PPH) 
remains a major cause of morbidity and mortality after pan-
creaticoduodenectomy (PD). It remains unclear, whether the 
performance of a pancreaticogastrostomy (PG) instead of a 
pancreaticojejunostomy (PJ) improves outcomes of PPH via 
better endoscopic accessibility.
Methods: Retrospective analysis of 944 consecutive PDs 
over a 9-year period with special emphasis on endoscopic 
success and the need for rescue therapies after PPH. All 
PPHs were analyzed according to the type of pancreatic 
anastomosis (PG vs PJ). The primary endpoint was the need 
for rescue therapy (angiography and/or surgery), with the 
type of anastomosis as the dependant variable. Secondary 
endpoints were the success rates of endoscopic and 
rescue-therapies.
Results: Of the 944 patients with PDs, 79 patients (8.3%) 
developed PPHs. Rescue therapy was required in 66% of PJs 
and 57.7% of PGs. Surgical re-exploration as the primary 
intervention was nearly thrice as common in the PJ group 
(30.2%), as in the PG group (11.5%). In contrast, the need 
for rescue treatment after failed endoscopic therapy was not 
different (52.9% PJ; 52.4% PG). Endoscopic treatment was 
successful in 60% of hemorrhages from the PG-anastomosis, 
but none from the PJ. However, because only 19.2% of PPHs 
resulted from the PG itself, this did not affect overall 
outcome. Endoscopic or conservative treatment was success-
ful in 42.3% and 32.0% of PPHs in the PG and PJ-group. 
Success rates increased to 84.6% and 90.5%, respectively, 
when surgery was included in the therapeutic algorithm.
Conclusions: PG is more accessible than PJ to endoscopic 
therapy and helps to control PPH from this location. However, 
since hemorrhage also frequently occurs from other lesions 
or from intraabdominal bleeds, a combined endoscopic and 
surgical algorithm is highly recommended in the treatment 
of PPH.
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SUBMAXIMAL CARDIOPULMONARY 
EXERCISE TESTING PREDICTS 
PANCREATIC LEAK IN PATIENTS 
UNDERGOING 
PANCREATICODUODENECTOMY
F. Ausania, C. Snowden, R. Lochan, S. White, B. Jaques, 
J. French, D. Manas and R. Charnley
Freeman Hospital, Newcastle Upon Tyne, United Kingdom
Background: Postoperative complications are increased in 
patients with reduced cardiorespiratory reserve undergoing 
major surgery. Pancreatic leak is responsible for most of the 
postoperative complications and mortality following pancre-
aticoduodenectomy. The aim of this study is to defi ne the 
role of Cardiopulmonary Exercise Testing (CPET) to predict 
pancreatic leak.
Method: All 310 patients who underwent a pancreaticoduo-
denectomy at the HepatoPancreatoBiliary Unit, Freeman 
Hospital, Newcastle, between January 2006 and July 2010 
were identifi ed from a prospectively held database. The study 
was restricted to 126 patients who had a CPET being assessed 
for pancreaticoduodectomy. Pancreatic leak was defi ned as 
drain fl uid amylase more than three times the serum level for 
more than 3 days postoperatively requiring therapeutic man-
agement. An Anaerobic Threshold (AT) cut-off value of 
10.1 mL/kg/min was used to identify patients with reduced 
cardiopulmonary reserve.
Results: Pancreatic leak occurred in 18 out of 126 patients 
(14%). 101 patients had an AT > 10.1 mL/kg/min (81%), 
whereas a reduced cardiopulmonary reserve was showed in 
25 patients (19%). Pancreatic leak occurred in 11 (10%) and 
7 (28%) patients respectively (P = 0.029).
Conclusions: CPET predicts pancreatic leak following pan-
creaticoduodenectomy and therefore represents a useful tool 
to select patients for surgery and stratify the risk of post-
operative complications.
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DETECTION OF COLORECTAL CANCER 
LIVER METASTASES – AN ASSESSMENT 
OF FOUR IMAGING MODALITIES
E. Jonas, H. Nilsson, J. Larsson and J. Freedman
Department of Clinical Sciences, Karolinska Institutet 
Danderyd Hospital, Stockholm, Sweden
Of patients diagnosed with colorectal cancer (CRC), 40–50% 
have liver metastases at the time of diagnosis of the primary 
tumour. In approximately 50% of cases metastases are 
detected synchronously while the rest present metachro-
nously. Recurrence of disease in the liver after liver resection 
is mostly the result of inability of pre-operative imaging to 
detect all hepatic disease. Aims: The aim of the study was to 
assess the sensitivity and specifi city of 4 imaging modalities 
in detecting liver metastases in patients with colorectal 
cancer. Methods: Between 2005 and 2007 all patients with 
CRC liver metastases who presented at our institution and 
were considered candidates for curative operative interven-
tion, were investigated with triple-phase contrast-enhanced 
abdominal CT (CE-CT), contrast-enhanced ultrasound 
(Sonovue®) (CE-US), MRI with hepatocyte-specifi c contast 
(Primovist®) (Pr-MRI) and FDG-PET. Patients who under-
went the complete pre-operative work-up and could be ren-
dered tumour-free by single-stage intervention were included 
in the study. Patients with concomitant resectable extra-
hepatic disease and previous hepatobiliary surgery, other 
than cholecystectomy, were excluded. All patients underwent 
intra-operative CE-US. Follow-up was in-house with CE-US, 
CE-CT or Pr-MRI at 3, 6, 12, 24 and 36 months. Results: 
Twenty patients with a total of 30 metastases (averagesize 
24 (8–80) mm) and 18 benign/non-tumour lesions (in 9 
patients) were included. Operative mortality and morbidity 
were 0% and 20% respectively. No additional metastases 
were detected intra-operatively and histology confi rmed the 
pre-operatively detected metastases in all resected cases. 
Sensitivity per patient for CE-US, CE-CT, Pr-MRI and 
FDG-PET was 100%, 90%, 100% and 95% respectively. 
Sensitivity per lesion was 86.7%, 83%, 96.7% and 80% 
respectively. On follow-up (38–67 months) 10 patients 
(50%) are alive, 6 without disease. Of the 10 patients who 
died, only one presented with isolated intra-hepatic recur-
rence. No progression of any of the assumed benign/non-
tumour lesions to tumour was seen. Conclusions: Pr-MRI 
seems to be superior to CE-US, CE-CT and FDG-PET in 
detecting CRC liver metastases, especially regarding lesions 
in the sub-centimeter range.
O38
ACCURACY OF MSCT AND MRI FOR 
PRE-OPERATIVE ASSESSMENT OF 
COLORECTAL LIVER METASTASES 
AFTER NEOADJUVANTE 
CHEMOTHERAPY
C. van Kessel, M. van Leeuwen, M. van den Bosch, 
I. B. Rinkes, W. Mali and R. van Hillegersberg
University Medical Centre Utrecht, Utrecht, Netherlands
Background: Optimal delineation of colorectal liver metas-
tases (CRLM) after neoadjuvant chemotherapy (NAC) is 
crucial for accurate surgical decision-making. However, 
NAC induces parenchymal changes resulting in diminished 
lesion delineation and decreased sensitivity of CT.
Objective: To determine the best imaging modality for 
pre-operative detection, characterization and measurement 
of colorectal liver metastases after neoadjuvant 
chemotherapy.
Materials and methods: A total of 79 lesions in 15 patients 
with colorectal liver metastases were included in this study. 
Following neoadjuvant chemotherapy, all patients received a 
multislice liver CT (MSCT) and MRI that were retrospec-
tively scored by two experienced radiologists for lesion 
number, type, diameter (mm) and segmental location. A con-
sensus reading was performed to review any differences 
between the two radiologists. Intra-operative fi ndings, histo-
pathology and follow-up imaging were used as reference 
standard for surgically treated patients; non-surgical candi-
dates underwent follow-up imaging.
Results: MSCT and MRI were similar for individual lesion 
detection with a detection rate of 60/79 (76%) and 62/79 
(78%) respectively (p = 0.021). Lesion characterization was 
signifi cantly superior (p = 0.021) at MRI with a sensitivity 
of 89% (kappa 0.747, p = 0.001) compared to MSCT with a 
sensitivity of 77% (kappa 0.235, p = 0.005). Inter-observer 
variability for diameter measurement was not signifi cant at 
MRI (p = 0.909 [95%CI −1.245 to 1.395]), but signifi cant at 
MSCT (p = 0.028 [95%CI −3.349 to −2.007]). Differences 
in diameter measurement were independent of the observer 
(p = 0.131), and no statistical effect from imaging modality 
on diameter measurement was observed (p = 0.095).
Conclusion: MRI is superior to MSCT for pre-operative 
characterization and delineation of colorectal liver metasta-
ses after neoadjuvant chemotherapy. Lesion detection rates 
for both modalities are comparable.
O39
DETAILED LIVER SPECIFIC IMAGING 
PRIOR TO PRE-OPERATIVE 
CHEMOTHERAPY PREVENTS LIVER 
RECURRENCE
B. Knowles, M. Rees, F. Welsh and T. John
Department of Hepatobiliary Surgery, Basingstoke and 
North Hampshire Foundation Trust, Basingstoke, United 
Kingdom
Background: Preoperative chemotherapy is increasingly 
used prior to resection of colorectal liver metastases (CLM) 
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and reduces the accuracy of liver imaging. Patients who do 
not undergo detailed liver-specifi c imaging prior to starting 
chemotherapy may have an increased risk of hepatic recur-
rence because they are inadequately assessed.
Design: Retrospective review of a prospective surgical data-
base and corresponding radiology.
Methods: From June 1 2003 to December 1 2009, 241 
patients with CRL underwent hepatic resection after receiv-
ing at least three cycles of Oxaliplatin or Irinotecan-based 
chemotherapy. All had a detailed MRI of the liver after che-
motherapy just prior to liver surgery. 92 patients had a 
detailed index MRI prior to commencing chemotherapy 
(Group A), and their disease-specifi c outcomes were com-
pared to the 149 patients who did not (Group B).
Results: Prior to chemotherapy, an index MRI of the liver 
(Group A) detected an additional 109 CLMs in 45 (49%) 
patients. Median follow for the whole cohort was 55 months. 
There was no signifi cant difference in liver recurrence, dis-
ease-free or overall survival between the two groups. 
However, Group B patients underwent signifi cantly more 
repeat CLM resections than Group A (23.6% versus 13.0%, 
p = 0.044). Disease progression or management of known 
disappearing lesions may confound our hypothesis and 
indeed analysis of the patients with the same number of CLM 
seen on pre- and post-chemotherapy imaging (n = 56 in 
Group A, n = 81 in Group B) revealed a signifi cant increase 
in the rate of intra-hepatic recurrence in Group B (Odds ratio 
2.02 (1.10–3.73), p = 0.024).
Conclusions: These results emphasize the need for liver-
specifi c imaging to identify all CLM prior to chemotherapy 
in order to reduce the rate of intra-hepatic recurrence and 
avoid repeat liver resection.
O40
THE ADDITIONAL VALUE OF GD-EOB-
DTPA IN DIFFERENTIATING FOCAL 
NODULAR HYPERPLASIA FROM 
HEPATOCELLULAR ADENOMA ON MRI
M. Bieze, J. W. van den Esschert, C. Y. Nio, V. Terpstra, 
T. M. van Gulik and S. S. K. S. Phoa
Academic Medical Center, Amsterdam, Netherlands
Introduction: It is important to differentiate Focal Nodular 
Hyperplasia (FNH) from Hepatocellular Adenoma (HCA). 
Unlike FNH, resection is recommended for HCA > 5 cm, 
because of potential risk of bleeding and malignant transfor-
mation. Differentiation between FNH and HCA remains 
challenging based solely on imaging studies. Gadolineum-
EOB-DTPA (Primovist®) combines the properties of a con-
ventional contrast agent, with a hepatobiliary agent, allowing 
MRI evaluation of hepatocyte uptake and biliary 
excretion.
Objectives: We assessed the value of the additional hepato-
specifi c contrast agent over conventional contrast enhanced 
MRI in differentiating FNH from HCA, with histological 
outcome as gold standard.
Methods: In this single center prospective study 63 patients 
suspected of FNH or HCA underwent a Gd-EOB-DTPA MRI 
of the liver. Conventional series included dynamic contrast-
enhanced T1 weighted FS series, T1 in/out of phase, T2, and 
diffusion, followed by delayed hepatobiliary phase. The two 
imaging studies were stored separately and evaluated by two 
independent and blinded abdominal radiologists. The readers 
made their diagnosis on conventional imaging based on 
lesion characteristics (shape, demarcation, lesion content, 
bleeding, central scar) and enhancement pattern. In addition, 
diagnosis was made on combined imaging studies including 
the hepatobiliairy phase. The latter series were regarded 
diagnostic for FNH if accumulation of contrast was seen and 
HCA without accumulation. Imaging results were compared 
to histological outcome.
Results: 58 patients were included and histological outcome 
showed HCA 27 and FNH 31. On conventional series 13 
cases (22.4%) remained inconclusive (histological outcome 
HCA 4; FNH 9) and 45 cases were diagnosed (HCA 23; FNH 
22), of which 10 (22.2%) did not correspond to histological 
outcome (HCA 6; FNH 4). After the hepatobiliary phase the 
accuracy increased from 77.8% to 94.8% as 55 cases matched 
histological outcome.
Conclusion: The hepatobiliary phase with Gd-EOB-DTPA 
contrast signifi cantly increases the accuracy of the MRI in 
differentiating FNH from HCA.
O41
A PROSPECTIVE COMPARATIVE 
EVALUATION OF PRE- AND INTRA-
OPERATIVE IMAGING TECHNIQUES IN 
CHEMO-PRETREATED OR NOT 
PRETREATED PATIENTS WITH 
COLORECTAL LIVER METASTASES
G. Ercolani1, M. Zanello1, L. Rojas2, M. Ravaioli1, 
M. Cescon1, M. D. Gaudio1, F. Tuci1, C. Pinto2, 
R. Golfi eri3 and A. Pinna1
1Hospital Sant’Orsola, Department of Surgery and 
Transplantation, Bologna, Italy; 2Department of Pathology 
and Oncology, Bologna, Italy; 3Department of Radiology, 
Bologna, Italy
Background: In patients with colorectal metastases receiv-
ing neoadjuvant chemotherapy, the accuracy of imaging 
techniques seems to be reduced.
Aim: To evaluate the diagnostic accuracy of the available 
imaging techniques in not preatreated patients (group A) 
compared to chemo-pretreated (group B).
Methods: Patients with potentially resectable metastases 
underwent in 3 weeks before surgery the following radio-
logic examinations: preoperatively, contrast-enhanced 
ultrasonography (CEUS), CT scan, FDG-PET scan, Magnetic 
Resonance (MRI), and intraoperatively, common ultrasound 
(IOUS) and IO-CEUS. A multidisciplinary analysis was per-
formed and every resected lesion was compared with imaging 
data.
Results: From November 2008 to November 2009 49 
patients, out of 70 which were prospectively enrolled in the 
study, underwent partial hepatectomy. Neoadjuvant chemo-
therapy was administered in 24 (49%) patients, while 25 
(51%) patients were not pretreated. Fifty-eight patients were 
resected in the group A (median resected mts 1, range 1–7), 
while 94 in the group B (median 2.5, range 1–15). Two 
lesions were not metastases in group A, while 7 were not 
metastases in the group B (3 were complete necrosis). 
Sensitivity, positive predictive value, and diagnostic accu-
racy for each technique are reported in the following 
table:
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CEUS CT MRI PET IOUS IO-CEUS
Sensitivity
Group A 87 89* 92 84* 98 98
Group B 80 77 89 41 97 95
Pos Pred Value
Group A 96 96 96 98 95 94
Group B 93 92 94 91 94 93
Accuracy
Group A 84 86* 88 83* 92 93
Group B 76 72 85 42 88 89
*P < 0.05.
Conclusions: The diagnostic accuracy of preoperative 
imaging techniques was high in group A but decreased, often 
signifi cantly, after neoadjuvant chemotherapy. MRI seems to 
maintain a better accuracy after chemotherapy. Intraoperative 
CEUS does not seem to add any advantage to the intraopera-
tive ultrasound; the latest two showed the highest accuracy.
O42
ASSESSMENT OF HEPATIC FUNCTION 
USING HEPATOBILIARY SCINTIGRAPHY 
IN PATIENTS WITH PARENCHYMAL 
LIVER DISEASE
W. de Graaf1, J. J. T. H. Roelofs2, L. T. Hoekstra1, 
R. J. Bennink3 and T. M. van Gulik1
1Academic Medical Center, department of surgery, 
Amsterdam, Netherlands; 2Academic Medical Center, 
department of pathology, Amsterdam, Netherlands; 
3Academic Medical Center, department of nuclear 
medicine, Amsterdam, Netherlands
Background: Compromised livers (fi brosis, steatosis, cho-
lestasis or severe infl ammation) are considered to have an 
impaired function and the limit for safe resection is therefore 
set at a future remnant liver volume of 40% instead of 25%. 
No quantitative scoring system exists to identify patients 
with a compromised liver and the specifi c effect of different 
liver diseases on liver function is unknown.
Aim: To assess the value of a quantitative scoring system 
for identifying compromised livers and to evaluate the spe-
cifi c effect of different liver diseases on liver function mea-
sured by 99mTc-mebrofenin hepatobiliary scintigraphy (HBS).
Methods: In 111 patients, preoperative HBS was performed 
to measure liver function after which resection specimens or 
perioperative biopsies were scored by an experienced pathol-
ogist: Fibrosis (0 = absent; 1 = fi brous expansion of portal 
areas; 2 = incomplete portoportale septa; 3 = marked porto-
portale bridging; 4 = cirrhosis) and steatosis (0 = absent, 1 = 
<5% of hepatocytes, 2 = 5–30%, 3 = 30–60%, 4 = >60%) 
were scored on a 5-point scale. Cholestasis and infl ammation 
were scored on a 4-point scale (0 = absent; 1 = mild, 2 = 
moderate, 3 = severe). A compromised liver was defi ned as: 
either fi brosis ≥3, or steatosis ≥3, cholestasis ≥2 infl amma-
tion ≥2.5, or a combination of mild-moderate diseases with 
a total score ≥4.5 (with ≥3 for (fi brosis+steatosis+cholesta
sis), with either fi brosis or steatosis = 2)
Results: Liver function was signifi cantly impaired in com-
promised livers (n = 54) vs. normal (n = 57) livers (7.07 ± 
1.70%/min/m2 vs. 8.19 ± 1.53%/min/m2, P = 0.0004). Liver 
function in fi brotic livers was 6.55 ± 2.24%/min/m2 (n = 16), 
in steatotic livers 7.35 ± 1.13%/min/m2 (n = 11) and choles-
tatic livers 6.99 ± 1.83%/min/m2 (n = 26). A combination of 
mild-moderate diseases was seen in 9 patients with an uptake 
function of 7.40 ± 0.90%/min/m2
Conclusion: A quantitative scoring system identifi es 
patients with a compromised liver. Liver function was most 
impaired in patients with severe fi brosis or cholestasis.
O43
THE ANAESTHETIST AS A RISK FACTOR 
FOR PERIOPERATIVE COMPLICATIONS 
IN LIVER SURGERY
S. McNally, L. Massie, R. Parks, O. J. Garden and 
S. Wigmore
University of Edinburgh, Edinburgh, United Kingdom
Introduction: Excessive blood loss during liver surgery 
contributes to post-operative morbidity and mortality. 
Minimising blood loss improves outcomes, however due to 
confl icting evidence, strategies such as low CVP anaesthesia 
are not universally adopted. This study examines which pre 
and intra-operative factors contribute to blood loss and iden-
tifi es areas for improvement in peri-operative management.
Methods: All patients who underwent elective hepatic 
resection in our institution from August 2007 to August 2009 
were identifi ed. Patients were grouped depending on which 
anaesthetist managed their case. Detailed information on the 
pre and peri-operative clinical course were analysed using 
Mann-Whitney and Chi squared tests as appropriate. 
Multivariate analysis was used to identify factors associated 
with peri-operative blood loss.
Results: 175 patients were managed by 7 different anaes-
thetists and 95 (54%) underwent resection of 3 or more 
segments (major resection). The median blood loss was 
782 mls. Greater blood loss was seen in patients undergoing 
major resections, prolonged surgery and with higher intraop-
erative fl uid administration (all p < 0.001), and was associ-
ated with increased postoperative complications (p = 0.026). 
CVP > 10 was associated with increased blood loss (p = 
0.013). Despite no difference in case-mix, blood loss and 
length of stay also varied signifi cantly between anaesthetists, 
as did intra-operative volumes of intravenous fl uids.
Discussion: This data confi rms the relationship between 
CVP and blood loss in hepatic resection. Intraoperative CVP 
values were higher than described in the literature (typically 
5–6), which may account for previous studies failing to dem-
onstrate this relationship. There was substantial variation in 
the intra-operative anaesthetic management of these patients 
which in turn is associated with prolonged hospital stay. 
Collaboration between surgical and anaesthetic teams is 
required to minimise blood loss and standardisation of intra-
operative anaesthetic practice may improve the outcomes 
associated with liver surgery.
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O44
EVALUATION OF HISTOLOGICAL 
DIAGNOSIS OF FNH AND HCA USING 
BIOPSY AND/OR RESECTION SPECIMEN
M. Bieze, J. W. van den Esschert, V. Terpstra, 
O. R. C. Busch, D. J. Gouma and T. M. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Introduction: It is important to differentiate Focal Nodular 
Hyperplasia (FNH) from Hepatocellular Adenoma (HCA) 
because of the therapeutic consequences. Unlike FNH, resec-
tion is recommended for HCA > 5 cm, because of potential 
risk of bleeding and malignant transformation. The gold stan-
dard for diagnosis is histological outcome, but this remains 
challenging based solely on biopsy material.
Objectives: To evaluate the diagnostic accuracy of percuta-
neous biopsy material compared to resection specimen in 
differentiating HCA from FNH.
Methods: This single center prospective study (part of a 
larger trial) was performed between January 2008 and June 
2010. Patients, 18 years of age or older, with a lesion in the 
liver suspected of FNH or HCA on imaging studies, were 
included and underwent a 16 gauge biopsy, resection of the 
suspected lesion(s), or both.
Analysis: Immunohistological staining including HS, CK 7 
and CK 19 were performed to assess diagnoses.
Results: Of the 66 patients included (3 male, 63 female, 
mean age 39), 12 patients underwent surgical resection only 
(HCA 11; FNH 1). 54 patients underwent biopsy of the liver 
lesion, providing a diagnosis in 33 patients (HCA 15; FNH 
18). In 21 (31.8%) of the patients, diagnosis remained incon-
clusive due to sampling errors (n = 9), or doubt (n = 12). Six 
of these patients underwent subsequent resection, because 
either HCC could not be excluded (n = 4), differentiating 
FNH from HCA was impossible (n = 1 male), or because of 
severe abdominal complaints (n = 1). In patients (n = 15) in 
whom both conclusive biopsy material and resection speci-
men were obtained, histological outcome corresponded in all 
cases. A total of 33 patients underwent resection providing 
defi nitive histological diagnosis in all cases (HCA 26; FNH 
7).
Conclusion: Diagnosis of FNH and HCA (HCC) based on 
histological outcome obtained by liverbiopsy is 100% spe-
cifi c, but has a poor sensitivity of 68.2%, due to sampling 
errors and unrepresentative tissue sample causing doubt.
O45
POST-OPERATIVE MORBIDITY 
FOLLOWING SURGERY FOR 
COLORECTAL LIVER METASTASIS: 
EFFECTS ON LONG-TERM OUTCOME
M. C. de Jong1, R. M. van Dam1, S. A. W. G. Dello1, 
S. W. M. O. Damink1,2, M. H. A. Bemelmans1 and 
C. H. C. Dejong1
1Department of Surgery, Maastricht University Medical 
Centre + & NUTRIM School for Nutrition, Toxicology and 
Metabolism, Maastricht University, Maastricht, 
Netherlands; 2Hepato-Pancreato-Biliary and Liver 
Transplant Surgery, Royal Free Hospital, University 
College London, London, United Kingdom
Background: The impact of post-operative morbidity on 
the long-term outcome following curative intent surgery for 
colorectal liver metastasis (CRLM) is controversial. We 
sought to determine the infl uence of post-operative morbid-
ity on overall and recurrence-free survival.
Methods: Between 2000–2010, 195 patients underwent 
surgery for CRLM at our institution. Therapeutic, operative 
and outcome data were prospectively collected and subse-
quently analyzed. Post-operative morbidity was classifi ed 
according to Clavien Grade.
Results: Of the 195 patients, 112 patients underwent a 
major hepatic resection (57.4%) and 8 patients (4.1%) under-
went resection combined with ablation. Overall, 62 patients 
(31.8%) developed post-operative morbidity, of whom 30 
patients (15.4%) developed a major complication (Clavien 
Grade 3 or 4). Moreover, the majority of adverse events were 
liver-associated (n = 44; 22.6%). When comparing patients 
with and patients without post-operative morbidity, there 
were no differences with regard to tumor number, extent of 
resection, concomitant extrahepatic metastasis and presence 
of co-morbidities (all p > 0.05). Conversely, patients who 
developed complications had larger lesions, more operative 
blood loss, a longer operative time and were less likely to 
receive post-operative chemotherapy (all p < 0.05). After a 
median recurrence-free interval of 21 months, 81 patients 
(41.5%) recurred, of whom 47 patients (24.1%) within the 
liver. The recurrence-free survival was comparable, irrespec-
tive of post-operative complications (median, complications: 
22 months versus no complications: 14 months; p = 0.22). 
For all patients, median overall (5-year) survival was 54 
months (46.1%). The occurrence of post-operative morbidity 
was not correlated with overall (5-year) survival (complica-
tions: 43 months (49.6%) versus no complications: 58 
months (34.2%); p = 0.28). However, the number of lesions 
(HR:1.18; p < 0.001), a bilobar distribution (HR:1.34; p = 
0.014) and the presence of extrahepatic disease (HR:2.69; 
p < 0.001) were found to adversely impact survival.
Conclusion: While a considerable number of patients 
develop post-operative morbidity after surgery for CRLM, 
the occurrence of post-operative complications does not 
seem to infl uence the long-term outcome for these patients.
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APPLICATION OF PROTEOMICS TO 
BILE BIOMARKER DISCOVERY IN 
CHOLANGIOCARCINOMA
S. Farid1,2, R. Craven1, J. Peng1, D. P. Perkins1, P. Selby1, 
R. Banks1 and R. Prasad2
1Cancer Research UK, St James University Hospital, 
Leeds, United Kingdom; 2St James University Hospital, 
Leeds, United Kingdom
Introduction: We have investigated the utility of bile as a 
proximal bio-fl uid for biomarker discovery compared to 
serum and characterise the bile proteome in patients with 
cholangiocarcinoma (CCA) using complimentary proteomic 
approaches.
Methods: 2D DIGE was used to compare the protein pro-
fi les of bile and serum in 4 patients with CCA and gels were 
analysed by Progenesis SameSpots™ (v3.3). In parallel a 
‘shotgun’ Gel-LC-MS/MS approach was uitilsed to charac-
terise the bile proteome using nano-HPLC/MS/MS and data 
searched against the IPI database with the Mascot search 
engine (v2.3).
Results: Principal component analysis of 2D gel profi les 
detected 205 of 713 protein spots to have a signifi cant dif-
ference in abundance between bile and serum. A shotgun 
approach identifi ed 922 unique proteins in bile of patients 
with CCA and 180 proteins were common to all patients. 
Ingenuity Pathway analysis (v8.6, Ingenuity Systems Inc) for 
protein localization and function applied to these common 
proteins demonstrated the presence of a number of proteins 
relevant to diseases such as bile duct cancer and cellular 
proliferation including vimentin, phosphoglycerate kinase 1 
and heat shock protein 70.
Conclusion: Our preliminary results support the hypothesis 
that bile contains cancer-associated proteins leaking from the 
tumour microenvironment in higher abundance to the general 
circulation. Our study is the largest to date and the fi rst to 
catalogue biliary proteins in multiple patients, considerably 
extending the knowledge of bile proteome in CCA.
Abbreviations: 2D DIGE: Two-dimensional Difference in 
Gel Electrophoresis; HPLC/MS/MS: High pressure Liquid 
Chromatography/Mass Spectrometry.
O47
STAGING LAPAROSCOPY FOR HILAR 
CHOLANGIOCARCINOMA: IS IT STILL 
WORTHWHILE
A. T. Ruys, O. R. C. Busch, D. J. Gouma and  
T. M. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Aim: to evaluate the benefi t of staging laparoscopy (SL) for 
staging in patients with suspected hilar cholangiocarcinoma 
(HCCA) in the last 10 years.
Introduction: Only 50–60% of patients with HCCA under-
going laparotomy are ultimately amenable to a potentially 
curative resection. In a previous study we recommended 
routine use of SL in order to prevent unnecessary laparoto-
mies. The accuracy of imaging techniques however, has sig-
nifi cantly improved in the past decade, which is likely to 
impact the yield and accuracy of SL.
Methods: From 2000 to 2010, 195 patients with suspected 
HCCA were analyzed. The yield and accuracy of SL were 
calculated by dividing total number of avoided laparotomies 
by the total number of laparoscopies or by all patients 
with unresectable disease, respectively. Factors associated 
with better yield and accuracy were assessed using 
chi-square-test.
Results: Of 195 HCCA patients, 175 patients underwent 
SL. The yield of SL was 14% and the accuracy 32%. 
Operative morbidity of SL was 3%, operative morbidity of 
laparotomy for unresectable disease was 33%. No clear 
factors infl uencing yield of SL were found.
Conclusion: Overall yield and accuracy of SL for HCCA in 
the present series decreased to 14% and 32%, respectively, 
as compared to earlier reports. This fi nding is likely the result 
of improved imaging techniques as evolved in the past 
decade. SL should not anymore be routinely performed in 
the work-up of patients with resectable HCCA.
O48
HAEMATOPOIETIC BUT NOT 
MESENCHYMAL BONE MARROW 
DERIVED STEM CELLS CONTRIBUTE 
TO THE STROMAL 
MICROENVIRONMENT IN 
CHOLANGIOCARCINOMA
A. Robson1,2, K. Samuel3, A. Pellicoro2, D. Wojtacha2, 
S. Wigmore1, J. Garden1, J. Iredale2 and S. Forbes2
1Department of Surgery, University of Edinburgh, 
Edinburgh, United Kingdom; 2Centre for Infl ammation 
Research, University of Edinburgh, Edinburgh, United 
Kingdom; 3Scottish National Blood Transfusion Service, 
Edinburgh, United Kingdom
Background: Cholangiocarcinoma (CC) is characterised by 
a pronounced infl ammatory stroma of tumour-associated 
myofi broblasts, macrophages, immune cells and modifi ed 
extracellular matrix. Furthermore, in animal models of 
gastric cancer, reports suggest that mesenchymal stem cells 
may contribute to the epithelial compartment of tumours. 
Understanding the source of tumour-associated cells in CC 
will inform therapy in the future.
Methods: The composition of the tumour niche was studied 
in humans and the thioacetamide (TAA) rat model of CC 
over 1 year. Reconstituted wild type recipients of sex-mis-
matched and GFP+ bone marrow (BM) were administered 
TAA. Extra-hepatic derivation of cells was studied using 
independent techniques to tract Y-Chromosome FISH and 
GFP+ together with dual immunofl ourescence for CK19 
(biliary epithelium), aSMA (myofi broblasts), ED1, ED2 
(macrophages) and MPO (neutrophils). Flow cytometry of 
blood, spleen and BM was performed to investigate GFP+ 
donor reconstitution of the haematopoietic compartment in 
recipient rats. BM of transplanted animals was cultured in 
mesenchymal stem cell (MSC) selective media and fl ow 
cytometry analysis for co-expression of stro-1 (a marker of 
MSC) and GFP was performed.
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Results: In human and rat tissue, the tumour cellular micro-
environment comprised of myofi broblasts, migratory macro-
phages (CD68+) and immune cells. In transplanted rats, 
GFP+ reconstitution of the haematopoietic and mesenchymal 
stem cell compartments was identifi ed. Expression of 
stro1+GFP+ cultured cells was similar in transplanted 
animals and control GFP+ animals. In tumours, macrophages 
(ED1, ED2) and neutrophils (MPO) were overwhelmingly 
GFP+, whereas myofi broblasts (aSMA) did not express GFP. 
Additionally, benign and malignant bile ducts were GFP 
negative. These fi ndings were confi rmed by independent cell 
tracking of Y-Chromosome.
Conclusions: A stereotypical niche forms around cholan-
giocarcinoma in developing and malignant lesions. We found 
no evidence of a BM-derived stem cell contribution to the 
epithelial component of cholangiocarcinoma. The haemato-
poietic but not the mesenchymal components of the tumour 
stroma were of BM origin.
O49
PROGNOSTIC VALUE OF LYMPH-NODE 
DISSECTION AND LYMPH-NODE RATIO 
IN INTRAHEPATIC AND PERIHILAR 
CHOLANGIOCARCINOMA
A. Guglielmi, A. Ruzzenente, T. Campagnaro, S. Conci, 
C. Tezza, F. Bagante and C. Iacono
Department of Surgery, Division of General Surgery ‘A’, 
GB Rossi University Hospital, Verona, Italy
Background: Prognostic signifi cance of LN dissection 
(LND) and of number of metastatic LNs are still under 
debate in intrahepatic (ICC) and peri-hilar (PCC) cholangio-
carcinoma. The aim of this study is to evaluate the prognostic 
value of LND and Lymph-Node Ratio (LNR) for ICC and 
PCC.
Methods: Number and status of harvested LN were retro-
spectively evaluated in patients with ICC and PCC submitted 
to surgical resection with curative intent between 1990 and 
2009.
Results: One hundred and seventeen patients (49 with ICC 
and 68 with PCC) underwent to surgical resection. In 95 
patients (81%) LND was performed; a totally 741 LNs were 
retrieved. Median number of LNs examined was 5.8 (1–26) in 
ICC and 7.3(1–25) in PCC. LNs were positive (N+) in 10 
patients (27%) with ICC and in 26 patients (45%) with PCC 
(p = 0.08). Median survival for patients with 0 LNs, between 
1–3 LNs and more than 3 LNs retrieved, was 32, 40 and 117 
months, respectively, for ICC (p = 0.16), and was 8, 18 and 
28 months, respectively, for PCC (p = 0.01). Median survival 
in N0 compared to N+ patients was 56 and 19 months, respec-
tively, in ICC (p = 0.01) and 41 and 22 months, respectively, 
in PCC (p = 0.02). Median survival for patients with LNR 0, 
LNR below 0.25 and LNR >0.25 was 56, 8 and 19 months (p 
= 0.01), respectively, for ICC and was 41, 22 and 14 months 
(p = 0.01), respectively, for PCC. Multivariate analysis showed 
that negative prognostic factors associated with survival were 
LNR >0.25 and vascular invasion with HR of 1.8 and 2.8 for 
ICC and of 1.6 and 2.3 for PCC, respectively.
Conclusion: Lymph-node dissection improves tumor 
staging stratifi cation and may improve survival in both ICC 
and PCC. Lymph-node ratio confi rmed its prognostic value 
in both ICC and PCC.
O50
METASTATIC LYMPH NODES IN HILAR 
CHOLANGIOCARCINOMA: DOES SIZE 
MATTER?
A. T. Ruys, F. J. ten Kate, O. R. C. Busch, 
M. R. Engelbrecht, D. J. Gouma and T. M. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Aim: To evaluate the association between lymph node (LN) 
size and the presence of metastasis and to defi ne specifi c size 
categories for optimal assessment of nodal status in patients 
with hilar cholangiocarcinoma (HCCA).
Introduction: LN metastasis is one of the most signifi cant 
independent prognostic factors in patients with HCCA. At 
this time, despite the well known lack of sensitivity and 
specifi city, one of the most used clinical criteria for nodal 
metastases is LN size.
Methods: Pathologic specimens of 147 patients who had 
undergone laparotomy for HCCA were assessed. The size 
(maximum diameter) of each single node was retrieved from 
the pathology report or measured from section on the glass 
slide by using a stereo microscope and a calibrated ruler 
integrated in the software. When a metastatic lesion was 
detected the proportion of the lesion in relation to the LN 
size was estimated.
Results: Of 147 surgical specimens 645 LN were retrieved 
and measured. 106 Nodes showed evidence of metastasis. 
The proportion of positive nodes increased from 8% in nodes 
<5 mm to 37% in nodes >30 mm. Ten percent of LN smaller 
than 10 mm are positive, whereas only 23% of LN larger 
than 10 mm are metastastically involved. In 50% of positive 
LN the metastatic lesion accounts for 10% or less of the LN 
size.
Conclusion: The cut-off point of 10 mm for LN in HCCA 
patients as a predictor of nodal malignancy is strikingly inac-
curate. No cut-off point could be determined for accurately 
predicting nodal involvement. Thus imaging studies should 
not rely on LN size when assessing nodal involvement.
O51
CHOLANGIOCARCINOMA: OPENING 
THE DOOR FOR MOLECULAR BASED 
PROGNOSTIC TESTING?
S. C. McKay1,2, K. Unger2, S. Pericleous1,2, G. Stamp3, 
G. Thomas2, D. Spalding2 and R. Hutchins1
1Barts and The London Hospital, London, United 
Kingdom; 2Imperial College London, London, United 
Kingdom; 3The Royal Marsden Hospital, London, United 
Kingdom
Introduction: Survival from cholangiocarcinoma (CC) 
remains poor, despite improvements in surgical technique 
and medical therapy. Accurate prognostic information 
enables clinicians to better inform patients to aid their treat-
ment pathway decisions.
Method: Thirty-two patients with either intra- or extrahe-
patic CC were included in the study, with a median age of 
62.5 years (range 25–77), and male-to-female ratio of 2.2 :1. 
DNA was extracted from archival diagnostic CC tissue 
samples. 1Mb BAC arrays with 3,400 BAC-clones 
(CodeLink, GE Healthcare) covering the whole human 
genome in triplicate were used. Tumour and sex-mismatched 
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reference DNA (Promega) were differentially labelled with 
Cy3-dCTP and Cy5-dCTP (CyScribe kit, Amersham), then 
hybridized for 60 hours at 60°C and scanned at 5 micron 
resolution using a microarray scanner (Agilent). Data was 
analysed within the R statistical environment.
Results: Two regions of loss on chromosomes 3 and 11 
were found to correlate signifi cantly with poor survival. Loss 
at chromosome 3q13.2-q13.33 correlated with poor survival 
(median survival 10 months) compared to good survival in 
the group with no loss (median survival 23 months), with an 
FDR of 0.19 (p-value 0.004). Loss at 11p15.4-q14.1 also 
correlated with poor survival (12 vs 25 months median sur-
vival), with an FDR of 0.26 (p-value 0.014).
Conclusion: We have identifi ed two regions of DNA loss 
on chromosomes 3 and 11 that correlate with poor survival 
in CC. Molecular interrogation of these two regions in 
patients with CC could signifi cantly improve prognostic 
information available to clinicians and patients, and play a 
key role in deciding how aggressively to treat the 
malignancy.
O52
ANALYSIS OF PROGNOSTIC FACTORS 
FOR SURVIVAL AFTER RESECTION OF 
EXTRAHEPATIC 
CHOLANGIOCARCINOMA
N. van der Gaag, J. Kloek, J. de Bakker, B. Musters, 
R. Geskus, O. Busch, A. Bosma, D. Gouma and 
T. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Introduction: Extrahepatic cholangiocarcinomas (CCA) 
occur throughout the entire bile duct and are often designated 
as proximal, mid and distal CCA, based on surgical approach. 
Tumor node metastasis (TNM) stage grouping predicts sur-
vival on the basis of pathological tumor extension. Aim of 
the current study was to evaluate the role of tumor location 
on survival after resection, to analyze the predictive value of 
TNM staging, and to compare different prognostic models.
Methods: Consecutive patients who had a potentially cura-
tive resection of extrahepatic CCA were included. We per-
formed Cox regression analyses to examine the association 
between risk factors and time to death (cancer-specifi c sur-
vival) from (recurrent) CCA. The concordance index, calcu-
lated after bootstrapping, was used to measure accuracy of 
prediction of survival of the different constructed prognostic 
models.
Results: Between 1992–2007 a consecutive series of 175 
patients underwent resection for extrahepatic CCA. Median 
length of follow-up was 19 months (IQR 10–37) for deceased 
patients and 54 months (IQR 34–99) for the 36 patients 
(21%) alive at last follow-up. Overall cancer-specifi c sur-
vival rate was 83%, 58%, and 26% at 1, 2 and 5 years 
respectively. Tumor location was not an independent signifi -
cant predictive factor (P = 0.06). A prognostic model using 
all potential prognostic variables outperformed TNM staging 
(concordance index 0.65 versus 0.63). A reduced model con-
taining only lymph node status, microscopically residual 
tumor status and tumor differentiation grade, also outper-
formed TNM staging (concordance index 0.66).
Conclusion: Tumor location of extrahepatic CCA does not 
independently predict cancer-specifi c survival after resec-
tion. A prognostic model with lymph node status, micro-
scopically residual tumor status at resection plane, and tumor 
differentiation grade predicted survival better than TNM 
staging.
O53
ANALYSIS OF LONG-TERM SURVIVAL 
IN 235 PATIENTS WITH RESECTABLE 
AND UNRESECTABLE HILAR 
CHOLANGIOCARCINOMA
A. T. Ruys, S. T. van Haelst, E. A. Rauws, O. R. C. Busch, 
D. J. Gouma and T. M. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Introduction: Radical resection remains the only curative 
treatment for hilar cholangiocarcinoma (HCCA). Only a 
limited proportion of patients is however eligible for resec-
tion. Unresectable patients generally undergo palliative 
biliary drainage. The survival and prognostic factors of these 
patients are largely unknown.
Aim: To evaluate survival in the denominator of patients 
presenting with HCCA and to defi ne prognostic factors.
Methods: The denominator of HCCA patients seen in our 
center between March 2003 and March 2009 were identifi ed. 
Demographics, treatment, pathology results and survival 
were analyzed.
Results: 235 patients with suspected HCCA were identifi ed. 
109 Patients (46%) underwent laparotomy, and in 71 (65%) 
of these patients resection was performed. Overall median 
and 5-year survival of resected patients were 39 months and 
44%, respectively, as compared to 13 months and 6%, in 
unresectable patients. Survival was better in unresectable 
patients who had undergone explorative laparotomy (16 vs 
10 months, p = 0.02). In unresectable patients, best median 
survival was found in patients with locally advanced disease 
(16 months) and worst median survival in patients with liver 
metastasis (4 months, p < 0.001). Of 164 unresectable 
patients, 16 (10%) survived longer than 3 years. Pathological 
confi rmation of malignancy was available in 9 (56%) of 
these patients.
Conclusion: Of all 235 patients referred to our center, a 
resection was performed in 71 patients (30%) with a median 
survival of 39 months. Prognosis for unresectable patients is 
poor, especially for patients with liver metastasis. Yet, long-
term survival was still found in 10% of patients undergoing 
palliative biliary drainage.
O54
PK11195, A PERIPHERAL 
BENZODIAZEPINE RECEPTOR LIGAND, 
POTENTIATES CYTOTOXIC ACTION ON 
CHOLANGIOCARCINOMA CELL LINES
S. Pericleous1,2, W. Mathieson1, N. Middleton3, 
S. McKay1,2, A. Biswas1, G. Thomas1, D. Spalding1 and 
R. Hutchins2
1Imperial College London, London, United Kingdom; 
2Royal London Hospital, London, United Kingdom; 
3Cyprus University of Technology, Nicosia, Cyprus
Cholangiocarcinoma (CC) is an uncommon disease with a 
dismal prognosis. Patients with surgically unresectable 
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disease benefi t little from conventional anticancer therapies 
such as chemotherapy and radiotherapy. 1-(2-chlorophenyl-
N-methylpropyl)-3-isoquinolinecarboxamide (PK11195) is a 
benzodiazepine receptor ligand which antagonizes Bcl-2 and 
Bcl-XL function thus preventing the inhibition of apoptosis. 
Our aim was to determine the effect of adding PK11195 in 
vitro to commercially available chemotherapy agents on 
cultured CC cell lines.
Methods: We tested the agents gemcitabine, 5-fl uorouracil, 
cisplatin and etoposide at concentrations of 1 × 10−4 to 1 × 
10−9 M. This was done both alone and in combination with 
PK11195 on the following CC cell lines: Sk-ChA-1, HuCCT-1, 
KKU-M213. Each cell line is derived from a different subtype 
of CC. Cell survival was measured using the Sulforhodamine 
B (SRB) colorimetric assay. Results were analysed using 2-way 
analysis of variance (ANOVA) with Bonferroni post hoc tests 
comparing the different concentrations.
Results: When used at concentrations of less than 1 × 10−5, 
PK11195 monotherapy had no signifi cant effect. It did, 
however, have a potent effect at concentrations higher than 
this; hence testing for a potential additive effect was restricted 
to low concentrations of PK11195 (<1 × 10−5). PK11195 
enhanced the cytotoxic effect of most chemotherapy agents 
in all cell lines to various degrees. The table depicts the 
individual agent and concentration at which the greatest 
improvement was achieved for each cell line. The percentage 
enhancement by addition of PK11195, 95% confi dence inter-
vals and the P value is also included.
Conclusion: We have shown how PK11195 can enhance the 
action of available chemotherapeutic agents of different CC 
cell lines in an in vitro setting.
Cell line Most effective agent Concentration (M) % enhancement by PK11195 (95% CI) P-value
SkChA-1 Fluorouracil 1 × 10−8 33.81% (7.93–59.71%) P < 0.001
HuCC T-1 Gemcitabine 1 × 10−9 23.31% (5.80–40.91%) P < 0.001
KKU M213 Cisplatin 1 × 10−6 73.10% (49.44–96.83%) P < 0.001
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O55
SUBTOTAL HEPATECTOMY AND 
AUXILIARY ORTHOTOPIC LIVER 
TRANSPLANTATION FOR 
ACETOMINOPHEN INDUCED ACUTE 
LIVER FAILURE
I. Rajput, G. Toogood, R. Prasad, M. Attia, S. Polard and 
P. Lodge
St. James’s University Hospital, Leeds, United Kingdom
Introduction: Ninety per-cent of patients who fulfi l the 
Kings College Criteria for acetaminophen induced liver 
failure die without transplantation. Treatment with liver 
transplantation leads to an overall survival of around 70%. 
Orthotopic liver transplantation leads to lifelong immuno-
suppression. In this cohort of patients compliance with 
immunosuppression is an issue and this can lead to further 
morbidity.
Auxiliary liver transplantation (ALT) involves only resect-
ing part of the native liver and transplanting a donor liver. 
Immunosuppression is withdrawn at an appropriate time and 
the donor liver undergoes atrophy. ALT is often performed 
as auxiliary partial orthotopic liver transplantation (APOLT). 
In this case, a hemihepatectomy is performed and a corre-
sponding split donor graft left in situ.
We performed a novel technique exclusively for acetomi-
nophen induced liver failure, using a subtotal hepatectomy 
(right trisectionectomy) with transplant of a whole donor 
graft (WGALT).
Methods: During the study period (January 2005 to May 
2010), 24 patients underwent WGALT for acetominophen 
induced liver failure. At the time of surgery, the patient 
underwent a right hepatic trisectionectomy and whole graft 
implantation in an orthotopic manner.
Results: 16 of 24 (67%) patients remain alive. There were 
7 post operative deaths. Thirteen patients have ceased immu-
nosupression. Two patients had recent transplants and the 
other had a regraft in the form of OLT. Comparing those who 
survived with those who died, donor age (40.4 vs 53.9, p = 
0.043) and blood transfusion requirements (4.3 vs 7.6, p = 
0.0043) were found to be signifi cant.
Conclusion: Acetominophen overdose is the leading cause 
for acute liver failure in the UK and US. OLT has a 70% 
survival at 1 year, and 65% at 5 years. Problems with man-
agement of immunosuppression can lead to further morbidity 
and potentially graft failure leading to death. WGALT has 
given equivocal results to OLT, but importantly, survivors 
are off immunosupression with normal liver function.
O56
POSTINTERVENTIONAL TUMOR 
NECROSIS PREDICTS RECURRENCE-
FREE LONG-TERM SURVIVAL IN LIVER 
TRANSPLANT PATIENTS WITH HCC
A. Kornberg1,2, B. Küpper2, B. Krause2, O. Habrecht2, 
A. Petrovitch3, P. Büchler1 and H. Friess1
1TU Munich, Klinikum rechts der Isar, Munich, Germany; 
2Department of Surgery, FSU Jena, Jena, Germany; 
3Department of Interventional Radiology, Klinikum Bad 
Berka, Bad Berka, Germany
Introduction: Between Nov. 1998 and Dec. 2008, a total of 
89 liver transplant candidates with HCC were included in 
this trial. Indication for listing was based on Milan criteria, 
while patient delisting was related to signifi cant tumor pro-
gression, such as macrovascular permeation and extrahepatic 
tumor spread. If being eligible, patients underwent pretrans-
plant interventional tumor treatment by transarterial chemo-
embolisation (TACE) or radiofrequency ablation (RFA). The 
impact of this treatment on tumor recurrence rate and 
survival has been investigated in uni- and multivariate 
analysis.
Results: Current overall posttransplant follow-up was 
ranging between 5 and 162 months (mean: 64.3 mo). 57 
patients underwent interventional bridging therapy (IBT; 
64%; TACE n = 49; RFA n = 8) pre-LT. Twenty patients 
developed post-LT tumor recurrence (22.5%), 9 patients in 
the non-treatment group (28.1%) and 11 patients in the IBT 
group (19.3%, P = 0.3). Recurrence-free survival rates were 
68% in the non-treatment population and 76% in the IBT 
group after 5 years (P = 0.38). Clinical tumor down staging 
resulted in a signifi cantly better 5-year recurrence-free sur-
vival rate (93%) than non-response to interventional therapy 
(49.5%; P = 0.001).
In patients revealing partial or complete tumor necrosis at 
explant pathology, HCC recurrence rate was signifi cantly 
lower (2.4%) than in patients without postinterventional 
tumor necrosis (66.6%; P < 0.001). Tumor necrosis at explant 
pathology was identifi ed as most important independent pre-
dictor of recurrence-free survival (odds ratio 53; P < 0.001). 
Milan Out patients with postinterventional tumor necrosis 
achieved an excellent recurrence-free survival at 5 years 
(91% versus 0%; P < 0.001). AFP-level < 100 U/ml (P = 
0.01) and absence of 18F-FDG tumor uptake (P < 0.001) 
predicted postinterventional tumor necrosis.
Conclusion: Postinterventional tumor necrosis by TACE or 
RFA improves signifi cantly outcome after LT for HCC. 
Patients with advanced HCC beyond the Milan criteria may, 
thereby, achieve an excellent long-term survival. Low AFP 
levels and PET – status indicate favorable tumor biology, 
realizing an adequate response to interventional treatment 
pre-LT.
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O57
IMPLICATIONS FOR THE USAGE OF 
THE LEFT LATERAL LIVER GRAFT FOR 
INFANTS ≤ 10KG BASED ON A SINGLE 
CENTRE EXPERIENCE-ARE 
MONOSEGMENTAL OR 
HYPERREDUCED GRAFTS 
REDUNDANT?
M. Schulze1, B. Dresske1, M. Burdelski2, M. Kohl2, 
F. Braun1 and D. Bröring1
1Department of Surgery, University of Schleswig Holstein, 
Campus Kiel, Kiel, Germany; 2Department of Pediatrics, 
University of Schleswig holstein, Campus Kiel, Kiel, 
Germany
The shortage of organ donors for low-weight infant liver 
transplant recipients has lead to an increase in splitting and 
living donation. In cases where even the left lateral graft 
(Couinaud’s Segments II and III) results in a ‘large for size 
syndrome’ with an estimated graft to body weight ratio of >4 
monosegmental grafts have been developed. This technique 
however bears other complications due to a greater resection 
plane and suboptimal vascular in and outfl ow.
Our standard technique for pediatric liver transplantation 
is the usage left lateral graft from either living donors or 
deceased donors. In cases of marginal intraabdominal space 
we insert a silicon foil for temporary closure.
Between 2006 and 2010 we transplanted 41 pediatric patients 
<10 kg. We used the left lateral graft in 37 cases. In this study 
we evaluated the outcome of 22 cases with a GBWR of ≥4.
We didn’t see any statistical difference in vascular com-
plications or bile problems. Although we more frequently 
inserted a temporary abdominal closure we did not have a 
higher rate of infections.
Overall patient and graft survival was excellent in both 
groups. We feel that the ventro-dorsal diameter of the graft 
and not the actual graft size is the factor that will lead to 
potential pressure on the graft and necrosis.
In conclusion we think that the usage of monosegmental 
grafts is not necessary if transplantation of the left lateral 
graft is performed by an experienced multidisciplinary team, 
and temporary abdominal closure is favoured in cases of 
increased abdominal pressure.
O58
LIVER-DERIVED MICRORNAS IN 
HUMAN BLOOD AS MARKERS FOR 
HEPATIC INJURY IN LIVER 
TRANSPLANTATION
W. R. R. Farid1, Q. Pan2, P. E. de Ruiter1, 
V. Ramakrishnaiah1, J. de Jonge1, J. Kwekkeboom2, 
H. L. A. Janssen2, H. J. Metselaar2, H. W. Tilanus1, 
G. Kazemier1 and L. J. W. van der Laan1
1Erasmus MC – University Medical Center, Department of 
Surgery, Rotterdam, Netherlands; 2Erasmus MC – 
University Medical Center, Department of 
Gastroenterology & Hepatology, Rotterdam, Netherlands
Background: MicroRNAs (miRNA), a class of small non-
coding RNAs, play an important regulatory role in many 
cellular functions and additionally hold great promise as 
non-invasive diagnostic biomarkers. Recent preclinical 
studies have demonstrated the utility of circulating miRNAs 
in marking drug-induced liver injury in rodents. The aim of 
this study is to investigate the potential of circulating hepa-
tocyte-derived miRNAs as markers for liver injury in patients 
with liver disease before and after liver transplantation.
Methods: Liver graft biopsies from liver transplant recipi-
ents (n = 46), and serum samples (n = 85) and peripheral 
blood mononuclear cells (PBMCs) (n = 14) from end-stage 
liver disease and liver transplant recipients, were analyzed 
by quantitative RT-PCR for the hepatocyte-derived miRNAs 
miR-122, miR-148a and miR-194, and control miRNAs, 
miR-133a and miR191.
Results: The expression of miR-122 and miR-148a in liver 
tissue showed a signifi cant reverse correlation with the dura-
tion of the graft’s warm ischemia time (R = −0.31 and R = 
−0.40 respectively, P < 0.05). All three hepatocyte-derived 
miRNAs were detectable in serum and their levels were 
signifi cantly elevated during hepatic injury, in contrast to the 
control miRNAs (P < 0.005). Moreover, serum levels of 
miR-122 and miR-148a strongly correlated with serum 
levels of aspartate transaminase (AST) and alanine transami-
nase (ALT) (R ≥ 0.75, P < 0.0001). In patients with an 
episode of acute rejection, levels of serum miR-122 and 
miR-148a followed similar patterns as serum AST and ALT 
levels and dropped quickly after treatment of rejection. 
Surprisingly, hepatocyte-derived miRNAs were also detected 
in PBMCs, and signifi cantly correlated with miRNA levels 
in serum (R = 0.68, P = 0.008), suggesting cellular uptake of 
miRNAs from serum. In vitro experiments confi rmed the 
uptake of miRNAs by blood cells.
In conclusion, circulating hepatocyte-derived miRNAs in 
patient blood and serum are markers for liver injury. The 
transfer of miRNAs from liver to blood cells prompts further 
research into their possible role in injury-related danger sig-
naling and repair mechanisms.
O59
EARLY PORTAL VEIN (PV) THROMBOSIS 
(PVT) IS ONE OF THE MOST FREQUENT 
SURGICAL COMPLICATIONS 
FOLLOWING PEDIATRIC LIVER 
TRANSPLANTATION(LT)
R. Charco1,3, M. Pérez-Lafuente2, C. Venturi3, A. Segarra2, 
I. Barber2, J. A. Molino3, A. Romero3, J. Ortega4, 
I. Bilbao1,3, V. Martinez-Ibañez5 and J. Bueno3,5
1HBP Surgery and Transplants Department. Hospital 
Universitario Vall d’Hebron, Barcelona, Spain; 
2Interventional Radiology Unit.Hospital Universitario Vall 
d’Hebron, Barcelona, Spain; 3Pediatric Liver 
Transplantation Unit.Hospital Universitario Vall d’Hebron, 
Barcelona, Spain; 4Pediatric Intensive Care Unit.Hospital 
Universitario Vall d’Hebron, Barcelona, Spain; 5Pediatric 
Surgery Department.Hospital Universitario Vall d’Hebron, 
Barcelona, Spain
We describe a different technique for the treatment of early PV 
complications following pediatric LT with a combination of 
minimally invasive surgery without hepatic hilum manipulation 
and endovascular treatment by interventional radiology.
A ‘no-touch’ hilum technique used in fi ve children with 
body weight <10 kg is described. Four patients developed 
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thrombosis and one portal fl ow absence secondary to col-
lateral steal fl ow post-LT. A vascular sheath was placed 
through the previous laparotomy in the ileocolic vein (n = 
2), inferior mesenteric vein (n = 1) or graft umbilical vein (n 
= 1). Portal clots were mechanically fragmented with balloon 
angioplasty. In addition, coil embolization of competitive 
collaterals (n = 3) and stent placement (n = 1) were per-
formed. The catheter was left in place and exteriorized 
through the wound (n = 2) or a different transabdominal wall 
puncture (n = 3).
A continuous transcatheter perfusion of heparin was sub-
sequently administered. One patient developed recurrent 
thrombosis 24 hours later which was resolved with the same 
technique. Catheters were removed surgically after a mean 
of 10.6 days. All patients presented portal vein patency at the 
end of follow-up. Three patients are alive after 5 months, 1.5 
and 3.5 years, respectively; one patient required retransplan-
tation 18 days post-procedure and the remaining patient died 
of adenovirus infection 2 months post-procedure.
O60
GENE EXPRESSION PROFILES OF 
APOPTOSIS INDUCED BY ISCHEMIA 
AND REPERFUSION IN THE RAT LIVER 
WITH OR WITHOUT ISCHEMIC 
PRE-AND POSTCONDITIONING
A. R. Knudsen1, A-S. Kannerup1, M. Kruhøffer2, 
P. Funch-Jensen1 and F. V. Mortensen1
1Department of Surgical Gastroenterology L, Aarhus 
University Hospital, Aarhus, Denmark; 2AROS Applied 
Biotechnology A/S, Aarhus, Denmark
Background and aim: Ischemic pre- (IPC) and postcondi-
tioning (IPO) has been shown to reduce (I/R) injury in the 
liver. It has been speculated that IPC and IPO activates anti 
apoptotic pathways and might be responsible for the protec-
tive properties of IPC and IPO. The aim the present study 
was to investigate the effect of IPC and IPO on apoptotic 
gene expression.
Methods: Thirty-eight male Wistar rats were divided into 
four groups: sham (n = 8), IRI (n = 10), IPC (n = 10), IPO 
(n = 10). All rats, except shams, were subjected to 30 min of 
liver ischemia. IPC consisted of 10 min of liver ischemia 
followed by 10 min of reperfusion. IPO consisted of three 
cycles of 30 sec of reperfusion and 30 sec of ischemia, 
applied immediately after the 30 min of total liver ischemia. 
Liver biopsy and standard liver parameters were sampled 
after 30 min of reperfusion. Total RNA was extracted from 
the biopsy and used for microarray analysis.
Results: ALT was elevated in intervention groups compared 
to the sham group (p = 0.010). GO Biological process terms 
identifi ed 563 genes affecting apoptosis, which were used in 
the following analysis. When comparing groups to sham, 
animals in the IRI group had 17 genes signifi cantly up-reg-
ulated, in the IPC group 72 genes were signifi cantly up-
regulated and 1 down-regulated. In the IPO group 171 genes 
where signifi cantly up-regulated. Multiclass analysis 
revealed 117 (30%) of genes affected. Ingenuity pathway 
analysis of these genes showed up-regulation of pathways 
involved in cellular death and liver necrosis but also activa-
tion of cell cycle and cell repair, cell signalling and gene 
expression.
Conclusions: IPC and IPO do not seem to confer protection 
by up-regulation of anti apoptotic pathways. In fact IPC and 
IPO increases expression levels of apoptotic genes.
O61
A PREOPERATIVE PROTEIN FREE DIET 
PROTECTS AGAINST HEPATIC 
ISCHEMIA AND REPERFUSION INJURY
T. M. van Ginhoven, T. Saat, M. Verweij, 
J. N. M. IJzermans and R. W. F. de Bruin
Erasmus MC, Rotterdam, Netherlands
Introduction: We have previously shown that 3 days of 
preoperative fasting protects against hepatic ischemia and 
reperfusion (I/R) injury. As pre-operative fasting is currently 
considered an unwanted necessity, the aim of the current 
study was to design a clinically applicable diet that protects 
against hepatic I/R injury. Therefore, we investigated the 
effect of a 3 day preoperative protein free diet on hepatic I/R 
injury.
Materials and methods: Male C57BL/6 mice were fed a 
control diet for 2 weeks. Hereafter, mice were randomized 
into three groups. They received either control food, no food 
or protein free food 3 days prior to I/R injury. I/R was 
induced by clamping the hepatic artery and vein to 70% of 
the liver for 75 minutes. Liver damage was assessed by 
means of serum ALAT and LDH levels, and percentage of 
hemorrhagic necrosis on haematoxylin and eosin stained 
sections.
Results: Three days of fasting reduced bodyweight by 
17.6% (±3.3%), and protein restriction by 9.6% (±1.8%). Ad 
libitum fed control animals gained 3.2% (±0.7%). At 6 hours 
after reperfusion both serum ALAT and LDH of the protein 
restricted group were signifi cantly lower when compared to 
the controls and the fasted group. At 24 hours after reperfu-
sion they were signifi cantly lower than the control group. 
Furthermore, preoperative protein restriction signifi cantly 
reduced the amount of hemorrhagic necrosis at 24 hours after 
reperfusion (Table 1).
Conclusions: A Preoperative protein free diet reduces 
weight loss and results in a more robust protects against 
hepatic I/R injury as compared to preoperative fasting. This 
nutritional intervention is a promising new strategy to imple-
ment in the clinical setting.
O62
ISCHEMIC PRECONDITIONING 
ENHANCE INSULIN-LIKE GROWTH 
FACTOR 1 PRODUCTION IN A PIG 
LIVER
A-S. Kannerup1, A. R. Knudsen1, H. Grønbæk2, 
A. Flyvbjerg3, J. Frystyk3 and F. V. Mortensen1
1Department of Surgical Gastroenterology L, Aarhus 
University Hospital, Aarhus, Denmark; 2Department of 
Medicine V, Aarhus University Hospital, Aarhus, Denmark; 
3Department of Medicine M, Aarhus University Hospital, 
Aarhus, Denmark
Background: Hepatic infl ow occlusion results in ischemia/
reperfusion (I/R) injury to the liver. Ischemic precondition-
ing (IPC) protects the liver against these injuries. Insulin-like 
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growth factor 1 (IGF-1) has also showed protective effect on 
I/R injury. The aim of this study was to monitor the effect of 
IPC on IGF-1 and IGF-binding protein-3 (IGFBP-3), before, 
during and after warm ischemia.
Methods: Sixteen randomized pigs, eight in each group, 
underwent laparotomy followed by 60 minutes of total isch-
emia with or without IPC (10 minutes of ischemia followed 
by 10 minutes of reperfusion) continued by 3 hours of reper-
fusion. Samples for IGF-1 and IGFBP-3 analysis were drawn 
from three catheters; carotic artery (CA), carotic vein (CV) 
and a hepatic vein (HV) and measured during the study 
period as well as liver parameters, alanine-aminotransferase, 
alkaline phosphatase, bilirubin, and prothrombin time, were 
performed.
Results: In the ischemic group IGF-1 and IGFBP-3 in both 
CA and HV decreased continuously from the beginning of 
ischemia and reach minimal levels 30 min after reperfusion 
before a slightly increase. In the IPC group IGF-1and 
IGFBP-3 in both CA and HV increased immediately from 
the beginning of ischemia and reach signifi cantly high levels 
30 min after reperfusion followed by a decrease. Only minor 
differences were observed in liver parameters.
Conclusions: IPC signifi cantly enhance IGF-1 and IGFBP-3 
expression during reperfusion whereas, ischemia signifi -
cantly decrease IGF-1 and IGFBP-3 expression in the same 
period. This change may be involved in the hepatoprotective 
mechanism induced by IPC.
O63
ISCHEMIC PRECONDITIONING BEFORE 
15/5 ISCHEMIA-REPERFUSION DURING 
LIVER RESECTION – A RANDOMIZED 
CONTROLLED STUDY
A. Winbladh1,4, B. Björnsson1,4, P. Gullstrand1, 
K. Offenbartl2, E. Svartholm3, L. Trulsson4, L. Bojmar4 and 
P. Sandström1,4
1Dep of Surgery, Linköping, Sweden; 2Dep of Surgery, 
Eksjö, Sweden; 3Dep of Surgery, Jönköping, Sweden; 
4Clinical and Expermental Medicine, Linköping, Sweden
Introduction: Intermittent infl ow occlusion (15 min isch-
emia/5 min reperfusion, 15/5) during liver resection causes 
less ischemia reperfusion injury (IRI) than continuous occlu-
sion. Previous studies have shown that ischemic precondi-
tioning (IP) also protects from IRI. No previous study has 
compared 15/5 with IP + 15/5.
Method: 32 consecutive patients with suspicion of malig-
nant liver disease had liver resections (minimum 2 segments) 
performed with infl ow occlusion 15/5. 16 were randomized 
to receive IP (10/10). The patients were stratifi ed according 
to volume of resection. No patient had chronic liver disease. 
The patients were followed for 5 days with microdialysis 
(μD).
Results: There were no differences between the groups 
regarding demographics or perioperative parameters (bleed-
ing, duration of ischemia, resection volume, complications 
and serum lab tests). There were no deaths. μD revealed 
lower levels of lactate (2.4 vs. 3.0 mM,), pyruvate (124 vs. 
164 mM) and glucose (6.4 vs. 7.8 mM) in the IP group, all 
p < 0.001. B-glucose levels were lower in the IP group 
throughout the study 8.1 (0.1) vs. 8.7 (0.1) mmol/L, p < 
0.001. Nitrite and nitrate levels decreased postoperatively 
but no differences were seen between the groups. One patient 
had an elevated glycerol curve before diagnosed with a 
stroke.
Conclusion: IP reduces the levels of lactate locally in the 
liver but not in serum, indicating that IP increases aerobic 
metabolism, possibly by reducing insulin resistance. μD can 
detect some complications early
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ROLE OF C-REACTIVE PROTEIN, 
APACHE II AND GLASGOW SCORE IN 
EARLY PREDICTION OF SEVERITY OF 
ACUTE PANCREATITIS
D. Bajec1, D. Radenkovic1, P. Gregoric2, N. Ivancevic2, 
V. Jeremic2 and B. Karadzic2
1Clinic for Digestive Surgery, Clinical Center of Serbia 
and School of Medicine, University of Belgrade, Belgrade, 
Serbia; 2Clinic for Emergency Surgery, Clinical Center of 
Serbia and School of Medicine, University of Belgrade, 
Belgrade, Serbia
Background/Aim: The early prediction of the severity of 
an acute attack of acute pancreatitis (AP) has important 
implications for management and timely intervention. The 
aim of this study was to compare the accuracy of Glasgow 
and Apache II scores and C-reactive protein (CRP) level in 
prediction of severity of acute pancreatitis.
Methods: Ninety one consecutive patients with acute pan-
creatitis primarily admitted were prospectrively studied. 
APACHE II score was recorded on admission, while Glasgow 
score and CRP levels were determinated 48 hours later. 
Severity of AP was defi ned according to Atlanta classifi ca-
tion system. Two study groups comprising 33 patients with 
mild AP (MAP) and 58 patients with severe AP (SAP) were 
compared.
Results: Mean values of Glasgow and Apache II scores and 
CRP were 4 and 10 points and 331 mg/L, respectively in 
SAP group, while in MAP group it were 1 and 4 points and 
62 mg/L, respectively. The accuracy of Glasgow and 
APACHE II scores, and CRP level, in prediction of severity 
of AP, using cut-off values of 8 and 3 points, 150 mg/l, 
respectively (derived from ROC curves), were calculated. 
The sensitivity and specifi city of Glasgow and Apache II 
scores and C-reactive protein were 79% and 81%, 72.7% and 
100%, 90.9% and 85.7%, respectively.
Conclusion: The CRP offers little, if any, advantage over 
the Glasgow and APACHE II score. CRP level and Glasgow 
score proved to be powerful a prognostic model as the more 
complicated APACHE II scoring systems, but with the dis-
advantage of a 24-hour delay.
O65
STATINS AND PROGRESSION OF ACUTE 
PANCREATITIS
V. Kanakala, V. Krishnan and K. Seymour
Northumbria Healthcare NHS Trust, North Shields, 
Newcastle upon Tyne, United Kingdom
Introduction: Statins are widely prescribed in the commu-
nity for the treatment of chronic vascular diseases. Statin use 
has been associated improved prognosis from acute pancre-
atitis in animal studies but with the development of acute 
pancreatitis (AP) in man. We sought to examine the effect of 
statin use on the progression of AP.
Methods: We performed a matched case (statin user) con-
trolled study in patients from two district general hospitals. 
The controls were matched for sex and age and cause of 
pancreatitis. Demographic details, cause of pancreatitis, 
statin use were recorded from Oct 2006–March 2009. 
Details of severity and progression of AP were assessed 
using Glasgow score, APACHE-2 and rise in C-reactive 
protein.
Results: 108 patients in statin group (SG) and 115 in control 
group (CG) were compared. Male to female ratio was equal 
in both groups [Male: Female 50%]. Total average duration 
of stay was equal in both groups (SG vs CG (11 vs 10 days). 
There is no signifi cant difference in admission to high depen-
dency (p = 0.36) or intensive care unit (p = 0.427) in either 
group. SG had less severe pancreatitis compared to CG (14% 
vs 26%). There is no statistical difference in the progression 
of AP in either group (p = 0.072). Mortality was equal in 
both groups [SG (5) vs CG (4)].
Conclusion: We found that statin use did not infl uence 
important markers of progression of acute pancreatitis. A 
trend for less severe disease was observed in the statin group 
suggesting larger studies could establish a protective role for 
statins.
O66
HYDROXYETHYL STARCH (130/0.4) 
COMBINED WITH GLUTAMINE 
DIPEPTIDE MODULATE 
INFLAMMATORY REACTION AND 
SUSTAIN INTESTINAL BARRIER IN 
VOLUME RESUSCITATION OF PATIENTS 
WITH SEVERE ACUTE PANCREATITIS
G. Zhao and C. Wang
Pancreatic Disease Institute, Union Hospital, Wuhan, 
China
Background and Aim: The present research aimed to 
compare the effect of different fl uids on infl ammatory reac-
tion and intestinal barrier in the resuscitation of severe acute 
pancreatitis (SAP).
Methods: 60 patients with SAP were divided into 3 groups 
at random, who were treated with isotonic saline alone 
(group C), combination of isotonic saline and Hydroxyethyl 
Starch (HES 130/0.4) (group H), combination of isotonic 
saline, HES 130/0.4 and glutamine dipeptide (group G). The 
patients were conducted to compare the clinic results, volume 
of resuscitation fl uid, and time of liquid balance, infl amma-
tory reaction and intestinal barrier function.
Results: Compared to the group C, the complications includ-
ing pancreatic pseudocyst, MODS, respiratory infl ammation 
of group H and group G were signifi cantly less (P < 0.05), 
while no signifi cant difference was showed between group H 
and group G. Furthermore, the days in ICU and LOHS of 
group H (10 ± 9, 22 ± 18) and group G (11 ± 6, 21 ± 23) were 
signifi cantly less than those of group C (14 ± 8, 26 ± 22, P < 
0.05). The volume of resuscitation fl uid of group H (442.36 ± 
78.24ml/kg/d) and group G (428.45 ± 68.44 ml/kg/d) were 
signifi cantly less than that of group C (488.53 ± 53.24 ml/
kg/d, P < 0.05). SpO2 and pHi of group H and group G 
increased more quickly than group C. Compared to group C, 
TNF-α, IL-8 and CRP level of group H and group G were 
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obviously lower at T4 and T8. L/M ratio and serum endotoxin 
of group H and group G were signifi cantly lower than those 
of group C. What’s more, there was statistical difference 
between group H and group G at T8. L/M ratio of group G 
was signifi cantly lower than that of group C both at T4 and 
T8 (P < 0.05).Serum endotoxin of group G was elevated more 
slightly and obviously lower than group C at T8 (P < 0.05), 
no statistical difference was showed between group H and 
group C. Though the mortality of the group H (3/20) and group 
G (2/20) were lower than that of group C (5/20), no signifi cant 
difference was showed among the three groups.
Conclusion: Combination of crystalloid and HES (130/0.4) 
might be more effective than crystalloid alone to improve 
microcirculatory derangements by modulating infl ammatory 
reaction and attenuating the intestine ischemical reperfusion 
injury in SAP. Glutamine dipeptide supplemented as resus-
citation fl uid might sustain the intestinal barrier in early stage 
of SAP and facilitate modulating infl ammatory reaction. It 
implied that combination of crystalloid, HES (130/0.4) and 
glutamine dipeptide might be performed in the early stage to 
attenuate the complications and improve the outcomes of 
SAP.
O67
EVALUATION OF TWENTY-FOUR HOUR 
INFUSION OF HUMAN RECOMBINANT 
ACTIVATED PROTEIN C (XIGRIS) EARLY 
IN SEVERE ACUTE PANCREATITIS: 
INITIAL REPORT OF THE XIGAP-1 
STUDY
A. Siriwardena1, C. Miranda1, J. Mason4, R. Bedair2, 
J. Eddleston2, B. Babu1, M. France3, P. Pemberton3 and
S. Smith1
1The Manchester Hepato-Pancreato-Biliary Centre, 
Manchester Royal Infi rmary, Manchester, United Kingdom; 
2Critical Care Unit, Manchester Royal Infi rmary, 
Manchester, United Kingdom; 3Department of Clinical 
Biochemistry, Manchester Royal Infi rmary, Manchester, 
United Kingdom; 4School for Health, University of 
Durham, Durham, United Kingdom
Introduction: Severe acute pancreatitis (SAP) remains a 
condition with a high morbidity and risk of death with no 
specifi c pharmacologic treatment. Human recombinant acti-
vated protein C (xigris) modifi es coagulation and infl amma-
tory cascades and reduced mortality in a large randomized 
trial in sepsis (PROWESS). As xigris can cause haemor-
rhage, SAP was a specifi c exclusion criterion in PROWESS. 
This study reports the initial clinical experience with the use 
of xigris for the early treatment of SAP.
Methods: SAP was defi ned as CT-confi rmed AP within 96 
hours of severe pain and 72 hours of admission; Acute 
Physiology And Chronic Health Evaluation (APACHE II) 
score > 9, plus a minimum of two of four systemic infl am-
matory response (SIRS) criteria measured on two occasions 
separated by at least 24 hours plus a Marshall organ dysfunc-
tion score (MODS) of = 2 for any system. Following regional 
ethics committee approval, XIGAP-1 opened to recruitment 
in November 2009. Of 71 screened AP admissions to a ter-
tiary hepatobiliary unit, 11 were eligible and 6 enrolled (4 
female, gallstone 3, alcohol 3). Median (range) APACHE II 
score prior to infusion of xigris was 18 (12–22). Median 
in-patient stay was 21 (9–58) days and median Critical Care 
Occupancy 17 (1–24) days. The focus of early experience 
was on haemorrhage.
Results: Infusion of xigris was not associated with either 
pancreatic, gastrointestinal or remote bleeding. Median 
MODS score prior to infusion was 5 (2–7) and post-xigris 
1.5 (0–4). 30 day mortality was 1.
Conclusion: Early administration of xigris to a carefully-
defi ned population of SAP is not associated with an increased 
incidence of haemorrhage. Further experience is required before 
an assessment can be made as to whether there should be an 
international multi-centre randomized trial of xigris in SAP.
O68
OPEN NECROSECTOMY AS TREATMENT 
FOR INFECTED NECROTIZING 
PANCREATITIS RESULTS IN AN 
INCREASED RISK OF MORTALITY 
COMPARED TO MINIMALLY INVASIVE 
TECHNIQUES
R. Charnley1, R. Lochan1, J. French1, J. Scott2, J. Rose2, 
R. Jackson2, K. Oppong3 and A. Kilner4
1Department of HPB Surgery, Freeman Hospital, 
Newcastle upon Tyne, United Kingdom; 2Department of 
Radiology, Freeman Hospital, Newcastle upon Tyne, 
United Kingdom; 3Department of Gastroenterology, 
Freeman Hospital, Newcastle upon Tyne, United Kingdom; 
4Critical Care Unit, Freeman Hospital, Newcastle upon 
Tyne, United Kingdom
Background: Minimally invasive techniques are increas-
ingly being used in infected pancreatic necrosis. We have 
analysed outcomes in our patients treated in a tertiary pan-
creatic unit.
Methods: All patients with bacteriologically confi rmed 
infected pancreatic necrosis obtained at their fi rst interven-
tional procedure were prospectively identifi ed. Patients were 
grouped into 3 time periods: Group A, 1995–1999: only open 
necrosectomy was offered; Group B, 1999–2005: open and 
minimally invasive (percutaneous and/or endoscopic) tech-
niques; Group C, 2005–2010: only minimally invasive 
methods of treatment were offered as primary modality of 
treatment. All continuous variables are reported as Mean 
(95% CI).
Results: During the study period 179 patients (m:f = 111:68) 
with bacteriologically confi rmed infected necrosis at fi rst 
intervention were treated: Group A, n = 33; Group B, n = 89 
and Group C, n = 57. Primary treatment modality: open 
necrosectomy, n = 90; percutaneous, n = 69; endoscopic n = 
20. There was an increasing trend in APACHE2 score on day 
of admission: Group A: 10.8 (9.4–12.3); Group B: 13.4 
(12.1–14.2); Group C: 16.9 (16.1–17.6) – p = 0.00. ICU stay 
has not changed signifi cantly: Group A: 12.8 (6.8–18.8); 
Group B: 20.6 (16.0–25.2); Group C: 27.6 (17.6–37.6) – p 
= 0.28. Total hospital stay signifi cantly increased: Group A: 
66.8 (54.3–79.3); Group B: 56.6 (46.4–66.7); Group C: 77.1 
(65.1–89.0) – p = 0.042 but mortality rates between the 3 
time periods have signifi cantly decreased; Group A:
12/33 (36%); Group B: 31/89 (34%); Group C: 7/50 (14%), 
p = 0.02.
Multi-variate regression analysis controlling for severity of 
disease and individual patient factors (age and co-morbidity) 
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identifi es open surgery as the only signifi cant independent 
factor [OR (95% CI) of 2.48 (1.05–5.94)] for in-hospital 
mortality.
Conclusion: Open surgery results in a signifi cantly higher 
risk of death from infected necrosis but minimally invasive 
techniques are associated with longer hospital stay.
O69
BYPASS SURGERY FOR BILIARY 
OBSTRUCTION IN CHRONIC 
PANCREATITIS
J. Omoshoro-Jones1,2, C. Jeppe1 and M. Smith1,2
1Chris Hani-Baragwanath Hospital, Johannesburg, South 
Africa; 2University of the Witwatersrand, Johannesburg, 
South Africa
Introduction: In chronic pancreatitis bile duct stricture 
occurs in 10–30%. Hepaticojejunostomy (HPJ) or choledo-
chojejunostomy (CD-J) and pancreaticoduodenectomy form 
the standard of care. There are also reports of the opening 
the intrapancreatic bile duct with incorporation into the pan-
creaticojejunostomy. This paper presents a South African 
experience with the use of HPJ or CD-J in the treatment of 
distal common bile duct stenosis (DCBDS) in patients under-
going duodenal preserving pancreatic resection for chronic 
pancreatitis.
Method: From a prospectively studied cohort of patients 
undergoing local resection of head of pancreas and pancre-
aticojejunostomy (LR LPJ), those that underwent concurrent 
HPJ or CD-J (performed to a section of the same Roux loop 
used for the LPJ) were analysed. Outcome measures include 
operative time, morbidity and mortality, and hospital stay.
Results: Of 97 patients that underwent LR LPJ for chronic 
pancreatitis between October 1994 and December 2009, 33 
(34%) had concurrent HPJ (11) or CD-J (22). Of 26 patients 
that had DCBDS, jaundice was present in all, with 11 pre-
senting with cholangitis managed with pre-operative endo-
scopic drainage used in all jaundiced patients. The median 
operative time, blood loss and transfusion rates were 5 
(3–9.6) hours, 0.7(0.3–2.5) L and 1 (1–3) units respectively. 
The morbidity rate was 37.8%. 7 patients (11.11%) devel-
oped pancreatobiliary related complications: 3 self-limiting 
bile leak, 4 pancreatic fi stulae (2 self-limiting, 1 required 
endo-therapy and 1 required re-operation). Two patients 
(0.06%) died: 1 from sepsis and multiple organ dysfunction/
failure, the other from pulmonary complications). The 
overall median hospital stay was 19 (6–59) days. No patient 
has recurrent jaundice.
Conclusion: DCBDS is common in chronic pancreatitis. 
Concurrent HPJ or CD-J at the time of the primary LR LPJ 
is simple and safe with minimal morbidity and mortality and 
good long term results. This procedure is recommended as 
an alternative to draining the bile duct by incorporating it 
into the pancreaticojejunostomy.
O70
THE EFFECT OF RENIN ANGIOTENSIN 
SYSTEM GENETIC VARIANTS UPON 
OUTCOME FROM CHRONIC 
PANCREATITIS
J. Skipworth1, T. Zayadine1, D. Raptis1, S. Vyas2, 
C. Imber2, S. Humphries1, S. Oldedamink1,2, M. Malago1,2, 
A. Shankar2 and H. Montgomery1
1University College London, London, United Kingdom; 
2Royal Free Hospital NHS Trust, London, United Kingdom
Background: Local renin-angiotensin systems (RAS) are 
now known to exist in diverse cells and tissues, where they 
have para/autocrine roles in the regulation of metabolism, 
blood fl ow, infl ammation and healing. Increased RAS activ-
ity has been implicated in the initiation and propagation of 
pancreatic infl ammation through a number of possible angio-
tensin II type 1 receptor (AT1R)-mediated mechanisms. 
Vitamin D may downregulate pancreatic RAS. We sought to 
investigate the role of functional RAS/vitamin D polymor-
phisms in the aetiology and severity of chronic pancreatitis 
(CP).
Methods: Sixty-fi ve CP patients were genotyped for eight 
polymorphisms of the renin-angiotensin and vitamin D 
systems, utilising polymerase chain reaction on a TaqMan® 
machine, and subsequently compared to over 5000 
controls.
Results: Of CP cases, 33 (51%) were secondary to alcohol 
disease, 8 (12%) idiopathic, 6 (9%) due to biliary disease, 4 
(6%) autoimmune, 2 (3%) due to pancreas divisum, 1 (2%) 
to hypercalcaemia, 1 (2%) IPMN and 10 (15%) unknown.
The I allele of the ACE I/D polymorphism was signifi -
cantly associated with development of new-onset diabetes 
following chronic pancreatitis (p = 0.003); however, no other 
polymorphisms were associated with disease development, 
aetiology or severity (assessed by no. acute admissions, 
quality of life/pain scores, requirement for operation, devel-
opment of exocrine dysfunction or development of pseudo-
cyst/pseudoaneurysm).
Discussion: An association of CP-related diabetes with the 
ACE I allele is contrary to the hypothesis that increasing 
RAS activity results in a likelihood of developing more 
severe disease. However, multiple angiotensin-I processing 
enzymes are now known to exist (e.g. chymase, chymotryp-
sin, tonin, aminopeptidase A, B and N, prolylendopeptidase, 
and neutral endopeptidase), and ACE levels may not there-
fore truly represent overall or local RAS activity.
Further, larger samples of CP patients are required to 
confi rm these results but it may be that the therapeutic poten-
tial for RAS-modulating agents, remains signifi cantly 
untapped.
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O71
PREDICTORS OF MORTALITY AND 
OUTCOME OF NON OPERATIVE 
MANAGEMENT, IN GRADE III and IV 
BLUNT PANCREATIC TRAUMA
K. S. Bhushan, N. Bheerappa and R. A. Sastry
Nizams Institute Of Medical Sciences, Hyderabad, Andhra 
Pradesh, India
Background: Although surgery is the standard treatment for 
grade III and IV pancreatic trauma, there are reports of 
success with non operative management (NOM).
Objective: To analyze the role of NOM and analyze the 
predictors of mortality and outcome of NOM after grade III 
and IV pancreatic trauma.
Patients and Methods: 60 patients with blunt pancreatic 
trauma presenting to our hospital over past 13 years were 
studied. Patients with grade I, II and V pancreatic injury and 
those associated with major injuries to other organ systems 
were excluded. Of the 44 patients that were included in the 
study, nine patients were operated early (<48hr) and formed 
the operative management (OM) group. Rest of the 35 
patients was classifi ed into NOM group. Data regarding 
demographics, management strategy (NOM vs. OM), com-
plications, and outcomes were collected from a prospectively 
maintained database. Univariate and multivariate analysis 
were performed using SPSS 18.
Results: Twenty of the 35 patients in the NOM group 
required surgery later and were considered failures. All the 
fi ve deaths occurred in this group. Pancreas specifi c compli-
cations were higher in NOM group (88% vs 33% ).
The signifi cant predictors of failure of NOM on univariate 
analysis were grade of injury (p:0.012), pancreatic contusion 
on CT (p:0.013), presence of ileus (p:0.001),associated pan-
creatitis (p:0.0001), presence of necrosis (p:0.0001), overall 
pancreatic complications (p:0.014). Pseudocyst (p:0.005) 
was the only factor predicting success of NOM. On binary 
logistic regression only grade of injury and necrosis were 
signifi cant factors. The signifi cant predictors of mortality on 
univariate analysis were female sex (p:0.005), pancreatic 
contusion on CT (p:0.036), presence of ileus (p:0.004), asso-
ciated pancreatitis (p:0.001), pancreatic necrosis(p:0.009) 
and failure of NOM (p0.034). On binary logistic regression 
only associated necrosis (p:0.02) was found to be signifi cant 
factor.
Conclusions: Grade III and IV injuries, have high mortality 
when not operated. They should be operated when associated 
with contusion in addition to ductal transection. Presence of 
necrosis and grade of injury are the signifi cant factors infl u-
encing outcome of NOM in grade III and IV injuries, while 
associated necrosis is the only signifi cant factor infl uencing 
mortality.
O72
CIVILIAN LOW VELOCITY GUNSHOT 
INJURIES OF THE PANCREAS: AN 
ANALYSIS OF 219 PATIENTS TREATED 
AT A LEVEL 1 TRAUMA CENTRE
G. Chinnery, J. Krige, U. Kotze, F. Hameed, P. Navsaria 
and A. Nicol
Department of Surgery, University of Cape Town Health 
Sciences Faculty, Cape Town, South Africa
Aims: This study sought to establish the morbidity and mor-
tality of low velocity gunshot injuries to the pancreas treated 
at a level 1 trauma centre.
Method: Demographic data, clinical presentation, operative 
management, morbidity and mortality were evaluated in a 
single centre retrospective review of all patients who sus-
tained a pancreatic gunshot injury from January 1976 to 
December 2009.
Results: 219 patients (205 male, 14 female) mean age: 28.6 
years (range 14–69), average RTS 11.25 (range 0–12) were 
treated. 96 (43.8%) presented with shock. Injuries involved 
pancreatic head and neck in 43%, body in 28% and tail in 
29%. All 219 had associated intra-abdominal injuries and 
123 (56.2%) had 3 or more associated injuries. 56 (25.6%) 
had combined pancreaticoduodenal injuries. 59 patients 
(26.9%) had associated vascular injuries, IVC (n = 30), renal 
artery/vein (n = 16), aorta (n = 6), portal vein (n = 6). 43 
(19.6%) patients required an initial damage control proce-
dure before defi nitive surgery. 103 (43.4%) patients had 
drainage of the pancreatic injury only, 58 (26.5%) a distal 
pancreatectomy and 11 required a pancreaticoduodenectomy 
for nonreconstructable damage to the pancreatic head. Forty 
six patients (21%) died due to exsanguinating intraoperative 
bleeding (n = 17), sepsis (n = 6) and MODS (n = 14). 148 
(67.6%) patients had postoperative complications (mean 2.8, 
range 1–7). Pancreatic-related complications were most 
common (n = 31 pancreatic fi stula), followed by abdominal 
sepsis, DIC and bleeding, respiratory failure and pneumonia. 
Shock at presentation was highly predictive of developing a 
complication. Mean intensive care unit and total hospital stay 
for the 219 patients were 5.9 (0–153) days and 23.1 (1–255) 
days.
Conclusion: Morbidity and mortality after gunshot inj-
uries of the pancreas are closely related to associated intra-
abdominal and vascular injuries. Lesser injuries require 
drainage only, 25% need a distal resection and 4% a pancre-
atoduodenectomy. Shock at presentation is predictive of sub-
sequent complications.
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SURGICAL VERSUS NON SURGICAL 
THERAPY OF HCC ON CIRRHOSIS: 
RESULTS OF AN OBSERVATIONAL 
STUDY ON 692 CASES
A. Guglielmi1, A. Ruzzenente1, F. Capra2, T. Campagnaro1, 
A. Valdegamberi1, D. Ieluzzi2, G. Turcato1 and C. Iacono1
1Department of Surgery, Division of General Surgery ‘A’, 
GB Rossi University Hospital, Verona, Italy; 2Department 
of Medicine, Internal Medicine ‘C’, GB Rossi University 
Hospital, Verona, Italy
Background: Barcelona Clinic Liver Cancer (BCLC) 
staging system is widely accepted for clinical decision 
making of patients with HCC on cirrhosis. The aim of our 
study is to evaluate survival of surgical and non surgical 
therapy of HCC on cirrhosis in a cohort of 692 patients.
Methods: Retrospective analysis of a multi-institutional 
database of 692 cirrhotic patients with HCC, prospectively 
evaluated between 1991 and 2009. Diagnosis of HCC was 
performed according with American Association of the 
Study of Liver Diseases (AASLD) guidelines. Patients were 
treated with surgical liver resection (LR), percutaneous local 
ablative treatment (LAT) as ethanol injection (PEI) and 
radiofrequency ablation (RFA), chemoembolization (TACE) 
or supportive therapy (ST).
Results: 476 (68.7%) patients were in Child–Pugh class A, 
193 (27.8%) in class B, and 23 (3.3%) in class C. 388 
(56.1%) patients had unifocal HCC, 190 patients had 2 or 3 
HCCs (27.4%) and 114 (16.5%) had more than 3 HCCs. 181 
patients (26.2%) were submitted to LR, 302 (43.6%) to LAT, 
77 (11.1%) to TACE and 132 (19.1%) to ST. 3 and 5 years 
survival for patients submitted to LR was 57.7% and 44.9%, 
to LAT was 46.9% and 19.9%, and to TACE was 41.6% and 
0% (p < 0.05).
O74
VIABLE TUMOR TISSUE ADHERENT TO 
NEEDLE APPLICATORS AFTER LOCAL 
ABLATION: A RISK FACTOR FOR 
LOCAL TUMOR PROGRESSION
N. Snoeren1, J. Huiskens2, A. Rijken3, R. van 
Hillegersberg1, A. van Erkel4, G. Slooter5, J. Klaase6, 
P. van den Tol7, F. ten Kate2, M. Jansen2 and T. van Gulik2
1University Medical Centre, Utrecht, Netherlands; 
2Academic Medical Centre, Amsterdam, Netherlands; 
3Amphia Hospital, Breda, Netherlands; 4Leiden University 
Medical Centre, Leiden, Netherlands; 5Maxima Medical 
Centre, Veldhoven, Netherlands; 6Medisch Spectrum 
Twente, Enschede, Netherlands; 7VU Medical Centre, 
Amsterdam, Netherlands
Background: Local tumor progression (LTP) is a serious 
complication after local ablation of malignant liver tumors, 
negatively infl uencing patient survival. LTP may be the result 
of incomplete ablation of the treated tumor. In this study we 
determined whether viable tumor cells attached to the needle 
applicator after ablation was associated with LTP and 
disease-free survival.
Methods: In this prospective study, tissue was collected of 
96 consecutive patients undergoing local liver ablations for 
130 liver malignancies. Cells and tissue attached to the 
needle applicators were analyzed after ablation for viability 
using glucose-6-phosphate-dehydrogenase (G6PD) staining 
and autofl uorescence intensity levels of H&E stained sec-
tions. Patients were followed-up until disease progression.
Results: Viable tumor cells were found on the needle appli-
cators after local ablation in 26.7% of patients. The type of 
needle applicator used, an open approach and the omission 
of track ablation were signifi cantly correlated with viable 
tumor tissue found adherent to the needle applicator. The 
presence of viable cells was an independent predictor of LTP 
as determined with uni- and multivariable analysis. Mean 
time to local disease progression was 9 months. The attach-
ment of viable cells to the needle applicators was associated 
with a shorter time to LTP, but not with disease free or overall 
survival.
O75
HEPATIC RESECTION FOR 
HEPATOCELLULAR CARCINOMA WITH 
PORTAL VEIN THROMBOSIS
C. S. Ahn, S. G. Lee, Shin hwang, K. H. Kim, 
G. B. Moon, H. Y. Ha, G. W. Song, D. H. Jung, 
G. C. Park and Y. D. Yu
Asan Medical Center, college of Medicine, University of 
Ulsan, Seoul, Korea
Purpose: Surgical resection for hepatocellular carcinoma 
(HCC) is considered as the most effective treatment. But if 
the tumor is accompanied with portal vein thrombosis (PVT), 
the surgical strategy is not yet established because of its high 
recurrence rate and poor prognosis. Some authors consider 
it as a contraindication for resection. But some reported long 
survival after surgery. So we analysis the role of surgery in 
HCC with PVT.
Methods: From Jan.2006 to Dec.2007, we underwent 63 
cases of hepatic resections for HCC with PVT, and their 
clinical data were analyzed retrospectively.
Results: Major hepatectomy was done in 38 cases (60.3%) 
and minor resection in 25cases. Most common type of resec-
tion was right lobectomy in 33 cases (52.4%). Portal vein 
tumor thrombosis is confi rmed only in 31 cases (49.2%) by 
pathologic examination. Microscopic vascular invasion was 
detected in 38 cases (60.3%). Overall survival for 1 and 3 
year was 73.0% and 48.8%. (84.4% and 61.8% for non-
tumor thrombosis, 58.6% and 33.6% for tumor thrombosis, 
p = 0.012). There was no perioperative mortality. Minor 
complications occurred in 14patients including ascites 
requiring diuretics. One patient was died due to late hepatic 
failure.
Conclusions: HCC with portal vein tumor thrombosis 
resulted in poor prognosis. but less than half of preoperative 
PVT were proven to real tumor throbi. And postoperative 
morbidity after major hepatectomy for these patients were 
similar with HCC without PVT.
So surgical resection should included as a treatment tool 
positively for selective patients with comparable good results.
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O76
RESULTS FROM A SPECIALIST CENTRE 
FOLLOWING RESECTION OF 
HEPATOCELLULAR CARCINOMA 
ARISING WITHIN A NON-CIRRHOTIC, 
NON-FIBROTIC, SERONEGATIVE LIVER
A. L. Young, R. A. Adair, K. R. Prasad, G. J. Toogood and 
J. P. A. Lodge
St James’s University Hospital, Leeds, West Yorkshire, 
United Kingdom
Background: Hepatocellular carcinoma (HCC) most com-
monly arises in patients with chronic liver disease. Data on 
outcome post liver resection in patients with non-diseased 
livers is limited. The largest series of such patients is reported 
here. Differences in prognostic factors and outcomes between 
patients presenting with HCC arising in diseased and non-
diseased livers were investigated.
Methods: There were 142 patients identifi ed of whom 81 
had no background liver disease. Clincopathological data 
from this group was analyzed, comparing it with the group 
of patients who had liver disease present.
Results: HCCs resected from patients with normal back-
ground parenchyma were more likely to be larger (p < 
0.001), require major resections (p = 0.002) and present as 
solitary tumours (p = 0.025). There was no signifi cant differ-
ence in survival outcomes between patients who had HCC 
in ‘normal’ and ‘abnormal’ livers. In patients with ‘normal’ 
livers, the only factors signifi cant at predicting overall sur-
vival on multivariate analysis was blood transfusion require-
ment (p = 0.003) and age >65 (p = 0.009) and the only 
signifi cant factor at predicting recurrence free survival on 
multivariate analysis was presence of multiple tumours (p = 
0.025). In contrast, in HCC resected from patients with back-
ground liver disease, the only signifi cant prognostic variables 
on multivariate analysis were a pre-operative tumour biopsy 
(p = 0.017) or a high neutrophil-lymphocyte ratio (p = 0.001) 
which predicted a poorer recurrence free survival.
Conclusion: HCC presenting in patients with a normal 
background parenchyma appear to present a different spec-
trum of the disease. However, excellent outcomes can be 
achieved after liver resection but this often requires the use 
of extensive resections and advanced techniques.
O77
LIVER RESECTION (LR) FOR LARGE 
HEPATOCELLULAR CARCINOMA (HCC) 
WITH UNDERLYING LIVER DISEASE
J. Salceda, C. Tayar, A. Laurent, D. Cherqui and 
D. Azoulay
Hôpital Henri Mondor – Université Paris 12, Paris, 
France
Introduction: For patients who have developed an HCC 
larger than 7 cm over a chronic liver disease, liver resection 
is the only potentially curative therapy. Morbidity and mor-
tality after major LR are higher among these patients. The 
aim of this study is to report the outcomes of LR for HCC 
larger than 7 cm over a chronic liver pathology.
Methods: Between 1989 and 2010, 321 patients underwent 
a liver resection for HCC. Out of these, 79 were resected for 
having an HCC larger than 7 cm developed over a chronic 
liver pathology (METAVIR F3 or F4). There were 71 men 
and 8 women, median age was 56.6 ± 12.6 years, and 95% 
were Child A.
Underlying hepatopathy was: 42% virus B, 23% virus C, 
34% alcoholic, 8% NASH.
There were no patients with metastases and AFP serum 
levels have a median value of 2308 ± 5882 ng/dl.
Results: 80% of patients received a major liver resection 
and 19% after portal vein embolization.
94% of the hepatectomies were anatomic resections and 
12% were performed through a laparoscopic approach.
Median operative time was 218 minutes (r: 90–420 min).
75% of resections, clamping maneuvers were performed, 
and 31% were transfused with a media of 4 units.
Post-operative mortality was 12.6%.
23% of patients have a complication grade III or IV. 
(Clavien Classifi cation).
Median hospital stay was 15 ± 11 days.
R0 resection was achieved in 84% of cases, median tumor 
size was 107 ± 36 mm, 68% have satellite nodules and 41% 
macroscopic vascular invasion.
After a median follow-up moyen of 2.0 ± 2.1 years, global 
survival and disease free survival rates were at 1, 2, 3 and 5 
years, 61%, 47%, 34%, 27% and 55%, 38%, 33%, 19% 
respectivelly.
Conclusions: Even associated to a post-operative mortality 
of 12% and a major morbidity of 23%, hepatic resections for 
patient with large HCC over chronic liver pathology is the 
only treatment who could offer a 3-year survival rate for the 
33% of the patients.
O78
PROGNOSIS AFTER HEPATIC 
RESECTION FOR ‘BCLC STAGE A’ 
HEPATOCELLULAR CARCINOMA
E. Opocher, R. Santambrogio, M. Barabino, M. Costa, 
A. P. Ceretti and E. De Nicola
San Paolo Hospital, Milan, Italy, Italy
Introduction: BCLC is one of the most widely diffused 
algorithms for the staging and strategy planning of hepato-
cellular carcinoma (HCC) in cirrhotic patients. Nevertheless, 
this score has been pointed out to be too strict in allocating 
patients for hepatic resection (HR) in early stage [BCLC A] 
(HR rate: 10–20%).
Aim: to assess, in a cohort of patients followed in clinical 
practice, the capability of BCLC A in allocating subjects to 
HR and the effect on survival.
Methods: We enrolled, between January 1997 and February 
2010, 132 patients with HCC amenable to HR. There were 
65 BCLC A1, 28 A2, 7 A3, and 32 A4 patients. Ninety-fi ve 
percent were Pugh-Child A, 76% were MELD ≤9, and 56% 
were LCSGJ 1/2. All patients underwent US-guided anato-
mical HR and then peri-operative results and overall survival 
were evaluated.
Results: There were no statistical differences between the 
four sub-groups in baseline pre-operative features. No 30-day 
mortality occurred. Morbidity increases according to BCLC 
subgroups. Overall survival got worse from A1 to A4 (P < 
0.0271). Peri-operative and long-term results were similar 
with or without portal hypertension [PH] (P = 0.1389). 
Among all peri-operative factors, AFP levels (>20 ng/mL) 
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resulted the only independent predictors of survival. By 
matching AFP levels with BCLC system we identifi ed two 
major sub-groups with different 5-years survival rate: A1-A2 
with normal AFP (5y-S: A1 57%, A2 65%) and A1-A2 with 
abnormal AFP, A3-A4 (5y-S: 36%).
Conclusion: BCLC score confi rmed an high value in HCC 
staging, but seemed to fail in adequately allocating patients 
in stage A with respect to prognosis. PH may not represent 
a contraindication a priori, thus in favorable selected patients 
we can increase HR pool of candidates.
O79
INFERIOR VENA CAVA RESECTION 
WITH HEPATECTOMY: CHALLENGING 
BUT JUSTIFIED
D. J. Malde, V. Upasani, K. R. Prasad, G. J. Toogood and 
J. P. A. Lodge
The Hepatobiliary and Transplant Unit, St. James 
University Hospital, Leeds, United Kingdom
Introduction: The objective of this study was to evaluate 
the clinical signifi cance of hepatectomy combined with IVC 
resection and reconstruction for treatment of invasive liver 
tumours. This approach with its high surgical risks and poor 
long term survival has improved with recent advances.
Methods: From February 1995 to September 2010, 35 
patients underwent hepatic resection with IVC resection. 
They had a mean age of 58 years (range 32–84). There were 
18 male and 17 female patients. Resections were carried out 
for colorectal liver metastasis (n = 21), Hepatocellular carci-
noma (n = 6), Cholangiocarcinoma (n = 3) and other (n = 5). 
Major hepatectomy (≥3 segments) was carried out in 30 
(85.7%) cases and the caudate lobe was resected in 15 cases 
(42.9%). The liver resections carried out included 32 fi rst, 2 
second and 1 third hepatectomy. Resections were carried out 
with total vascular occlusion in 34 cases and without in one. 
Intraoperative hypothermic perfusion was performed in 4 
and Ex-vivo in 6 cases.
Results: There were 3 (8.6%) early deaths from multiple 
organ failure. Post operative complications occurred in 14 
(40%) cases with 3 (8.8%) requiring reoperation. Median 
operative time was 255 minutes (range 90–660) and median 
post operative hospital stay was 12 days (range 6–45). 
Transfusion was necessary in 19 (55.8%) patients (median 5 
units). All vascular reconstructions were patent at last follow 
up. The overall median survival was 20 months and median 
disease free survival was 16 months (5 year survival 14.7%). 
The 1-, 2- and 5- year survival was 76.2%, 38.1% and 9.5% 
for colorectal liver metastasis. The 1 year survival for HCC 
and Cholangiocarcinoma was 80% and 33% respectively.
Conclusion: Aggressive surgical management of liver 
tumours with IVC involvement offers the only hope for cure 
or palliation in selected cases. Resection by specialist teams 
affords acceptable peri-operative morbidity and mortality.
O80
THE PROGNOSTIC SIGNIFICANCE OF 
PREOPERATIVE SERUM LEVELS OF 
EXTRACELLULAR MATRIX PROTEIN 1 
IN PATIENTS WITH HEPATOCELLULAR 
CARCINOMA
H. Chen, J. Li, W. Jia, G. Xu and W. Wang
Centre for the Study of Liver Cancer and Department of 
Hepatic Surgery, Anhui Provincial Hospital, Anhui Medical 
University, hefei, China
Introduction: Extracellular matrix protein 1 (ECM1) is a 
glycoprotein involved in many biological processes. To eval-
uate the prognostic value of preoperative serum ECM1 levels 
in patients with hepatocellular carcinoma (HCC).
Patients and methods: Preoperative serum levels of ECM1 
were detected by enzyme-linked immunosorbent assay 
(ELISA) in 117 patients with HCC and 53 healthy volun-
teers. And their correlations to the clinicopathological char-
acteristics and patients’ survival rate were analyzed.
Results: We found that the median serum ECM1 level in 
HCC patients was signifi cantly higher than that in healthy 
volunteers (166.39 vs 132.78 pg/ml, P < 0.001). Median 
serum ECM1 levels were signifi cantly higher in patients with 
advanced TNM stage (P < 0.001), multiple nodule (P = 
0.028), vascular invasion (P < 0.001), severe liver cirrhosis 
(P < 0.001) and larger tumor size (P = 0.001). On the basis 
of the receiver operating characteristics curve, 180 pg/ml 
was defi ned as the critical value for the ECM1 levels, the 
sensitivity was 80.9%, and specifi city was 80.0%.
The median for serum ECM1 levels of the HCC patients 
with recurrence was signifi cantly higher than those without 
recurrence (P < 0.001). On Cox proportional-hazard model 
multivariate analysis, high serum ECM1 level (>180 pg/ml) 
was an independent prognostic factor for overall survival and 
disease free survival of HCC patients.
Conclusion: Serum ECM1 levels are signifi cantly correlated 
to the invasive phenotypes and survival rate. Thus, serum 
ECM1 level can be used as a predictive marker for recurrence 
and prognostic factor of HCC patients after surgery.
O81
PREDICTOR OF PROGNOSIS IN 
PATIENTS WITH LIVER CIRRHOSIS 
WHO UNDERWENT ELECTIVE EXTRA 
HEPATIC SURGERY
S. H. Kim, N. K. Kim, W. J. Lee, S. H. Noh, C. B. Kim 
and K. S. Kim
Dept. of Surgery, Yonsei University College of Medicine, 
Seoul, Korea
Background: Underlying liver cirrhosis is closely related 
with high morbidity and mortality rate after surgery. Some 
studies have recently reported contrary results about the 
capacities of Child-Turcotte-Pugh (CTP) and Model of End-
stage Liver disease (MELD) score to predict prognosis. In 
this study, we designed to compare the capacities of CTP, 
MELD, MELD plus sodium (MELD-Na) and delta MELD-Na 
score to predict prognosis in patients with liver cirrhosis 
underwent elective extra hepatic surgery.
Method: Medical records of 79 patients with liver cirrhosis 
who underwent elective extra hepatic surgery under general 
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anaesthesia from Dec. 1999 to Dec. 2009 were reviewed 
retrospectively.
Results: During median 21 months (range 1–123 months) 
follow-up periods, 19 (24.1%) of the 79 patients died. Among 
clinical and operative characteristics, albumin level and 
intraoperative transfusion amounts were signifi cantly differ-
ent between survival and non-survival group. All CTP, 
MELD, MELD-Na and Delta MELD-Na score were higher 
in non-survival group than that in survival group. In log rank 
test, albumin, CTP class, ascites, encephalopathy and intra-
operative transfusion amounts were meaningfully associated 
with prognosis. However, in Cox proportional hazards 
model, Delta MELD-Na (postoperative 7 days MELD-Na 
minus preoperative MELD-Na) was only signifi cant in rela-
tion to the prognosis (P = 0.001, OR = 3.574, 95% CI = 
1.252–10.204).
Conclusion: Delta MELD-Na was the only test item signifi -
cantly correlated with mortality in patients with liver cir-
rhosis underwent elective extra hepatic surgery. Larger-scale 
studies will be needed to more accurately defi ne predictive 
capacities of Preoperative scores and delta MELD-Na.
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O82
COMBINED PALLIATIVE STENTING 
FOR MALIGNANT BILIARY AND 
DUODENAL OBSTRUCTION
C. Price, J. Krige, J. Shaw, S. Burmeister, P. Bornman and 
S. Beningfi eld
Department of Surgery, University of Cape Town Health 
Sciences Faculty, Cape Town, South Africa
Background: This study evaluated the clinical effi cacy of 
combined palliative stenting in patients who had advanced 
biliary and duodenal malignant obstruction.
Patients and methods: Consecutive patients with advanced 
biliary and duodenal malignant obstruction not suitable for 
surgical bypass were referred for palliative duodenal stenting 
using self expanding metal stents (SEMS) and biliary stent-
ing using either SEMS or 10 or 12 Fr plastic stents were 
followed prospectively from January 2009 to March 2010. 
Data were collected prospectively. Demographic data, nature 
of the malignant stricture, stent deployment success rates, 
stent patency, procedural complications and survival times 
were recorded.
Results: Forty two patients (pancreatic carcinoma n = 31; 
cholangiocarcinoma n = 4; gallbladder carcinoma n = 3; 
antral gastric carcinoma n = 4) underwent double stenting. 
In 40 patients the biliary obstruction occurred before the 
onset of duodenal obstruction, and in 2 patients the duodenal 
obstruction preceded biliary obstruction. Mean pre-stenting 
bilirubin was 297 umol/L and Gastric Outlet Obstruction 
Severity Score (GOOSS) was 0. Duodenal stenting was suc-
cessful in all 42 patients; in 3, oral intake after stenting was 
inadequate. Endoscopic biliary stents were placed in 33 
patients (SEMS n = 29, plastic n = 4) and nine biliary stents 
were inserted using radiological percutaneous transhepatic 
biliary access (SEMS n = 7, plastic n = 2).
Mean hospital stay for each procedure after stenting was 
3.8 days. Functional success rates with relief of jaundice 
were 95% (40/42) and improved GOOSS scores were 93% 
(39/42). Complications occurred in 3 patients with duodenal 
stents (GI bleeding in 2, stent migration in 1). During follow-
up, 5 duodenal stents and 5 biliary stents blocked. The 
median survival after combined stenting was 85.2 days, 
range 4–320 days.
Conclusion: Biliary and duodenal stenting is safe and 
effective in malignant biliary and duodenal obstruction and 
provides effective palliation in patients with advanced malig-
nancy that is unsuitable for bypass surgery and has a limited 
life expectancy.
O83
LOCALLY ADVANCED PANCREATIC 
AND PERIAMPULLARY CANCER – IS 
PALLIATIVE RESECTION JUSTIFIED?
W. J. Eshuis, O. R. C. Busch, T. M. van Gulik and 
D. J. Gouma
Academic Medical Center, Amsterdam, Netherlands
Background: After pancreatoduodenectomy (PD) for 
cancer in the pancreatic head area, a radical (R0) resection 
is the most important predictor of survival. A bypass proce-
dure is generally accepted as palliative treatment for locally 
advanced disease. Currently, a non-radical (R1/R2) resection 
is more frequently advocated for these patients.
Aim: To analyse perioperative outcomes and survival after 
non-radical PD and palliative bypass procedure (PBP) for 
locally advanced pancreatic and periampullary cancer.
Methods: In a prospective database of patients who under-
went surgery for suspected pancreatic and periampullary 
cancer, we identifi ed patients who had undergone non-radical 
PD (R1/R2-group) or PBP for locally advanced disease 
(in absence of metastasis, bypass-group). In these groups, 
we analysed demographics, perioperative outcomes and 
survival.
Results: Between 1992–2009, 1182 explorations for sus-
pected pancreatic or periampullary cancer were performed, 
resulting in 790 PDs and 382 PBPs. 192 PDs were non-
radical (R1/R2-group), and 197 PBPs were performed 
because of locally advanced disease (bypass-group). Mean 
age in these two groups was 62.2 and 62.8 years, respec-
tively. In the R1/R2-group, 48% of patients were male, 
versus 58% in the bypass-group (P = 0.039). Overall morbid-
ity rates were 50% (R1/R2-group) and 35% (bypass-group) 
(P = 0.003). Hospital mortality rates were 1% (R1/R2-group) 
and 2.5% (bypass-group) (P = 0.27). Median hospital stay 
was 15 days in the R1/R2-group, versus 10 days in the 
bypass-group (P < 0.001). 5-Years follow-up was complete 
for 96% of patients. Estimated median survival times were 
17.1 months (R1/R2-group) and 9.8 months (bypass-group), 
log-rank test, P < 0.001.
Conclusions: Non-radical PD can be performed at an 
acceptable morbidity rate with low mortality. Survival after 
non-radical PD is better than after PBP for locally advanced 
disease. Despite a selection bias, these results support the 
idea that PD can be considered in selected patients with 
intraoperatively encountered locally advanced disease. If 
there is doubt about the local resectability, resection should 
be performed.
O84
LONGITUDINAL HEALTH-RELATED 
QUALITY OF LIFE AND SELF 
REPORTED TREATMENT PREFERENCE 
OF PATIENTS SCHEDULED FOR 
PANCREATODUODENECTOMY WITH 
OR WITHOUT PREOPERATIVE BILIARY 
DRAINAGE
N. van der Gaag, S. de Castro, W. Eshuis, M. Sprangers, 
O. Busch, E. Rauws, M. Bruno, T. van Gulik, P. Bossuyt 
and D. Gouma
Academic Medical Center, Amsterdam, Netherlands
Introduction: In patients suspected to have a pancreatic 
tumor the value of preoperative biliary drainage (PBD) to 
reduce overall treatment complications was investigated in a 
two-arm multicenter RCT (early surgery vs. PBD). In a par-
allel study we analyzed health-reported quality of life (HR-
QoL) for both treatment arms, and we asked which arm 
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patients would have preferred as treatment strategy if not for 
randomization.
Methods: The RCT comprised 202 patients of whom 82 
were recruited at the initiating trial centre, and who were 
asked to participate in the current study. Of 82 patients 73 
(89%) self-completed the EORTC QLQ-C30, PAN-26 QoL 
and the treatment preference questionnaires prior to random-
ization, 2 weeks following PBD [PBD-group only], and three 
and 6 weeks after hospital discharge following surgery.
Results: Mean age of the study cohort was 64 years (SD 
9.8), 67% male. Of 73 patients 38 (52%) underwent early 
surgery and 35 (48%) PBD. Clinicopathological and opera-
tive characteristics were not signifi cantly different between 
groups, and closely resembled the original trial cohort. Mean 
reported global health status (possible range 0–100) for the 
entire group was 49 (95%CI: 43–55) before randomization, 
54 (95%CI: 43–64) 2 weeks following PBD, and 57 (95%CI: 
51–32) and 61 (95%CI: 56–67) three respectively 6 weeks 
after hospital discharge. The within-group improvement over 
time was signifi cant (P 0.002), but there was no between-
group difference (P 0.16). For another 12 HR-QoL subdo-
mains patients from both groups also improved equally over 
time. Only for the hepatic symptom domain (jaundice, pru-
ritus) patients that underwent PBD improved slightly better 
(B −34; 95%CI −40 to −28), compared to early surgery 
patients (B −25; 95%CI −32 to −18) (P 0.04). Before ran-
domization 81% preferred to undergo early surgery, 7% 
PBD, and 12% did not have a treatment preference, while 
after ending treatment 74% still preferred early surgery, 10% 
PBD, and 16% had no preference.
Conclusions: We observed a signifi cant improvement over 
time for nearly all HR-QoL domains following surgery for a 
suspected pancreatic tumor, without signifi cant differences 
between an early surgery or PBD strategy except for the 
hepatic domain. From the perspective of HR-QoL both treat-
ment strategies can be considered equivalent. However, the 
large majority of patients consistently admit early surgery 
to be the preferred treatment strategy from their own 
perspective.
O85
TO DRAIN OR NOT TO DRAIN: A TRIAL 
SEQUENTIAL META-ANALYSIS 
REGARDING THE POST-OPERATIVE 
USE OF ABDOMINAL DRAINS AFTER 
PANCREATICODUODENECTOMY FOR 
PANCREATIC MALIGNANCY
A. A. Van der Wilt1, I. H. J. T. De Hingh2, 
C. H. C. Dejong1 and R. M. Van Dam1
1Maastricht University Medical Centre, Maastricht, 
Netherlands; 2Catharina Ziekenhuis Eindhoven, Eindhoven, 
Netherlands
Background: In several fi elds of abdominal surgery, post-
operative use of abdominal drains was once considered stan-
dard practice. However, since accumulating evidence 
suggests that drains do not contribute to patients’ wellbeing, 
prolong hospital stay and may even be harmful, the use of 
drains has been abandoned for most abdominal procedures. 
We assessed whether there is also suffi cient evidence to 
abandon post-operative drainage after pancreaticoduodenec-
tomy for pancreatic malignancies.
Method: A systematic review of the evidence in Pubmed 
and a heterogeneity-adjusted trial sequential meta-analysis.
Data export and analysis: Our search produced 45 potentially 
relevant papers. Of these, two papers met our predefi ned 
inclusion criteria. The absolute difference in post-operative 
complication rate was 6% (−0.24 to −0.12) and 8% (−0.22 
to −0.08), respectively, favoring the no-drain group. A het-
erogeneity-adjusted sample size calculation showed that 814 
patients are needed to demonstrate a 10% reduction in com-
plication rate (from 30% to 20%; α = 0.05; power = 80%; 
two-sided; heterogeneity = 25%). With the two studies that 
have been conducted, 11 and 33% of the required number of 
patients has been included. The cumulative z-scores of these 
studies are −0.67 and −1.33, respectively. These z-scores did 
not transgress the monitoring boundaries of the O’Brien and 
Fleming alpha-spending function.
Conclusion and discussion: Currently, there is insuffi cient 
evidence to conclude that post-operative use of abdominal 
drains after pancreaticoduodenectomy results in a higher 
incidence of major complications. Taking into account the 
available evidence, a further 550 patients need to be enrolled 
in future trials investigating the usage of abdominal drains 
after pancreaticoduodenectomy. A randomized clinical trial 
investigating this topic is currently prepared in the 
Netherlands.
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OPPOSITE EFFECTS OF TWO BH3-ONLY 
PRO-APOPTOTIC BCL-2 MEMBERS IN 
PANCREATIC CANCER
M. Erkan1, S. Streit1, C. Reiser-Erkan1, T. Samkharadze1, 
M. Özer1, N. Giese2, I. Esposito3, H. Friess1 and J. Kleeff1
1Department of General Surgery, Technische Universität 
München, Munich, Germany; 2Department of General 
Surgery, University of Heidelberg, Heidelberg, Germany; 
3Institute of Pathology, Technische Universität München, 
Munich, Germany
Background: BNIP3 and BNIP3L are BH3-only pro-apop-
totic Bcl-2 proteins. Both are induced by hypoxia and share 
80% homology in their transmembrane domains. While, loss 
of BNIP3 leads to apoptosis resistance and worsened prog-
nosis in pancreatic cancer, the role of BNIP3L in pancreatic 
cancer is unknown.
Methods: cDNA-microarray, quantitative RT-PCR, and 
immunoblot analyses were used to evaluate BNIP3L expres-
sion. Correlation of BNIP3L positivity with p53-status of 
tumors and patient survival was analyzed by semiquantita-
tive immunohistochemistry using PanIN tissue-microarrays 
(n = 188) and tissues of normal pancreas (n = 20), chronic 
pancreatitis (n = 20) and pancreatic cancer (n = 75). 
Modulation of BNIP3L expression was achieved using two 
different siRNA molecules and by hypoxia. The effect of 
chemotherapeutic agents on pancreatic cancer cells was 
assessed utilizing MTT assay.
Results: Independent of the disease, linear regression analy-
sis revealed a signifi cant reciprocal expression of BNIP3 and 
BNIP3L mRNAs in pancreatic tissues of 69 patients (p < 
0.0001, F = 27.74). Compared with normal pancreas, the 
expression of BNIP3 mRNA decreased 80% in pancreatic 
cancer while BNIP3L expression increased 14-fold (p < 
0.001). In cell lines, BNIP3L was induced by hypoxia up to 
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9-fold. There was a signifi cant (p = 0.004) reduced expres-
sion of BNIP3 in p53-mutated tumors. Silencing of BNIP3L 
did not infl uence apoptosis resistance in cancer cell lines. 
Median survival of BNIP3L positive patients was signifi -
cantly shorter than BNIP3L negative patients (17 months, 
95%CI 13.4–20.6 months vs. 34 months 95% CI 12.3–55.7 
months, p = 0.009).
Conclusion: Expressions of BNIP3 and BNIP3L were 
inversely correlated. Unlike BNIP3, higher expression of 
BNIP3L in pancreatic tumors was a signifi cant negative 
prognostic factor.
O87
MAGNIFICATION ASSISTED 
PANCREATICO-JEJUNOSTOMY (MAP-J) 
IN PANCREATICODUODENECTOMY
D. Chhabra, K. Sutariya, R. Shah and P. Jagannath
Lilavati Hospital & Research Centre, Mumbai, India
Background: Pancreatic fi stula (PF) is the single most sig-
nifi cant cause of morbidity and mortality following pancre-
aticoduodenectomy. A precisely performed anastomosis is 
the key to reduce PF. Various techniques have been proposed 
to reduce PF including use of surgical microscopes.
Study design: A prospective database of 64 pancreatoduo-
denectomies performed in a single unit from 2008 through 
2010 was analysed. An end to side duct-to-mucosal pancre-
aticojejunostomy (without stent) was performed in all cases 
with fi ne (number 5–0) polydiaxone interrupted sutures. 
Pancreaticojejunostomy was completed with surgical loupes 
(with 3.5 × magnifi cation) in 32 patients (‘Magnifi cation 
assisted pancreaticojejunostomy’ MAP-J group) and without 
surgical loupes in 32 patients (Control group). Drain fl uid 
amylase content was measured on postoperative day 3 and 
7. Incidence of clinically relevant pancreaticojejunostomy 
leak (Grade B and C) was determined using the International 
Study Group of Pancreatic Surgery (ISGPF) classifi cation. 
Pancreas related complications including collections, delayed 
gastric emptying (DGE) and haemorrhage were also 
analysed.
Results: The characteristics of patients with respect to age, 
sex, pre-operative biliary drainage, type of resection, intra-
operative texture of pancreas and the mean pancreatic duct 
diameter were similar in both groups (Table 1). Within the 
64 pancreaticoduodenectomies, the clinically relevant pan-
creaticojejunostomy leak occurred in 14% cases (n = 9). The 
leak rate was 3% (n = 1; grade B) in MAP-J group, compared 
to 25% (n = 8; 4 grade B & 4 grade C) in control group (p 
< 0.001). Pancreas related complications included 7 pancre-
atic collections, 2 haemorrhage and 3 DGE in control group 
compared to single case of DGE in MAP-J group.
Conclusions: Magnifi cation assisted pancreaticojejunostomy 
(MAP-J) with increased visual acuity with surgical loupes(3.5×) 
signifi cantly improves technical performance of pancreatico-
jejunostomy and reduces clinically relevant pancreatic fi stula 
and pancreas related complications. We strongly advocate the 
routine use of surgical loupes with 3.5× magnifi cation for a 
duct-to-mucosa pancreaticojejunostomy.
O88
LAPAROSCOPIC SPLEEN-PRESERVING 
DISTAL PANCREATECTOMY: WITH OR 
WITHOUT SPLENIC VESSELS 
PRESERVATION
J-P. Adam, A. Jacquin, C. Laurent, B. Masson, D. Collet 
and A. S. Cunha
Centre Hospitalo-Universitaire, Bordeaux, France
The aim of this study was to evaluate the feasibility and 
postoperative outcomes of laparoscopic left pancreatectomy 
with splenic preservation, depending on splenic vessels pres-
ervation or not.
Methods: From April 1997 to May 2010, 57 patients who 
underwent laparoscopic left pancreatectomy with splenic 
preservation (PG) were selected from a prospective database. 
An intent-to-treat with preservation of vessels (Group V+) 
was planned for 20 patients and without preservation of the 
vessels (Group V-) for 37 patients. Clinical characteristics, 
tumor features, opérative and postoperative outcomes were 
compared.
Results: Regarding clinical and tumor features, there were 
no signifi cant différence between the two groups. The suc-
cessful splenic conservation rate was 90% in Group V+ and 
73% in Group V−. The conservation of the splenic vessels 
was possible in 15 patients (75%); in the 5 remaining patients, 
the occurrence of a vascular wound was treated by vessels 
ligation (n = 2) or splenic artery (n = 1) and a splenectomy 
was necessary cause of adhésions (n = 2). Rate of conversion 
to laparotomy (20% vs 19%, p = 0.92), overall morbidity rate 
(35% vs 43%, p = 0.54), pancreatic fi stula rate (10% vs 30%, 
p = 0.09), and reoperation rate (10% vs 5.4%, p = 0.61) did 
not differ signifi cantly between the 2 groups. However, ope-
rative time (253 min vs 210, p = 0.05) and blood loss (308 ml 
vs 167, p = 0.04) were signifi cantly higher in Group V+. In 
group V−, splenic complications occurred in 7 patients 
(19%): intraoperative splenic ischemia (n = 3) and splenic 
infarction (n = 4) requiring reoperation in one patient.
Conclusion: Laparoscopic spleen-preserving distal pancre-
atectomy with splenic vessels preservation is feasible without 
increased morbidity. Splenic complications in the short and 
long-term effects associated with the Warshaw technique 
should lead to prefer the PG with splenic vessels 
preservation.
O89
COMPARISON OF SHORT TERM 
OUTCOME BETWEEN LAPAROSCOPIC 
PANCREATICODUODENECTOMY AND 
OPEN PANCREATICODUODENECTOMY
C. Palanivelu, V. Vaithiswaran and P. Praveenraj
GEM Hospital and Research Centre, Coimbatore, India
Background: Having published our results of laparoscopic 
Pancreaticoduodenectomy recently, we have compared its 
short term outcome with that of open Pancreaticoduodenectomy.
Aim: To compare the short term outcome after laparoscopic 
Pancreaticoduodenectomy and open Pancreaticoduodenectomy.
Methodology: Retrospective analysis of data of all 
Laparoscopic and open Pancreaticoduodenectomies per-
formed between Jan 2007 and Jun 2010 was performed. In 
both Laparoscopic and open groups the reconstruction was 
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by a pancreaticojejunostomy. In later half of the series a 
Roux en Y reconstruction was used.
Results: There were 34 patients in the laparoscopic group 
and 62 in open group. The mean operating time was signifi -
cantly shorter in the open group than in laparoscopy group 
(244 min vs. 348 min). Blood loss was signifi cantly more in 
open group (320 ml vs. 74 ml). The hospital stay was shorter 
in laparoscopy group (8.2 vs. 11.4 days). The overall post-
operative morbidity was lesser in Laparoscopy group (25.6% 
vs. 38.4%). There was no mortality in both the groups. The 
difference in the average number of lymph nodes removed 
by either method was not statistically signifi cant (14 in lapa-
roscopy group and 15 in open group) and margin positivity 
rate was also similar.
Conclusion: Laparoscopic Pancreaticoduodenectomy 
has lesser morbidity and is as radical as open 
Pancreaticoduodenectomy.
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O90
INTERMITTENT PRINGLE MANOEUVRE 
IS ASSOCIATED WITH GUT INJURY IN 
PATIENTS UNDERGOING LIVER 
RESECTION
S. Dello1, K. Reisinger1, M. De Jong1, R. van Dam1, 
S. O. Damink1,2, M. Bemelmans1, C. Dejong1 and 
M. Poeze1
1Maastricht University Medical Center & Nutrim School 
for Nutrition, Toxicology and Metabolism., Maastricht, the 
Netherlands., Netherlands; 2University College London 
Hospitals, and University College London, Londen, United 
Kingdom, United Kingdom
Introduction: In order to avoid blood loss during liver tran-
section, a total intermittent Pringle manoeuvre (IPM) is fre-
quently performed. Clamping of the hepatoduodenal ligament 
results in abrogation of the hepatic infl ow, however it also 
impedes the outfl ow of the gut vasculature. Consequences of 
the IPM for intestinal epithelial damage are currently 
unknown. This is important because intestinal damage might 
result in bacterial translocation, potentially inducing sys-
temic complications. The aim of this study was to investigate 
whether intestinal damage was present in patients under-
going liver resection with IPM.
Methods: Patients planned for liver resection were eligible 
for inclusion. Preoperatively, patients were randomly 
assigned to IPM with 15 (15IPM) or 30 (30IPM) minutes of 
ischemic intervals and 5 minutes of reperfusion. Patients not 
requiring IPM (noIPM) served as controls. To assess gut 
damage, intestinal fatty acid binding protein (i-FABP), a 
selective marker for intestinal epithelial integrity loss was 
measured in arterial blood samples, after incision, after isch-
emia, after reperfusion, after liver transection, 8 hours after 
start of surgery and on the fi rst postoperative day.
Results: 15 patients (10 males) were included, of whom 5 
patients received 15 minutes IPM and 4 patients 30 minutes 
IPM. 6 patients were included in the control group. In 
patients that required IPM, a signifi cant increase in circulat-
ing i-FABP 8 hours after start of surgery compared to base-
line was noticed (P < 0.005). In the control group, no 
signifi cant increase in i-FABP was observed at any time point 
compared to baseline. There were no signifi cant differences 
in i-FABP levels between the 15IPM and 30IPM group.
Conclusion: This study demonstrates that the use of IPM in 
patients undergoing liver resection is associated with an 
increase in arterial i-FABP, pointing to gut injury. This might 
lead to bacterial translocation and systemic complications 
and therefore adversely affect the outcome of these patients.
O91
SINGLE SYNCHRONOUS RESECTABLE 
COLORECTAL LIVER METASTASIS: 
MONOCENTRIC MANAGEMENT IN 
TERTIARY REFERRAL HPB CENTRE 
IMPROVES SURVIVAL OUTCOMES
L. Vigano1, S. Langella1, A. Ferrero1, E. Sperti2, 
R. Lo Tesoriere1 and L. Capussotti1
1Dept HPB Surgery – Ospedale Mauriziano Umberto I, 
Torino, Italy; 2Dept Oncology – Ospedale Mauriziano 
Umberto I, Torino, Italy
Background: management of patients with synchronous 
colorectal liver metastases (SCLM) is complex and should 
be tailored to single patient since diagnosis. However many 
patients are referred to HPB centres only after colorectal 
resection. To compare outcomes of patients managed by 
HPB referral centre since diagnosis with those of patients 
referred for liver resection (LR).
Methods: Seventy-three patients with initial diagnosis of 
single resectable SCLM undergoing LR between 1998 and 
2009 have been divided into two groups: 52 managed since 
diagnosis (Group A) and 21 referred for LR (Group B)
Results: Patients characteristics were similar except for 
higher age in Group A (67 vs. 59 years, p = 0.0002). Up-front 
chemotherapy was more common in Group A (21.2% vs. 
4.8%, p = 0.087). Chemotherapy before LR was more often 
administered in Group B (61.9% vs 28.8%, p = 0.009) with 
higher number of cycles (10 vs 5, p = 0.003). At diagnosis 
metastasis diameter was similar (49 vs. 50 mm), while at LR 
it was larger in Group B (60 vs. 39 mm, p = 0.028). Median 
interval between diagnosis and LR was longer in Group B 
(7.1 vs. 1.2 months, p < 0.0001).
Number of surgical procedures was lower in Group A 
(simultaneous resection in 78.8% vs. 0%, p < 0.00001). Short 
term-outcomes were similar: mortality 1.9% vs. 0% and mor-
bidity 28.8% vs. 28.6%.
After a median follow-up of 31.1 months, overall survival 
was similar (at 3 years 74.1% vs. 72.3%), while disease-free 
survival was higher in Group A: at 3 years 62.9% vs 38.3%, 
p = 0.031). In Group B, higher rate of extrahepatic recur-
rences occurred (47.6% vs. 13.5%, p = 0.002).
Conclusions: Monocentric management in tertiary referral 
HBP centre of single resectable SCLM is associated with 
shorter preoperative chemotherapy, better disease control, 
lower number of surgical procedures and higher disease-free 
survival rates. Treatment strategy planning by HBP referral 
centre is recommended at diagnosis.
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O92
EVOLUTION OF LONG-TERM 
OUTCOMES OF LIVER RESECTION FOR 
COLORECTAL LIVER METASTASES: 
ANALYSIS OF 5-YEAR SURVIVORS 
THROUGH TWO DECADES
L. Vigano, N. Russolillo, A. Ferrero, R. L. Tesoriere, 
S. Langella and L. Capussotti
Dept HPB Surgery – Ospedale Mauriziano Umberto I, 
Torino, Italy
Background: Since 80’s liver resection (LR) has been rec-
ognized as the only potentially curative treatment of colorec-
tal liver metastases (CRLM). Thanks to staging refi nement 
and chemotherapy adoption, results improvement has been 
expected, but comparison of actual long-term data is lacking. 
To evaluate evolution of outcomes by 5-year survivors 
analysis.
Methods: 393 patients undergoing LR for CRLM before 
2006 were analyzed. Patients with R2 resection (4), postop-
erative mortality (4) or incomplete 5-year follow-up (13) 
were excluded. 372 patients were included and divided into 
three groups according to LR date: before 1995 88 patients 
(Group A), 1995–2000 92 (Group B), after 2000 192 (Group 
C).
Results: Patient characteristics and proportion of N+ 
primary tumors, synchronous metastases, and extrahepatic 
disease were similar. Group C had higher proportion of mul-
tiple (vs. A/B, 54.7% vs. 43.2%, p = 0.016) and small metas-
tases (<50 mm, 18.8% vs. 33.3%, p = 0.001). Overall survival 
(OS) progressively increased: 20.5%, 32.6% and 46.4%, p < 
0.0001. Early recurrence rate (at 1 year) did not decrease 
(27.3%/40.2%/38.5%), while in group C early extrahepatic 
recurrences increased (vs. A/B, 16.7% vs. 8.9%, p = 0.025). 
At 5 years, disease-free and recurrence-free survival rates 
improved in the last group (vs. A/B, 35.9% vs 21.1%, p = 
0.002 and 23.4% vs 13.9%,p = 0.019) thanks to reduction of 
liver recurrences (18.8% vs. 28.3%, p = 0.029). Survival 
after recurrence progressively increased (at 5 years 
4.0%/14.2%/21.4%, p < 0.0001). OS improvement was con-
fi rmed for multiple (p = 0.014) and synchronous metastases 
(p = 0.018) and N+ tumors (p = 0.006). OS improvement was 
observed also in patients without neoadjuvant chemotherapy 
(p < 0.0001). LR date (Group A/B/C) was an independent 
predictive factor of OS at multivariate analysis (p < 0.0001).
Conclusions: Long-term outcomes of LR for CRLM pro-
gressively improved in the last two decades thanks to liver 
recurrences reduction and better survival after recurrence. 
Improvement was not only related to preoperative chemo-
therapy and occurred even in patients with negative prognos-
tic factors. Further improvements could be limited by the 
increase of extrahepatic recurrence rate.
O93
SHORT- AND LONG-TERM RESULTS OF 
EXTENDED LEFT HEPATECTOMY FOR 
COLORECTAL METASTASES
D. Wicherts1, R. de Haas1, P. Andreani1, A. Ariche1, 
C. Salloum1, G. Pascal1, D. Castaing1,2, R. Adam1,2 and 
D. Azoulay1,2
1Hôpital Paul Brousse – Centre Hépato-Biliaire, Villejuif, 
France; 2Université Paris-Sud, Villejuif, France
Background: Extended left hepatectomies involve complex 
resections for centrally located tumors. Operative outcomes 
following this resection for colorectal liver metastases 
(CLM) remain unclear owing to the inclusion of mixed 
tumor etiologies in all previous series.
Methods: We analyzed short- and long-term outcome fol-
lowing extended left hepatectomy for CLM in a large single 
center cohort. Herefore, consecutive patients that underwent 
extended left hepatectomies between January 1990 and 
January 2006 were included. The impact of caudate lobec-
tomy on postoperative morbidity and survival was also 
assessed.
Results: From a consecutive series of 802 resected patients, 
31 patients that underwent extended left hepatectomy were 
included. Maximum tumor size at diagnosis was more than 
60 mm in the majority of patients (54%). Twenty-six patients 
(84%) presented with initially unresectable patients, mainly 
related to large tumor size (42%) and close relation with 
major vascular structures (23%). Preoperative chemotherapy 
was administered to 29 patients (94%). Combined vascular 
resection was performed in 5 patients (16%). Mortality rate 
at 90 days was zero with a morbidity rate of 55%. Three- and 
fi ve-year overall survival were 38% and 27%. Morbidity did 
not differ between patients with and without caudate lobec-
tomy (53% vs 57%, respectively) (P = 0.82). Three- and 
fi ve-year overall survival rates were 45% and 26% for 
patients with caudate lobectomy versus 29% and 29% in the 
control group (P = 0.90).
Conclusion: Although technically challenging, extended 
left hepatectomies for CLM can be performed with accept-
able morbidity and signifi cant long-term survival. Caudate 
lobectomy does not impact surgical outcome.
O94
LONG-TERM SURVIVAL FOLLOWING 
DELAYED RESECTION OF 
COLORECTAL LIVER METASTASES – 
A STING IN THE TAIL
P. Swan, F. Welsh, K. Chandrakumaran and M. Rees
Dept Hepatobiliary Surgery, North Hampshire Hospital, 
Basingstoke, Hampshire, United Kingdom
Introduction: Long-term survival from metastatic colorectal 
cancer (CRC) is partly dependent on favourable tumour 
biology. Large case series from North America show improved 
survival following hepatectomy for colorectal liver metastases 
(CRLM) in patients diagnosed with metastases >12 months 
following index CRC surgery (metachronous), compared to 
those presenting with metastases (synchronous).
This study investigated why this has not been shown in 
the UK with the primary aim of determining whether delayed 
hepatic resection for CRLM affects long-term survival.
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Methods: 1202 consecutive patients undergoing hepatic 
resection for CRLM in a single centre (1987–2007) were 
categorised into 3 groups according to the timing of hepa-
tectomy relative to their index bowel surgery: Group 1 (syn-
chronous, <12 months), Group 2 (12–36 months) and Group 
3 (>36 months). Cancer-specifi c survival (CSS) was calcu-
lated from a prospective database using Kaplan Meier 
analysis.
Results: There were 577 patients (48.0%) in Group 1, 467 
(38.9%) in Group 2 and 158 (13.1%) in Group 3. Overall 
5-year CSS was 42.2%. Following liver surgery, there was 
no difference in 5-year (40.4%, 42%, 43.2%) or 10-year 
(24.6%, 31.9%, 29.3%) CSS between Groups 1, 2 and 3 
respectively (p = 0.53). However, survival analysed from the 
CRC primary surgery showed a survival advantage for 
Group 3 at both 5 (94.1%) and 10 years (47.6%), compared 
to Groups 1 (46.3%, 24.9%) and 2 (57.1%, 35.0%) (p < 
0.003). Further analysis of the survival graphs from 5 to 10 
years shows a steeper negative gradient for Group 3 (−0.80) 
compared to Groups 1 and 2 (−0.34 and −0.37), indicating 
an accelerated mortality rate in this group. The 5-year CSS 
following hepatectomy signifi cantly improved over time, 
from 30.6% (1987–1993), to 35.6% (1994–2000) and 46.7% 
(2001–2007) (p < 0.001).
Conclusions: In the UK, patients undergoing delayed liver 
resection for CRLM have a survival advantage that has 
improved over 21 years but is lost during long-term 
follow up.
O95
REGIONAL TUMOUR DIFFERENCES IN 
PROSTAGLANDIN E2 LEVELS MAY 
PROMOTE DEVELOPMENT OF 
COLORECTAL LIVER METASTASES BY 
PROMOTING EPITHELIAL-
MESENCHYMAL TRANSITION
A. Young1, M. Hull1,2 and G. Toogood1
1St James’s University Hospital, Leeds, United Kingdom; 
2Leeds Institute of Molecular Medicine, University of 
Leeds, Leeds, United Kingdom
Blocking Prostaglandin (PG) E2 production using COX 
inhibitors has proven benefi t in treating cancer patients. 
NAD+dependent-15-PG Dehydrogenase (15-PGDH) repre-
sents another level of control over tissue PGE2 levels as it 
controls the rate-limiting step in their breakdown. The 
hypoxic tumour microenvironment may affect PGE2 levels, 
promoting cancer cell invasion and metastasis (epithelial-
mesenchymal transition (EMT)). We investigated control of 
PGE2 levels in colorectal cancer liver metastases (CRCLM) 
in relation to hypoxia and EMT.
Paired central and peripheral tissue from 20 CRCLM were 
obtained to measure tissue PGE2 and NAD+ levels, 15-PGDH 
enzyme activity as well as immunoreactive 15-PGDH and 
COX-2 protein. Parallel in vitro studies used a LIM1863 
CRC cell model of EMT.
PGE2 levels were increased in the centre of CRCLM rela-
tive to peripheral tissue by a mean of 26% (95% CI: 1–52%, 
p = 0.045). Counter-intuitively, 15-PGDH protein levels 
were also increased in the centre of tumours (immunoreactiv-
ity p = 0.036, [3H]PGE2 catabolism p = 0.016). However, 
NAD+ levels were 59% (25–72%, p = 0.015) lower in the 
centre of CRCLM than the periphery suggesting ineffi cient 
15-PGDH-dependent catabolism may explain raised PGE2 
levels. In central areas of CRCLM, cancer cells exhibiting 
low E-cadherin expression (EMT marker) had higher expres-
sion of 15-PGDH than neighbouring E-cadherin-positive 
cells. Our tissue observations were mirrored by in-vitro 
experiments. 15-PGDH activity was signifi cantly decreased 
in hypoxic compared with normoxic counterparts when 
NAD+ was present at a limiting concentration. Furthermore, 
PGE2 (10 μM) promoted TGFβ-induced EMT in LIM 1863 
cells in a concentration-dependent manner.
Regional differences in PGE2 levels and 15-PGDH 
expression/function are apparent in CRCLM (possibly linked 
to a hypoxic micro-environment). PGE2 promotes EMT in 
human CRC cells. We present a new mechanism for how 
hypoxia promotes EMT through depletion of NAD+ leading 
to decreased 15-PGDH function and increased PGE2 
levels.
O96
PREOPERATIVE CALORIE 
RESTRICTION REDUCES HEPATIC 
TUMOUR LOAD AFTER EXPOSURE TO 
CIRCULATING COLONCARCINOMA 
TUMORCELLS IN A MOUSE MODEL
T. M. van Ginhoven1, J. W. van den Berg1,2, W. A. Dik1,2, 
J. N. M. IJzermans1 and R. W. F. de Bruin1
1Erasmus MC, Surgery, Rotterdam, Netherlands; 2Erasmus 
MC, Immunology, Rotterdam, Netherlands
Background: The infl ammatory response after surgery con-
tributes to tumour metastasis by increasing the expression of 
cellular adhesion molecules. We have recently shown that 
short term DR, a 30% reduction in daily calorie intake during 
2 weeks, is able to confer protection against surgically 
induced infl ammation, leading to reduced expression of 
adhesion molecules. We hypothesized that preoperative DR 
therefore leads to less expression of adhesion molecules and 
subsequent reduced development of metastasis.
Methods: Male BALB/c mice were subjected to 2 weeks of 
DR (30% reduction in calorie intake) prior to the procedure. 
Intrasplenic injection of 5 × 105 c26-coloncarcinoma cells 
was followed by removal of the spleen. Animals were 
allowed to eat ad libitum postoperatively and sacrifi ced after 
10 days. Hepatic tumor load was scored as a percentage 
(tumor surface/total liver surface) on haematoxylin and eosin 
stained sections. Serum from mice was used in experiments 
assessing in vitro tumor growth and adhesion capacity. Liver 
mRNA expression of adhesion molecules was determined.
Results: Preoperative DR led to a signifi cant reduction in 
tumor growth 10 days after tumor inoculation (p = 0.0355). 
In vitro experiments showed no infl uence of DR serum on 
the c26 tomor growth. DR signifi cantly reduced adhesion of 
c26 cells to endothelial cells. mRNA expression levels of 
E-selectin in the liver were signifi cantly lower after DR when 
compared to the ad libitum fed group.
Conclusion: Preoperative dietary restriction reduced hepatic 
tumor load 10 days after exposure to circulating tumorcells. 
The signifi cantly reduced in vitro adhesion and reduced 
mRNA expression of E-selectin suggest that DR reduced 
tumor load by lowering the adhesion of circulating tumor 
cells to hepatic vascular endothelium.
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O97
ANALYSIS OF HEPATIC 
MITOCHONDRIAL FUNCTION USING A 
PERCUTANEOUS NEEDLE BIOPSY 
SAMPLE
M. Chu1, A. Hickey1, A. Bartlett1,2, A. Dare1, S. Munn2 and 
A. Phillips1,2
1University of Auckland, Auckland, New Zealand; 2New 
Zealand Liver Transplant Unit, Auckland, New Zealand
Background: Non-alcoholic fatty liver disease (NAFLD) or 
hepatic steatosis is associated with poor outcome following 
liver resection. Currently the severity of NAFLD is assessed 
histologically; however there is poor correlation between 
histological changes and hepatic synthetic function. We are 
currently investigating if livers with NAFLD may also have 
impaired mitochondrial function which maybe a useful alter-
native index of assessing hepatic function. To date hepatic 
mitochondrial function measurement has been limited to 
open biopsy samples, where larger tissue amounts permit 
easier analysis, and there are no published data on using 
needle biopsy samples for this purpose. The ability to 
measure hepatic mitochondrial function either pre- or post-
open surgery by using needle biopsies would greatly enhance 
opportunities for research into the signifi cance of its role in 
NAFLD.
Aim: To determine if complex mitochondrial function 
assays could be undertaken using tissue obtained from a 
standard single percutaneous needle biopsy.
Methods: The available liver tissue mass from a standard 
Bard® Maxcore® 18G biopsy needle was measured. Hepatic 
mitochondrial function was measured using a multiple sub-
strate and inhibitor titration protocol in conjunction with a 
high resolution respirometry oxygraph (OROBOROS® 
Oxygraph 2K). Five biopsies were taken from normal Wistar 
rat liver to confi rm the reproducibility of the methodology.
Results: The mass of available rat liver tissue obtained by 
a single 18G needle biopsy was 4.12 ± 0.19 mg (mean; 
SEM). The biopsy was bisected and mitochondrial function 
analysis was undertaken using only 2.44 ± 0.09 mg of tissue. 
Mitochondrial function analysis (measured as rate of oxygen 
consumption per mass of tissue) showed State 3 respiration 
rate of 19.1 ± 2.3 pmol O2 (s.mg)−1 and a respiratory control 
ratio of 5.0 ± 0.2. These results were consistent with other 
published data and will be discussed.
Conclusion: Consistent measurement of mitochondrial 
function was successfully performed on liver tissue obtained 
using a single percutaneous needle biopsy sample. This data 
suggests that preoperative assessment of liver mitochondrial 
function is feasible, providing liver surgeons with another 
potential means to assess the degree of hepatic impairment 
in patients with NAFLD prior to surgery.
O98
MECHANISM OF MICROWAVE CELL 
DEATH AFTER ABLATION OF 
COLORECTAL LIVER METASTASES AND 
HEPATIC PARENCHYMA
R. Jones1,3, N. Kitteringham2, H. Malik3, S. Fenwick3, 
G. Poston3 and P. Ghaneh3
1Division of Surgery and Oncology, University of 
Liverpool, Liverpool, United Kingdom; 2Department of 
Pharmacology, University of Liverpool, Liverpool, United 
Kingdom; 3Department of Hepatobiliary Surgery, Aintree 
University Hospital NHS Foundation Trsut, Liverpool, 
United Kingdom
Microwave ablation involves delivery of microwave energy 
directly to tumour, inducing microwave cell death (MCD), a 
distinct mode of cell death different to apoptosis or oncosis 
characterised by well preserved cellular morphology.
Aim: A pilot study to investigate the mechanism of micro-
wave cell death.
Materials and methods: 8 patients underwent resection of 
colorectal liver metastases. Samples were analyzed using 
H&E histopathology, NADH immunohistochemistry (a 
marker of metabolic activity). Protein expression was inves-
tigated using 2-D SDS-PAGE, a quantitative proteomics 
approach (iTRAQ) and Western immunoblotting.
Results: H&E staining showed a zone of histologically pre-
served cells (microwave fi xed cells), surrounded by a zone 
of damaged and necrosing cells. NADH staining showed a 
lack of metabolic function within the ablated zone. Function 
appeared to be normal outside the ablated zone. There was 
a sharp demarcation (~1 mm) between these zones, which 
did not correlate with obvious changes on H&E. iTRAQ 
analysis identifi ed 1652 proteins. Proteins expressed at the 
same level in control tissues (±5%) with marked reduction 
in ablated tissue (>40% change) were chosen as prospective 
targets. Four proteins of interest were detected at lower levels 
in ablated tissue. Western blotting did not verify the differ-
ential expression of the target proteins identifi ed by iTRAQ.
Conclusions: Despite normal histological appearances, 
ablated tissue is not metabolically active. iTRAQ analysis 
suggested signifi cant changes in protein expression between 
ablated and non-ablated tissue, but this was not confi rmed 
by immunoblotting. Protein cross-linking caused by micro-
wave energy may distort iTRAQ quantifi cation, without 
altering levels detected by immunoblotting. This supports 
protein cross-linking as part of the mechanism of microwave 
cell death.
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
FREE PAPERS 12
O99
PORTAL VEIN EMBOLIZATION: THE 
EFFECT OF DIFFERENT EMBOLIC 
AGENTS ON THE HYPERTROPHY 
RESPONSE OF THE LIVER
L. Hoekstra1, N. van den Esschert1, Krijn van Lienden2, 
W. de Graaf1, M. Heger1 and T. van Gulik1
1Department of Surgery, Academic Medical Center 
Amsterdam, Amsterdam, Netherlands; 2Department of 
Radiology, Academic Medical Center Amsterdam, 
Amsterdam, Netherlands
Objective: To assess the effect of several permanent and 
temporary embolic agents for PVE on the hypertrophy 
response of the future remnant liver (FRL).
Methods: New Zealand White rabbits were allocated to a 
control, Spongostan, Tissucol, Polyvinylalcohol particles 
with coils and Histoacryl group (n = 5/group). The portal 
vein branches to the cranial liver lobes were occluded (±80% 
of total liver volume). Occlusion of the portal vein was 
assessed by portography. Regeneration of the FRL was mea-
sured using CT-volumetry, which was performed the day 
before PVE and repeated at day 3 and 7 after which the 
rabbits were sacrifi ced. Liver function and damage parame-
ters were assessed at several time points and liver tissue was 
stained for proliferating hepatocytes (Ki-67).
Results: Portography showed recanalisation of the portal 
vein in the Spongostan group after 7 days. Liver damage was 
minimal and transient and liver function was preserved for 
all groups. There was a signifi cant increase of FRL from day 
0 till 3 for all embolic agent groups and from day 3 till 7 in 
the permanent embolic agent groups. A signifi cant higher 
volume increase was found for all embolic agent groups 
compared to the control group on day 3 and for all permanent 
embolic agents compared to the control and Spongostan 
group on day 7. In concordance, a signifi cant higher number 
of proliferating hepatocytes was found in the hypertrophic 
liver lobe for all 3 permanent embolic agent groups com-
pared to the control and Spongostan group.
Conclusion: The use of permanent embolic agents for PVE 
is superior to Spongostan in inducing a hypertrophy response.
O100
UP-FRONT CHEMOTHERAPY 
FOLLOWED BY SIMULTANEOUS 
COLORECTAL AND HEPATIC 
RESECTION: A SAFE STRATEGY FOR 
SYNCHRONOUS METASTASES?
L. Vigano, S. Langella, A. Ferrero, R. L. Tesoriere, 
N. Russolillo and L. Capussotti
Dept HPB Surgery, Ospedale Mauriziano Umberto I, 
Torino, Italy
Background: Selected patients with synchronous colorectal 
liver metastases (SCLM) benefi t from neoadjuvant chemo-
therapy (NeoCTx). The most common strategy is colorectal 
resection, CTx and delayed liver resection (LR). Up-front 
NeoCTx followed by simultaneous colorectal and hepatic 
resection (SimRes) can be an alternative. To evaluate out-
comes of this strategy.
Methods: 160 patients with SCLM underwent LR between 
2005 and 2009; 87 managed since diagnosis were consid-
ered. Indications to NeoCTx were >3 SCLM, extra-hepatic 
disease, metastases site requiring complex LR. 40 (46%) 
patients scheduled for up-front NeoCTx followed by SimRes 
were included in the present study.
Results: Primary tumor site was the rectum in 21 (52.5%) 
patients. Two patients with symptomatic primary tumor 
underwent positioning of endoscopic metallic stent; the 
remaining patients were asymptomatic. Median number of 
metastases was 4 (1–25) and diameter 46 mm (10–100). 24 
(60%) patients had multiple bilobar metastases, including 15 
scheduled for two-stage hepatectomy; 10 (25%) had extra-
hepatic disease. NeoCTx included Oxaliplatin in 35 cases, 
Irinotecan in 4 and both in 1. Seven patients received associ-
ated Bevacizumab and 4 Cetuximab. Median number of 
cycles was 6 (2–12). Three patients (7.5%) developed intes-
tinal obstruction, requiring emergency colorectal resection in 
2 cases and colostomy in 1. The patient receiving colostomy 
was then scheduled for SimRes. One patient had disease 
progression while on NeoCTx. SimRes was performed in 38 
patients (95%), including 5 major hepatectomies. One patient 
died (pulmonary embolism). Morbidity rate after SimRes 
was 32.5% (13), including 3 grade 3–5 morbidities. No liver 
disfunction and one anastomotic leak occurred. After a mean 
follow-up of 25 months, 3-year overall and disease-free sur-
vival rates were 73.4% and 37.6%. 14 (35%) patients had 
recurrence: 6 hepatic, 4 extra-hepatic and 4 hepatic and 
extra-hepatic.
Conclusions: Up-front NeoCTx followed by SimRes could 
be the strategy of choice in management of selected patients 
with SCLM.
O101
COMBINED PORTAL EMBOLIZATION 
AND NEOADJUVANT CHEMOTHERAPY 
PRIOR TO LIVER RESECTION FOR 
COLORERECTAL LIVER METASTASES
L. Spelt, P. Norman, L. Törnqvist, B. Tingstedt and 
R. Andersson
Dept of Surgery, Clinical Sciences Lund, Lund University, 
Lund, Sweden
Background: Liver resection is the treatment of choice in 
colorectal cancer (CRC) liver metastases. Preoperative portal 
vein embolisation (PVE) and neoadjuvant chemotherapy 
may make initially unresectable tumors resectable.
Aim: To compare perioperative course and long-term mor-
tality after liver resection for CRC metastases between 
patients who had preoperative treatment with PVE and 
chemotherapy or chemotherapy alone.
Methods: Among patients undergoing liver resection for 
CRC metastases following preoperative chemotherapy treat-
ment, 17 patients who had received PVE (group A) was 
compared with a group of 17 patients who had not (group B) 
and who were matched according to TNM-staging of the 
CRC, presence of lung metastases, radicality of resection and 
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extent of operation. The perioperative course and long-term 
mortality were compared between group A and B and 
between group A and the entire group of 77 patients with 
preoperative chemotherapy (group C).
Results: Baseline characteristics for the matched groups A 
and B were similar. Group C differed slightly, with less major 
resections. Mean intraoperative bleeding was 2274 mL in 
group A, as compared to 1288 mL in group B and 1138 mL 
in group C (p < 0.05 vs group A). Mean postoperative stay 
was comparable, being 10.1, 11.9 and 9.8 in groups A, B and 
C, respectively. The only intraoperative parameter that sig-
nifi cantly differed between was the mean operation time 
(571 min in group A vs 447 min in group B; p < 0.05). 
Mortality after 30 days and 1, 2 and 5 years was similar in 
groups A and B (0%, 11.8%, 28.6% and 75.0% in group A 
and 0%, 5.9%, 40.0% and 84.6% in group B). When compar-
ing group A with group C, no signifi cant differences were 
found.
Conclusion: Perioperative outcome and long-term survival 
did not differ comparing liver resection for CRC liver metas-
tases preceded by PVE and chemotherapy or chemotherapy 
alone, except operation time. The study supports the safety 
of this ‘aggressive’ combination approach in patients in need 
of tumor ‘downstaging’ and PVE to increase the remnant 
liver volume.
O102
PREDICTING THE FEASIBILITY OF 
TWO-STAGE HEPATECTOMY FOR 
BILOBAR COLORECTAL METASTASES: 
FACTORS IDENTIFIED DURING THE 
FIRST STAGE
F. Faitot, O. Scatton, P. Balladur and O. Soubrane
Hôpital Saint-Antoine, Paris, France
Introduction: Two-stage hepatectomy has been designed to 
treat patients presenting with multiple bilobar metastases in 
a curative intent. The literature reports a mean 22% failure 
rate of the strategy due to tumor growth or insuffi cient liver 
remnant volume.
Objectives: The goal of our study was to determine predic-
tive factors of feasibility of the second stage based on pre-
operative and perioperative parameters.
Patients and methods: 51 patients underwent a fi rst stage 
hepatectomy consisting of left liver clearance by either liver 
resection (LR), radiofrequency ablation (RFA) or combina-
tion of both with or without right portal vein occlusion 
(PVO). Parameters concerning primary tumor, preoperative 
treatment, liver metastases and perioperative parameters 
were studied and compared between the patients who 
achieved or not a curative two-stage hepatectomy by univari-
ate analysis. Two patients are currently waiting for a poten-
tial second stage and were excluded from the analysis.
Results: The two stages could be performed in 35 patients. 
The cause for not achieving the second stage was tumor 
progression in all patients. The fi rst stage consisted of LR in 
34, RFA in 3, combination in 14 with PVO in 39. Major 
complications occurred in 8 patients and 1 patient died. The 
parameters associated with a higher risk of not achieving the 
second stage were: male gender (p = 0.003), vascular inva-
sion in the primary tumor (p = 0.01), segment 1 metastases 
(p = 0.047), progression under chemotherapy (p = 0.02), 
resection margin in millimeters (p = 0.01). Patients having 
more than 2 ablations had statistically a lower chance of 
achieving the second stage (p = 0.03).
Conclusion: In patients with multiple bilobar colorectal 
liver metastases, two-stage hepatectomy is feasible and 
enables a curative treatment in more than 2/3 of the patients. 
Among the parameters identifi ed to predict failure of the 
two-stage strategy is the necessity to realize more than 2 LR 
or RFA.
O103
EXTENDING RESECTABILITY AND 
IMPROVING SHORT TERM OUTCOME: 
35 CASES OF TWO STAGE 
HEPATECTOMY FOR COLORECTAL 
LIVER METASTASES
F. Ratti, F. Cipriani, M. Catena, C. Soldati, M. Venturini 
and L. Aldrighetti
Dipartimento di Chirurgia Generale e Specialistica – Liver 
Unit. IRCCS H San Raffaele, Università Vita-Salute San 
Raffaele, Milano, Italy
Background: Most of patients with colorectal liver metas-
tases (CLM) presents with unresectable disease at diagnosis, 
while only 15–25% are candidates for surgery. The best 
strategy to address the problem of non-resectability is the use 
of a multidisciplinary approach: liver function and volume 
evaluation, modern imaging and advanced surgery tech-
niques, PVE, new CT patterns. The purpose of this study was 
to evaluate the short-term outcome of the Two-stage 
Hepatectomy Approach (THA) to CLM.
Materials and methods: Between January 2006 and July 
2010, 41 patients with multiple bilobar CLM were candi-
dates to THA (fi rst-stage resection of the left-sided metasta-
ses with a right PVE and then resection of the right hemiliver) 
at the Liver Unit of HSR. In each patient CT study was 
performed to evaluate liver volume before PVE and 4 weeks 
later.
Results: Thirty-fi ve patients (87.5%) have completed the 
THA program. The average volume of the FRL at the time 
of the procedure and after 4 weeks was resepectively 412.7 cc 
(±189.56) and 573.78 cc (±180.25) with an average increase 
of 50.7% (±32.95). The duration of the portal clamping, 
intraoperative blood loss and hospital stay were always 
minor in the fi rst than the second stage. It was calculated a 
morbidity of 12% and 39% respectively related to the fi rst 
and second stage surgery. During the postoperative course of 
the second stage, 2 patients showed progressive and irrevers-
ible signs of liver failure (mortality 5.7%).
Conclusion: PVE and NACT increase the rate of comple-
tion of THA. The second resection should be completed only 
when disease progression has been excluded and appropriate 
FRL has been provided. With this highly selective approach 
the rate of completion of the procedure is high and the results 
show that, despite a higher rate of complications associated 
with the second stage, mortality is acceptable and similar to 
that reported in the literature.
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O104
FIRST REPORT OF REPEAT LIVER 
RESECTION FOLLOWING HEPATIC 
TRISECTIONECTOMY: A SERIES OF 30 
PATIENTS
I. Rajput, O. Ziff, R. Adair, G. Toogood, R. Prasad and 
P. Lodge
St. James’s University Hospital, Leeds, United Kingdom
Introduction: Hepatic trisectionectomy is the largest liver 
resection performed for malignancy. We report a series of 30 
patients who had at least one repeat resection following 
hepatic trisectionectomy.
Methods: A retrospective analysis of a prospective database 
from January 1996 to September 2010 found 30 patients who 
had a repeat hepatectomy after trisectionectomy. We anal-
ysed a variety of factors with respect to survival including 
use of chemotherapy, R0 vs R1 resection, and tumour size.
Results: Thirty patients underwent repeat hepatic resection 
following trisectionectomy (24 right, 6 left). Indications 
were colorectal liver metastases (n = 23), neuroendocrine 
tumour (n = 3), hepatocellular carcinoma (n = 1), cholangio-
carcinoma (n = 1), renal cell carcinoma (n = 1), gastrointes-
tinal stromal tumour (n = 1). Overall 1-, 3- and 5- year 
survival rates after repeat resection were 97%, 52% and 41% 
respectively.
In the CRLM group all patients had one repeat resection, 
7 patients had a second repeat resection, 3 patients had a third 
repeat resection. Following the fi rst repeat resection overall 
1-, 3-, and 5-year survival for in the CRLM group was 100%, 
46%, and 31%. Patients who received chemotherapy after 
trisectionectomy had a 1–3- and 5-year survival rate of 
100%, 69%, and 46% vs chemotherapy prior to trisectionec-
tomy 100%, 23% and 11% (p = 0.033). R0 resection vs R1 
resection showed a 1–3- and 5-year survival rate 100%, 86%, 
57% vs 100%, 34% and 26% (p = 0.15). Patients with recur-
rent tumours >5 cm (n = 6) had 1-, 3-, and 5- year survival 
rates of 100%, 17% and 0% vs 100%, 57% and 44% for 
tumours <5 cm (n = 15) (p = 0.097).
Conclusion: Repeat resection following hepatic trisectio-
nectomy can yield good survival rates. Patients who received 
chemotherapy adjuvant to the trisectionectomy had better 
survival rates than those who had neoadjuvant chemotherapy 
in relation to trisectionectomy.
O105
NEOADJUVANT TRANS-ARTERIAL 
CHEMO-EMBOLIZATION (TACE) USING 
IRINOTECAN BEADS (DEBIRI) FOR 
EASILY RESECTABLE COLORECTAL 
LIVER METASTASES: A PHASE II STUDY
R. Jones1, L. O’Grady2, M. Terlizzo3, H. Malik1, 
S. Fenwick1 and G. Poston1
1Department of Hepatobiliary Surgery, Aintree University 
Hospital NHS Foundation Trust, Liverpool, United 
Kingdom; 2Department of Radiology, Aintree University 
NHS Foundation Trust, Liverpool, United Kingdom; 
3Department of Histopathology, Aintree University NHS 
Foundation Trust, Liverpool, United Kingdom
Background: Peri-operative chemotherapy confers a 3-year 
disease free survival (DFS) advantage for patients with 
colorectal liver metastases. Recent reports have also corre-
lated degree of post-chemotherapy tumour necrosis to 
improved post-hepatectomy disease free survival. Studies to 
date have only examined multiple cycles of systemic neoad-
juvant chemotherapy. The aim of this study is to examine the 
feasibility and safety of single DEBIRI TACE 1 month 
before hepatectomy.
Methods: Patients with easily resectable colorectal liver 
metastases treated at 4 centres were recruited. DEBIRI 
TACE was administered 1 month before surgery. Primary 
end-point was tumour resectability, Secondary end points 
include pathological tumour response, centrally assessed by 
one blinded pathologist and complication free TACE and 
hepatectomy.
Results: TACE attempted in 26 patients and was successful 
in 19, for 27 individual metastases. All 19 patients underwent 
hepatectomy. DEBIRI TACE was not possible in 7 patients 
because of bilobar disease (n = 2), arterial abnormality (n = 
1), vascular access issues (n = 1), angiography issues (n = 
1), hepatoma (n = 1) and concomitant infection (n = 1). There 
were no treatment related deaths (post TACE), but there were 
2 unrelated deaths (1 anaesthetic complication, 1 C.Diff 
colitis). There was 1 post-TACE liver abscess (recognised 
TACE complication), and no signifi cant post-hepatectomy 
morbidity. Complete pathological response was seen in 7 
(26%) lesions, major response in 12 (44%), minor response 
in 7 (26%) and no response in 1 (4%).
Conclusions: Neoadjuvant DEBIRI TACE for resectable 
colorectal liver metastasis is not associated with any increased 
post-hepatectomy complications and resulted in major or 
total pathological response in 70% of patients, which may 
translate to improved DFS. DEBIRI TACE may offer a cost-
effective alternative to systemic neoadjuvant chemotherapy 
in these patients.
O106
NON-EXPERT DECISION MAKING IN 
THE MANAGEMENT OF METASTATIC 
COLORECTAL CANCER
R. Jones, S. Fenwick, G. Poston and H. Malik
Department of Hepatobiliary Surgery, Aintree University 
Hospital NHS Foundation Trust, Liverpool, United 
Kingdom
Improved surgical techniques and chemotherapeutic regi-
mens have meant that the defi nition of resectable metastatic 
liver disease is evolving. UK NICE guidance 176 implies 
that all patients with liver-only metastatic colorectal cancer 
should have their treatment managed by an MDT with access 
to specialist liver surgeons.
Aim: To assess local colorectal MDT decision-making on 
resectability of liver-only metastatic colorectal cancer.
Results: Between Jan-Dec 2009, 110 patients were treated 
with palliative chemotherapy at a regional oncology unit for 
metastatic colorectal disease. 37 patients had been discussed 
at the supraregional hepatobiliary MDT prior to commencing 
chemotherapy, and were excluded.
CT reports for the initial staging scan were reviewed in 
the remaining 73 patients. 18 had widespread metastatic 
disease, and were excluded. The initial CT scans for the 
remaining 55 patients with liver-only metastatic colorectal 
cancer were retrieved, and reviewed by a panel of 3 specialist 
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liver surgeons who reached a consensus decision on 
management.
14 patients (25%) had resectable disease at presentation, 
26 patients (47%) had borderline resectable disease, and 
would benefi t from downstaging chemotherapy and reassess-
ment, whilst 13 patients (24%) were irresectable at 
presentation.
Conclusions: Non-expert decisions on resectability are 
leading to inappropriate patient management, with potentially 
curable patients being referred for palliative treatment.
Specialist liver surgery review is essential for all patients 
with liver only metastatic disease.
O107
RESULTS OF LIVER RESECTION IN THE 
OCTOGENARIAN (≥80 YEARS)
D. J. Malde, K. R. Prasad, J. P. A. Lodge and 
G. J. Toogood
The Hepatobiliary and Transplant Unit, St. James 
University Hospital, Leeds, United Kingdom
Introduction: Between 1998 and 2004 the National Cancer 
Database only identifi ed 47 (1.5%) patients undergoing 
resection of colorectal liver metastasis in England over the 
age of 80.We present our units data on the outcomes of 
patients over 80 years undergoing liver resection in order to 
show whether the age factor negatively affects the outcome 
of liver resections.
Methods: A prospectively collected database identifi ed 105 
consecutive patients, 80 years or above undergoing liver 
resection from January 1995 to June 2010. Resections were 
carried out for colorectal liver metastasis (n = 75), 
Hepatocellular carcinoma (n = 19), Cholangiocarcinoma 
(n = 3) and other (n = 8).
Results: The 105 patients had a median age of 82 years 
(range 80–92), with 42 female and 63 male patients. The 
liver resections included 47 non-anatomical, 20 segmental 
resections (1–2 segments) and 38 major resections (≥3 seg-
ments; including 5 trisectionectomies). 97 cases underwent 
a fi rst liver resection and 8 second resections. 7 (6.7%) 
needed intra-operative blood transfusion. 30 day morbidity 
and mortality were 22.9% (24/105) and 1.9% (2/105) respec-
tively. 3 cases (2.9%) needed re-operating for haemorrhage, 
bile leak and wound dehiscence. 9 patients (8.6%) needed 
post operative ICU stay. The median post operative hospital 
stay was 9 days (range 3–78). The overall median survival 
was 18 months (range 0–90). The actuarial 1-, 2-, 3-, 4- and 
5 year survival for colorectal metastasis was 87.9%, 59.6%, 
42.2%, 34.2% and 32% and 1 year survival for HCC was 
52.9%. The median disease free survival was 15 months 
(range 0–90) for colorectal liver metastasis and 12 months 
(range 0–48) for HCC.
Conclusion: The results indicate that hepatic resection for 
elderly patients over 80 can be safely performed given 
careful patient selection with acceptable morbidity and mor-
tality rates. Age alone should not be a contraindication in 
elderly patients in whom liver resection is the only chance 
for cure.
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P0001B
SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY COMPARED TO 
STANDARD LAPAROSCOPIC 
CHOLECYSTECTOMY: A SINGLE 
CENTER EXPERIENCE
T. Artis, C. Kucuk, M. Akyuz, E. Sozuer, F. Mutlu, 
A. Akay and Z. Yilmaz
ERCIYES UNIVERSITY MEDICAL SCHOOL 
DEPARTMENT OF GENERAL SURGERY, KAYSERI, 
Turkey
Introduction: Single incision laparoscopic surgery has 
been commonly performed brought renewed attention to 
cholecystectomy due to the promise of improved cosmesis 
and less parietal trauma. Single incision laparoscopic surgery 
is becoming more popular due to its improve cosmetic results 
and less parietal trauma. Various operations has been perfor-
med but cholecystectomy series demonsrated the feasibility 
of this technique. However outcomes comparing single inci-
sion laparoscopic cholecystectomy (LC) with standart lapa-
roscopic cholecystectomy has not been well defi ned. Our 
study aims to compare the outcomes of both techniques.
Methods: We performed a prospective study of patients 
who underwent single incision LC between June 2009 and 
September 2010. These patients were compared with an 
equal number of randomly selected patients undergoing LC 
during the same period. We performed 30 attempted single 
incision LC, which were included in our analysis.
Results: Single incision LC was successfully performed in 
27 patients, with only 3 patients requiring conversion to 
standart LC. Acute cholecystitis were present in 4 patients in 
single incision LC group and 5 in the standart LC. The cri-
tical view of safety was achieved in 25 of 27 patients under-
going a successful single incision Operative time was 
comparable in both groups. Mean operation time was 50 ± 
18 min. in single incision LC group and 40 ± 6 min in the 
standart LC group. In 7 patients a suture passer helped to 
retract the gallbladder. In 4 patients, 1 additional 10 mm port 
was utilized and all of them had acute cholecystitis. 
Complications were minor and comparable between the 2 
groups. However in single incision group one patient had 
partially biliary stricture which was succesfully managed 
with endoscopic dilatation an one patient had bilioma needed 
parcutaneous drainage.Both cases had acute cholecystitis. 
Postoperative hospital stay was comparable in both groups.
Conclusion: Although single incision LC is technically 
more challenging, it has a short learning curve. Overall out-
comes are comparable with standart LC.It can also be per-
formed for some selected acute cholecystitis patients.
P0002B
LONG TERM FOLLOW UP OF A PATIENT 
BORN WITH BILIARY ATRESIA
J. H. R. Becker
University of Pretoria and Steve Biko Academic Hospital, 
Department of Surgery, Faculty of Health Sciences, School 
of Medicine, Pretoria, Gauteng, South Africa
IB was born on 1982/12/06; the diagnosis of Biliary Atresia 
(BA) was made. He had received a Kasai operation (KO) at 
3 weeks of age and a liver transplantation (LT) at 17 years. 
He is currently 28.
As he is one of the few patients privileged to live this long, 
it is good for his clinicians to refl ect on what ‘the price of 
his life’ entails.
Chronological list of major medical events during the 
(almost) 3 decades of his life:
• Roux-Y loop portoenterostomy.
• Recurrent attacks of ascending cholangitis
• progressive liver failure,
• liver transplant – repeated bouts of rejection
• psoas abscess
• sub acute bacterial endocarditis with Osler nodules
• septicaemia splenomegaly, splenic abscess
• currently being treated for tuberculosis
The incidence of BA is 5–10/100,000 births, i.e. a.005% 
chance. After a successful Kasai operation, 50% will die by 
5 years, unless they have an LT. 20% will live to 20 years 
with the native liver before LT, where after there is a 10 year 
survival rate of 80%.
In conclusion: IB has had a diffi cult life of 28 years but, 
comparatively speaking, he has had a reasonable quality of 
life, given the fact that he survived until 17 when he had a LT.
With a successful KO his chance of survival to 17 was 1 
in a 100,000 (0.001%). After the LT, he only had a 0.00125% 
chance of surviving as he has done to the age of 28.
P0003B
SINGLE PORT LAPAROSCOPIC 
CHOLECYSTECTOMY: A NEW 
EVOLVING TECHNIQUE
G. Belli, C. Fantini, A. D’Agostino, L. Cioffi , G. Russo, 
A. Belli and P. Limongelli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital, Naples,Campania, Italy
Background: Although multiple groups have reported 
initial success with single port laparoscopy, no consensus 
exists concerning the technical aspect of this surgery.
Aim: To describe in detail our technique of single port lapa-
roscopic cholecystectomy.
Material and methods: Twelve cases of single port laparo-
scopic cholecystectomy for gallbladder stones were per-
formed in our surgical unit.
Results: There was only one conversion during the fi rst 
operation of the series to standard laparoscopy, and never to 
open operation. No intraoperative adverse events or major 
perioperative complications were reported. All the patients 
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have been discharged within 48 hours, with uneventful post-
operative course, nearly painless, without any discomfort, 
and no visible scar.
Conclusions: Single port laparoscopic surgery is a promising 
option for the treatment of gallbladder stones providing 
that technical and oncological surgical principles are respected.
P0004B
SAFETY MEASURES DURING 
CHOLECYSTECTOMY: RESULTS OF A 
NATIONWIDE SURVEY
K. T. Buddingh, H. S. Hofker, H. O. T. C. Hoedemaker, 
G. M. Van Dam, R. J. Ploeg and V. B. Nieuwenhuijs
University Medical Centre Groningen, Department of 
Surgery, Groningen, Netherlands
Background: This study aimed to identify safety measures 
practiced by Dutch surgeons to prevent bile duct injury (BDI) 
during laparoscopic cholecystectomy.
Method: An electronic questionnaire was sent to all 
members of the Dutch Society of Surgery with a registered 
e-mail address.
Results: The response rate was 40.4% and 453 responses 
were analyzed. The distribution of the respondents with 
regard to types of hospitals was similar to the general distri-
bution of surgeons in the Netherlands.
The CVS technique is used by 97.6% of the surgeons. 
CVS is documented mostly in the operation report (80.0%), 
but often augmented by photography (42.7%) or video 
(30.2%). If the CVS is not obtained 50.9% convert to open 
approach, 39.1% continue laparoscopically and 10.0% 
perform additional imaging studies. Of the Dutch surgeons, 
53.2% never perform IOC, 41.3% incidentally and only 2.6% 
of the surgeons perform IOC routinely.
A total of 105 BDI were self-reported in around 14387 
cholecystectomies (0.73%). The self-reported major BDI 
rate (involving the common bile duct) was 0.13%. A trend 
was observed towards lower rate of major BDI in university 
hospitals (p = 0.098) and a higher rate in surgeons 
who perform less than 10 cholecystectomies per year 
(p = 0.082).
Conclusion: The CVS approach in laparoscopic cholecystec-
tomy is embraced by virtually all Dutch surgeons. It is accom-
panied by a very low self-reported major BDI rate (0.13%), 
but these fi gures need to be confi rmed in other studies. The 
course of action when CVS is not obtained varies. IOC seems 
to be an endangered skill as over half the Dutch surgeons never 
perform it and the rest performs it only incidentally.
P0005B
DOCUMENTING CORRECT 
ASSESSMENT OF BILIARY ANATOMY 
DURING LAPAROSCOPIC 
CHOLECYSTECTOMY
K. T. Buddingh, A. N. Morks, H. O. T. C. Hoedemaker, 
R. J. Ploeg, H. S. Hofker and V. B. Nieuwenhuijs
University Medical Center Groningen, Department of 
Surgery, Groningen, Netherlands
Background: Correct assessment of biliary anatomy may 
be documented by photographs of the ‘critical view of safety’ 
(CVS), but also by images acquired during intraoperative 
cholangiography (IOC).
Method: Photographs of the CVS and IOC images of 63 
patients were presented to three expert observers in a random 
and blinded fashion. The observers answered questions per-
taining to whether the biliary anatomy had been conclusively 
documented.
Results: CVS photographs were judged conclusive in 
27.0%, probable in 34.9% and inconclusive in 38.1%. IOC 
performed better: conclusive in 57.1%, probable in 25.4% 
and inconclusive in 17.5% (p < 0.001 compared with CVS 
photographs).
The observers indicated that they would feel comfortable 
transecting the cystic duct based on the CVS photographs in 
52.4% of cases and based on the IOC images in 73.0% of 
cases (p = 0.004). The interobserver agreement was moderate 
for both modalities (kappa-values 0.4–0.5).
In patients with (a history of) cholecystitis, both the CVS 
photographs and the IOC images were less frequently judged 
suffi cient to transect the cystic duct (p = 0.006 and 0.017 
respectively).
Conclusion: In this series, IOC was superior to photographs 
of the CVS for documenting biliary anatomy during laparo-
scopic cholecystectomy. However, both modalities were 
judged conclusive only in a limited proportion of patients, 
especially in case of cholecystitis. This study highlights that 
documenting assessment of the biliary anatomy is not as 
straightforward as it seems and that protocols are necessary. 
Documentation of biliary anatomy should be addressed 
during training courses for laparoscopic surgery.
P0006B
THE ROLE OF ERCP AND PTC IN THE 
MANAGEMENT OF BILE LEAKS AFTER 
PENETRATING LIVER TRAUMA S 
BURMEISTER
S. Burmeister, J. Krige, P. Bornamn, A. Nicol and 
P. Navsaria
Department of Surgery, University of Cape Town Health 
Sciences Faculty, Cape Town, South Africa
Introduction: This study evaluated the optimal manage-
ment and outcome of persistent biliary fi stulae and strictures 
following penetrating liver trauma in a tertiary referral 
trauma centre.
Patients and methods: The study included all patients 
admitted to Groote Schuur hospital with penetrating liver 
trauma who had a persistent bile leak or developed a biliary 
stricture. Patient data were reviewed retrospectively using 
the liver trauma data base and endoscopy records. Imaging 
of the biliary system was by ERCP (n = 61) or PTC (n = 9). 
Lesions were classifi ed according to their anatomic location 
on cholangiography as either extra-hepatic (common bile 
duct, common hepatic duct or left and right hepatic ducts) or 
intra-hepatic (central or peripheral segmental ducts). Bile 
leaks or strictures which did not resolve after endoscopic 
stenting underwent surgical repair.
Results: Between 1985 and 2009, 66 patients presented 
with either a persistent bile leak (n = 56), a biliary stricture 
(n = 3) or a combination of both (n = 7). 21 patients had 
postoperative bile drainage while 31 patients had percutane-
ous radiological and 9 subsequent surgical drainage. 23 
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patients had biliary pleural effusions drained either via an 
intercostal chest drain (n = 21) or percutaneous catheter (n 
= 2). The site of the biliary lesion was identifi ed by ERCP 
in 48 patients. Of the 42 intra-hepatic injuries, 38 resolved 
with endoscopic therapy. Of the 17 extra-hepatic injuries 11 
required surgical intervention.
Conclusion: Central and peripheral intra-hepatic bile leaks 
are likely to resolve with endoscopic stenting. While endo-
scopic therapy should be considered, extra-hepatic injuries 
invariably require surgical intervention.
P0007B
IDENTIFICATION OF DIFFERENTIALLY 
EXPRESSED PROTEINS IN HILAR 
CHOLANGIOCARCINOMA USING A 
LABEL FREE SHOTGUN PROTEOMIC 
APPROACH
S. Farid1,2, R. Craven1, A. Zougman1, D. Cairns1, P. Selby1, 
R. Banks1 and R. Prasad2
1Cancer Research UK, St James University Hospital, 
Leeds, United Kingdom; 2St James University Hospital, 
Leeds, United Kingdom
Introduction: Hilar cholangiocarcinoma (HCCA) contin-
ues to be associated with poor prognosis due to late presenta-
tion and diagnostic inaccuracy. Bile is in close contact to the 
tumour environment so offers an enriched source of potential 
biomarkers. We present the fi rst study of its kind to compare 
the protein profi les of bile in benign and malignant biliary 
disease to identify candidate biomarkers.
Methods: Bile samples from 5 age and sex matched patients 
with cholethiasis and histopathologically confi rmed HCCA 
respectively were obtained at ERCP. Bile was subjected to 
albumin/immunoglobubin depletion, in solution tryptic 
digestion and nanoLC/MS/MS using LTQ XL* Linear Ion 
Trap Mass Spectrometer. Differentially expressed proteins 
were identifi ed by label free quantifi cation using MaxQuant 
v1.1.1.14 and the Wilcoxon-Mann-Whitney statistical test 
(p < 0.05). Validation studies were carried out using Western 
blotting.
Results: In total 1276 unique proteins were described, 
which is the largest catalogue of bile proteins published to 
date. Of these, 41 were differentially expressed between 
benign and malignant disease; in addition to proteins whose 
expression was previously shown to be altered in CCA (such 
as downregulation of apolipoprotein AI), several novel pro-
teins were identifi ed. Western blotting confi rmed overexpres-
sion of a number of these proteins in bile from HCCA 
patients.
Conclusion: This study represents the most comprehensive 
bile protein catalogue and identifi ed a number of proteins not 
previously reported as differentially expressed in HCCA. 
Preliminary validation has confi rmed over expression of 
selected proteins in bile and these are the subject of further 
studies to assess their potential as biomarkers.
P0008B
AETIOLOGICAL DISCRIMINATION OF 
THE CAUSES OF BILIARY 
OBSTRUCTION IN THE PRESENCE OF 
GALLSTONES IN THE BILIARY SYSTEM
L. Ferndale1,2, V. Govindasamy1,2, M. Mjoli1,2, 
G. Chinnery1 and S. Thomson2
1Greys Hospital, Pietermaritzburg, South Africa; 
2University of Kwazulu Natal, Durban, Sri Lanka
Introduction: Malignant bile duct obstruction and choledo-
cholithiasis are the commonest aetiologies of biliary obstruc-
tion. Trans-abdominal ultrasound can identify gallbladder 
stones with high sensitivity but does not accurately foretell the 
aetiology of the biliary obstruction. We looked at the utility of 
other clinical and biochemical markers in predicting the actual 
cause of the biliary obstruction in this group of patients.
Materials and methods: We performed a retrospective 
analysis of a prospectively collected ERCP database. Data 
on patients undergoing ERCP for suspected choledocholi-
thiasis over a 2 year period were reviewed. Data collected 
included demographic data, presence of co-morbidities and 
laboratory investigations like liver function, renal function 
and haematology tests.
Results: A total of 162 patients were identifi ed. Forty 
patients were excluded because of failed cannulation or the 
fi nding of a normal cholangiogram. Of the 122 patients 
studied 82 patients had confi rmed bile duct stones (Group 1) 
and 40 had alternative diagnoses (Group 2). The mean age 
of patients in group 1 was 50.7 years vs. 58.2 years in group 
2 (p < 0.05). The female to male ratio was also higher in 
group 1 than in group 2. Higher serum bilirubin and liver 
enzymes and lower albumin levels also signifi cantly pre-
dicted the fi nding of alternative diagnoses in these patients.
Conclusion: Although trans-abdominal ultrasound provides 
accurate information about the presence of gallstones in 
patients with biliary obstruction, other factors like age, sex, 
serum bilirubin, albumin and liver enzyme levels may predict 
the possibility of alternative diagnoses in these patients.
P0009B
HOW TO REDUCE BILIARY FISTULAS 
RATE AFTER LIVER SURGERY
A. Frena, G. L. Guardia, P. Marinello, R. Ferrara, 
S. Imperiale, R. Polato, M. Ciola, M. G. Schellner and 
F. Martin
Central Hospital of Bolzano – Dept. of General Surgery, 
Bolzano, Italy
Background: Standardization of hepatic resective treat-
ment has reduced mortality and morbidity rates. Anatomical 
resection and effective hemostasis have led to a reduction in 
postoperative complication rate (4–7%). One of the most 
fearful complications is the onset of a biliary fi stula, namely 
bile leakage following parenchymal transection.
Aims: Although numerous methods for the intraoperative 
detection of bile leaks have been developed through practice 
and chemical substances have been manufactured for fi stula 
management, the problem of biliostasis is still debated 
worldwide.
Methods: Our experience began in 1995: we have attempted 
to improve intraoperative biliostasis to minimize the risk of 
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postoperative fi stula development by testing different materi-
als. In the early 2005, we began employing the collagen 
sponge coated with fi brinogen and thrombin. The resected 
surface must be cleaned of blood and subsequently the 
sponge, moistened with saline solution, can be applied, 
gently pressing for 3–5 minutes.
Results: In our clinical experience, prior to sponge use, a 
biliary fi stula developed in 3.9% of elective resections (4/103 
cases) and 5.1% of surgical procedures to treat bleeding due 
to hepatic trauma (4/79 cases): conversely, there were no 
postoperative bile leaks in the 14 patients (11 hepatic resec-
tions and 3 traumas) treated with collagen sponge coated 
with fi brinogen and thrombin and the drain was always 
removed 3–5 days after surgery.
Conclusion: Although the limited number of cases do not 
constitute clinical evidence, of note is the fact that hepatobili-
ary surgeons can rely on local products for biliostasis, 
enabling them to safely carry out hepatic resection or post-
traumatic liver biliostasis. Absent or reduced biliary fi stula 
incidence has a positive impact on both patients (lower septic 
complication and re-operation rates) and institutions (shorter 
mean hospital stay and reduced costs).
P0010B
LONG-TERM OUTCOME OF EARLY 
COMPARED TO DEFERRED 
RECONSTRUCTION OF IATROGENIC 
BILE DUCT TRANSECTION AT 
LAPAROSCOPIC CHOLECYSTECTOMY
S. Jegatheeswaran, T. Satyadas, A. Sheen and 
A. Siriwardena
The Manchester Hepato-Pancreato-Biliary Centre, 
Manchester Royal Infi rmary, Manchester, United Kingdom
Introduction: It is accepted that transectional injuries of the 
bile duct recognised at operation are best repaired during the 
operation by a surgeon with hepatobiliary expertise. The 
management of injuries not recognised at time of injury is 
less clear: drainage of sepsis and biliary diversion with late 
repair is advocated by some and contrasts with early Roux 
reconstruction. Given the infrequency of biliary injury, ran-
domised comparison is not possible. This study reports out-
comes of early compared to late reconstruction.
Methods: Biliary reconstruction was undertaken by an indi-
vidual specialist hepatobiliary surgeon (AKS) in a regional 
HPB surgery unit serving a population of 1.5 million over a 
5-yr period to December 2005. During this period there were 
11 patients. Excluding 1 who underwent intra-operative 
repair, six patients under went early repair: median (range) 
age in years 57 (49–71), median delay from injury to repair 
being 1 (1–2) days. Four patients underwent late repair: 
median (range) age in years 46 (26–75), median delay from 
injury to repair being 8 (5–60) days [P = 0.015 vs early repair 
group; Mann-Whitney U-test]. All reconstructions were by 
Roux hepaticojejunostomy.
Results: In the early repair group, during a median follow-
up of 65 (45–85) months there was 1 early post-operative 
death (from acute myeloid leukaemia) and 1 symptomatic 
stricture (17%) treated by percutaneous radiological dilata-
tion. Time to stricture was 12 months. In the late repair 
group, during a median follow-up of 71 (44–100) months 
there have been no recurrent strictures.
Conclusion: This is a small series but benefi ts from long-
term follow-up. Good results can be achieved by either early 
or late repair for iatrogenic injury that is not recognised at 
the time of laparoscopic cholecystectomy.
P0011B
HOW MANY ERCPS ARE REQUIRED TO 
ACHIEVE DUCTAL CLEARANCE IN THE 
MANAGEMENT OF COMMON BILE 
DUCT STONES?
O. Jones, Z. Baha, R. Hussein and J. Slavin
Leighton Hospital, Crewe, Cheshire, United Kingdom
Background: Bile duct stones are found in 7–20% of patients 
with symptomatic gallstones. Treatment is essential due to the 
risk of jaundice, pancreatitis and biliary sepsis. The goal of 
therapy is to achieve ductal clearance with the fewest number 
of interventions, lowest cost and least morbidity/mortality.
Aim: To investigate factors which could potentially infl u-
ence or indicate the number of ERCPs that may be required 
to achieve complete ductal clearance in those patients suffer-
ing from stones in the common bile duct.
Methods: Hospital databases were searched retrospectively 
for patients diagnosed with common bile duct stones over a 
6 month period in 2009. Only those patients whose duct was 
managed purely with ERCPs were included. Data collected 
included, age, sex, diagnosis, gallbladder status, liver func-
tion tests, bile duct diameter, size of largest ductal stone on 
imaging, number of stones in duct, number of ERCPs needed 
to achieve ductal clearance, and mortality.
Results: 40 patients (26 females) met the inclusion criteria. 
Mean age of patients was 70 years (Range 20–90 years). 22 
patients suffered from uncomplicated choledocholithiasis, 12 
from cholangitis and 6 from gallstone pancreatitis. 7 patients 
had previously undergone a cholecystectomy. Median 
number of ERCPs required to achieve ductal clearance was 
1 (Range 1–5). A dilated CBD (p = 0.008), >1 CBD stone 
(p = 0.04) and size of the largest stone on imaging (p < 0.001) 
were related to an increased number of ERCPs. 30 day and 
1 year mortality was 2.5% and 5% respectively.
Conclusion: The presence of a large ductal stone, ductal 
dilatation and greater than one ductal stone on preprocedure 
imaging can be used as predictors of the number of ERCPs 
that may be necessary to achieve clearance. This information 
could potentially be of benefi t in both patient counselling, 
and healthcare planning.
P0012B
MODIFIED RADICAL 
CHOLECYSTECTOMY; AN EFFECTIVE 
TECHNIQUE FOR THE MANAGEMENT 
OF SUSPECTED GALLBLADDER 
CANCER
R. Jones, A. Al-Sarireh, G. Sarno, S. Fenwick, H. Malik 
and G. Poston
Department of Hepatobiliary Surgery, Aintree University 
Hospital NHS Foundation Trust, Liverpool, United 
Kingdom
Aims: Incidental fi nding of gallbladder cancer after laparo-
scopic cholecystectomy (IGC) is associated with a poor 
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prognosis as R0 resection may not be achieved. Performing 
a radical resection is known to improve outcomes in patients 
with gallbladder cancer. Our unit has adopted a policy of 
performing a modifi ed radical cholecystectomy (RC) where 
imaging is suspicious for early gallbladder cancer.
Methods: Between 2002–2009, all patients referred to our 
unit with imaging suspicious of early gallbladder cancer, or 
incidental fi nding of gallbladder cancer after laparoscopic 
cholecystectomy, were recorded. Outcomes were assessed 
by retrospective casenote review
Results: RC was performed in 49 patients (33F:16M) with 
a median age of 62 years. Six histologically confi rmed car-
cinomas were found (12.3%), of TNM stage 1 x TisN0M0, 
1 x T2N0M0, 1 x T3N0M0, 1 x T3N1M0, and 2 x T4N2M0. 
Morbidity after RC was 20.4%, with a median length of 
hospital stay of 6 (IQR 4–11) days.
11 patients were referred with IGC (8F:3M), with a median 
age 70 years. 5 had gallbladder perforation during cholecys-
tectomy, and were therefore unsuitable for further interven-
tion. 1 patient had metastases on further imaging, and 1 
patient was unfi t for further surgery. 4 patients were therefore 
offered further surgery, of which 2 had early stage disease. 
Only 1 patient had a potentially curative laparoscopic 
cholecystectomy.
Overall median survival for the 17 patients with gallblad-
der cancer was 9 months (IQR 6–26). Median survival was 
14 months (IQR 8–51) in the radical cholecystectomy group 
compared to 9 months (IQR 3–10) months in the incidentally 
discovered group (P = 0.2). Median survival for the 9 patients 
(3 ICG and 6 RC) who had an R0 resection was 12 months 
(IQR 9–35) compared to 6 months (IQR 2.5–9.5)for those 
with positive margins (P = 0.043).
Conclusions: Despite a small number of patients there is a 
trend toward survival benefi t from R0 resection in either ICG 
or RC. Modifi ed RC may be useful in cases where imaging 
is suspicious for early GB cancer, reducing the number of 
cases of IGC.
P0013B
A COMPARATIVE STUDY OF 
INTRADUCTAL PAPILLARY NEOPLASIA 
OF THE BILIARY TRACT AND 
PANCREAS
J. Kloek1, N. van der Gaag1, D. Erdogan1, E. Rauws1, 
O. Busch1, D. Gouma1, F. ten Kate1,2 and T. van Gulik1
1Academic medical center, Amsterdam, Netherlands; 
2University Medical Centre, Utrecht, Netherlands
Introduction: Intraductal papillary mucinous neoplasm of 
the pancreas (IPMN-P) is a rare but well-established entity 
in contrast to IPMN of the biliary tract (IPMN-B). The aim 
of this study was to compare the clinicopathological features 
of IPMN-B and IPMN-P.
Methods: Twenty patients who underwent resection for 
IPMN-B were compared with 29 cases resected for IPMN-P. 
Clinicopathological characteristics and resection specimens 
of all patients were reassessed and immunohistochemically 
screened for expression of a distinct set of tumor markers.
Results: Median age of patients with IPMN-B and IPMN-P 
was 66 and 62 years, respectively (P < 0.05). Twelve IPMN-B 
patients (60%) had neoplasms with infi ltrating carcinoma, 
compared to 6 IPMN-P patients (21%, P < 0.05). Cytokeratin 
(CK) 7 and CK20 expression were equal in biliary and pan-
creatic IPMNs. CK20 expression was mainly found in intes-
tinal type tumors. Gastric, pancreaticobiliary and oncocytic 
subtypes were all observed in the IPMN-B group. The dis-
tribution was signifi cantly different from the IPMN-P group. 
The 3-year overall survival rate of malignant biliary and 
pancreatic IPMN was 63% and 65%, respectively (P = 0.80). 
Univariable regression analysis demonstrated that positive 
lymph nodes and a high expression of MUC1 were associ-
ated with a signifi cantly shorter overall survival in patients 
with malignant IPMN (P < 0.05). Finally, p53 and Ki67 
proliferation index were both associated with the carcinogen-
esis of IPMN whereas DPC4 and CDX2 were not.
Conclusions: Clinicopathological features of IPMN-B 
largely resemble those of IPMN-P although IPMN-B was 
associated with a higher malignancy rate at the time of surgi-
cal treatment. The level of MUC1 expression and positive 
lymph nodes are signifi cant prognosticators in patients with 
malignant IPMN.
P0014B
PERCUTANEOUS DRAINAGE FOR 
ACUTE CALCULOUS CHOLECYSTITIS 
IN HIGH RISK PATIENTS
K. Kortram, D. Boerma, B. van Ramshorst, M. Wiezer and 
T. de Vries Reilingh
St. Antonius Hospital, Nieuwegein, Netherlands
Laparoscopic cholecystectomy (LC) is the gold standard in 
treating acute calculous cholecystitis. In elderly patients with 
serious comorbidity LC can result in morbidity and even 
mortality. In these patients percutaneous drainage (PC) may 
be a preferable method. However, current literature does not 
convincingly demonstrate an advantage of PC over LC in the 
treatment of acute calculous cholecystitis in high risk 
patients.
The aim of this study was to assess the place of percutane-
ous drainage in the treatment of acute calculous cholecystitis 
in high risk patients.
Data of 27 consecutive patients undergoing percutaneous 
drainage in acute calculous cholecystitis between December 
2008 and May 2010 were collected in a prospective database. 
Primary outcomes were time to recovery, mortality and need 
for cholecystectomy during follow-up.
Median age of the patients was 83 years, median ASA 
score was 3. Indication for drainage was high surgical risk 
in 24 cases and duration of symptoms in three cases.
Relief of symptoms occurred in 26 patients. Mean time to 
full recovery was 8 days, the drain was in situ for a median 
period of 19 days (range 5–57). Drain luxation occurred in 
nine patients, only in two patients with clinical consequences. 
Overall mortality rate was 14.8% (n = 4). With a mean 
follow-up of 8 weeks, four patients underwent interval 
cholecystectomy.
Percutaneous drainage in acute calculous cholecystitis 
seems to be a safe and successful treatment option in patients 
less eligible for surgery. There are many controversies in 
currently available literature and evidence based guidelines 
for the indication of PC in the treatment of acute calculous 
cholecystitis are needed. Therefore, a multi center random-
ized controlled clinical trial has been initiated.
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P0015B
PERI-OPERATIVE ANTIBIOTIC 
THERAPY IN THE TREATMENT OF 
ACUTE CHOLECYSTITIS
K. Kortram, D. Boerma, B. van Ramshorst, M. Wiezer and 
B. Vlaminckx
St. Antonius Hospital, Nieuwegein, Netherlands
A single prophylactic dose of antibiotics has been proven to 
lower infectious complications after laparoscopic cholecys-
tectomy for acute cholecystitis, but there is no evidence in 
current literature that postoperative prolongation of antibiot-
ics is benefi cial. Since agents are preferably administered 
intravenously, hospital admission is lengthened and therefore 
costs are higher. In addition, bacterial resistance can occur 
making future treatment more diffi cult.
Aim of this study was to evaluate the use and benefi ts 
of peri-operative antibiotics in the treatment of acute 
cholecystitis.
All patients undergoing laparoscopic cholecystectomy for 
acute cholecystitis between June 2002 and June 2010 were 
retrospectively divided into three groups: no antibiotic 
treatment (I), single prophylactic dose (II) and extended 
antibiotic therapy (III). Primary outcomes were infectious 
complications (wound, intra-abdominal, pulmonary, urinary 
tract), secondary outcomes mortality and length of 
admission.
284 Consecutive patients were included (median age 60 
years). 34 Patients did not get antibiotics, 108 patients got a 
single dose, 143 patients were administered antibiotics for 
3–5 days. Reason for extending therapy was abdominal 
sepsis in a small number of cases, but in most patients no 
particular reason could be detected. Regarding patient char-
acteristics there was no indication that these cases were 
more severe. One patient in group I developed an infection 
(3%), 7 (6.5%) in group II and 21 (14.6%) in group III. 
Overall mortality was 1% (N = 3). Median duration of 
admission was 2 days in groups I and II versus 5 days in 
group III.
Our study demonstrates that there is no consensus on peri-
operative use of antibiotics in acute cholecystitis: the indica-
tion for extended therapy is based on the surgeon’s assessment 
and preference. Although selection bias must be prominent 
in this study, extended treatment does not seem to lower the 
incidence of infectious complications. A multicentre, ran-
domised controlled trial has been initiated to provide an 
evidence based guideline.
P0016B
VALUE OF ADAPTED SMALLER 
INCISIONS AND VIDEO-LAPAROSCOPY 
IN CHOLECISTOLITHIASIS 
TREATMENT: PROSPECTIVE AND 
COMPARATIVE STUDY
P. E. Lada, F. Florez, C. Janikow, A. Arias, E. Fornies and 
L. Gramatica
Hospital Nacional de Clínicas, Córdoba, Argentina
Background: Laparoscopic cholecystectomy is ben consid-
erate like the gold standard for the treatment of gallbaldder 
stones, however, in the international literature the adapted 
smaller incisions is still an alternative proceedment.
Objectives: Compare the results of the laparoscopic chole-
cystectomy with the cholecystectomy by adapted smaller 
incisions.
Design: Prospective and comparative protocolized study.
Materials and methods: Between January of 1994 and 
Dicember 2006, we have made 2422 cholecystectomy in the 
General Surgic Service ‘Pablo Luis Mirizzi’ of the National 
Clinic Hospital of Córdoba. In 1135 patients we made lapa-
roscopic cholecystectomy and in 1287 we made cholecystec-
tomy by adapted smaller incisions. This two groups are 
comparable in age, gender, previous surgics and preoperative 
diagnostic.
Results: We had nonmortality, 84 cases (7.40%) in the lapa-
roscopic cholecystectomy was converted to open surgery and 
262 (20%) of the adapted smaller incisions was extend to the 
rectum. Postoperatory complications was share in two 
groups, medical and surgery. Medical complications in lapa-
roscopic cholecystectomy was 3.5%, and in cholecystectomy 
by adapted smaller incisions 9%, surgery complications for 
the fi rst one was 2.5% and for the second one 7%. Bilirraghe 
was superior and more serious in laparoscopic cholecystec-
tomy with an incidence of 0.57%, cholecystectomy by 
adapted smaller incisions had 0.23% of bilirraghe.
Conclusions: In expert hands, laparoscopic cholecystec-
tomy is the gold standard for the treatment of gallbaldder 
stones. However, in place with restricted butget the chole-
cystectomy by adapted smaller incisions can be an alterna-
tive gold standard. It´s a sure and economic proceedment, 
with a reasonable complexity and less index of surgical 
lesions.
P0017B
EFFECTIVENESS OF PERCUTANEOUSLY 
PLACED SELF EXPANDING METAL 
STENTS FOR PALLIATION OF 
MALIGNANT BILIARY OBSTRUCTION
A. Lawson1, J. Krige1, P. Rischbieter2, S. Burmeister1 and 
S. Beningfi eld1
1University of Cape Town, Cape Town, South Africa; 
2Themba Hospital, Mpumulanga, South Africa
Background: Percutaneously placed self-expanding metal 
stents (SEMS) have been widely used for palliation of malig-
nant biliary obstruction as an alternative to major bypass 
surgery or when endoscopic drainage is not technically fea-
sible. We report our experience in the placement of SEMS 
at Groote Schuur Hospital.
Methods: A retrospective chart review was done of patients 
who had percutaneously placed SEMS for obstructing biliary 
malignancy between May 2008 and July 2010. Data included 
demographic information, level of biliary obstruction, effi -
cacy and complications of SEMS insertion. Boston Scientifi c 
6F, 69 mm*10 mm, Wallstent SEMS were used in all 
patients.
Results: Fifty patients (28 men, 22 women, mean age 61, 
range 48–80 years) underwent percutaneous SEMS. Stent 
insertion was successful in all patients. Twenty-one patients 
had obstruction at the level of the hilum, 5 in the mid 
common bile duct and 24 in the low common bile duct. In 
20 (40%) patients SEMS were placed during the fi rst attempt 
at biliary decompression. Five (10%) patients required bilat-
eral SEMS insertion. The mean serum bilirubin decreased 
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from 294 umol/L to 129 umol/L (56% decrease) 5 days post 
stent insertion. Mean hospital stay post stent insertion was 
4.1 days. Twelve patients (24%) developed complications 
unrelated to SEMS insertion which included gastric outlet 
obstruction requiring endoscopic stenting (n = 9), myocardial 
ischaemic events (n = 2) and pneumonia (n = 1). Nine 
patients (18%) developed a procedure-related complication 
which included cholangitis after stent insertion (n = 4), chol-
angitic liver abscess (n = 1), subphrenic liver collection (n = 
1), bile leakage (n = 1) and cholecystitis (n = 2). Stent occlu-
sion occurred in 4 patients (8%) within a week as result of 
stent migration (n = 3) or biliary sludge (n = 1). Two (4%) 
stents occluded between 7 days and 1 month. Four (8%) 
patients died during hospital admission due to pre-existing 
cholangitic sepsis (n = 3) and pneumonia (n = 1). Four (8%) 
patients survived less than 1 month, 12 (24%) survived 
between 1 month and 3 months, 11 (22%) survived between 
three and 6 months, 10 (20%) survived beyond 6 months. 
Nine (18%) patients from distant referral institutes were not 
seen after discharge.
Conclusion: These data demonstrate that percutaneously 
placed SEMS achieved satisfactory palliation with a low 
complication rate in a high risk patient group with advanced 
malignant biliary obstruction.
P0018B
IMMUNOHISTOCHEMICAL DETECTION 
OF LYMPH NODE MICROMETASTASES 
IN PATIENTS WITH OTHERWISE NODE-
NEGATIVE HILAR 
CHOLANGIOCARCINOMA: DOES IT 
AFFECT SURVIVAL?
H-J. T. J. Mantel, M. T. de Boer, E. Sieders, K. P. de Jong, 
P. M. J. G. Peeters, J. J. Doff, A. S. H. Gouw and R. J. Porte
University Medical Center Groningen, Groningen, 
Netherlands
Objective: To investigate the clinical signifi cance of immu-
nohistochemically demonstrated lymph node micrometasta-
ses in patients with histologically node-negative (pN0) hilar 
bile duct cancer.
Background: Lymph node metastases have been recog-
nized as a strong negative predictor of survival after surgery 
for hilar cholangiocarcinoma. The clinical signifi cance of 
immunohistochemically detected lymph node micrometasta-
ses has been evaluated in various tumors. However, there is 
no consensus on the value of lymph node micrometastases 
in hilar cholangiocarcinoma.
Methods: In a consecutive series of 56 patients who under-
went combined resection of a part of the liver, extrahepatic 
bile duct and hilar lymph nodes for hilar cholangiocarcinoma 
between 1990 and 2009, 28 patients were identifi ed as his-
tologically lymph node-negative. Additional immunostain-
ing with an antibody against cytokeratin 19 was performed 
on a total of 115 lymph nodes from these 28 patients. Clinical 
variables were compared between groups and postoperative 
survival was assessed in relation to lymph node status. 
Median follow-up was 45 months.
Results: Immunostaining identifi ed lymph node microme-
tastases in 4 of the 28 patients (14%) who were initially 
identifi ed as lymph node-negative by routine histological 
examination and in 6 of the 115 lymph nodes examined. 
There were no signifi cant differences in clinical variables in 
lymph node-negative and node-positive patients (either his-
tologically or immunohistochemically). Five-year survival 
rates in patients without lymph node (micro-)metastases 
were signifi cantly higher than in patients with histological 
node metastases (44% versus 9%, respectively; p = 0.005). 
However, the survival curves in patients with or without 
micrometastases were similar (5-year survival rate 25% 
versus 44%; p = 0.29).
Conclusion: Immunohistochemical detection of lymph 
node micrometastasis has no signifi cant impact on survival 
in patients with otherwise node-negative hilar cholangiocar-
cinoma. Therefore, we do not recommend extensive lymph 
node sectioning with cytokeratin immunostaining in these 
patients.
P0019B
CYSTIC LESIONS OF THE BILIARY 
TREE: PROPOSAL OF A REVISED 
CLASSIFICATION SYSTEM FOR 
CHOLEDOCHAL CYSTS
T. Mofokeng1,2, R. Barry1,2 and O. Buchel1,2
1Universitas hospital, Bloemfontein, Free State, South 
Africa; 2University of the Free State, Bloemfontein, Free 
State, South Africa
A 46 year old man presented with a choledochal cyst associ-
ated with an abnormal pancreaticobiliary duct junction 
(APBDJ). Surgical excision of a cyst and hepaticojejunos-
tomy were performed. The cyst was a type I according to 
Todani’s classifi cation.
This classifi cation (I to V) describes a heterogeneous 
group of conditions with separate aetiologies and different 
malignant potential. We therefore propose a revised classifi -
cation system of cystic lesions of the biliary tree, i.e. types 
A to D. Type A cysts are associated with an APBDJ. An 
APBDJ leads to biliary cyst formation proximally, in the 
extrahepatic and intrahepatic biliary tract and also 
predisposes to malignant transformation of the biliary 
epithelium.
Types B and C are possibly congenital duplications and 
type D is a ductal plate anomaly with cysts only in the intra-
hepatic bile ducts (Caroli’s disease). We also propose that the 
conditions grouped under the Todani classifi cation be called 
‘cystic lesions of the biliary tree’, instead of ‘choledochal 
cysts’, as some cysts do not involve the choledochus.
P0020B
SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY IS SAFE AND 
FEASIBLE WITH CONVENTIONAL 
INSTRUMENTS
M. Narasimhan, S. Kurhade, P. Swaminathan and 
R. Ardhanari
Meenakshi Mission Hospital and Research centre, 
Madurai, Tamilnadu, India
Introduction: Laparoscopic cholecystectomy is tradition-
ally done through four ports or three ports. Single incision 
cholecystectomy technique has been recently described with 
use of special triport system or articulating instruments. 
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However we present the novel technique of single incision 
cholecystectomy using the conventional ports and hand 
instruments.
Materials and methods: Through a single 3 cm periumbili-
cal incision three conventional ports are inserted with differ-
ent fascial entries and using 5 mm telescope and conventional 
instruments cholecystectomy completed laparoscopically. 
Specimen retrieved through same incision.
Results: Fourty patients with symptomatic cholelithiasis 
and one patient of gall bladder polyp were subjected to single 
incision laparoscopic cholecystectomy using the conven-
tional ports and instruments through the umbilicus. Five 
patients were post ERCP. One patient also underwent appen-
dicectomy through the same incision. In one patient another 
3 mm port was used for intra-operative cholangiography. 
Single incision laparoscopic cholecystectomy was accom-
plished in all 41 patients. There was no conversion. There 
was no intra operative complication in any patient. Post 
operatively only two patients had serous discharge from port 
site which was self limited.
Conclusions: Single incision laparoscopic cholecystectomy 
is feasible and safe using conventional ports and instruments 
without any additional cost.
P0021B
EARLY LAPAROSCOPIC 
CHOLECYSTECTOMY AFTER ERCP& 
NASO-BILIARY DRAINAGE IS SAFE AND 
EFFECTIVE FOR CBD CALCULI
M. Narasimhan, S. Kurhade, P. Swaminathan and 
R. Ardhanari
Meenakshi mission hospital and research centre, madurai, 
tamilnadu, India
Method: A retrospective analysis was done for the patients 
admitted in our hospital in a period of 2005–2009 with CBD 
calculi or with high suspicion for CBD calculi. All patients 
had preoperative endoscopic retrograde cholangiography 
(ERC) with stone extraction and nasobiliary drainage. 
Majority of these patients underwent laparoscopic cholecys-
tectomy next day, except in patients with cholangitis and 
high risk patients, who underwent surgery after stabilization 
in same admission.
All these patients underwent Naso biliary cholangiogram 
post-cholecystectomy on fi rst post operative day and removed 
if normal.
For residual stones NBD replaced with stent. Patients 
requiring laparoscopic CBD exploration for diffi cult CBD 
calculi, suspected malignancy and choledochal cyst excluded 
from study.
Results: In the study period Jan 2005–Dec 2009, total 205 
patients underwent early laparoscopic cholecystectomy 
following ERCP and nasobiliary drainage. There was no 
conversion to open surgery; in one patient procedure was 
abandoned suspecting carcinoma. Post operatively naso-
biliary cholangiogram done and NBD removed if normal. 11 
(5.3%) patients had residual stones in whom repeat ERCP 
and stenting was done. Post operative complications includes 
fever (21 patients), Bile leak (2 patients), liver abcess (2 
patients), ARDS (1 patient), ARF on CRF (1 patient). One 
patient with cirrhosis died due to post operative liver failure.
Conclusion: Early laparoscopic cholecystectomy after 
ERCP& nasobiliary drainage reduces the total hospital stay, 
duration of treatment, stent related complications, over-
all reduced cost of treatment, with acceptable morbidity. 
We recommend this approach for the treatment of 
choledocholithiasis.
P0022B
A PROSPECTIVE COMPARISON OF THE 
TWO-PORT AND THREE- PORT 
TECHNIQUES FOR PERFORMING 
LAPAROSCOPIC CHOLECYSTECTOMY
J. T. Oh1, D. E. Park1, K. O. Jung1, G. D. Kim2 and 
K. M. Chae1
1Department of Surgery, Wonkwang University College of 
Medicine, Iksan, Korea; 2Department of Radiology, 
Wonkwang University College of Medicine, Iksan, Korea
Background: Laparoscopic cholecystectomy has been 
evolved to various methods: four-port, three-port or two-
port. In recent days, some authors recommend 2 port 
laparoscopic cholecystectomy with useful method.
Aim: We compared the clinical characteristics of the two-
port method and three-port method, and we estimated the 
usefulness of each port method.
Method: We performed a prospective analysis of 40 patients 
that underwent a laparoscopic cholecystectomy by single 
surgeon from September 2008 to January 2009. 2 port and 3 
port technique were done alternatively by one surgeon, who 
had enough experience of laparoscopic surgery in wonkwang 
university hospital, had done operation during study periods. 
We compared two groups with the parameters of operation 
time, intraoperative complication, conversion rate, postop-
erative complication, and postoperative hospital stay, trocar 
site pain and patient’s satisfaction.
Results: There were signifi cant difference between the two 
and three port groups in terms of the mean operation time, 
conversion rate and intraoperative events. The mean opera-
tion time (2port; 38.95 ± 10 min., 3port;23.25 ± 5 min.: P < 
0.01), conversion rate (2port; 5case, 3port; 0case: P = 0.016) 
and intraoperative events in three port technique were less 
than two port technique (2port; 14events, 3port; 2events: P 
< 0.01). There were no signifi cant difference in trocar site 
pain, hospital stay and patient’s satisfaction.
Conclusion: Considering our results, three port technique 
could be regarded as the optimal surgical technique com-
pared to 2 port technique in the laparoscopic cholecystec-
tomy, as long as the new instrutment for gall bladder traction 
and new port were not developed.
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P0023B
ACUTE CHOLECYSTITIS ASSOCIATED 
WITH CLONORCHIS SINENSIS 
INFECTION
J. T. Oh1, D. B. Kang1, G. D. Kim2, H. J. Jo3, D. E. Park1 
and K. M. Chae1
1Department of Surgery, Wonkwang University college of 
Medicine, Iksan, Korea; 2Department of Radiology, 
Wonkwang University college of Medicine, Iksan, Korea; 
3Department of Pathology, Wonkwang University college of 
Medicine, Iksan, Korea
Introduction: Clonorchis sinensis is a trematodasis caused 
by ingestion of a raw fi sh that contains the infective cysts. 
On ingestion of raw fi sh, encysted parasites are freed by the 
action of gastric juice and the cyst wall is digested by trypsin 
in the duodenum, and become mature worms. The adult 
fl ukes take up residence predominantly in intrahepatic bile 
ducts, occasionally in the gallbladder, pancreatic duct and 
extrahepatic bile ducts.
The clinical manifestations depend on the number of 
fl ukes, the period of infestation and the complications such 
as pericholangitic abscess, cholangitis, bile duct stones and 
cholangiocarcinoma. However, acute cholecystitis associ-
ated with Clonorchis sinensis infection is extremely rare. 
Herein, we report on a case of acute cholecystitis associated 
with Clonorchis sinensis infection without dilatation of the 
intrahepatic ducts.
Case: A 68-year old man presented to the Emergency 
Department with a 2-day history of RUQ pain and fever. This 
patient lived in a town located on a river and reported a 
history of occasional ingestion of raw freshwater fi sh (eaten 
as sashimi). On past history, he was undergone radical sub-
total gastrectomy and B-II anastomosis due to gastric cancer 
10 years ago. His vital signs were BP 140/80 mmHg, PR 84/
min, RR 20/min, and BT 37.8°C. A physical examination 
revealed tenderness in the right upper abdominal quadrant 
without scleral icterus. Routine hematological and biochemi-
cal investigations revealed a leukocytosis and obstructive 
liver function tests; WBC 12,400/mm3, AST 64 U/L, ALT 
94 U/L, and Bilirubin(T/D) 3.8/3.1 U/L. Contrast-enhanced 
computed tomography (CT) of the abdomen showed dis-
tended gallbladder with wall thickening and pericholecystic 
fl uid collecton. Minimal dilatation of extrahepatic bile ducts, 
but peripheral intrahepatic bile duct is not dilated. MR chol-
angiography showed distended gallbladder, pericholecystic 
fl uid collection, and mild extra-hepatic bile duct dilation 
without obstructive lesion. We performed open cholecystec-
tomy and removal several fl ukes on cystic duct and extra-
hepatic bile duct during cholangiography. After removal of 
fl ukes, neither bile duct dilatation nor obstruction lesion was 
shown on intraoperative cholangiography. Pathologic fi nd-
ings of GB revealed mucosal infl ammatory change and also 
shown several fl ukes in the GB, which is confi rmed by 
Clonorchis sinensis. The postoperative course was unevent-
ful, and was discharged after praziquantel medication.
P0024B
THE CHANGE OF DIAGNOSTIC AND 
TREATMENTAL PATTERNS OF ACUTE 
CHOLANGITIS IN JAPAN FROM 2004 TO 
2009 AFTER PUBLISHING THE CLINICAL 
GUIDELINE
K. Okuma, M. Sekimoto and Y. Imanaka
Department of Healthcare Economics and Quality 
Management, Kyoto University Graduate School of 
Medicine, Kyoto, Japan
Background: Prior to the publication of the ‘Scientifi c 
Evidence-based Guidelines for the Diagnosis and Treatment 
of Acute Cholangitis and Cholecystitis’ in 2005 and the 
‘Tokyo Guidelines for the management of acute cholangitis 
and cholecystitis’ in 2007, there were no evidence-based 
guidelines for the diagnosis and treatment of acute cholan-
gitis in Japan. Since their publication, these guidelines have 
become widely utilized in clinical settings in Japan. However, 
due to variations in causes, clinical progress and prognosis 
of acute cholangitis, investigations into the diagnostic and 
treatment processes and outcomes are complicated and dif-
fi cult. As such, there have been no multi-institutional analy-
ses concerning acute cholangitis that have been conducted in 
Japan.
Objective: The objective of this study was to conduct a 
multi-institutional analysis of the changes observed in 
various clinical indicators for acute cholangitis using admin-
istrative data in order to evaluate the impact of the guidelines 
around the period of publication.
Methods: Using administrative data from hospitals enrolled 
in the Quality Indicator/Improvement Project, a program 
developed and administrated by our department, we con-
ducted a multi-institutional analysis of the changes in the 
patient characteristics, process and outcome indicators, and 
medical resource utilization in 2-year increments from April 
2004 to September 2009.
Results: Using data comprising of 14,816 cholangitis 
patients from 228 hospitals in Japan, we observed the fol-
lowing statistically signifi cant changes in the years following 
guideline publication: increases in endoscopic therapy, stent 
therapy and laparoscopic surgery; and reductions in the 
administration duration of intravenous antimicrobials, percu-
taneous therapy, length of hospital stay and medical 
cost.
Conclusions: This study is the fi rst large-scale multi-insti-
tutional analysis of the effects of published guidelines on 
acute cholangitis to be conducted in Japan. Our results 
showed that in general, the changes observed corresponded 
to the standards outlined in the published guidelines.
P0025B
MANAGEMENT OF MAJOR BILE DUCT 
INJURIES IN A DEVELOPING COUNTRY
S. Rambarran*, F. Anderson, L. Ferndale and S. Thomson
*Department of Surgical Gastroenterology, Nelson R 
Mandela School of Medicine, University of Kwazulu Natal, 
Durban, Kwazulu Natal, South Africa
Background: South Africa, a developing country, has 
inherent resource challenges compounding the effective 
management of Bile Duct Injuries (BDI). We audited our 
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experience with BDIs and identifi ed factors peculiar to our 
practice that infl uenced outcome.
Methods: A retrospective descriptive audit of all patients 
with major BDIs referred to a single surgical unit over a 13 
year period (1997–2010) was performed. Patient demograph-
ics, operative details, management at the time of injury, 
complications and outcomes of defi nitive surgery were 
analysed.
Results: Twenty seven patients had major BDI were entered, 
17 were female and 10 male with a mean age of 45 years 
(range 19–78). Injuries were chiefl y related to laparoscopic 
cholecystectomy (LC) 21, followed by hepatic resection 3, 
CBD surgery for ascariasis 2 and penetrating trauma 1. The 
level of injury was confl uence 13 (48%), common hepatic 
duct injury 10 (37%), left hepatic duct 4 (10%). Injuries were 
recognised in 11 at the time of LC and 2 were diagnosed 
within 48 hours at laparotomy. Of these 13, 8 were managed 
defi nitively with Roux-en-y Hepaticojejunostomy (HJ) at the 
time of injury and 5 were temporised with biliary drainage 
or diversion. Two of the 8 repaired by the primary surgeon 
required revision HJ due to early stricture formation. In the 
delayed injuries and those not primarily repaired 14 of 27, 6 
presented with complications related to bile peritonitis and 
stricture formation. Defi nitive surgical management was 
performed after a minimum of 4 weeks in 11 of these 
patients. Three patients who developed late strictures 
were managed endoscopically. At 6 months 78% were well 
with a normal sonar and bilirubin level. Follow-up was only 
52% at 1 year after defi nitive repair. Four died, 2 following 
repair of left hepatic duct strictures following hepatic resec-
tion, 1 due to biliary sepsis with a cardiac event and the last, 
post LC BDI, developed a postoperative DIC at her second 
repair.
Conclusion: 80% of BDIs are from LC. Primary surgeon 
repair surgery caused two strictures. Early and late repair 
performed by experienced hepato-biliary surgeon had good 
intermediate outcomes. Follow-up of our patients is poor 
after a year and long term outcome speculative.
P0026B
THE INCIDENCE OF BACTOBILIA 
INCREASES OVER TIME AFTER 
ENDOSCOPIC SPHINCTEROTOMY
J. S. Reinders1, K. Kortram1, B. Vlaminckx1, B. van 
Ramshorst1, D. J. Gouma2 and D. Boerma1
1St. Antonius Hospital, Nieuwegein, Netherlands; 
2Academic Medical Centre, Amsterdam, Netherlands
Patients with combined choledochocystolithiasis are usually 
treated by endoscopic retrograde cholangiography (ERC) 
with sphincterotomy (ES) followed by laparoscopic chole-
cystectomy (LC). It is known that LC after ES is more dif-
fi cult than in uncomplicated gallstone disease. A possible 
explanation is that destruction of Oddi’s sphincter leads to 
bacterial colonization of the common bile duct, infl ammation 
and scarring of the hepatoduodenal ligament.
The goal of this study was to evaluate if the presence of 
bactobilia infl uences the peri- and postoperative outcome of 
LC after ES.
Data were obtained from a randomized clinical trial on the 
timing of LC after ES for choledochocystolithiasis. Ninety-
six patients were randomly allocated to either LC within 72 
hours after ES (early LC [ELC]) or 6 to 8 weeks after ES 
(delayed LC [DLC]). Bile-samples were collected peropera-
tively under aseptic conditions.
In 64 of 96 patients a bile-samples were obtained; 26 ELC 
patients vs 38 DLC patients.
The overall prevalence of bactobilia was 62.5% (40/64); 
50% of ELC patients (n = 13) versus 71.1% in DLC group 
(n = 27) (p = 0.088). Patient characteristics did not differ 
between patients with or without bactobilia. A multivariate 
regression analysis showed age (p < 0.001) and group (i.e. 
ELC/DLC) (p = 0.039) to be independent predictors for the 
presence of bactobilia.
The presence of bactobilia did not infl uence operating time 
and –diffi culty, conversion rate or postoperative complica-
tions. Recurrent biliary events in period between ES and LC 
occurred more often in patients with bactobilia (44% versus 
28%). This was not signifi cantly different.
Almost two thirds of patients after ES for choledochocys-
tolithiasis present with bactobilia at the time of surgery. The 
prevalence of bactobilia increases with age and time after 
ES. Bactobilia doesn’t lead to more perioperative complica-
tions, however patients with bactobilia tend to develop more 
biliary complications awaiting surgery.
P0027B
THIOACETAMIDE AND EXPERIMENTAL 
IN VIVO MODELS OF 
CHOLANGIOCARCINOMA
A. Robson1,2, P. Ramachandran2, A. Pellicoro2, 
S. Wigmore1, J. Garden1, J. Iredale2 and S. Forbes2
1Department of Surgery, University of Edinburgh, 
Edinburgh, United Kingdom; 2Centre for Infl ammation 
Research, University of Edinburgh, Edinburgh, United 
Kingdom
Background: Cholangiocarcinoma (CC) is rapidly increas-
ing in incidence. Treatment options are very limited. 
Development of appropriate medical therapies requires 
tumour models that are histologically and anatomically real-
istic. Oral thioacetamide (TAA) at low doses has been previ-
ously used in male rats to induce CC but there is no 
information regarding reliable dosing regimes. TAA has not 
previously been used in mouse models.
Methods: Male Sprague Dawley rats were commenced on 
standard low dose and a revised high dose of oral TAA in 
drinking water for up to 1 year. Female rats were provided 
with low dose TAA only. Wild type and MMP12-/- (macro-
phage metalloelastase) male C57bl6 mice were also com-
menced on the low and high doses for up to 15 months. 
Livers were harvested at regular intervals (n = 3–4 each time 
point). Livers were compared histologically to human 
lesions. Immunohistochemistry for biliary cells (CK19), 
myofi broblasts (aSMA), migratory macrophages (CD68+), 
immune cells (MPO) and extracellular matrix components 
was performed.
Results: Lesions did not form in wild type or MMP12-/- 
mice during the study period, regardless of dosing regime. 
In male rats on low dose TAA, tumour formation was vari-
able and unreliable by 28 weeks. However, on the high dose, 
there was a 100% incidence of CC by 16 weeks. In female 
rats, tumours were present by 1 year. Histologically, in 
human and rat tissue, a laminin-rich extracellular matrix 
66 Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
ensheathed neoplastic cholangiocytes. In both species, a 
pronounced tumour-associated cellular microenvironment 
comprised of stereotypical arrangements of myofi broblasts 
(aSMA), migratory macrophages (CD68+) and immune cells 
(MPO).
Conclusions: The rat model of high dose TAA administra-
tion provides a rapid, reliable model of intrahepatic CC with 
100% penetrance. The histological correlation with human 
lesions is excellent. The TAA rat model provides close 
correlation to human intrahepatic lesions with formation 
of a pronounced tumour microenvironment.
P0028B
MINIMIZATION OF BILE LEAKAGE OR 
STENOSIS AFTER BILIOENTERIC 
ANASOMOSIS BY OPTIMIZATION OF 
THE SURGICAL TECHNIQUE-LESSONS 
LEARNED FROM LIVING RELATED AND 
SPLIT LIVER TRANSPLANTATION
M. Schulze, H. Honarpisheh and D. Bröring
Department of Surgery, University of Schleswig Holstein, 
Campus Kiel, Kiel, Germany
In over 20 years experience with living related liver trans-
plantation and split liver transplantation in Hamburg and 
Kiel, Germany, we have managed to minimize biliary com-
plications dramatically.
In the last 5 years there we did not observe any biliary 
complications such as bile leakage in donors. Even in recipi-
ents of living related grafts we could minimize the rate of 
biliary complications down to 5%. These were mainly stric-
tures at the anastomotic site. Bile leakage from the bilioene-
teric anastomosis was equally minimized to about 1%. In 2% 
of the cases we observed a bile leakage from an aberrant bile 
duct that what not seen during the transplantation.
In split liver transplantation however we did see a higher 
rate of biliary complications such as leakage from the anas-
tomotic site, mainly when the organ was splitted elsewhere 
and therefore cold ischemic time increased signifi cantly. We 
believe that these good results are due to the surgical tech-
nique that has been developed an established by our group. 
In any donor operation or major liver resection we do not 
devascularize or even visualize the bile duct or its bifurcation 
unless it needs to be resected for oncological reasons.
Furthermore the hilar plate is always dissected with a 
scalpel, never by coagulation or ultrasound dissection.
Therefore we always deal with a very well visualized and 
bleeding bile duct or hilar plate for anastomosis.
In the donor we perform a continuous suture on the hilar 
plate with 7/0 PDS using magnifying loops. Any visual bile 
ducts are sutured separately with 6/0 or 7/0 PDS.
The bilioenteric ansotomisis is performed, after probing 
of each orifi ce, with every draining bile duct, with PDS 6/0 
or 7/0 with interrupted sutures. The opening on the small 
bowl is kept as small as possible, by using an electric needle.
The dorsal part of the anastomisis is performed with intra-
lumally located knots, the ventral part with extralumaaly 
located knots under vision with magnifying loops (×4).
In our view the reproducibility of this distinct technique 
enabled us to achieve the above mentioned results.
P0029B
CHOLECYSTITIS ACUTA – WHY EARLY 
CHOLECYSTECTOMY?
S. Sekulic1, A. Sekulic-Frkovc2, M. Popovic3, V. Popovic1 
and J. Vasic1
1C. H. C. Pristina-Gracanica, Surgical Clinic, Medical 
Faculty, Gracanica, Serbia; 2C. H. C. Pristina-Gracanica, 
Pediatric Clinic, Medical Faculty, Gracanica, Serbia; 
3C. H. C. Pristina-Gracanica, Inerna Clinic, Medical 
Faculty, Gracanica, Serbia
Background: Cholecystitis is the most common problem 
resulting from gallbladder stones. It occurs when a stone 
blocks the cystic duct, which carries bile from the gallblad-
der.At least 90% of people with acute cholecystitis have 
gallstones
Method and results: Since 2287 operated during the six-
year period in surgical clinic C.H.C Pristina to Gracanica, 
365 or 12.7% were operations on the biliary tractus.Male was 
71 or 19.45% female and 294 or 80.5%. The average age of 
our patients was between 40–60 years of 201 or 55.1%. 
Calculosis chronic gallbladder was found in 244 or 69.7% of 
patients. Calculosis acute infl ammation of the gallbladder in 
107 or 29.3% of patients as follows: Empyem gallbladder or 
in 27 (25.2–7.4%), hydrops 5 or (4.7–1.4%), gangrene gall-
bladder 19 or (17.8–5.2%), gangrene with perforation and 
abscessus 17 or (15.9–4.7%), phlegmonisis gallbladder 21 or 
(19.6–5.8%), acute gallbladder at calculosis 14 or (13.1–
3.8%) and biliodigestivne fi stula at 4 or (3.7–1.1%) of our 
patients. Acalculosis gallbladder was found in 7, or (6.7–
1.9%) patients.Operated of hospital admission -24-48 h – 63 
(55, 3%), 72 h (21–19, 6%), and over 72 h (30–26, 3%).
Average length of classical surgery: 24–48 h of receipt 50 
minutes, 72 h 65 minutes and over 72 h 90 minutes.The 
length of treatment is abaut 3–4 days in the fi rst 72 hours of 
surgery. Postoperative complications we had with chronic 
stone gallbladder in 23, or 9.4% and acute in: postoperative 
complication of hospital admission and to: 24–48 h 
(3–4.76%), 72 h (2–9.5%) and over 72 h (5–16.7%) our 
patients.Mortality did not have.
Conclusion: Clasical or laparoscopyc surgery is the method 
of choice in treating acute imfl amatory stones gallbladder.
Patients with this disease should hospitalize, rapidly pre-
pared and operated. Operation within 24–48 hours is best 
because: stli not developed oedema of tissue, not to create a 
solid adhesion,no purulent collections, it is easier to operate 
and operation of shorter duration and hospital stay. Treatment 
shorter and cheaper.
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P0030B
TRANSCYSTIC VERSUS RETROGRADE 
GUIDEWIRE-ASSISTED ENDOSCOPIC 
STONE REMOVAL DURING 
LAPAROSCOPIC 
CHOLECYSTECTOMY FOR 
CHOLECYSTOCHOLEDOCHOLITHIASIS
J. Schoug, E. Hultberg, P-J. Blind, R. Andersson and 
C. Sturesson
Clinical Sciences, Lund University, Lund, Sweden
Background: One option to treat simultaneous stones in the 
gallbladder and the common bile duct is laparoscopic chole-
cystecomy (LC) and intraoperative endoscopic retrograde 
cholangiopancreatography (ERCP). In this case, ERCP can 
be performed by guidance of a transcystic guidewire placed 
by the surgeon or by retrograde guidewire-assisted cannula-
tion from the duodenum. The aim of this retrospective study 
was to compare these two techniques in terms of success rate 
of stone removal and rate of complications.
Methods: Retrospective data from 109 consecutive patients 
undergoing LC and intraoperative ERCP were retrieved. 69 
patients had transcystic guidewire-assisted ERCP (TGW-
ERCP) and 40 patients had retrograde guidewire-assisted 
ERCP (RGW-ERCP).
Results: In the TGW-ERCP group, transcystic passage of 
guidewire to the duodenum was possible in 61 patients 
(88%). Retrograde passage of guidewire was possible in 7 of 
remaining 8 patients. 65 patients (94%) were made stone free 
by endoscopic means during LC. In the RGW-ERCP group, 
cannulation of the bile duct was possible in 38 patients 
(95%), of whom 36 patients (90%) were made stone free 
endoscopically during LC. There was no difference in stone 
clearance rate between methods (P = 0.46). Postoperative 
pancreatitis was registered in 5 (7.2%) and 2 (5.0%) patients 
in the TGW-ERCP and RGW-ERCP group, respectively. 
There was no difference between groups in terms of total 
postoperative morbidity (P = 0.20).
Conclusions: Endoscopic removal of stones in the common 
bile duct during LC is effective and safe, whether a transcys-
tic guidewire, or retrograde insertion of guidewire for ERCP, 
is used. The choice of method should be at the preference of 
the endoscopist.
P0031B
BILE DUCTS CARCINOMA – 
RETROSPECTIVE ANALYSIS OF 4 
YEARS
A. Tavares, J. Carrapita, F. Viveiros, C. Cidade and 
J. Maciel
Centro Hospitalar de V.N. Gaia – Oporto, Oporto, 
Portugal
Introduction: The biliary cancer develops from the epithe-
lium of the bile ducts, which comprise about 5–30% of liver 
cancer. More than 90% of cases are Aden carcinomas. The 
etiology of most carcinomas of the biliary tract remains 
unclear. Usually have a slow growth, with infi ltration of the 
wall of the bile ducts. Located more often in the choledocus 
and common hepatic bile duct. Jaundice is the most common 
clinical presentation, present in more than 90% of patients. 
The preoperative diagnosis is uncommon. Complete surgical 
resection is the only treatment that provides healing. 
However, early detection occurs in only 10% of patients 
who are candidates for curative surgical resection. 
Objective: Review of cases of biliary carcinoma diagnosed 
in a Service of General Surgery, from January 2003 to 
December 2006. 
Methods: Retrospective study of patients with biliary car-
cinoma between January 2003 and December 2006. The data 
were obtained by research in the Department of Statistics and 
replay clinical fi les. 
Conclusion: Occurred predominantly in male and mean age 
at diagnosis between 60 and 65. The most frequent histologi-
cal type was Aden carcinoma, located preferentially in the 
choledocus. In most patients the jaundice was the clinical 
presentation. Pre-operatively the histological diagnosis was 
possible in a minority of cases. Only about 46% of patients 
underwent surgical resection with curative intent. The prog-
nosis is poor, with low survival rates in advanced stages.
P0032B
PROPHYLACTIC LAPAROSCOPIC 
CHOLECYSTECTOMY CAN BE SAFELY 
PERFORMED FOR CHOLELITHIASIS IN 
PATIENTS WITH HEREDITARY 
ANGIOEDEMA
A. Cockbain, R. Dave, J. Gooi and G. Toogood
St James’s University Hospital, Leeds, United Kingdom
Background: Hereditary angioedema (HAE) is an autoso-
mal dominant disease caused by a lack of C1-esterase inhibi-
tor protein. It is typifi ed by recurrent episodes of angioedema 
involving the face, upper airways, extremities or gastrointes-
tinal tract. There is currently no consensus on the manage-
ment of cholelithiasis in these patients. There is a very real 
potential for gallstones to trigger acute angioedema. However 
this must be balanced against the risk of anaesthesia and 
laparoscopic cholecystectomy (LC) to trigger symptoms in 
the elective setting.
Aims: To present our experience of and management guide-
lines for LC in patients with hereditary angioedema.
Methods: A database of all patients with HAE under the 
care of the Department of Clinical Immunology was inter-
rogated, and patients who had undergone LC were identifi ed. 
Their anaesthetic, surgical and perioperative management 
was reviewed from the case-notes.
Results: Sixty-eight patients with HAE were identifi ed. 
Seven had undergone LC; 4 for asymptomatic gallstones, 1 
for gallstone pancreatitis, and 2 for gallstones in a different 
trust. All patients were jointly managed by the Clinical 
Immunologist and the Surgical team. HDU beds were avail-
able for all patients postoperatively. All patients received 
prophylactic Fresh Frozen Plasma or infusion of C1 esterase 
concentrate 30 minutes prior to surgery and 30–60 minutes 
postoperatively. Routine cholecystectomy by a standard 4 
port technique was achieved in all patients with no complica-
tions. Median length of stay was 2 days.
Conclusion: Despite a paucity of data, it remains the fi rm 
belief of the Clinical Immunologists that prophylactic LC is 
the best management for cholelithiasis in patients with HAE. 
This can be performed safely in the elective setting.
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P0033B
EVOLUTION OF THE SURGICAL 
MANAGEMENT OF PERIHILAR 
CHOLANGIOCARCINOMA IN A 
WESTERN CENTER DEMONSTRATES 
IMPROVED SURVIVAL WITH 
ENDOSCOPIC BILIARY DRAINAGE AND 
REDUCED USE OF BLOOD 
TRANSFUSION
A. L. Young, T. Igami, Y. Senda, R. A. Adair, S. G. Farid, 
G. J. Toogood, K. R. Prasad and J. P. A. Lodge
St James’s University Hospital, Leeds, West Yorkshire, 
United Kingdom
Introduction: Perihilar cholangiocarcinoma (PHCCA) 
remains a surgical challenge with few large reported series, 
particularly in Western centers. We investigated which 
factors affected survival in our unit.
Methods: A prospectively maintained database was inter-
rogated to identify all resections. Clinico-pathological data 
was analyzed and assessed for impact on survival. 
Subsequently data for resections during the periods 1994–
1998, 1999–2003 and 2004–2008 were compared.
Results: 83 patients underwent resection. Almost 3/4 
required hepatic trisectionectomy. Overall survival was 70% 
at 1 year, 36% at 3 years and 20% at 5 years. Size of tumour, 
R0 status, distant metastasis, tumour grade, portal vein resec-
tion, microscopic direct vascular invasion, T-stage, and blood 
transfusion requirement signifi cantly affected outcome on 
univariate analysis. Distant metastases (p = 0.040), percuta-
neous biliary drainage (p = 0.015) and blood transfusion 
requirement (p = 0.026) were signifi cant on multivariate 
analysis. Survival outcomes improved signifi cantly in the 
most recent period and in addition blood transfusion require-
ment was signifi cantly reduced in the most recent time 
period.
Conclusion: This is the fi rst series to report blood transfu-
sion requirement and pre-operative percutaneous biliary 
drainage as independent poor prognostic indicators follow-
ing resection of PHCCA. Long term survival can be achieved 
following aggressive surgical resection of this tumour but a 
learning curve is apparent which supports the management 
of these patients in high volume centers to achieve improved 
outcomes.
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P0001L
TREATMENT OUTCOMES AND MSKCC 
SCORING IN 1281 PATIENTS 
UNDERGOING RESECTION FOR 
COLORECTAL LIVER METASTASES
R. Adair, A. Young, A. Cockbain, R. Prasad, G. Toogood 
and P. Lodge
St James’s Univeristy Hospital, Leeds, West Yorkshire, 
United Kingdom
Background: Hepatic resection remains the only curative 
option for patients with colorectal liver metastases (CRLM). 
Here, we report treatment outcomes for our large, single 
centre series of resections and assess the predictive value 
of the Memorial Sloan-Kettering Cancer Centre (MSKCC) 
scoring system in an independent cohort.
Methods: Patients who underwent liver resection for 
CRLM in a single, tertiary referral, Hepatobiliary centre 
were identifi ed from a prospectively kept database. Clinico-
pathological variables based on the MSKCC scoring system 
were then analysed to assess factors predictive of survival 
using univariate/multivariate analysis. (PASW® version 
17.0)
Results: A total of 1281 patients underwent hepatic resec-
tion between 1992 and 2009. Median age was 63 years. 1108 
underwent primary hepatectomy with 173 undergoing repeat 
resection. Overall, disease-specifi c survival at 1, 3, 5 and 10 
year survival was 87%, 52%, 36% and 21% respectively 
and the median follow-up was 26.9 months. Thirty day mor-
tality was 2.6% and morbidity 16.4%. Of the 5 MSKCC 
prognostic criteria, only node positive primary disease (p = 
<0.001 95% CI 1.26–2.04) and tumour size greater >5 cm (p 
= <0.04 95% CI 1.01–1.61) predicted poorer outcome in our 
group on multivariate analysis. The actuarial 5 year survival 
was 49% for those scoring 0 points and 21% for those 
scoring 5.
Conclusion: In our patient cohort the MSKCC prognostic 
score did not accurately predict survival and this highlights 
the importance of independent validation of scoring systems. 
Moreover, the contemporary focus on liver rather than 
tumour related factors in determining resectability means 
that prognostic scores may now prove more useful in predict-
ing response to adjuvant, cytotoxic therapy.
P0002L
SIZE OF TUMOUR PREDICTS OUTCOME 
IN REDO RESECTION FOR 
COLORECTAL LIVER METASTASES
R. Adair, A. Young, D. Malde, R. Prasad, P. Lodge and 
G. Toogood
St James’s University Hospital, Leeds, West Yorkshire, 
United Kingdom
Background: Seventy-fi ve to 80% of patients undergoing 
liver resection for colorectal liver metastases develop recur-
rence. A signifi cant number of these can be considered for 
re-do liver surgery. We examined the outcomes of re-do liver 
resection for the treatment of recurrent colorectal metastases 
confi ned to the liver.
Methods: Patients who underwent repeat liver resection in 
a single, tertiary referral, Hepatobiliary centre were identi-
fi ed from a prospective database. Clinico-pathological vari-
ables were analysed to assess factors predictive of survival 
using univariate/multivariate analysis. (PASW® version 
17.0)
Results: A total of 173 patients underwent repeat resection 
between 1992 and 2009. Median age was 63 years and the 
median interval between 1st resection to repeat was 13.6 
months. Disease-specifi c 1, 3 and 5 year survival was 89%, 
44% and 25%. Thirty day mortality was 2.3% and morbidity 
13.8%. Twenty-eight patients underwent completion hemi-
hepatectomy with the remainder undergoing non-anatomical 
or segmental resection. Tumour size greater than 5 cm was 
the only independent predictor of overall survival (p = 0.001, 
RR 2.32, 95% CI 1.44–3.77). Neoadjuvant chemotherapy, 
blood transfusion, bilobar disease and multiple metastases 
were among factors which did not signifi cantly infl uence 
survival.
Conclusion: With the advent of future liver remnant deter-
mination and advances in cytotoxic therapy re-defi ning 
resectability, re-do surgery should be considered for patients 
presenting with recurrent metastatic disease confi ned to the 
liver.
P0003L
THE NATURAL HISTORY OF LIVER 
REGENERATION IN RATS – 
DEVELOPMENT OF AN ANIMAL MODEL 
FOR LIVER REGENERATION STUDIES
K. J. Andersen1, A-S. Kannerup1, A. R. Knudsen1, 
H. Sasanuma2, Y. Yasuda2 and F. V. Mortensen1
1Århus University Hospital, Århus, Denmark; 
2Jichi Medical School, Tochigi, Japan
Background: Many suggestions of how and when to assess 
the regenerated liver in animal models have been proposed. 
The aim of the present study was to evaluate the natural 
history of liver regeneration in healthy rats, regarding size, 
weight and functional capacity. The study was meant as a 
precursor for further interventional studies in healthy and 
cirrhotic animals.
Material and methods: Partial hepatectomy (PHx) of 70% 
was performed on 64 rats. After PHx the animals were ran-
domised into 8 groups for evaluation. The animals in each 
group were evaluated on same postoperative day (POD) from 
POD 1 to 8.
Results: At PHx the animals had a mean body weight of 
238.4 g (211.4;286.5). Mean weight of resected liver was 
6.25 g (5.2;7.3) and an estimated total liver weight of 8.9 g. 
Liver weight analysis showed an ascending curve, with max 
slope POD 1-3, reaching a steady state of ca 9 g on day 5–8. 
When correlated to body weight, through regeneration rate, a 
similar pattern was seen, with a RR of 100% reached day 5–8.
Interleukin-6 (Il-6) peaked POD 1 and was falling to 
undetectable levels day 4. Alfa-2-Macroglobulin (α-2-M) 
levels were high POD 1-3 before falling to low levels. 
Tumor-necrosis-factor-alpha (Tnf-α) was undetectable 
throughout the period.
70 Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
At the moment functional capacity of the regenerating liver, 
is analysed by the enzymatic method BTR (Ratio of 
Branched-Chain Amino Acids to Tyrosine).
Stereological aspects are looked into regarding KI-67 
analysis and blood vessel density estimation, as is more 
serological markers (Alanin-amino-transferase, Bilirubin, 
Alkaline-phosfatase and Hepatocyte-growth-factor).
Conclusion: Liver regeneration, regarding size and weight, 
were at top speed day 1–3. Full liver regeneration reached a 
plateau after 5–8 days, and should after this point be consid-
ered practically at end.
Liver regeneration should in further studies be evaluated 
on postoperative day 1, 3 and 8.
P0004L
MAJOR LIVER RESECTION IN HILAR 
CHOLANGIOCARCINOMA: ANALYSIS 
OF POSTOPERATIVE COMPLICATIONS
V. Ardiles, F. Bersano, G. Moriconi, N. Resio, M. Lenz 
and O. Mazza, J. Pekollj, E. de Santibañes
HPB surgery, Hospital Italiano de Buenos Aires, Buenos 
Aires, Argentina
Background: Surgical resection for hilar cholangiocarci-
noma is the only potentially curative treatment. However, 
this procedure results in a high incidence of postoperative 
morbidity and mortality in these patients.
Aim: To analyze postoperative morbidity and mortality in a 
consecutive series of major liver resection for hilar 
cholangiocarcinoma.
Material and methods: Between 1994 and 2008, 67 
patients with hilar cholangiocarcinoma were explored surgi-
cally with curative intent. In 40 cases we were able to com-
plete a major liver resection and in 27 palliative surgeries 
were performed. We analyzed demographic, preoperative, 
surgical and pathological variables and its relationship to 
postoperative complications.
Dindo´s classifi cation for complications were used as well as 
chi2 and t test for univariate analysis and actuarial method 
for free-disease and global survival.
Results: 40 patients, 25 were male (62%) with a mean age 
of 58.2 ± 11 years. Jaundice was the most common symptom 
(70% of cases) being the mean values of BT and BD l: 9.6 
± 7.8 mg/dl and 6.6 ± 5.8. 19 patients underwent PBD and 
3 preoperative portal embolization. There were 18 right and 
9 left trisectionectomies, and 4 right and 9 left hepatecto-
mies. Resection of the caudate was associated in all cases, 
and reconstruction of portal vein and IVC in 6 and 2 cases 
respectively. Node dissection was completed in 15 cases. 
Postoperative morbidity was 37.5% (15 cases).The compli-
cations were grade 1 in 3 cases, grade 2 in 5, grade 3a in 1, 
grade 4a in 2 and grade 5 in 4 cases.
In univariate analysis, only the level of direct bilirubin al 
presentation was associated with postoperative complica-
tions (mean DB 9.8 vs. 4.9, p = 0.015) and the levels of 
preoperative serum protein and albumin with postoperative 
mortality (mean 3.9 vs 4.9 p = 0.014 and 1.5 vs 2.5, p = 
0.008). With a mean follow up of 36 months, disease-free 
survival at 1, 3, and 5 years was 63%, 34% and 24% and 
overall survival at 1, 3 and 5 years was 86%, 55% and 43%.
Conclusions: Major liver resection for hilar cholangiocar-
cinoma can be performed with acceptable morbidity and 
mortality despite being higher than those of hepatic resec-
tions for other indications. However, the long-term results 
justify the aggressive approach.
P0005L
NATIONAL MULTICENTER-REGISTRY 
OF LIVER METASTASES OF 
COLORECTAL CANCER: RESULTS AT 
ONE YEAR OF THEIR PRESENTATION
V. Ardiles1, G. F. Moriconi1, O. C. Andriani2, 
A. G. Campaña2, J. P. Grondona3, E. L. Huertas4, 
F. A. S. Loria4, J. C. Lendoire5, L. P. Gil5, R. J. Maurette6, 
M. A. Ciavarelli7, L. Mc Cormack8, R. A. Bracco9, 
D. L. Fernandez9, G. E. Gondolesi10, J. A. Neffa11, 
E. A. Murguía12, J. Ismael12 and E. de Santibañes1
1Hospital Italiano de Buenos Aires, Buenos Aires, 
Argentina; 2Hospital Universitario Austral, Pilar, Pcia. 
Buenos Aires, Argentina; 3UNACIR, San Isidro, Pcia. 
Buenos Aires, Argentina; 4Instituto Alexander Fleming, 
Buenos Aires, Argentina; 5Hospital General de Agudos 
Cosme Argerich, Buenos Aires, Argentina; 6Hospital 
Británico de Buenos Aires, Buenos Aires, Argentina; 
7UOM, San Martín, Pcia. Buenos Aires, Argentina; 
8Hospital Alemán de Buenos Aires, Buenos Aires, 
Argentina; 9UNACIR, Mar del Plata, Pcia. Buenos Aires, 
Argentina; 10Fundación Favaloro, Buenos Aires, Argentina; 
11Hospital Italiano de Mendoza, Mendoza, Argentina; 
12Hospital Municipal de Vicente López, Vte. López, Pcia de 
Buenos Aires, Argentina
Background: The importance of changes in the management 
of CRC liver metastases are associated with high disparity in 
the treatment of these patients. With the ultimate goal of unify-
ing the treatment and promote a multidisciplinary approach, 
in November 2009 we created a National Registry of Hepatic 
Metastases of Colorectal Cancer in Argentina.
Aim: To describe the results of the National Register of 
CRC liver metastases at 1 year of its implementation.
Design: Multicentric, descriptive, observational, retrospec-
tive of prospective collected database study.
Methods: All participating centers began from February 
2010 to record data of patients with colorectal liver metas-
tases that are assessed regardless of resectability.
Results: From February 2010 there were 47 registered 
centers, 25 of which made an active registry of patients. Data 
were collected from 247 patients, 55% male with a mean age 
of 60.1 ± 14.9 years. The primary tumor was located in the 
sigmoid in 27% of cases in the rectum in 25.5%, on the left 
colon in 20.9%. In 88% resection of primary was performed, 
28 cases by laparoscopy and in 56 simultaneously with liver 
metastases. 25% were single liver lesions and in 40% 
between 2 and 4 metastases were diagnosed, 55% of lesions 
were bilateral. 67% of patients were estimated to be resect-
able and an hepatectomy was made in 90% of patients surgi-
cally explored. In 26% anatomical resections were performed, 
being 25 major resections. 28 patients had associated local 
procedures, all of them radiofrequency thermal ablation 
(open in 20 cases). The mean length of hospital stay was 10 
± 5 days (r 2–35) and postoperative morbidity was 25%. No 
postoperative mortality was reported.
Conclusions: This registry is still in its infancy and, because 
of the small follow up of patients, is not yet possible to draw 
 Abstracts 71
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
valid conclusions about the infl uence of different factors 
associated with recurrence and survival. But it is a fi rst step 
in a multicenter and multidisciplinary effort to describe the 
characteristics of this population in Argentina, described the 
results of different treatments, promote unifi cation of criteria 
for treatment and management of these patients according to 
international standards and promote a multidisciplinary 
approach.
P0006L
THE EFFECT OF HYPERTHERMIA ON 
THE FUNCTION OF THE ENERGETIC 
SET OF LIVER CELLS
T. Vanagas1, R. Zukiene2, Z. Nauciene2, A. Gulbinas3 and 
G. Barauskas1
1Department of Surgery, Kaunas University of Medicine 
Hospital, Kaunas, Lithuania; 2Centre of Environmental 
Research, Faculty of Natural Sciences, Vytautas Magnus 
University, Kaunas, Lithuania; 3Institute for Biomedical 
Research, Kaunas University of Medicine, Kaunas, 
Lithuania
Aim of study: To evaluate the alterations in the energetic set 
of liver cells within transition zone after RFA.
Methods: Experiments had been carried out on viable liver 
tissue mitochondria extracted from Wistar race rats livers. 
The livers had been perfused for 15 min. at the temperatures 
of 38, 40, 42, 46, 48, 50, 52°C to simulate temperatures in 
the transition zone. After perfusion mitochondria, adenine 
nucleotides and reduced pyridine dinucleotides were 
extracted to investigate respiration rate, membrane potentials 
and for high-performance liquid chromatography (HPLC). 
The mitochondria functions had been investigated with 
oxidation of succinate and pyruvate + malate.
Results: After perfusion at 42°C respiration rate in third 
metabolic state (V3) of mitochondria decreased for 41% oxi-
dizing succinate and for 38% oxidizing pyruvate + malate. 
The respiration rate in second metabolic state (V2) remained 
unchanged. At 46°C V3 decreased for 61% and 65%, V2 – for 
40% and 36% oxidizing succinate and pyruvate + malate 
respectively. At 50°C V3 decreased 3 times oxidizing succi-
nate and >4 times oxidizing pyruvate + malate. The mem-
brane potentials decreased for 9.0 ± 0.5 mV in second 
metabolic state (MS2) and for 2 ± 0.3 mV in third metabolic 
state (MS3) at 42°C. At 46°C membrane potentials decreased 
for 22 ± 1.5 mV in MS2 and 17 ± 2 mV in MS3. At 52°C, 
the potentials in MS2 were lower than in MS3. The total 
amount of nucleotides determined by HPLC increased with 
increasing temperatures up to 48°C and was 48% higher as 
compared with controls. The amount of ADP increased 
twice, ATP – 7 times. Concentration of AMP decreased for 
39%. After perfusion, the total amount of nucleotides 
decreased for 34% at 52°C.
Conclusions: Hyperthermia markedly and irreversibly 
inhibits activity of respiratory chain components, activates 
membrane leak subsystem and determines the loss of energy 
supply functions.
P0007L
THE RELATIONSHIP BETWEEN 
HEPATIC SYNTHETIC DYSFUNCTION 
AND DEVELOPMENT OF POST-
OPERATIVE COMPLICATIONS 
FOLLOWING LIVER RESECTION
P. Sanjay, A. Marioud, I. Ong, A. Bartlett and J. McCall
Auckland City Hospital, Auckland, New Zealand
Introduction: The relationship between postoperative INR 
and bilirubin following liver resection and development of 
post-operative complications has not been well character-
ised. The study aimed to identify independent pre-operative 
variables that predict post resection hepatic dysfunction to 
help determine whether there is a relationship between these 
measures of hepatic dysfunction and development of post-
operative complications.
Methods: Pre- and post-operative INR and bilirubin to the 
time of discharge were recorded on consecutive patients. The 
effect of steotosis, preoperative portal vein embolisation, 
chemotherapy, extent of resection (major ≥3 segments), 
intra-operative blood loss (<500 ml or >500 ml), blood 
transfusion, use of Pringle manoeuvre and postoperative 
complications (Clavien grade 1–5) on post-resection hepatic 
dysfunction were analysed.
Results: 181 patients who underwent liver resection over a 
5 year period (2000–2005) were reviewed retrospectively. 89 
patients had colorectal cancer, 15 cholangiocarcinoma, 21 
benign lesions and 41 hepatocellular carcinoma, of which 17 
had underlying cirrhosis. 114 patients underwent a major 
resection with a median of 4 (range 4–6) segments resected 
per patient. Post-operatively the median time to the peak INR 
was day 2 (1–13) and peak bilirubin was day 4 (1–69). 
Logistic regression identifi ed major resection (p = 0.002) and 
cirrhosis (p = 0.007) as independent factors predicting an 
increase in INR post resection. Postoperative elevation of 
bilirubin was predicted by major resection (p = 0.003), cir-
rhosis (p = 0.002) and intra-operative blood loss of >500 ml 
(p = 0.012). Patients who developed postoperative complica-
tions (p = 0.01) or had Clavien grade 1 complications (p = 
0.03) were more likely to have a less signifi cant post-
operative hepatic synthetic dysfunction.
Conclusion: The relative increase of INR and bilirubin is 
greater in the presence a major liver resection (>3 segments), 
cirrhosis and signifi cant intra-operative blood loss. The 
absence of postoperative dysfunction was associated with 
low likelihood of signifi cant complications (Clavien grade II 
or more).
P0008L
A NEW METHOD FOR INDUCTION OF 
LIVER HYPERTROPHY PRIOR TO 
RIGHT TRISECTIONECTOMY: A 
REPORT OF THREE CASES
J. Baumgart1, S. Lang2 and H. Lang1
1University Medical Centre of the Johannes Gutenberg-
University Mainz, Mainz, Germany; 2University Medical 
Center Regensburg, Regensburg, Germany
Although there have been huge improvements and advance-
ments of chemotherapeutics and biological drugs concerning 
the clinical treatment of primary or secondary liver tumors 
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during the last decades, the surgical resection still remains 
the only curative option for many patients.
Of peculiar interest are those liver tumors which seem to 
be inoperable at fi rst by the risk of developing a postopera-
tive liver failure based on a too small remaining liver volume. 
Utilizing the livers ability of regeneration induced by a selec-
tive hypertrophy, the rate of resectable liver tumors could be 
increased.
Therefore, two main methods are performed with regular-
ity: the selective portal vein embolization (PVE) or the selec-
tive portal vein ligation (PVL). Both strategies lead to a 
hypertrophy of the contralateral liver lobe that allows the 
surgical resection in a second step. In special cases, including 
large tumor volumes, the long time between the ligation/
embolization and the following surgical resection could 
induce serious problems by further tumor growth.
We would like to report our results of a new method for 
induction of liver hypertrophy prior to right trisectionectomy 
by performing a complete portal vein dissection and liver 
transsection including the segments I, V-VIII and IVb under 
leaving the right hepatic artery and right liver vein. The 
second procedure was followed after 6–7 days to remove 
the right liver lobe.
In the three cases the left liver lobe volume rose about 62, 
75 and 80% controlled by CT-scan performed on the day 
before and on the sixth or seventh postoperative day after 
the fi rst surgical procedure.
Besides the surgical technique and the liver volume, the 
analysis also focuses on potential complications related 
to the new method and specifi c clinical data of the three 
presented cases.
P0009L
THE ROLE OF LIVER RESECTION OF 
METASTASES FROM GASTRIC 
CARCINOMA: EVIDENCE BASED OR 
JUST INDIVIDUAL CASE DECISIONS. A 
SYSTEMATIC REVIEW AND META-
ANALYSIS FROM 1990 TO 2010
J. Baumgart, M. Möhler and H. Lang
University Medical Centre of the Johannes Gutenberg-
University Mainz, Mainz, Germany
The appearance of liver metastases from gastric cancer is 
associated with a poor prognosis for the patients’ median 
survival and long term outcome. Therefore, the role of liver 
resection for isolated metastatic gastric cancer still remains 
unclear. We demonstrate a systematic review and meta-
analysis of the published literature of the prognosis after 
surgical resection of liver metastases from gastric cancer 
concerning the morbidity and mortality, prognostic risk 
factors and median survival as well as long term survival. 
The included studies were found by performing a Pub-med 
study containing the years 1990 to 2010.
Regarding the results of the mortality, median survival and 
long-term outcome in patients with liver resection of isolated 
gastric cancer metastases, we declare for selective cases an 
improvement of the prognosis and of the course of 
disease.
Overall, liver resection could be an individual effective 
therapy option but the indication has to be discussed care-
fully case-by-case.
P0010L
MORBIDITY AND MORTALITY AFTER 
ULTRASOUND GUIDED LAPAROSCOPIC 
RADIOFREQUENCY ABLATION FOR 
PRIMARY AND SECONDARY LIVER 
TUMOR
G. Belli, A. D’Agostino, C. Fantini, L. Cioffi , G. Russo, 
A. Belli and P. Limongelli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital, Naples, Campania, 
Italy
Introduction: In the modern treatment of hepatocellular 
carcinoma, the radiofrequency ablation plays an important 
role. Though generally performed percutaneously by radiolo-
gist, such therapy can be employed by surgeons 
laparoscopically.
Aim: To report short term results of intraoperative radiofre-
quency ablation with or without ultrasound guided hepatic 
resection for primary and secondary liver tumor.
Material and methods: A total of 35 patients with primary 
and secondary liver tumor up to 3 cm underwent intra operative 
radiofrequency ablation; 11 out of 35 had also an ultrasound 
guided hepatic resection. Feasibility, safety and radiologic 
changes 1 month after the procedure were assessed.
Results: The procedure was fully accomplished in all 
patients; intraoperative ultrasonography highlighted new 
lesions in 7 patients. Deaths related to the procedure were 
nil. Postoperative morbidity was 2.8% (1/35) for a postopera-
tive infection managed with antibiotic therapy. At 1 month 
follow up, a complete response with a 100% necrosis was 
observed in 32 out of 35 patients (91%).
Conclusion: The present study has shown radiofrequency 
ablation with or without ultrasound guided hepatic 
resection is a feasible and safe treatment for primary 
and secondary liver tumor. It allows to perform an intraop-
erative staging and to treat those lesions associated to an 
higher risk of complications, with a complete control of 
bleeding.
P0011L
LAPAROENDOSCOPIC SINGLE SITE 
LIVER RESECTION FOR RECURRENT 
HEPATOCELLULAR CARCINOMA IN 
CIRRHOSIS: FIRST TECHNICAL NOTE
G. Belli, C. Fantini, P. Limongelli, A. D’Agostino, 
C. Luigi, B. Andrea and R. Gianluca
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital, Naples, Campani, 
Italy
Introduction: Single port access laparoscopic redo liver 
resection for hepatocellular carcinoma on cirrhosis trough a 
single transumbilical skin incision has not been reported in 
literature so far.
Aim: To report on a case of single site laparoendoscopic 
redo liver resection for hepatocellular carcinoma on cirrhosis 
(HCC) trough a single transumbilical skin incision.
Material and methods: A wedge resection of segment III 
lesion with a laparoendoscopic single site surgical incision 
is described in detail analyzing the technical aspects of the 
procedure.
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Results: There were no intraoperative complications with 
no intraoperative or perioperative blood transfusions. A 
Pringle maneuver was not used. Operating time was 130 
minutes. The patient had an uneventful postoperative course 
and was discharged on the second postoperative day. The 
surgical resection margin was not invaded and had a width 
of 1.8 cm.
Conclusion: In this report, laparoendoscopic single site 
liver resection for peripheral located HCC on cirrhosis 
seemed a feasible technique. This is technically demanding 
and should be undertaken only with proper training in high 
volume centres, by surgeons with expertise in both liver 
advanced laparoscopic surgery.
P0012L
LAPAROSCOPIC SPLENECTOMY FOR 
THE TREATMENT OF HYPERSPLENISM 
AND SEVERE THROMBOCYTOPENIA IN 
ONE PATIENT WITH HEPATOCELLULAR 
CARCINOMA ON HCV-RELATED LIVER 
CIRRHOSIS
G. Belli, C. Fantini, A. D’Agostino, L. Cioffi , G. Russo, 
A. Belli and P. Limongelli
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital, Naples,Italy, Italy
Introduction: Patients with hepatocellular carcinoma on 
liver cirrhosis and marked hypersplenism are generally 
deemed not fi t for liver resection due to severe 
thrombocytopenia.
Aim: To report on a patient with severe thrombocytopenia 
(PLT < 30 10∧3/mm3) associated with hepatocellular carci-
noma on liver cirrhosis treated by laparoscopic 
splenectomy.
Material and methods: A 68-year old patient with a 
10 cm hepatocellular carcinoma localized in segment VI-VII 
of a cirrhotic liver and with a child B7 and a MELD 11 
scores, underwent a laparoscopic splenectomy with the 
intention to treat a severe thrombocytopenia (PLT: 22 10∧3/
mm3)
Results: Postoperative course was uneventful but a 
subcutaneous hematoma observed on the right fl ank close 
to the abdominal drainage. Platelet count steadily increased 
in the postoperative period reaching a peak of 90 10∧3/mm3 
on postoperative day 9 when patient was discharged 
home.
Conclusion: Laparoscopic splenectomy might be a safe sur-
gical procedure for the treatment of hypersplenism and 
severe thrombocytopenia aiming to increment the number of 
patients with HCC on liver cirrhosis amenable to surgical 
therapy.
P0013L
HOW TO REDUCE THE RISK OF 
RECURRENCE AFTER SURGICAL 
TREATMENT OF COLORECTAL LIVER 
METASTASES?
L. Benhaim, D. Goéré, S. Bonnet, F. Dumont, D. Malka, 
C. Eveno, M. Ducreux and D. Elias
Institut Gustave Roussy, Villejuif, France
Introduction: After surgery with curative intent for colorec-
tal liver metastases (MHCCR), liver recurrence occurs in 
more than 60% of patients, despite the administration of 
adjuvant systemic chemotherapy. The objective of this study 
was to compare the prognosis of patients operated on 
MHCCR with high risk of recurrences in the liver, treated 
by postoperative chemotherapy hepatic arterial infusion 
(HAI) by oxaliplatin, to that obtained after adjuvant systemic 
chemotherapy.
Patients and methods: From January 2000 to December 
2009, 113 patients who underwent curative resection of more 
than 3 MHCCR were selected from a prospective database. 
Among these 113 patients, 47 had received postoperative 
HAI associated with systemic chemotherapy (HAI+) and 66, 
systemic chemotherapy alone (HAI-).
Results: The two groups were comparable in age, sex, stage 
of primary, rates of synchronous (>75%) and bilobar (>90%) 
MHCCR. The number of MHCCR was signifi cantly higher 
in the group HAI+ (p < 0.0001). Twenty-seven patients 
(57%) received more than 6 courses of HAI. HAI was dis-
continued in 6 patients (12%) due to technical problems with 
the catheter.
After a median follow up of 75 months [7–125], the 
overall survival and recurrence-free survival at 5 years 
were higher for patients HAI+ compared to those HAI−, 
respectively 52.9% vs 12.3% (p = 0.06) and 30.8% vs 2% 
(p < 0.0001).
Conclusion: The postoperative administration of oxalipla-
tin-based HAI associated to systemic chemotherapy after 
cure of MHCCR, improves recurrence-free survival of 
patients at high risk of hepatic recurrence, compared to 
systemic chemotherapy alone.
P0014L
MICROWAVE ABLATION FOR 
UNRESECTABLE HEPATIC TUMOURS: 
LONG TERM CLINICAL RESULTS
N. B. Bhardwaj, W. Ngu, A. Strickland, M. Elabassy and 
D. L. Loyd
University Hopsitals Leicester, Leicester, United Kingdom
Introduction: Liver resection for primary or secondary car-
cinoma results in 5 year survival of 25–44%, with a mortality 
rate of 0–6% and is considered the gold standard treatment. 
Unfortunately only 20–30% of patients are considered 
resectable due to tumour anatomical factors and/or signifi -
cant patient co-morbidities. Microwave ablation is a now a 
well established ablation modality used in the treatment of 
unresectable liver tumours. The purpose of this study is to 
present long term results in patients deemed to have inoper-
able tumours treated with microwave ablation.
Methods: From 2001–2009 all patients with primary or sec-
ondary liver tumours deemed unresectable were recruited 
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and treated with curative intent. A total of 211 lesions in 48 
patients (23 colorectal metastases, 13 HCC and 12 with other 
metastases) were treated with microwave ablation (Microsulis 
Medical Ltd, Denmead, UK). The mean tumour size was 
20 mm (range 2–135 mm) and the majority of patients were 
treated between 2–4 minutes at 100 watts. All patients under-
went the procedure at laparotomy except one patient with a 
parathyroid hormone metastasis who underwent laparo-
scopic ablation. Thirteen patients underwent a concomitant 
liver resection.
Results: No ablation related complications such as abscess 
formation, haemorrhage or bile leak occurred. Nineteen 
patients are alive post ablation with a median survival of 33 
months (range 12–98 months). Twenty-nine patients died, 4 
of whom died within 30 days post ablation and the rest had 
a median survival of 26 months (range 4–57 months). The 3 
and 5 year survival were 50% and 31% respectively with an 
overall recurrence rate of 10%.
Conclusion: Microwave ablation of liver tumours has an 
extremely low complication and recurrence rate. Although 4 
early post-operative deaths are unfortunate, these occurred 
in the early period of the study and none were found to be 
directly related to microwave ablation but deemed to be due 
to signifi cant patient co-morbidities. This probably refl ects 
the lack experience in patient recruitment. The overall 
survival is extremely encouraging and with its excellent 
safety profi le and ability to create large burns quickly and 
effi ciently microwave ablation may supersede more estab-
lished ablation modalities such as and radiofrequency 
ablation.
P0015L
A REGIONAL LIVER SURGERY 
PROGRAM IN A SECONDARY 
TEACHING HOSPITAL IN THE 
NETHERLANDS, A FEASIBILITY STUDY 
AND CRITICAL APPRAISAL
C. Buis, R. van Dijk, R. Bosker, F. Smit and M. Liem
Deventer Ziekenhuis, Deventer, Netherlands
Introduction: The number of patients eligible for liver 
surgery is increasing, grossly due to the rise in surgical pos-
sibilities for colorectal liver metastasis. The number of patients 
has outgrown the capacity of the academic centres. Potentially 
inadequate care is provided when patients in regional hospitals 
will not be detected as potential candidates for surgery and 
cannot be operated within the optimal timeframe.
We present the data of our fi rst consecutive 79 cases of 
our regional liver surgery program.
Patients and methods: Ninety seven adult patients sched-
uled for liver resection were reviewed from the start of the 
program in 2006 until September 2010. Clinical information 
was obtained from a prospectively collected database. We 
adhered to a strict protocol that was developed before 
the initiation of the liver program. All patients underwent 
standard laboratory and radiology investigations and 
were reviewed by an experienced liver surgeon and 
radiologist. The principal surgeon had adequate training 
in a hepatobiliary and pancreatic surgery and liver 
transplantation unit.
Results: Patient characteristics included: male 40 (51%), 
mean age 65.7 (58.5–72.7).
Sixty (76%) patients were operated on with a history of 
colorectal cancer (CRC), of these 21 for rectal cancer 
metastases.
In 62 patients a liver resection was performed. Fourteen 
of these patients (18%) underwent a major resection. In 23 
radio frequency ablation (RFA) was performed, in 11 patients 
resection was combined with RFA. In 5 patients eventually 
neither RFA nor a resection was performed, due to e.g. 
extended peritoneal metastases.
Overall survival was 89%. 2 patients died, one due to liver 
failure and one because an iatrogenic anaesthetic complica-
tion (oesophageal perforation). Overall major complication 
rate included one bile leakage, two liver failures and one 
liver abscess following RFA.
Conclusion: In a 4 year time-period a liver- programme has 
been developed with comparable results to other liver pro-
grammes in our country. We believe it is vital to the infra-
structure of a country for regional centres to exist as otherwise 
adequate treatment for patients with CRC liver metastases 
may be withheld. This can excellently be done in regional 
centres such as ours with acceptable morbidity and mortality 
rates.
P0016L
RESECTION MARGIN STATUS DOES 
NOT PREDICT DISEASE RECURRENCE 
OR IMPACT ON SURVIVAL AFTER 
LIVER RESECTION FOR COLORECTAL 
LIVER METASTASES
M. Ullah, J. S. Hammond, J. Simpson, D. N. Lobo, 
A. Brooks, I. J. Beckingham and I. Cameron
Division of Surgery, Nottingham Digenstive Diseases 
Centre, University of Nottingham, Nottingham, United 
Kingdom
Background and aim: It is unclear whether the presence 
of positive resection margins after a macroscopically com-
plete liver resection for colorectal liver metastases affects 
long term outcome. The aim of this study was to assess the 
impact of resection margin status on rates of disease recur-
rence and survival after liver resection for colorectal liver 
metastases.
Methods: A review of patients undergoing liver resection 
for colorectal liver metastases between Jan 2006 and 
December 2009 was performed. Patients were followed up 
by serial CT scans and CEA measurements at 3, 12, 18, 24 
and 36 months after resection. Primary endpoints included 
histological characteristics of the resected liver tissue (resec-
tion margin status, vascular, biliary & diaphragmatic involve-
ment and the presence/characteristics of parenchymal 
disease) and patient outcome (recurrence & survival).
Results: 130 patients (47 female) underwent liver resection 
for colorectal liver metastases. Median age was 65.4 years 
(range 39.8–82.8 years). Resection margins were positive in 
22 patients. The median resection margin clearance was 
8 mm [interquartile range (IQR) 18 mm]. 30% had vascular, 
22% had biliary and 6% had diaphragmatic involvement. 
Parenchymal disease was present in 54%. The median length 
of follow-up was 26.5 months (range 9.8–56.9 months). 
There was recurrence in 71 patients, 43 of whom had extra-
hepatic recurrence. The median interval to recurrence was 
10.1 months (IQR 11.9). 5 patients were eligible for further 
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liver resection/ablation and 8 required lung resection. There 
were 32 deaths due to disease progression. There was no 
signifi cant difference in survival or recurrence rates between 
resection margin positive and negative patients.
Conclusions: Resection margin positivity does not predict 
recurrence following liver resection for colorectal liver 
metastases.
P0017L
CLINICAL EVIDENCE FOR A FIELD 
DEFECT IN HCC AND DISTINCT 
PROGNOSTIC SUBSETS
B. Carr1, R. Branch2, S. Buch2 and P. Pancoska2
1Thomas Jefferson University, Philadelphia, PA, United 
States; 2University of Pittsburgh, Pittsburgh, PA, United 
States
A novel, strategy based on graph theory was used to clini-
cally identify discrete HCC patient subsets with different 
prognoses, by taking into account stochastic variation, ambi-
guity and coherence, to identify biologically interpretable 
coherent structures in a case series of 790 patients with 
unresectable HCC who were then followed from time of 
diagnosis to time of death. We found that the tumor size 
adversely infl uenced survival in older patients (>65 years) 
but not younger ones (>45 years). In younger patients, there 
was a subset with multicentric tumors and a high probability 
of hepatitis B and/or C that survived longer than similarly 
aged patients with large tumors. There was no separation of 
the effects on survival, of tumor traits from tests of impaired 
liver function on survival, implying the presence of a tightly 
regulated process between tumor growth and liver dysfunc-
tion, consistent with the presence of a ‘fi eld’ defect in livers 
bearing HCCs.
P0018L
EXTRACELLULAR MATRIX PROTEIN 1, 
A NOVEL PROGNOSTIC FACTOR, IS 
ASSOCIATED WITH METASTATIC 
POTENTIAL OF HEPATOCELLULAR 
CARCINOMA
H. Chen, W. Jia, J. Li, G. Xu and W. Wang
Centre for the Study of Liver Cancer and Department of 
Hepatic Surgery, Anhui Provincial Hospital, Anhui Medical 
University, hefei, China
Introduction: Extracellular matrix protein 1 (ECM1) is a 
glycoprotein involved in many biological processes. To elu-
cidate the expression of ECM1 in hepatocellular carcinoma 
(HCC) and its association with clinicopathological charac-
teristics and prognosis.
Patients and method: Reverse transcription polymerase 
chain reaction and Western blotting were used to examine 
the expression level of ECM1 in fi ve HCC cell lines with 
various metastatic potentials. Immunohistochemistry assay 
was used to determine the expression of ECM1 in HCC and 
corresponding pericarcinomatous liver tissues from 77 
patients.
Result: ECM1 was detected in all fi ve HCC cell lines. The 
results of Western blotting were consistent with the results 
from RT-PCR analysis of ECM1 mRNA expression in cell 
lines. The expression of ECM1 mRNA and protein in 
HCC-LM3 and MHCC97-H cell lines were signifi cantly 
higher than that in MHCC97-L and HepG2 cells, while the 
lowest level of ECM1 among the fi ve HCC cells we tested 
was in Hep3B. Immunohistochemically, the expression of 
ECM1 in HCC was judged to be positive in 57 (74.0%) 
cases, signifi cantly higher than that in pericarcinomatous 
liver tissues (P < 0.01), and associated with TNM stage (P 
= 0.030) and venous invasion (P = 0.011). In particular, the 
expression of the ECM1 was found to be an independent 
factor for overall survival and disease free survival of HCC.
Conclusion: The expression level of ECM1 in HCC cells 
was associated with metastatic potential and its abnormal 
expression was an independent prognostic factor for OS and 
DFS of HCC.
P0019L
AN UNUSUAL CAUSE OF CHEST PAIN
N. A. Chopdat
African Institute Of Digestive Disease, Soweto, 
Johannesburg/Gauteng, South Africa
Case summary: In May 2009, a 43 year old man was 
referred with a cough for 2 weeks duration, right sided pleu-
ritic chest pain, 10 kg weight loss over the previous 5 months, 
and night sweats. He was a smoker and still drank alcohol 
On examination he was acutely ill in respiratory distress and 
pyrexial. He had decreased air entry in the right lower zone. 
We palpated a tender hepatomegaly. We found no spleno-
megaly or ascites.
Chest radiography showed a right pleural effusion, con-
fi rming our clinical suspicion of a pneumonia or pulmonary 
tuberculosis. We started antibiotics and sputum samples were 
sent for further investigation. A diagnostic pleural tap was 
attempted without success and he was sent for an ultrasound 
guided aspiration.
Ultrasonography revealed a liver abscess that had ruptured 
through the diaphragm and was now communicating with the 
right pleural space. A CAT scan revealed a multiloculated liver 
abscess in segment 8 eroding through the diaphragm into the 
right chest cavity, with a pleural effusion. An indirect haem-
magglutination assay was positive for Entamoebahistolyticca, 
at a titre of 1: 1024. The patient received Metronidazole for 
10 days and showed a favourable response.
Amoebiasis is one of the leading causes of death in the 
world and is caused by the protozoan parasite Entamoeba 
histolytica. Liver abscesses are the most common extra intes-
tinal complication. Ultrasonography, abdominal computed 
tomography, and magnetic resonance imaging are all excel-
lent for detecting liver lesions. This case refl ects the impor-
tance of having wider differential diagnoses for patients who 
present with right sided pleural effusion, especially in a 
South Africa where the prevalence of TB is high and is the 
most common cause of pleural effusion.
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P0020L
REGULATION OF COLON CANCER 
CELL MIGRATION BY THE RENIN 
ANGIOTENSIN SYSTEM
E. Ager and C. Christophi
Univeristy of Melbourne, Heidelberg, VIC, Australia
Background: Epithelial to mesenchymal transition (EMT) 
is implicated in tumour progression. We aimed to determine 
if the renin angiotensin system (RAS) affects colorectal 
cancer (CRC) cell EMT.
Methods: Migration of human CRC cells (DLD-1) treated 
with the RAS peptide ANG II alone or with blockers of the 
ANG II type 1 or 2 receptors (AT1R and AT2R) was assessed 
by wound scratch assay. Levels of epithelial (E-cadherin) 
and mesenchymal (ZEB1, Vimentin) markers, inducible 
nitric oxide synthase (iNOS), and MMP9 were determined 
by fl ow cytometry. Mice bearing CRC liver metastases were 
examined for ZEB1 and iNOS by immunohistochemical 
staining.
Results: ANG II increased DLD-1 migration and this effect 
was inhibited by either AT1R or AT2R blockade. AT1R 
blockade, but not AT2R blockade, increased E-cadherin and 
decreased ZEB1 and vimentin compared to ANG II treated 
cells. ANG II increased iNOS and MMP9 expression, which 
was decreased by AT2R blockade. In vivo, ZEB1 staining 
was higher in ANG II treated animals while activation of the 
AT2R led to an increase in iNOS.
Conclusions: ANG II induced migration of CRC cells via 
AT1 and AT2 receptors; the AT1R-mediated effects were 
associated with changes typical of EMT.
P0021L
IMPACT OF EXPANDING CRITERIA FOR 
RESECTABILITY OF COLORECTAL 
METASTASES ON SHORT- AND LONG-
TERM OUTCOMES AFTER HEPATIC 
RESECTION
R. de Haas1,2, D. Wicherts1,2, P. Andreani1, G. Pascal1, 
F. Saliba1, P. Ichai1, R. Adam1, D. Castaing1 and 
D. Azoulay1
1Hôpital Paul Brousse, Villejuif, France; 2University 
Medical Center Utrecht, Utrecht, Netherlands
Background: An expansion of resectability criteria of 
colorectal liver metastases (CLM) is justifi ed provided 
‘acceptable’ short-term and long-term outcomes. The aim of 
the present study was to ascertain this paradigm in an era of 
modern liver surgery.
Methods: All consecutive patients who underwent hepatic 
resection for CLM at our institute between 1990 and 2010 
were included in the study. Ninety-day mortality and morbid-
ity rates were determined in the total study population and 
in two separate time periods (group I: 1990–2000; group II: 
2000–2010). Similarly, overall and progression-free survival 
rates were determined. Independent predictors of postopera-
tive morbidity were identifi ed at multivariate analysis.
Results: Between 1990 and 2010, 1394 hepatectomies were 
performed in 1028 patients. Overall perioperative mortality 
and postoperative morbidity rates were 1.3% and 33%, 
respectively. Although patients in group II were older, had 
more often comorbid illnesses, and presented with more 
extensive liver disease, similar perioperative mortality rates 
were observed (1.1% in group I and 1.4% in group II; P = 
0.53). A trend towards a higher morbidity rate was observed 
in group II (34% vs. 31% in group I; P = 0.16). Independent 
predictors of postoperative morbidity were: treatment 
between 2000–2010, total hepatic ischemia time ≥60 minutes, 
maximum size of CLM ≥ 30 mm at histopathology, and pres-
ence of abnormalities in the nontumoral liver parenchyma. 
Although a trend towards lower overall survival was observed 
in patients with signifi cant postoperative complications, no 
signifi cant differences were observed in long-term outcomes 
between both treatment periods.
Conclusion: After an aggressive multidisciplinary treat-
ment of CLM, acceptable overall mortality and morbidity 
rates were observed. Perioperative mortality rates did not 
differ according to treatment period, however, more recently 
operated patients experienced more postoperative complica-
tions. These favorable short-term outcomes, without worsen-
ing of long-term outcomes, justify an expansion of the 
criteria for resectability in this patient category.
P0022L
ULTRASONOGRAPHY-GUIDED TWO-
STAGE HEPATECTOMY SPARING PART 
OF SEGMENT S5 IN A CASE OF BILOBAR 
COLORECTAL LIVER METASTASES
M. Mirarchi, E. De Raffele, S. Vaccari and B. Cola
Policlinico S.Orsola-Malpighi, Università di Bologna, 
Bologna, Italy
Background: Despite great advances in hepatic resection 
(LR) of colorectal liver metastases (CRLM), insuffi cient 
functional remnant liver parenchyma after curative resection 
is still a matter of concern. In patients with bilobar metasta-
ses, a two-stage LR can be the best therapeutic approach, 
based on the staged resection of the liver cancer and on the 
hyperplasia of the future remnant liver (FRL). We report the 
case of a patient who received an uncommon two-stage LR 
with the use of intraoperative ultrasound (IOUS) guidance, 
due to suboptimal hyperplasia of the FRL.
Case report: The patient was a 60-yrs old male with meta-
chronous bilobar CRLM previously treated with multiple 
regimens of chemotherapy. The CT-scan showed a stable 
liver disease with hypoplasia of the left hepatic lobe. A two-
stage LR approach was decided. During the fi rst-stage, two 
wedge resections of the metastases in S2-S3 and S4, respec-
tively, were achieved and the right portal branch was ligated. 
Forty days later, the CT-scan showed stable CRLM in S5, S7 
and S7-S8, respectively, with suboptimal hyperplasia of the 
left hemiliver; however, the median portion of S5 was disease 
free and showed a remarkable hyperplasia. During the sec-
ond-stage, the Color-Doppler IOUS showed that the median 
portion of S5 had an effi cient arterial supply and an adequate 
venous drainage; the right hepatectomy was then accom-
plished sparing the median portion of S5. The post-operative 
course was uneventful. The CT scans 16 and 40 days after 
LR, respectively, revealed an adequate hyperplasia of the 
residual liver and that the remnant segment S5 had an effi -
cient arterial supply without evidence of ischemia.
Conclusions: The two-stage LR strategy is effective in 
patients with bilobar CRLM. The appropriate use of Color-
Doppler IOUS during the LR may be useful to reduce the 
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extent of liver parenchyma removal in selected cases with 
suboptimal hyperplasia of the FRL.
P0023L
RESCUE ULTRASONOGRAPHY-GUIDED 
LIVER RESECTION AFTER SELECTIVE 
YTTRIUM-90 RADIOEMBOLIZATION IN 
A CASE OF BILOBAR COLORECTAL 
LIVER METASTASES
M. Mirarchi, E. De Raffele, S. Vaccari and B. Cola
Policlinico S.Orsola-Malpighi, Università di Bologna, 
Bologna, Italy
Background: Different therapeutic strategies have been 
developed for patients with bilobar colorectal liver metasta-
ses (CRLM) considered to be unresectable, including novel 
technologies which can potentially improve local control of 
liver disease. Hepatic artery radioembolization with yttrium-
90-loaded microspheres [(90)Y-RE] is a technique for 
administering radiotherapy internally to hepatic malignan-
cies. We report the case of a patient who received a rescue 
extended right hepatectomy with the use of intraoperative 
ultrasound (IOUS) guidance after (90)Y-RE.
Case report: The patient, a 67-yrs old male, came to our 
observation in June 2007 with metachronous bilobar CRLM. 
In May 2006 he had received (90)Y-RE to treat multiple 
bilobar CRLM unresponsive to multiple regimen of chemo-
therapy. Pretreatment assessment had revealed a common 
hepatosplenomesenteric trunk with left hepatic artery (LHA) 
originating from the common hepatic artery and the right 
hepatic artery originating from the superior mesenteric 
artery. The radiologist had decided to embolize the LHA in 
order to deliver the (90)Y-loaded microspheres to the neo-
plasm. At our observation, the CT scan showed multiple 
nodules in the right hemiliver, a large nodule in S4a-S5 and 
a nodule in S2-S3, respectively. The arterial perfusion of the 
left hemiliver was diffi cult to evaluate because of the previ-
ous embolization. The intraoperative Color-Doppler ultraso-
nography showed an effi cient revascularization of the LHA, 
and the patient underwent IOUS-guided right hepatectomy 
extended to S4a and wedge resection of S2-S3. The post-
operative course was uneventful.
Conclusions: The association of (90)Y-RE with cytotoxic 
and molecularly targeted agents has shown promising results 
in patients with CRLM. However, the embolization of the 
main vessels directed to the liver should be avoided in poten-
tial candidates to hepatectomy. The appropriate use of Color-
Doppler IOUS during hepatectomy may be useful in selected 
patients to defi ne the blood fl ow in the future remnant liver 
and to reduce the risk of postoperative liver failure.
P0024L
RADICAL BUT CONSERVATIVE 
ULTRASONOGRAPHY-GUIDED LIVER 
RESECTION SIMULTANEOUS TO 
COLORECTAL RESECTION FOR 
SYNCHRONOUS LIVER METASTASES
E. De Raffele, M. Mirarchi, S. Vaccari and B. Cola
Policlinico S.Orsola-Malpighi, Università di Bologna, 
Bologna, Italy
Background: Liver resection (LR) has become the standard 
treatment for patients with synchronous colorectal cancer 
liver metastases (SCRLM), even though the optimal timing 
of LR is still controversial, especially in patients requiring 
major hepatectomies. Recent reports demonstrate that intra-
operative ultrasonography (IOUS) reduces the need for 
major resections. This study aimed to determine whether 
simultaneous radical but conservative IOUS-guided LR and 
colorectal resection (CRR) are safe and effective in patients 
with SCRLM.
Methods: Seventy-fi ve patients with CRLM had LR 
between July 2005 and September 2010. Twenty-fi ve (33%) 
were admitted with colorectal cancer and SCRLM: 3 (12%) 
received staged resection; 3 (12%) received simultaneous 
fi rst-stage LR and CRR in a two-stage LR strategy; 19 (76%) 
had simultaneous IOUS-guided LR and CRR and were ana-
lyzed in the present study with respect to their intra and 
postoperative course.
Results: Nine patients (47%) had simultaneous lower ante-
rior resection of rectal cancer. Ten patients (53%) had bilobar 
SCRLM. Due to IOUS guidance, however, only 5 patients 
(26%) had a major hepatectomy. The mean ± SD operation 
time was 562 ± 135 minutes (range 350–820); 3 patients 
(16%) required blood transfusions. LR margins of 0 mm 
were obtained in 4 patients (21%) and were ≥1 mm in the 
others. Postoperative mortality was nil. Four patients (21%) 
had minor postoperative complications. The mean ± SD 
hospital stay was 12 ± 3 days (range 9–19).
Conclusions: This study confi rms that IOUS guidance is 
effective in reducing the extension of LR in patients with 
SCRLM, even in those with biliobar SCRLM. Since major 
p.o. morbidity and mortality are frequent in candidates to 
simultaneous major LR and CRR, reducing the extent of liver 
parenchyma removal may have a favourable impact on post-
operative course. Simultaneous radical but conservative 
IOUS-guided LR and CRR is safe and effective in patients 
with SCRLM and could serve as a primary option for selected 
cases.
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P0025L
THE EFFECT OF PREOPERATIVE 
CHEMOTHERAPY ON LIVER 
REGENERATION AFTER RIGHT 
HEPATECTOMY ASSESSED WITH 
CT-VOLUMETRY AND OSIRIX
S. Dello1, R. van Dam1, M. De Jong1, S. O. Damink1,2, 
M. Bemelmans1 and C. Dejong1
1Maastricht University Medical Center & Nutrim School 
for Nutrition, department of surgery, Maastricht, 
Netherlands; 2University College London Hospitals, 
department of surgery, London, United Kingdom
Background: Each year, an increasing number of patients 
undergo a major liver resection following preoperative che-
motherapy regimens. The infl uence of this cytotoxic therapy 
on liver regeneration and subsequent postoperative liver 
function is of great clinical importance and is currently 
unknown. The aim of the present study was to evaluate liver 
regeneration in patients who received pre-operative chemo-
therapy, by using CT-volumetry and OsiriX.
Methods: Patients planned for a right hepatectomy were 
identifi ed retrospectively from a prospective database; spe-
cifi cally the receipt of pre-operative chemotherapy was 
noted. Group 1 underwent preoperative chemotherapy and 
group 2 did not. The future remnant liver volume (FRLV) 
was calculated prospectively by measuring the total func-
tional liver volume (total liver volume – tumour volume) and 
the resection specimen on preoperative CT-scans. The actual 
remnant liver volume (ARLV) was measured on postopera-
tive scans. Percentage total liver regeneration was calculated: 
[(ARLV- FRLV)/FRLV]* 100%. Comparisons were per-
formed using the Mann-Whitney test, and a p-value of less 
than 0.05 was considered signifi cant. The data are expressed 
as median (range).
Results: Nine patients (4 male) were analyzed, of whom 6 
patients received preoperative chemotherapy and 3 patients 
did not. The postoperative CT-scan was at day 7 (4–9 days). 
FRLV was 485 mL (360–855 mL) and the ARLV 1000 mL 
(477–1326 mL). The ARLV at day 7 (4–9 days) showed a 
79% (33–152%) increase in volume from the FRLV, without 
a signifi cant difference between groups 1 and 2 (p = 0.9).
Conclusion: A substantial part of liver regeneration follow-
ing right hepatectomy takes place in the fi rst week. There 
was no signifi cant difference in liver regeneration capacities 
following resection between patients who received preopera-
tive chemotherapy and patients who did not. However, more 
patients need to be studied.
P0026L
PORTAL AND MESENTERIC VEIN 
THROMBOSIS COMPLICATED BY 
ACUTE MESENTERIC ISCHEMIA
G. Diepenhorst, R. van Golen, P. Gilijamse and 
T. van Gulik
Dept of Surgery, Academic Medical Center, Amsterdam, 
Netherlands
Introduction: Portal vein thrombosis (PVT) and mesenteric 
venous thrombosis (MVT) are uncommon disease entities in 
adults. In a minority of cases, PVT and MVT lead to acute 
mesenteric ischemia (AMI). Little is known about the clini-
cal importance of this complication in thrombotic patients. 
The aim of this study was to describe clinical outcomes and 
risk factors in patients with PVT and/or MVT complicated 
by AMI.
Methods: Hospital records and clinical data of all patients 
with PVT and/or MVT between 1995 and 2010 were 
reviewed. Clinical features, laboratory fi ndings, etiologic 
factors, and treatment modalities were recorded and assessed 
as possible risk factors for mortality. All deaths within 30 
days of the start of treatment (surgery/anticoagulation) were 
considered to represent mortality.
Results: Twenty-eight patients (16 male, 12 female) were 
identifi ed as having PVT and/or MVT using ultrasound or 
CT scan. Clinical outcomes of 9 out of 28 (32%) patients 
were complicated by acute mesenteric ischemia. One out of 
these 9 patients underwent an explorative laparotomy, 7 
underwent bowel resection without revascularisation, and 
one patient was treated conservatively with anticoagulation. 
In those patients complicated by acute mesenteric ischemia, 
none demonstrated pre-existent coagulopathies, whereas 
those patients not complicated by AMI demonstrated pre-
existent coagulopathies in 25% of cases. Patients with PVT 
or MVT undergoing surgery for mesenteric ischemia dem-
onstrated a 30-day mortality rate of 25%, whereas patients 
without mesenteric ischemia all survived 30 days after anti-
coagulatory treatment. No etiological or clinical independent 
predictor of mortality could be identifi ed in the small study 
group.
Conclusions: PVT and MVT complicated by acute mesen-
teric ischemia carries a substantial morbidity and mortality 
and should be considered as the underlying etiology in cases 
of AMI.
P0027L
HCC RECURRENCE FACTORS IN 
PATIENTS WHO MET THE MILAN 
CRITERIA AND UNDERWENT OLT
K. Dudek, K. Kobryn, O. Kornasiewicz, K. Zieniewicz, 
T. Wroblewski and M. Krawczyk
Department of General, Transplant and Liver Surgery, 
Medical University of Warsaw, Warsaw, Poland
Aim: The aim of this study was to identify recurrence 
factors of 80 patients, with hepatocellular carcinoma (HCC) 
in cirrhotic livers, treated by liver transplantation (OLT).
Material/methods: From January 2001 to January 2010 in 
the Department of General, Transplant and Liver Surgery, 
Warsaw Medical University a number of 770 LTx was per-
formed in 705 patients. HCC was diagnosed in 71 patients 
before OLTx and in 80 at histological examination of the 
explanted livers. 72% of the patients had met Milan criteria 
at histology.
Results: The median follow-up was 39 months (range, 
1–108). We analyzed patient’s age and gender, etiology of 
liver disease, Child’s score at transplantation, episodes of 
rejection, number and tumor’s size, presence of vascular 
invasion and tumor’s differentiation grade. We didn’t fi nd a 
statistically signifi cant difference in survival among patients 
grouped according to the MELD staging system for HCC. 
The outcome of a 3-year observation for HCC recurrence in 
OLT patients with low differentiated (G3) HCC was signifi -
cantly higher than in patients with moderately differentiated 
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(G2) or high-differentiated (G1) HCC (respectively, G3 50%, 
G2 19%, and G1 14%, p < 0.01). Patients with macro and 
micro-vascular invasion had higher recurrence episodes than 
patients without vascular invasion (84% vs. 38%, p < 0.01).
Conclusions: The analysis indicates that histological grade 
of the tumor and microscopic vascular invasion are the most 
predictive factors of overall HCC recurrence in patients after 
liver transplantation for Hepatocellular Carcinoma.
P0028L
RESULTS OF LIVER RESECTIONS FOR 
COLORECTAL LIVER METASTASES: IN 
THERE ANY DIFFERENCE IN THE LAST 
DECADE COMPARED TO THE ’90S?
G. Ercolani, M. Zanello, M. Cescon, M. Ravaioli, 
M. Del Gaudio, A. Cucchetti, A. Lauro, F. Tuci, 
P. Di Gioia and A. Pinna
Hospital Sant’Orsola, Department of Surgery and 
Transplantation, Bologna, Italy
Introduction: Liver resection remains the gold standard in 
the treatment of colorectal metastases.
Aim: To evaluate if there is any difference in clinical char-
acteristics and outcome in the last 10 years compared to 
previously, in resected patients for colorectal metastases.
Methods: Clinico-pathologic characteristics were com-
pared between 342 resected patients before 1999 and 
310 resected patients after 2000.
Results: There was no difference in term of sex, age, mean 
tumor diameter and synchronous vs metachronous between 
the 2 groups. The median number of resected metastases/
patient was signifi cantly increased after 2000 (1.7 ± 1 vs 2.4 
± 2, respectively). Postoperative mortality was similar (1.2 
vs 2.3%), but morbidity increased from 19% up to 27.1%. 
There was a tendency to perform less number of major hepa-
tectomies after 2000 (61.7% vs 55.2%, respectively). Blood 
transfusion was required in 44.7% of patients in the fi rst 
group, and in only 23.9% after 2000. Postoperative hospital 
stay decreased signifi cantly from 12.7 ± 11 days to 9.5 ± 13. 
The 5-year overall survival was 37% and 48%, respectively 
(p < 0.001) The 5-year disease-free survival was 33% and 
36%, respectively (p = n.s.). Among patients with single 
metastases, the 5-year overall survival did not change sig-
nifi cantly between the two periods (43% vs 46%); while 
5-year survival increased signifi cantly from 28% up to 47% 
after 2000, among patients with multiple metastases 
(p < 0.001).
Conclusions: Nethertheless an increased number of 
advanced patients were operated on after 2000, there is a 
tendency to perform a parenchimal-sparing resection and 
there was a signifi cantly improvements in overall survival 
rate, in particular among patients with multiple metastases 
probably due to the effi cacy of new adjuvant 
chemotherapy.
P0029L
LEFT HEPATIC TRISECTIONECTOMY 
FOR HEPATOBILIARY MALIGNANCY – A 
SINGLE CENTRE EXPERIENCE
S. Farid, N. Khan, G. Toogood, R. Prasad and P. Lodge
St James University Hospital, Department of HPB Surgery, 
Leeds, United Kingdom
Introduction: Left hepatic trisectionectomy (LHT) is the 
most challenging major anatomic hepatectomy with a high 
reported complication rate and a worldwide experience that 
remains small.
Methods: Short and long-term outcomes of 100 consecutive 
patients who underwent LHT for malignancy from January 
1993 to February 2008 were analysed.
Results: Overall morbidity, and 90-day mortality rates 
were 41%, and 12%, respectively. Preoperative jaundice and 
intraoperative blood transfusion were positive independent 
predictors for postoperative morbidity. Overall 1 & 5 year 
survival was 67% and 20% respectively. Outcomes were 
signifi cantly better for patients undergoing LHT with or 
without concomitant partial resection of the remaining liver 
for colorectal liver metastasis compared to HCC or cholan-
giocarcinoma. Time period analysis reveals a decreasing 
trend in blood transfusion and postoperative complications 
in the last 5 years.
Conclusions: This remains the largest series in left hepatic 
trisectionectomy highlighting preoperative obstructive jaun-
dice and blood transfusion being associated with greater 
morbidity risk. Overall survival and survival according to 
tumor type is acceptable compared to published data and 
continues to provide effective treatment for signifi cant 
tumour burden.
P0030L
LONG TERM RESULTS FOR LIVER 
RESECTION AND TRANSPLANTATION 
FOR PRIMARY CARCINOID TUMOR OF 
THE LIVER
N. de Liguori Carino, S. Farid, S. Pollard, G. Toogood, 
R. Prasad and P. Lodge
St James University Hospital, Department of HPB Surgery, 
Leeds, United Kingdom
Objective: To discuss the clinical course, management and 
long term follow- up of primary carcinoid tumor of the liver 
treated with liver resection (LR) and transplantation (OLT).
Methods: Between March 1994 and December 2008, we 
treated 11 patients (4 male, 7 female) with primary hepatic 
carcinoid tumors. Treatment was by LR in 8 patients, OLT 
in 3 and living related liver transplantation (LRLT) in 1. One 
patient underwent both resection and transplantation.
Results: The diagnosis was confi rmed histologically in the 
absence of an alternative primary site. Protocol follow-up 
was based on serial total body CT scan, Octreoscan and 
tumor markers. Follow-up ranged from 10 to 168 months. 
Only one patient died of recurrent disease within 5 months. 
Three patients had recurrence while six patients remain alive 
and disease free at 10, 12, 35, 116, 120, 127 and 130 and 
months respectively.
Conclusions: This series is the largest reported and the only 
one to include OLT, including LRLT, as a treatment option. 
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Exclusion of extrahepatic primary and long-term follow-up 
is essential for diagnosis of primary carcinoid of the liver. 
The mainstay of treatment should be liver resection, although 
liver transplantation may be considered in selected patient. 
A radical surgical approach is warranted as this disease 
carries a better prognosis than for other primary hepatic 
tumors and for secondary hepatic carcinoids
P0031L
INTRAOPERATIVE ULTRASOUND STILL 
IMPACTS ON SURGICAL STRATEGY 
FOR PATIENTS WITH COLORECTAL 
METASTASES IN THE MODERN ERA
A. Ferrero1, S. Langella1, F. Giuliante2, L. Vigano1, 
M. Vellone2, G. Zimmitti1, F. Ardito2, G. Nuzzo2 and 
L. Capussotti1
1Division of Hepato-bilio-pancreatic and Digestive Surgery, 
Ospedale Mauriziano, Torino, Italy; 2Unit of Hepato-
biliary Surgery, Università Cattolica del Sacro Cuore, 
Policlinico Gemelli, Roma, Italy
Background: Recent improvements in preoperative 
imaging might have reduce the importance of intraoperative 
ultrasound (IOUS) as staging technique in patients with 
colorectal liver metastases. Aim of this study is to evaluate 
the actual role of IOUS in intrahepatic staging and the impact 
on surgical strategy for patients with colorectal liver 
metastases.
Methods: Between January 2005 and December 2009, 515 
patients underwent liver resection for colorectal metastases 
(Ospedale Mauriziano, Torino and Policlinico Gemelli, 
Roma, Italy). Data from a prospectively collected database 
at the two Institutions were retrospectively analyzed. Early 
intrahepatic recurrence was registered at 3 and 6 months after 
the resection and was considered as residual disease unde-
tected by IOUS.
Results: A total of 1370 liver metastases were detected by 
preoperative imaging. Patients were investigated by a median 
of 3 preoperative imaging modalities (range 2–4). MRI and 
PET were performed in 50% and 42% respectively. Median 
days between last imaging and hepatic resection were 18 
(range 1–40). Contrast-enhanced IOUS (CEIOUS) was per-
formed in 136 patients (26.4%). A total of 1591 hepatic 
lesions were intraoperatively found, with 293 (21.4%) new 
nodules (285 by IOUS and 8 by CEIOUS). At the histology 
280 new lesions were confi rmed to be colorectal metastases 
(95.5%). At the multivariate analysis synchronous (p = 0.03) 
and bilobar (p = 0.04) metastases, number ≥ 3 (p = 0.01), 
BMI > 30 (p = 0.02) and last imaging within 18 days (p = 
0.0002) resulted predictive factors of new nodules IOUS 
detection. Overall surgical strategy was changed in 140 
patients (27.2%), according to the IOUS fi ndings. Early 
intrahepatic recurrences were 3.5% and 8.7% at 3 and 6 
months respectively.
Conclusions: Nowadays, the use of IOUS is still mandatory 
for a correct staging in patients with colorectal liver metas-
tases leading to modify surgical strategy, planned on preop-
erative fi ndings, in 27.2% of cases.
P0032L
OPTIMISED RECOVERY WITH 
MAGNESIUM OXIDE AFTER LIVER 
RESECTION. A RANDOMISED 
CONTROLLED TRIAL
F. Gillissen1, M. M. E. Coolsen1, R. M. van Dam1, 
M. H. Bemelmans1, S. W. O. Damink1,3, M. Malago3, 
U. P. Neumann2 and C. H. C. Dejong1
1MUMC, Maastricht, Netherlands; 2Universitätsklinikum, 
Aachen, Germany; 3UCL, London, United Kingdom
Background: The routine use of laxatives after liver surgery 
as part of an Enhanced Recovery After Surgery (ERAS) 
programme enhances recovery of gastrointestinal function 
and early tolerance of oral nutrition. The use of magnesium 
oxide as laxative during 1 week prior to liver resection could 
promote early return of gastro-intestinal function and accel-
erate recovery.
Methods: 70 patients programmed for partial liver resection 
will be randomised to either preoperative laxation with 
1000 mg Magnesium oxide daily 1 week prior to surgery 
until discharge, and postoperative laxation 1000 mg 
Magnesium oxide daily from the day of surgery until dis-
charge. All patients will be managed within an ERAS pro-
gramme of perioperative care. Primary outcome measure is 
recovery of gastro-intestinal function. Secondary outcome 
measures are functional recovery, length of hospital stay and 
patient activity level, measured by activPAL® activity meter. 
We estimate that we will require 35 patients in both groups 
to detect an effect on the mean change in the time to fi rst 
passage of stools post surgery and functional recovery. 
(power 80% and α = 0.05).
Discussion: This study is a multicentre RCT that may prove 
that the use of magnesium oxide during 1 week prior to liver 
resection leads to earlier return of gastro-intestinal function 
and accelerates recovery.
P0033L
PLACEMENT OF ARTERIAL HEPATIC 
CATHETER DURING MAJOR 
HEPATECTOMY: IS IT SAFE?
D. Goere, L. Benhaim, S. Bonnet, F. Dumont, 
F. Deschamps, T. De Baere and D. Elias
Institut gustave roussy, Villejuif, France
Introduction: Adjuvant hepatic arterial infusion after resec-
tion of colorectal liver metastases (LM) could improve the 
disease-free survival in patients at high risk of hepatic recur-
rence, defi ned on the resection of more than 3 LM. The aim 
of this study was to analyze the immediate postoperative 
results of patients who underwent major hepatectomy associ-
ated to placement of a catheter in the hepatic artery, and 
compare these results with those of major hepatectomy 
without catheter.
Methods: From 2000 to 2008, a major hepatectomy (≥3 
segments) for resection of a number greater than or equal to 
4 LM was performed in 58 patients. Among these 58 patients, 
a catheter was placed into the gastroduodenal artery in 23 
patients (group KT+). The data were issued from a prospec-
tive database.
Results: The 2 groups were comparable for age, body mass 
index, ASA score, the average number of preoperative 
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systemic chemotherapy (11.16 ± 5), performed in 57/58 
patients. The operating time, the clamping time (intermittent 
Pringle) did not differ signifi cantly between the patients KT− 
and those KT+, respectively 295 ± 85 vs 286 ± 55 min and 
58 ± 22 vs 53 ± 20 min. Blood loss was signifi cantly higher 
in group KT− (886 ± 674 vs 547 ± 430, p = 0.04). The com-
plication rate (Clavien-Dindo 1 to 4) was 53% and did not 
differ signifi cantly between the 2 groups (51.4% in KT− and 
56.5% in KT+, p = 1). A biliary fi stula was diagnosed in 5 
patients, all in group KT−.
Two patients (3.4%) died at D3 and D14. These 2 patients 
were in group KT+ and underwent a complex hepatectomy, 
combining major resection and radiofrequency ablation. 
Deaths were related to thrombosis of the portal vein fi rst, and 
then of the hepatic artery, causing hepatocellular insuffi -
ciency. Venous congestion was described at surgery in these 
2 patients.
Conclusion: The placement of a catheter into the gastroduo-
denal artery during a major hepatectomy is feasible and does 
not increase the rate of postoperative complications. 
However, for complex hepatectomy, more at risk of compli-
cations, deferred catheter placement in interventional radiol-
ogy, seems preferable to avoid occurrence of arterial 
thrombosis.
P0034L
PROGNOSTIC IMPACT OF 
DISSEMINATED TUMOR CELLS, 
HEPATOCYTE GROWTH FACTOR AND 
HEAT-SHOCK PROTEIN 70 SERUM 
EXPRESSION AFTER 
RADIOFREQUENCY ABLATION OR 
RESECTION OF COLORECTAL LIVER 
METASTASES
S. Hinz1, J-H. Egberts1, C. Röder2, J. Tepel1, 
D. C. Bröring1 and H. Kalthoff2
1University Hospital Schleswig-Holstein, Dept. of General 
Surgery, Kiel, Germany; 2University Hospital Schleswig-
Holstein, Institute of Experimental Cancer Research, Kiel, 
Germany; 3Dept. of General, Visceral and Thoracic 
Surgery, Osnabrück, Germany
Aims/objectives: Aim of this study was to analyze the 
impact of radiofrequency ablation (RFA) of colorectal liver 
metastases (CRLM) on dissemination of tumor cells (DTC) 
and serum hepatocyte growth factor (HGF) and heat-shock 
protein 70 (HSP70) levels.
Methods: In this prospective study 18 patients with CRLM 
were included. Blood was drawn prior to the operation, intra-
operatively and at different time points after the operation. 
DTC were detected with CK20 RT-PCR. Serum HGF and 
HSP70 levels were detected at different time points with 
ELISA. Patients were followed-up and clinical course was 
documented.
Results: Patients were devided into three groups: In group 
1 only RFA was used (5 patients), in group 2 RFA was com-
bined with resection of CRLM (5 patients) and in group 3 
CRLM were treated only with resection (8 patients). DTC 
were detected prior to the operation in 12/18 patients (group 
1 in 2/5 patients, group 2 in 3/5 patients, group 3 8/8 patients; 
p = 0.05). In 3 patients of group 1 without detection of DTC 
prior to the operation, DTC could be detected at various time 
points after the operation. HGF and HSP70 levels increased 
after the operation with a peak at day 1 for HGF and during 
the operation for HSP70. The relative increase of HSP70 and 
HGF levels after the operation was not signifi cantly different 
between the three treatment groups. The median overall sur-
vival (OS) of all patients was 32 months. HSP70 and HGF 
levels prior to operation did not signifi cantly infl uence OS.
Conclusions: Detection of DTC in the blood is an important 
factor for OS after resection of CRLM. In this series of 
patients we could show that RFA can promote dissemination 
of tumor cells during the operation. After RFA and resection 
of CRLM HSP70 and HGF serum levels are induced. In our 
series of patients HGF and HSP70 expression are not suitable 
as prognostic markers in patients with RFA, resection or 
combination-therapy of CRLM.
P0035L
THE ROLE OF DIAGNOSTIC 
LAPAROSCOPY IN PATIENTS WITH 
HEPATOCELLULAR CARCINOMA
L. T. Hoekstra, A. T. Ruys, O. R. C. Busch, D. J. Gouma 
and T. M. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Background: Diagnostic Laparoscopy (DL) has been found 
useful in staging malignancy, but has not been much applied 
in patients with hepatocellular carcinoma (HCC). The issue 
is that diagnostic laparoscopy may change treatment strategy, 
preventing unnecessary open exploration. An additional 
advantage of preoperative DL is the possibility of biopsy of 
the non-tumorous liver and assessment of fi brosis/cirrhosis. 
We examined this question in patients eligible for liver resec-
tion for HCC.
Aim: To determine the outcome of preoperative laparoscopy 
in patients with HCC.
Methods: A retrospective analysis was performed in 46 
patients with HCC, who underwent a diagnostic laparoscopy 
between January 1999 and May 2010. Patients’ demograph-
ics, preoperative imaging, surgical fi ndings, resectability, 
histology and complications were analyzed.
Results: Forty-six patients underwent DL to assess resect-
ability (29 men and 17 women; mean age, 62 years). DL was 
unsuccessful in two patients because of intra-abdominal 
adhesions. DL showed unresectability in 4 patients because 
of metastases (n = 1), tumor progression in patients with 
severe cirrhosis (n = 1), and severe cirrhosis in the contra-
lateral lobe (n = 2). Another four patients did not undergo 
resection due to imaging following DL (multifocality n = 3; 
liver failure n = 1). Exploratory laparotomy of the remaining 
38 patients revealed that an additional 5 (13%) were not 
resectable, due to advanced tumor (n = 4) or nodal metastases 
(n = 1). Consequently, the yield of DL was 9% and the accu-
racy 29%. A biopsy was performed in 36 patients who under-
went DL of which 15 (42%) showed cirrhosis and 14 (39%) 
showed fi brosis, leading to changes in management in 3 
(20%) patients.
Conclusion: Overall yield and accuracy of DL for HCC 
were 9% and 29%, respectively. DL is safe, but the change 
in treatment strategy is limited. Therefore, its use in clinical 
practice is questionable.
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P0036L
PREGNANCY IN PATIENTS WITH 
PORTAL HYPERTENSION – CASE 
SERIES
Z. Jabiry-Zieniewicz, B. Pietrzak, B. Najman, P. Kosiski, 
P. Małkowski, M. Wielg and K. Zieniewicz
Medical University, Warsaw, Poland
Women with diagnosed portal hypertension seldom need 
obstetrical care because of reduced fertility as a result of liver 
failure. Some of them intentionally do not plan pregnancy 
because of increased risk of thrombosis. The aim of this 
study is a retrospective analysis of pregnant patients with 
portal hypertension. We present three cases of pregnant 
women with portal hypertension of different etiology. There 
are no accessible guidelines for management of pregnant 
patients with portal hypertension and preferable delivery 
options. Thus each patient individually was consulted by 
obstetricians and liver transplant surgeons. All patients had 
elective cesarean section performed.
Case 1: 24 years old primipara was fi rst consulted at 6 
weeks of pregnancy. Her medical history revealed damage 
of the portal vain during cholecystectomy and subsequent 
hilar bile ducts obstruction, portal vein thrombosis and portal 
hypertension diagnosed 2 years before pregnancy. She had 
also endoscopic bile ducts prostheses insertions performed 
several times. She presented symptoms of preterm birth and 
received corticosteroids. She delivered at 36 weeks. There 
were no neonatological complications.
Case 2: The patient, 22-year old primipara was consulted at 
10 weeks of pregnancy. She had been diagnosed with Budd-
Chiari Syndrome as a complication of polycythemia vera. 
She also presented with portal vein obstruction, abdominal 
dropsy, liver enzymes and bilirubin elevation. She delivered 
at 37th week of pregnancy. No neonatological complications 
were diagnosed.
Case 3: 29-year-old primipara diagnosed with portal vein 
thrombosis and thrombocytopenia. Because of threatening 
miscarriage she received tocolysis. She delivered at 38th 
week of pregnancy. There were no neonatological complica-
tions. After 8 years in subsequent pregnancy she was diag-
nosed with toxoplasmosis. She delivered at 38th week. There 
were no neonatological complications.
Conclusion: Women with diagnosed portal hypertension 
must have eective cesarean section
P0037L
IN VIVO EVALUATION OF THE 
CHITOSAN-BASED TOPICAL 
HAEMOSTATIC AGENT Omni- StatTM IN 
EXPERIMENTAL PORCINE LIVER 
RESECTION
S. Jegatheeswaran1, U. Bhanot2 and A. Siriwardena1
1Manchester Royal Infi rmary, Manchester, United 
Kingdom; 2Memorial Sloan Kettering Medical Center, 
New York, United States
Introduction: Omni-StatTM is a powerful topical haemo-
static agent currently in use as a battlefi eld haemostat. It is 
made by de-acetylation of chitin and is a polysaccharide. 
This study undertakes the fi rst evaluation of the effi cacy of 
Omni-StatTM in an in vivo porcine liver resection setting.
Methods: Studies were in compliance with the Guide 
for Care of Laboratory Animals of the National Institutes 
of Health. Landrace pigs (Sus scrofa) of average weight 
40 kg were anaesthetised with oxygen and 2% isofl urane. 
Non-invasive monitoring of heart rate, blood pressure, 
mean arterial pressure and temperature was undertaken 
together with monitoring of respiratory rate and oxygen satu-
ration. Haematocrit and activated partial thromboplastin 
time were measured at baseline, prior to intervention and at 
the end of the procedure. Gauze swabs were weighed to 
assess blood loss. Fluid resuscitation was with 0.9% 
saline or hespan (6% hetastarch). Animals were monitored 
by veterinary physicians. A protocol of sequential liver 
resection was utilized. Parenchymal transection was by the 
Kelly clamp technique without infl ow control. Following 
completion of resection, the resected liver was weighed. 
Swabs were weighed and Omni-statTM was applied to the 
transection surface. In sequence, a total of 3 major and 2 
minor resections were undertaken in each animal. Animals 
were sacrifi ced by intra-cardiac injection of potassium chlo-
ride. After death, the remnant liver was weighed and a 
sample taken from the Omni-statTM cut surface for 
histology.
Results: 20 liver resections were undertaken in 4 animals (5 
per animal). All animals survived the entire protocol. 
Absolute haemostasis was achieved in all resections by the 
application of topical Omni-statTM and maintained for the 
5 hr period of the protocol. Median (range) blood loss for 12 
major resections was 239 (100–319) ml and for minor resec-
tions 21 (6–50) ml. Median resection specimen weight was 
152 (120–203) g for major and 15 (4–29) g for minor resec-
tions. Heart rate and systolic BP were unchanged before and 
after each resection (P = NS, Mann-Whitney U test) and at 
the end of the 5 h protocol compared to baseline pre-resec-
tion values ((P = NS).
Conclusion: These necessary preliminary data demonstrate 
that Omni-StatTM is a powerful topical haemostatic agent on 
liver transection surfaces. Evaluation in a recovery model is 
required to assess its absorptive properties.
P0038L
‘BENIGN’ LIVER TUMORS IN YOUNG 
WOMEN: A COMMON MIS-DIAGNOSIS
M. Johann1, J. Elcheroth2, B. Elias1 and M. Deneuville1
1Hopital St Andre, Metz, France; 2Hopital Kirchberg, 
Luxembourg, Luxembourg
Liver tumors-single or multiple- diagnosed in young women 
tend to be treated as benign, in spite of possible concerns 
about the gynaeco-obstetrical consequences. Surgical inter-
vention is rare in these cases. This fails to take proper account 
of tumours which are symptomatic, complicated or where the 
diagnosis is uncertain. Liver imaging is still not able to 
establish the nature of the tumour with certainly, and percu-
taneous biopsy is not always reliable. Is it good practice to 
neglect these questions, and on the basis of an arbitrary 
judgement on so-called benign tumours, refrain from surgi-
cal treatment ? A new classifi cation of subgroups of hepatic 
adenomas (HCA) has been proposed. This might make it 
possible in borderline cases to distinguish between adeno-
mas- where intervention might be justifi ed- and telangiecta-
sic nodular hyperplasia (T-FNH) –where surgery would not 
be indicated.
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Methodology: the paper is a retrospective analysis of 79 
women diagnosed between 1996 and 2010 with supposedly 
benign hepatic lesions (FNH, HCA, haemangioma). During 
this period 34 patients subsequently had surgery.
Results: Median age of the 34 operated patients was 38.4 
years. Histology of the resected tumours was: 23 FNH-of 
which 9 were multiple FNH- 3 HCA, 5 angiomas, 2 FNH-
angiomas and 1 necrotic tumor after embolisation. All FNH 
lesions were large with a median size of 7.03 cm. The deci-
sion to operate an FNH lesion was based on peri-tumoral 
bleeding in 3 cases, symptomatic tumours in 9, increasing 
tumor size in 3, close vascular tumour contact in 1, uncer-
tainly about the nature of the tumor in 6 and a history of 
alcohol abuse in 1. We performed 5 major hepatectomies, 9 
left lobectomies-some extended-7 bisegmentectomies, and 
13 tumourectomies or single segment resections, of which 2 
were segment 1. 32 of 34 patients had autogenous blood 
transfusion. Cell-saver was used occasionally. 3 had a sup-
plementary blood transfusion. There was no mortality. 3 
patients had complications: 2 minor pulmonary embolism 
and 1 lung infection.
Conclusion: supposedly benign tumours in women are not 
always harmless. Their gynaecological implications have to 
be considered. This study suggests that surgical resection of 
these tumours is indicated in a number of cases.
P0039L
FOLLOW UP AFTER HEPATECTOMY 
FOR COLORECTAL LIVER 
METASTASES; A SYSTEMATIC REVIEW 
AND META-ANALYSIS
R. Jones1,2, D. Dunne2, S. Fenwick2, G. Poston2, H. Malik1 
and P. Ghaneh1
1Division of Surgery, University of Liverpool, Liverpool, 
United Kingdom; 2Department of Hepatobiliary Surgery, 
Aintree University Hospital NHS Foundation Trust, 
Liverpool, United Kingdom
Background: Follow up of patients after liver resection 
offers two potential benefi ts; clinicians can assess the effi -
cacy of treatment, and recurrent disease can be detected and 
treated. The majority of recurrence occurs within the fi rst 2 
years of resection, and many centres concentrate follow up 
in this period.
Objective: To review the evidence surrounding follow up 
after liver resection for metastatic colorectal disease and 
defi ne an evidence base for intensive early follow up.
Methods: A systematic review using databases, trial regis-
ters and conference proceedings. We included any studies 
that described potentially curative primary resection of 
colorectal liver metastases that included a defi ned follow-up 
protocol between Jan 2003–May 2010. Studies were divided 
into intensive early follow up and standard follow up based 
on pattern of review.
Results: 335 studies were identifi ed, of which 35 met the 
inclusion criteria, involving 7330 patients. Intensive early 
follow up showed median survival of 39.8 months (95% CI 
34.3–45.3), with 1-, 3- and 5-year survival of 91.5% (95% 
CI 83.4–99.6), 57.6% (95% CI 50.7–64.5) and 41.9% (95% 
CI 34.4–49.4). Routine follow up showed median survival of 
40.2 months (95% CI 33.4–47.0), with 1-, 3- and 5-year 
overall survival of 86.7% (95% CI 78.3–95.1), 52.8% (95% 
CI 46.9–58.7) and 38.4% (95% CI 32.56–44.3) respectively.
Conclusions: Evidence surrounding follow up after liver 
resection is poor. Meta-analysis failed to identify an advan-
tage to intense early follow-up.
P0040L
SYSTEMATIC REVIEW OF ABLATION 
THERAPIES FOR THE TREATMENT OF 
UNRESECTABLE COLORECTAL LIVER 
METASTASES
R. Jones1,2, J. Tang2, S. Pathak1, C. Parmar1, S. Fenwick1, 
H. Malik1 and G. Poston1
1Department of Hepatobiliary Surgery, Aintree University 
Hospital NHS Foundation Trust, Liverpool, United 
Kingdom; 2Division of Surgery and Oncology, University of 
Liverpool, Liverpool, United Kingdom
Aim: To assess the long-term outcomes and complication 
rates of ablative techniques in the treatment of unresectable 
CRLM.
Methods: A literature search was performed on electronic 
databases including Medline, Cochrane Collaboration 
Library, NLM and ClinicalTrials.gov, of publications 
between January 1994 to January 2010. Inclusion criteria: 
original articles or RCTs with 1 yr minimum follow-up, abla-
tion via open, percutaneous or laparoscopic methods, sur-
vival and/or recurrence data and >10 patients with CRLM.
Results:
Technique Local recurrence 
(%)
Overall recurrence 
(%)
1-year 
survival
3-year 
survival
5-year 
survival
Major complications 
(%)
Cryotherapy 12–39 78–88 84 37 17 29
Microwave  5–13 50–78 73 30 16  7
Radiofrequency 10–31 47–86 85 36 24  6
Conclusions: Ablative therapies offer signifi cantly improved 
survival compared to palliative chemotherapy alone with 
5-year survival rates of 16–24% in unselected series. 
Complication rates amongst commonly used techniques 
(RFA &MCT) are low. In particular, MCT has the lowest 
local recurrence and comparable overall recurrence com-
pared to other ablative methods.
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P0041L
RERESECTION OF THE LIVER FOR 
COLORECTAL LIVER METASTASES 
– PERIOPERATIVE COURSE AND 
LONGTERM OUTCOME
K. Jönsson, G. Gröndahl, M. Salö, B. Tingstedt and 
R. Andersson
Dept of Surgery, Clinical Sciences Lund, Lund University, 
Lund, Sweden
Introduction: About 60% of patients with liver resection 
for colorectal liver metastases will develop recurrent disease 
and some may be candidates for a repeated liver resection. 
Previous studies have reported that intraoperative blood loss 
per se is a risk factor for complications after a repeated liver 
resection. The aim of this study was to evaluate differences 
in intraoperative blood loss and complications, comparing 
the primary and the repeated liver resection for metastases 
of colorectal cancer (CRC), as well as to evaluate differences 
in long-time follow-up.
Method: Between 1995 and 2009, 240 patients underwent 
a liver resection at the Department of Surgery, Lund 
University Hospital, Sweden, because of colorectal liver 
metastases. 33 patients underwent a repeated liver resection 
and 1 of these patients was subjected to a third liver resection 
due to recurrence. The aim of the study was to identify 
potential differences between the primary and the repeated 
liver resection, both concerning the intraoperative course and 
outcome at longterm follow-up.
Results: There were two patients who died within 30 days 
postoperatively. The mean expected survival after the 
primary resection was 88.5 months compared to 79 months 
following reresection (p = 0.556). The mean blood loss at 
reresection (2138 ml) was signifi cantly (p = 0.014) higher as 
compared to that noted at the primary liver resection 
(1530 ml). The primary liver resection was larger in extent 
than the reresections (p < 0.0001). There were no signifi cant 
differences in the rate of complications according to the 
Clavien and Dindo classifi cation, or the length of postopera-
tive hospital stay.
Discussion: In contrast to previous studies, we found that a 
repeated liver resection for CRC was associated with a 
higher intraoperative bleeding as compared to the fi rst resec-
tion. Possible explanations include the presence of adhe-
sions, deranged vascular anatomy and effects of chemotherapy 
following the fi rst liver resection.
P0042L
CARDIOPULMONARY EXERCISE 
TESTING (CPX) FOR PRE-OPERATIVE 
RISK ASSESSMENT PRIOR TO 
HEPATECTOMY
M. Junejo1, P. Foster2, D. Atkinson2, M. Parker2, J. Moore2, 
A. Sheen1 and A. Siriwardena1
1The Manchester Hepato-Pancreato-Biliary Centre, 
Manchester Royal Infi rmary, Manchester, United Kingdom; 
2Critical Care unit, Manchester Royal Infi rmary, 
Manchester, United Kingdom
Objective: Contemporary liver surgery practice must accu-
rately assess operative risk in increasingly elderly populations, 
with greater co-morbidity and in individuals who have received 
chemotherapy. Cardiopulmonary exercise testing (CPX) pro-
vides an objective functional evaluation of risk with patients 
who demonstrate either a low anaerobic threshold (AT) or a 
high ventilatory equivalent for carbon dioxide (VE/VCO2) at 
AT representing high risk groups. This study evaluates the role 
of CPX in patients undergoing hepatectomy.
Methods: Pre-operative CPX was undertaken in patients 
aged over 65 years (or younger with co-morbidity) undergo-
ing hepatectomy. Level of postoperative care was assigned 
based on CPX-derived risk. 204 patients were referred over 
a 28 month period with operable liver disease. 190 hepatec-
tomies were undertaken of whom 94 underwent pre-opera-
tive CPX. 14 patients were deemed unfi t for surgery based 
on CPX risk categorisation. Data were collected prospec-
tively on functional status, CPX parameters, postoperative 
complications (defi ned prospectively) and survival.
Results: 30 day postoperative mortality in 190 hepatecto-
mies was 2.1%. In a predictive regression model for post-
operative complications, VE/VCO2 > 34 was the most 
signifi cant predictor for cardiopulmonary complications (p = 
0.034) and all postoperative complications (p = 0.013). Low 
AT correlated with unplanned critical care admission (p = 
0.012) and postoperative mortality (p = 0.013) and was most 
signifi cant at a cut-off of <10 ml/kg/min (p = 0.004, AUC 
0.879). AT < 11 ml/kg/min was predictive of poor short-term 
survival (Log Rank p = 0.033) in all patients undergoing 
preoperative CPX at a median follow-up of 544 days (104–
928). Revised Cardiac Risk Index did not correlate with 
cardiopulmonary complications.
Conclusions: This study suggests that CPX based assess-
ment accurately predicts risk of morbidity and outcome in 
patients undergoing hepatectomy.
P0043L
CLINICAL CHARACTERISTICS OF 
HEPATOCELLULAR CARCINOMA 
PATIENTS WITH NEGATIVE FINDINGS 
IN ALPHA-FETOPROTEIN AND PROTEIN 
INDUCED BY VITAMIN K ABSENCE OR 
ANTAGONIST-II
S. H. Kim1, D. Y. Kim2, G. H. Choi1, S. H. Ahn2, 
J. S. Choi1 and K. S. Kim1
1Dept. of Surgery, Yonsei University College of Medicine, 
Seoul, Korea; 2Dept. of Internal Medicine, Seoul, Korea
Background: Alpha-fetoprotein (AFP) and protein induced 
by vitamin K absence or antagonist-II (PIVEK-II) were the 
most commonly using tumour marker to diagnose hepatocel-
lular carcinoma (HCC) and detect recurrence of tumour. 
However, combination tests of AFP and PIVKA-II revealed 
80% sensitivity. In this study, we designed to analyzed cor-
relation between prognosis and clinicopathological charac-
teristics of patients showing both AFP and PIVKA-II negative 
results.
Methods: Medical records of 84 hepatocellular carcinoma 
patients with both AFP and PIVKA-II negative results at the 
time of diagnosis and underwent hepatectomy from Jan. 
2000 to Dec. 2007 were reviewed retrospectively. The cor-
relations between prognosis and clinical, laboratory and 
pathological characteristics of patients were analyzed.
Results: 31 (36.9%) of 84 patients received neoadjuvant 
treatment, and 37 patients (44%) underwent major hepatec-
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tomy. According to AJCC 7th T stage, stage T1, T2, T3a, T3b 
and T4 patients were 49 (58.3%), 30 (35.7%), 1 (1.2%), 2 
(2.4%) and 1 (1.2%), respectively. Mean follow-up time was 
57.6 months and during the follow-up duration, 46 (54.8%) 
had disease recurrence. Median disease free survival and 
overall survival were 41 and 97 months, respectively. In Cox 
proportional hazards model, satellite nodule (P = 0.001, Odds 
ratio = 4.487, 95% CI = 1.821–11.056) and intrahepatic 
metastasis (p = 0.037, Odds ratio = 39.728, 95% CI = 1.238–
1275.218) were signifi cantly correlated with disease free 
survival and overall survival, respectively.
Conclusions: The result shows that patients with satellite 
nodule or intrahepatic metastasis in both AFP and PIVKA-II 
negative results group require regular postoperative surveil-
lance actively, and need adjuvant treatments. Though patients 
with both AFP and PIVKA-II negative results have good 
prognosis, further studies are needed to identify more sensi-
tive tumour marker for some patients with recurrence and 
poor prognosis.
P0044L
THE VALIDATION OF HCE1 AS TUMOR 
MARKER IN HCC WITH LOW AFP OR 
PIVKA-II LEVELS – PRELIMINARY 
RESULTS
S. H. Kim1, K. Na2, D. Y. Kim3, G. H. Choi1, S. H. Ahn3, 
J. S. Choi1, K. S. Kim1 and Y. K. Back2
1Dept. of Surgery, Yonsei University College of Medicine, 
Seoul, Korea; 2Biomedical Proteome Research Center, 
Yonsei University, Seoul, Korea; 3Dept. of Internal 
Medicine, Yonsei University College of Medicine, Seoul, 
Korea
Objective: Alpha-fetoprotein (AFP) and protein induced by 
vitamin K absence or antagonist-II (PIVKA-II) were most 
commonly used tumor marker to diagnosis hepatocellular 
carcinoma (HCC). However, These tumor markers did not 
react sensitively to early HCC. This study was designed to 
validate hCE1 as tumor marker in HCC with low AFP and 
PIVKA-II levels.
Methods: 74 patients with AFP < 20 ng/ml and PIVKA-II 
< 40 mAU/ml were planned to be enrolled in this study. We 
analyzed plasma of 10 patients as preliminary results. The 
Whole plasma of patients with antibody-coated magnetic 
beads was centrifuged. 1.5 folds result than that in normal 
healthy volunteer plasma was defi ned as positive.
Results: All 10 patients had early HCC and each tumor size 
in all patients was less than 3 cm. Monoclonal antibody and 
polyclonal antibody showed 70% and 60% sensitivity, 
respectively. Clinical characteristics and status of viral hepa-
titis did not affected the results of monoclonal and polyclonal 
antibody.
Conclusions: Although further study with more patients 
should be analyzed, hCE1 showed high probability of new 
tumor marker in HCC with low APF and PIVKA-II levels.
P0045L
A CASE STUDY OF CURATIVE 
RESECTION OF HEPATOCELLULAR 
CARCINOMA AFTER CONCURRENT 
CHEMORADIATION THERAPY IN 
ADVANCED HEPATOCELLUAR 
CARCINOMA
S. H. Kim1, S. R. Lee2, Y. N. Park2, J. S. Seong3, 
K-H. Han4 and K. S. Kim1
1Dept. of Surgery, Yonse University College of Medicine, 
Seoul, Korea; 2Dept. of Pathology, Yonsei University 
College of Medicine, Seoul, Korea; 3Dept. of Radiation 
Oncology, Yonse University College of Medicine, Seoul, 
Korea; 4Dept. of Internal Medicine, Yonse University 
College of Medicine, Seoul, Korea
Background: Hepatocellular carcinoma was the 5th common 
cancer worldwide. Although various kinds of nonsurgical 
treatments lead to good results recently, the fundamental 
treatment of HCC is the surgical resection. Due todelayed 
diagnosis and decompensated liver function, candidates of 
surgical resection were limited. A case of curative resection 
of hepatocellular carcinoma after concurrent chemoradiation 
therapy (CCRTx) in a patient with advanced hepatocelluar 
carcinoma will be presented.
Case report: 56-year-old man was diagnosed as hepatitis B 
virus carrier in 1999. After that time, he did not make a 
regular appointment with the doctor. In September 2006, he 
visited hospital complaining of dyspepsia and it suspicious 
for hepatocellular carcinoma. In the initial computer tomog-
raphy, the size of tumor was 11.2 × 10.2 cm and whole left 
lobe of liver was invaded by cancer cells. The patient had 
been received CCRTx (500 mg 5-FU on initial 3 days and 
last 3 days and 4,500 cGy radiation; 180 cGyX25 times) and 
partial response can be seen in follow-up image. He has 
received 3 additional intra-arterial 5-FU/DDP chemotherapy. 
After that, CT image showed near total necrotic tumor and 
atrophy in Lt. lobe, so left hemihepatectomy was done.
Conclusions: Because of delayed diagnosis, Many patients 
cannot undergo curative surgery. Though prospective studies 
will be needed to assess the effect of CCRTx, we present 
experience to curatively resect hepatocellular carcinoma 
after concurrent chemoradiation therapy.
P0046L
CHOLESTASIS EXACERBATES 
MITOCHONDRIAL REDOX STATES AND 
ENERGY DEPLETION DURING HEPATIC 
ISCHEMIA-REPERFUSION
J. Kloek1, M. Heger1, X. Maréchal2, A. van Kuilenburg1, 
R. Bezemer1, R. Nevière2 and T. van Gulik1
1Academic medical center, Amsterdam, Netherlands; 
2Lille University Hospital, Lille, France
Introduction: This study investigates the impact of isch-
emia reperfusion (I/R) injury on oxidative phosphorylation 
and hepatic energetics in bile duct ligated (BDL) rats so as 
to determine the restorative capacity of cholestatic livers and 
to elucidate oxidative stress-related molecular mechanisms 
that are responsible for corollary tissue damage.
Methods: Wistar rats were randomized into 2 groups and 
subjected to BDL or sham laparotomy. After 7 days, both 
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groups underwent 30 minutes partial liver ischemia. Animals 
were sacrifi ced before ischemia or after 15 m, 90 m, 6 h, and 
24 h reperfusion.
Results: Cholestasis is associated with a greater extent of 
necrosis and apoptosis as well as elevated plasma liver 
enzymes, redox state, and infl ammation and decreased 
energy status and antioxidative capacity. Cholestatic rat 
livers were less capable of coping with I/R injury as evi-
denced by the dysfunctional oxidative phosphorylation (per-
sistent pro-oxidative conditions), a retarded recovery of 
hepatic energy status, and an increased infl ammatory 
response after 90 min reperfusion, which coincided with 
extensive hepatocellular damage and widespread necrosis at 
24 hour reperfusion. Although a profound infl ammatory state 
was observed in cholestatic animals pre- and post-I/R, the 
low TNF-α concentration in cholestatic livers in opposite to 
the control group suggested that the extrinsic apoptosis 
pathway played no role in the histological/biochemical 
damage profi les.
Conclusions: A delayed energy recovery and increased leu-
kocyte adhesion during the early reperfusion phase could be 
cumulatively responsible for the extensive damage after I/R 
in cholestatic rat livers.
P0047L
AN IN VITRO MODEL FOR ISCHEMIA/
REPERFUSION INJURY INDICATES 
MATRIX METALLOPROTEINASE-9 AS A 
POTENTIAL TARGET FOR THERAPIES 
AIMED AT REDUCING ISCHEMIA/
REPERFUSION INJURY IN THE LIVER
K. Savage, J. Parker, S. Livingstone, T. Lee and I. Alwayn
Dalhousie University, Halifax, Nova Scotia, Canada
Objective: MMP-9 is a critical mediator of leukocyte 
migration and extracellular matrix remodelling. It has been 
associated with modulating responses to myocardial and 
cerebral ischemia but its potential role in hepatic ischemia/
reperfusion injury has not been extensively evaluated.
Methods: Human hepatocyte (HepG2) cultures were main-
tained throughout the experiment. Control cells were grown 
at 37°C in complete media. Cold ischemia was modelled by 
incubation of HepG2 cells in chilled anoxic HTK organ 
preservation solution for 6 hrs at 4°C. Warm ischemia was 
modelled when the cultures were subsequently transferred to 
37°C for 30 min, while reperfusion was mimicked by provid-
ing pre-warmed normoxic complete media for 3 hrs. Changes 
in protein expression were determined by Western blot.
Results: MMP-9 expression increased above baseline levels 
when HepG2 cultures were subjected to the in vitro model 
of ischemia/reperfusion injury.
Conclusion: The increase in MMP-9 expression observed 
in HepG2 cells resulted from the in vitro ischemia and reper-
fusion injury. This indicates MMP-9 as a target for therapies 
aimed at reducing cellular damage following ischemia/reper-
fusion injury.
P0048L
IS HEPATECTOMY INDICATED IN GIANT 
RIGHT PHAEOCHROMOCYTOMAS?
Q. Lu, J. K. Low, C. K. Ho and K. H. Liau
Tan Tock Seng Hospital, Singapore, Singapore
We report an unusual presentation of giant phaeochromocy-
toma in two patients and sought to review the reliability of 
radiological investigations. A 46 year-old male with 6 months 
history of epigastric pain and weight loss was diagnosed with 
a right hepatic tumor on ultrasound. A magnetic resonance 
scan of the lesion revealed a 18 cm × 18 cm right adrenal 
mass consistent with phaeochromocytoma. Bone scintigra-
phy showed suspicious solitary thoracic vertebral metastasis. 
Another 70 year-old female presented with acute epigastric 
pain and hypertensive crisis. She was found to have 8.5 cm 
by 8.5 cm adrenal mass on computed tomography scan. In 
both cases, there was no distinct plane between the tumour 
and the liver parenchyma on imaging studies, thus hepatec-
tomy was planned with tumourectomy. However, intra-
operatively there was a distinct surgical plane between the 
liver and the phaeochromocytoma, sparing liver resection. 
Post-operatively, they recovered uneventfully. Histology of 
the former concluded phaemochromocytoma without capsule 
invasion. Histology of the latter case showed a phaeochro-
mocytoma with extensive necrosis without capsule invasion. 
These two cases highlighted the unusual presentation of a 
rare condition where imaging studies does not reliably defi ne 
the interface between the tumour and the liver and tend to 
overestimate the extent of the tumour invasion into the liver.
P0049L
LIVER RESECTION IS A SAFE 
PROCEDURE EVEN AFTER 
PREOPERATIVE CHEMOTHERAPY: 
PROSPECTIVE STUDY BETWEEN TWO 
GROUPS OF PATIENTS, 
CHEMOTREATED VERSUS NON 
CHEMOTREATED
M. Massani, R. Bonariol, E. Cartozzolo, C. Ruffolo, 
F. C. di Pinto and N. Bassi
Regional Hospital, Treviso, Italy
Aim: The aim of this prospective study is to assess the 
effects of preoperative chemotherapy on hepatic parenchyma 
in a consecutive and homogeneous series of patients evaluat-
ing the outcome in terms of postoperative morbidity at 
30 days after surgery, liver function and the need of 
transfusion.
Materials and methods: Eighty-seven consecutive patients 
that underwent liver resection for colorectal metastases in IV 
unit of General Surgery of the Treviso’s Regional Hospital 
were included: the patients were divided into two groups: 
group 0 with 39 patients (45%) who only underwent liver 
resection and group 1 with 48 patients (55%) who received 
preoperative chemotherapy. All variables, which could infl u-
ence surgical outcome were analyzed: hepatic injury found 
on histologicy, liver function tests (total bilirubin, ALT, AST, 
Albumin, INR) before surgery till hospital discharage, che-
motherapy treatment (5FU, Oxaliplatin, Irinotecan, mono-
clonal antibodies, intraarterial or systemic), number of 
infusions, interval between chemotherapy and surgery, need 
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of transfusion, postoperative complications, length of hospi-
tal stay, comorbidities. Univariate, bivariate and multivariate 
analyses were performed.
Results: The probability of developing severe steatosis (2, 
58 times) and necrosis (4 times) wad higher in patients that 
received preoperative chemotherapy furthermore the risk of 
steatohepatitis in these patients was higher. The patients of 
group 1 underwent a major resection, compared to group 0 
and, as expected, the values liver function tests were worse 
(p 0.007). The number of infusions did not imply a higher 
number of surgery complications (p 0.075), but it was 
directly correlated with Bilirubin values and inversely cor-
related with Albumin values. No correlation was found 
between time interval from the last infusion and surgery and 
surgical outcome. With regard to transfusion need and length 
of hospital stay no difference between the two groups was 
found. Most changes of the variableness are signifi cative in 
the univariated analysis but not in the multivariated one.
Conclusions: Preoperative chemotherapy can cause liver 
damage without a negative infl uence on surgical outcome; 
therefore liver resection is a safe practice also after chemo-
therapeutic treatment.
P0050L
OUTCOMES AND LIVER FUNCTION 
AFTER RIGHT OR EXTENDED RIGHT 
HEPATECTOMY IN PATIENTS OVER 70 
YEARS
E. Melloul, N. Halkic and N. Demartines
Department of Visceral surgery, Centre Hospitalier 
Universitaire Vaudois, University Hospital, Lausanne, 
Switzerland
Background: To assess the infl uence of age on the outcome 
of right (RH) and extended right hepatectomy (ERH)
Method: From a prospective hepatobiliary database of 200 
patients (between 2006 and 2008), we retrospectively anal-
ysed all consecutive RH/ERH performed at our tertiary refer-
ral centre. Outcomes and liver function were compared 
between patients <70 and ≥70 years. Liver function was 
assessed using the 50/50 criteria.
Results: 77 consecutive RH/ERH (n = 17 in ≥70 years, n = 
60 <70 years) were included in the database. Median age was 
75 (70–85) and 57 (21–66) years, respectively. Baseline char-
acteristics were similar, except for the ASA score (52% vs. 
22% ASA 3, p = 0.038) and cardiac insuffi ciency rate (31% 
vs. 2%, p < 0.001) which were higher in patients ≥70 years. 
Indications, operative time and blood transfusions were statis-
tically not different. 90-day mortality rate was 12% in ≥70 
years and 3% in <70 years (p = 0.21), always related to cardiac 
insuffi ciencies in patients ≥70 years; major morbidity (grade 
III to V) was 18% and 20%, respectively (p = 0.75).
In patients ≥70 versus <70 years, the rate of liver failure 
(6% vs. 7%, p = 0.62), ascites (29% vs. 13%, p = 0.08) and 
biliary fi stula (12% vs. 18%, p = 0.72) were similar, respec-
tively. From POD1 to POD8, the bilirubin level and pro-
thrombine time were not different between the two groups. 
Predictors of postoperative death in patients ≥70 years after 
multivariate analysis included: ASA > 2 (p = 0.009), hyper-
tension (p = 0.022) and additional surgery (p = 0.005).
Conclusions: RH or ERH can be performed safely in 
patients ≥70 years. Liver function is not altered with age, but 
patients ≥70 years with ASA > 2 and hypertension should be 
closely monitored because of a higher mortality risk in 
cardiac insuffi ciency. Finally, additional surgery should be 
avoided whenever possible.
P0051L
ASSESSMENT OF LIVER FUNCTION AND 
VOLUME IN CIRRHOTIC AND NORMAL 
LIVERS USING GD-EOB-DTPA-
ENHANCED MRI
H. Nilsson1, L. Douglas2, A. Nordell2, L. Blomqvist3 and 
E. Jonas1
1Karolinska Institutet; Department of Clinical Sciences, 
Danderyd Hospital, Division of Surgery, Stockholm, 
Sweden; 2Department of Medical Physics, Karolinska 
University Hospital, Stockholm, Sweden; 3Department of 
Diagnostic Radiology, Karolinska University Hospital 
Solna, Institution for Molecular Medicine and Surgery 
Karolinska Institutet, Stockholm, Sweden
Background: Dynamic hepatocyte-specifi c magnetic reso-
nance imaging (DHCE-MRI) with Gd-EOB-DTPA can 
detect differences in liver function, expressed as the hepatic 
extraction fraction (HEF), between patients with mild cir-
rhosis and normal controls (HPB 2010 Oct;12(8):567–76).
Aims: This pilot study aimed at assessing if DHCE-MRI 
can be used to measure liver volume and also quantitatively 
estimate global liver function, expressed as the total HEF of 
the liver volume, and if this quantitative estimate differs 
between healthy controls and subjects with liver disease.
Method: T1-weighted dynamic Gd-EOB-DTPA-enhanced 
liver MRI was performed on 5 healthy volunteers and 5 
patients with liver cirrhosis. Informed consent was obtained 
prior to inclusion and the study was approved by the Regional 
Ethical Review Board. For a given time point, the liver 
parenchyma was manually defi ned in each slice, and in each 
image voxel, the hepatic extraction fraction (HEF) was cal-
culated using Fourier transform as described by Nilsson 
et al (JMRI 2009 Jun;29(6):1323–31). The volumes of all 
voxels was added to obtain the total liver volume, and the 
HEF-value of each voxel was added to obtain the total liver 
function, which was normalized to the subject’s body surface 
area.
Results: The median Child-score for patients was 7 (range 
5 to 12). The median liver volume for patients was 1761 ml 
(range 1377 to 1983 ml) and for controls 1335 ml (range 946 
to 1459 ml). The median total liver function estimate for the 
patients was 87 HEFml/m2 and 139 HEFml/m2 for the con-
trols (p < 0.05 Mann-Whitney U-test).
Conclusion: The study shows that DHCE-MRI can be used 
to assess both parenchymal volume and the total functional 
capacity of the liver. Since regional differences in parenchy-
mal function can be accounted for, we believe that this 
method could prove to be a valuable tool to predict remnant 
liver function in liver resections.
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P0052L
EVALUATION OF FIBROSIS IN PATIENTS 
WITH HCC
A. Pesce1, M. A. Trovato1, F. Fatuzzo2 and S. Puleo1
1Department of Surgical Sciences, Organ Transplantation 
and Advanced Technologies, University of Catania, 
Catania, Italy; 2Department of Infectious disease, 
University of Catania, Catania, Italy
Introduction: In recent decades liver resection for hepato-
cellular carcinoma (HCC) has become a safe procedure even 
in cirrhotic patients because of improved surgical techniques, 
better perioperative assessment and advances in anesthesia 
and medical care. Portal hypertension is frequently associ-
ated with cirrhosis and it has been reported as a negative 
prognostic factor and a relative contraindication to liver 
resection. Portal hypertension can be diagnosed indirectly by 
imaging methods (ultrasonography, CT scan, MRI) or 
directly with the measurement of portal pressure. The aim of 
this study is to evaluate a possible correlation between 
grading of fi brosis by transient elastography (Fibroscan®) 
and portal hypertension to consider if this technique could 
be useful in planning of liver resection in patients with HCC.
Materials and method: In this study 77 patients with cir-
rhosis, of which 42 with hepatocellular carcinoma, were 
enrolled between 2007–10. The mean age was 65.2 years old 
with 46 men and 31 women. As regards cirrhosis etiology, 
51 patients presented cirrhosis HCV-related, 9 HBV-related, 
3 alcohol-related, 2 HBV-HDV coinfections and 12 other 
etiology. Liver function was assessed according to the Child-
Pugh classifi cation: 60 patients were in Child A, 13 in Child 
B and 4 in Child C. We also considered as a parameter of 
liver function the value of serum cholinesterase that is a 
complex enzymatic protein mostly synthesized by the liver. 
In all patients liver stiffness measurement (LSM) was per-
formed using Fibroscan®. The presence of portal hyperten-
sion was indirectly defi ned as 1) esophageal varices detectable 
at endoscopy or 2) splenomegaly (major diameter of the 
spleen ≥12 cm) with a platelet count of <100.000/mm3.
Results: The mean value of liver stiffness was 27.9 kPa. 
Thirty-seven patients (48%) presented portal hypertension, 
forty patients (52%) no portal hypertension. The mean value 
of liver stiffness in patients with portal hypertension was 
33.4 kPa versus 23.2 kPa in patients without portal hyperten-
sion (p-value <0.02). The mean value of LS defi ned a severe 
fi brosis and confi rmed clinical and biochemical data of cir-
rhotic patients. The mean value of LS is higher in patients 
with portal hypertension and it could predict the develop-
ment of postoperative hepatic insuffi ciency in patients with 
hepatocellular carcinoma undergoing curative liver resection 
surgery.
Conclusions: Evaluation of liver fi brosis by transient elas-
tography could be useful in follow-up of cirrhotic patients. 
Direct correlation with portal hypertension could help us in 
the evaluation of surgical risk of patients with HCC which 
are candidates to liver resection.
P0053L
A RARE CASE OF ENTEROBIUS 
HEPATIC CYST
A. Pinho, R. B. de Melo, M. Sacchetti, H. Cristino, 
L. Graça and J. Costa-Maia
HBP Unit, General Surgery, Hospital Sao Joao, Porto, 
Portugal
Introduction: Enterobiasis is one of the most common hel-
minthic infections in the United States and Western Europe. 
Enterobius vermicularis has a simple life cycle, which con-
tributes to its high prevalence. The adults live in the human 
gastrointestinal tract, mainly in the cecum and appendix, and 
the female migrates out through the rectum onto the perianal 
skin to deposit her eggs. Adult pinworms can also travel to 
other ectopic sites.
Case report: We present a case of a 59-year old caucasian 
male with history of renal carcinoma, submitted to right 
nephrectomy in 2002 (pT2aN0M0), without any other 
pathologies. After 8 years of follow up without evidence of 
recurrence, CT-scan revealed a 25 mm hepatic lesion in 
segment VII with malignant characteristics. A percutaneous 
biopsy was done but it was inconclusive. Our oncologic 
group decided for excisional biopsy and a hepatic sub-
segmentectomy (VII) was performed. Pathology revealed a 
solitary parasitic cyst with necrosis and the presence of 
Enterobius vermicularis. He had no gastrointestinal symp-
toms or pruritus ani. The patient was further treated with 
albendazol without any other complications.
Conclusion: Enterobius hepatic cysts are very rare with few 
reports published. In our case, the suspicion of liver metas-
tases allowed the proper diagnosis.
P0054L
SHORT- AND LONG-TERM OUTCOME 
OF ULTRASOUND-GUIDED HEPATIC 
RESECTION FOR COLORECTAL LIVER 
METASTASES: A PROSPECTIVE 
COHORT STUDY
M. Donadon, M. Marconi, F. Procopio, M. Montorsi and 
G. Torzilli
Liver Surgery Unit, Third Dept. Of Surgery, University of 
Milan Istituto Clinico Humanitas IRCCS, Rozzano, Milan, 
Italy
Introduction: Hepatic resections (HR) are the treatment of 
choice for colorectal liver metastasis (CLM). The main limit 
to such treatment is the technical feasibility. With the use of 
intraoperative ultrasound (IOUS) the indications might be 
enlarged with the aim to offer curative treatment to a larger 
proportion of patients. The aim of this study was the analysis 
of short- and long-term outcome of ultrasound-guided HR in 
a consecutive cohort of patients.
Methods: A prospective collected series of 192 patients 
operated between 2001 and 2010 was the subject of the 
study. Exclusion criteria were: multiple extrahepatic disease, 
diffuse carcinosis, metastatic celiac lymph-nodes. Surgical 
strategy was based on previous reported IOUS criteria.
Results: Thirteen patients (7%) had exploratory laparotomy, 
while 179 had curative HR. The median tumor number was 
2 (range 1–49). Fifty-three patients (30%) had single CLM, 
79 (44%) 2–4 CLM, 32 (18%) 5–10 CLM, and 15 (8%) had 
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more than 10 CLM. Zero mm margins was reached in 68% 
of patients. Only 8 patients (5%) had major HR. The 90-day 
mortality was 0.7% (1 patient). Overall morbidity was 21%. 
After a median follow-up of 24 months, the overall survival 
at 1-, 3-, and 5-year were 95%, 69% and 56% respectively, 
while the disease-free survival at 1-, 3- and 5-year were 52%, 
29% and 15% respectively.
Conclusions: HR for CLM are safe and effective proce-
dures with adequate short- and long-term outcome even in 
patients with complex and multiple tumors. The systematic 
use of IOUS allowed us to offer curative treatments to a 
larger proportion of patients minimizing the rate of major 
HR, as well as of morbidity and mortality.
P0055L
MORE THAN 400 HEPATECTOMIES 
WITHOUT INTRAOPERATIVE 
CHOLANGIOGRAPHY: PROSPECTIVE 
VALIDATION OF THE ROLE OF 
ULTRASOUND
M. Marconi, V. Rotiroti, F. Procopio, M. Donadon, 
A. Palmisano, G. Scifo, M. Montorsi and G. Torzilli
Third Department of Surgery, University of Milan School 
of Medicine, IRCCS Istituto Clinico Humanitas, Via 
Manzoni 56, 20089 Rozzano, Milano, Italy
Background: Liver surgery should be considered an echo-
guided procedure to guarantee conservative but radical 
resections. We describe a further application of intraopera-
tive ultrasonography (IOUS) for studying the biliary 
tree along liver surgery with no need for formal 
cholangiography.
Methods: Out of 403 consecutive patients operated between 
June 2004 and June 2010, IOCUS was performed in 91 
patients (22.5%). Aims were to clarify the bile ducts anatomy, 
disclose eventual intrahepatic bile duct dilation, verify the 
patency of the bile duct after tumor detachment from a glis-
sonian sheat once bile leaks was evident and requested 
suture, check the drainage of a bile duct stump on the liver 
cut surface prior to bilio-enteric anastomoses. IOCUS was 
performed by direct ultrasound exploration or by injection of 
contrast agent (air alone or mixed with saline).
Results: IOCUS was safely performed in all patients. In 15 
(16.4%) patients the use of a contrast agent to clarify the bile 
duct anatomy was needed: in 12 air injection was used and 
in 3 air and saline was injected. In 5 patients IOCUS allowed 
biliary reconstruction without undrained liver portion. In 
84% of patients with tumor in contact with an intrahepatic 
glissonian sheat allowed conservation of the glissonian 
pedicle and in 16% clarifi ed the need for their division.
Conclusion: IOCUS with or without contrast agent is effec-
tive in clarifying the anatomy of the biliary tree, the tumor 
relations with the bile duct and in guiding the biliary recon-
struction, representing a further aid for radical and conserva-
tive resection.
P0056L
COULD LYMPH NODE RATIO HAVE A 
PREDICTIVE ROLE IN DEVELOPING 
COLORECTAL LIVER METASTASES?
M. A. Trovato, A. Pesce, G. L. Destri, F. Mosca and 
S. Puleo
Department of Surgical Sciences, Organ Transplantations 
and Advanced Technologies, University of Catania, 
Catania, Italy
Aims: Metachronous colorectal liver metastases (CRLM) 
occur in the 30–50% of colorectal cancer (CRC) patients 
within 3 years of standard surgical resection for the primitive 
disease. Recent literature has shown that lymph node ratio 
(LNR) is useful in predicting the prognosis in several malig-
nances, but its impact in the develop of CRLM is unknown. 
In this retrospective study we hypothesize that LNR may 
play a role as a predictive index in developing CRLM in 
patients affected from colon cancer.
Methods: We analysed data from 544 intra peritoneal CRC 
patients observed in our Institution from 1999 up to 2004 
and followed up for 5 years.
Patients have been classifi ed according to Astler Coller 
Dukes staging system and the LNR, that is the quotient 
between the number of positive lymph node sampled and the 
total number of lymph node harvested. The patients were 
categorized into four quartiles groups according to LNR 
values: LNR1 (0.01–0.11), LNR2 (0.12–0.23), LNR3 (0.24–
0.40), LNR3 (0.24–0.40) LNR4 (0.41–1), among those 
groups the spreading of CRLM has been calculated. Chi 
squared trend’s test was performed as statistical analysis.
Results: 185 patients belonging to the C1-C2 Astler Coller 
Dukes group had been statistically analyzed. The examina-
tion of our data proved a statistical dependence between 
LNR and develop of CRLM (ptrend = 0.0007). Our study sug-
gests that is useful being aware of not only the number of 
LN sampled or the number of positive LN, but also of LNR.
Conclusions: After curative resection for colorectal cancer, 
the LNR could be considered an important prognostic factor 
and should be used in stratifi cation schemes for future clini-
cal trials investigating tailored chemotherapy adjuvant treat-
ments and follow up modality and timing.
P0057L
‘CHEMOTHERAPY ASSOCIATED LIVER 
INJURY (CALI)’ IN PAEDRIATIC 
PATIENTS AFFECTED BY RESECTABLE 
HEPATIC MALIGNANCIES
M. A. Trovato1, A. Pesce1, L. Scalora2, M. G. Scuderi3, 
A. Di Cataldo2, V. Di Benedetto3, G. Magro4 and S. Puleo1
1Department of Surgical Sciences, Organ Transplantations 
and Advanced Technologies, University of Catania, 
Catania, Italy; 2Department of Paediatrics, University of 
Catania, Catania, Italy; 3Department of Paediatric 
Surgery, University of Catania, Catania, Italy; 4Department 
of Anatomy and Pathology, Catania, Italy
Background: Neoadjuvant chemotherapy for colorectal 
liver metastases could be responsible in adult patients of the 
so-called CALI, characterized by pathological liver response 
such as steatosis, steatohepatitis and sinusoidal obstruction 
syndrome which can induce peliosis, centrilobular perisinu-
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soidal/venular fi brosis and nodular regenerative hyperplasia. 
In the adult these alterations cause delayed operation for at 
least 6 weeks after neoadjuvant chemotherapy to reduce the 
risk of haemorrhage, portal hypertension and post operative 
hepatic failure. In the child affected by hepatic malignancies 
therapy schedule includes cytoreductive neoadjuvant chemo-
therapy followed by hepatic resection and eventual adjuvant 
chemotherapy. Some studies report signs of liver injury quite 
close to those above described, but only as late effects in 
aging childhood cancer survivors. Aim of this study is to 
evaluate retrospectively on paediatric patients affected by 
hepatic malignancies and undergone neoadjuvant chemo-
therapy and surgery whether CALI occurs.
Materials and method: 10 patients affected by hepatoblas-
toma (70%), undifferentiated hepatic sarcoma (20%), and 
fi brolamellar hepatocarcinoma (10%) has been considered. 
Patients median age was 5.5 years, and PRETEXT or TNM 
had been used as staging systems. 90% of patients underwent 
1 up to 5 cycles of neoadjuvant chemotherapy, all the patients 
underwent surgery a month later the last administration of 
chemotherapy. 9 patients were submitted to hepatic resection 
(4 right hepatectomies, 1 extended right hepatectomy, 2 left 
lobectomies, 1 left hepatectomy, 1 segmentectomy), 1 patient 
had been transplanted with the split liver technique.
Results: In the specimens analyzed we found as hepatic 
injury markers hepatocyte ballooning, portal infl ammation 
but no any sign of steatohepatitis or necrosis. Thus no CALI 
phenomena have been recorded, none postoperative morbil-
ity neither mortality. When available a period of follow up 
longer than 3 years we reported a survival rate of 60% (80% 
after 1 year).
Conclusion: Other studies are requested to clarify why pae-
diatric liver is not affected by chemotherapy associated liver 
injury, whether paediatric liver responds differently to stress 
or whether the different childhood cancer chemotherapy 
schedule can be completely safe in the early period, being 
aware that we should enlarge our group of patients and our 
follow up.
P0058L
PORTAL VEIN EMBOLIZATION AND 
MAJOR HEPATIC RESECTIONS: A 
SINGLE CENTER OUTCOME 
EVALUATION IN 62 PATIENTS
F. Ratti, F. Cipriani, C. Soldati, M. Catena, M. Venturini 
and L. Aldrighetti
Dipartimento di Chirurgia Generale e Specialistica – Liver 
Unit. IRCCS H San Raffaele, Università Vita-Salute San 
Raffaele, Milano, Italy
Introduction: The extent of liver resection is limited by the 
residual functional reserve of the liver (FRL). The introduc-
tion of portal vein embolization (PVE), with the rationale of 
inducing compensatory hypertrophy of the FRL has signifi -
cantly reduced morbidity and in particular the impact of 
‘small for size syndrome’ (SFSS). Objective of the study is 
to evaluate the feasibility and effectiveness of PVE in 
patients candidates for right hepatectomy at high risk of 
SFSS.
Materials and methods: Between January 2006 and 
December 2009, 62 patients suffering from primary or meta-
static liver tumor, underwent PVE at the Department of 
Surgery – Liver Unit HSR. CT assessment of hepatic volume 
was performed in each patient, prior and 4 weeks after the 
procedure. The outcome was evaluated in terms of feasibility 
of surgery, increasing FRL (calculated as: [FRL after PVE 
– PVE FRL pre] × 100/FRL pre PVE), morbidity and mortal-
ity associated with PVE and surgery.
Results: Of the 62 patients undergoing PVE, 6 (9.7%) have 
not benefi ted from further surgery: of these, 4 showed spread 
of disease in the FRL to CT control, while in the remaining 
2 adequate compensatory hypertrophy was not reached. The 
average volume of the FRL at the time of the procedure and 
after 4 weeks was respectively 437.03 cc (±172.54) and 
615.15 cc (±187.49) with an average increase of 50.3% 
(±30.31). During the postoperative period only 2 patients 
(3.2%) showed mild and transient signs of the SFSS.
Discussion: The technique of PVE makes it possible to per-
forme, in an effective and safe way, major liver resections in 
patients with high risk of SFSS.
P0059L
SYNCHRONOUS COLORECTAL LIVER 
METASTASES: LAPAROSCOPIC OR 
OPEN APPROACH FOR COLORECTAL 
SURGERY?
F. Ratti, L. Aldrighetti, S. Di Palo, E. Orsenigo, M. Catena, 
E. Guzzetti, L. Ghirardelli, C. Staudacher and G. Ferla
Dipartimento di Chirurgia Generale e Specialistica – Liver 
Unit. IRCCS H San Raffaele, Università Vita-Salute San 
Raffaele, Milano, Italy
Background: 30% of patients with colorectal cancer pres-
ents with liver metastases at diagnosis. Long-term survival 
is infl uenced by obtaining a complete removal (R0) of the 
primary tumor and liver metastases. Aim of this study was 
to assess the short-term outcome of combined resection of 
colon or rectum cancer and liver metastases, comparing the 
results of the primary tumor resection performed laparo-
scopically or by laparotomy.
Materials and methods: From January 2004 to July 2010, 
69 patients underwent combined resection of colorectal 
cancer and synchronous liver metastases. Forty patients 
underwent laparoscopic colorectal resection (LPS Group), 
and were compared with 29 patients undergoing colorectal 
resection by laparotomy (LPT Group). The liver resection 
was performed by laparotomy. It was performed further 
analysis, including only the colonic resection.
Results: LPS Group was associated with a lower postopera-
tive morbidity (25% vs 51.7%, P = 0.031), and a shorter 
postoperative hospital stay (10.5 vs. 15.1 days, P = 0.002). 
The analysis of the subgroup of patients undergoing colon 
resection showed a signifi cant reduction in postoperative 
morbidity (18.7% vs 50%, p = 0.049) and length of hospital 
stay (9 vs 15.2 days, P = 0.002).
Conclusions: The minimally invasive approach to colorec-
tal surgery has signifi cant advantages over the traditional 
technique: hospital stay and overall morbidity were lower in 
LPS Group; postoperative course was reduced, allowing an 
earlier recovery for patients who need to complete the onco-
logic treatment with chemotherapy. In simultaneous resec-
tions of colorectal cancer and liver metastases, the length of 
postoperative hospital stay is mainly conditioned by intesti-
nal surgery, rather than resection, as shown stratifying 
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patients by the extent of hepatic resection (P not signifi cant). 
Laparoscopic resection of colorectal cancer in patients 
undergoing simultaneous resection of liver metastases by 
laparotomy is associated with a reduction of morbidity and 
postoperative hospital stay, without affecting the oncologic 
radicality.
P0060L
TREATMENT OF RECURRENT 
COLORECTAL LIVER METASTASES: IS 
REPEAT SURGERY SAFE AND 
EFFECTIVE? A SINGLE CENTRE 
EXPERIENCE
F. Ratti, F. Cipriani, M. Catena, M. Paganelli, 
L. Aldrighetti and G. Ferla
Dipartimento di Chirurgia Generale e Specialistica – Liver 
Unit. IRCCS H San Raffaele, Università Vita-Salute San 
Raffaele, Milano, Italy
Introduction: Hepatic resection is the only potentially cura-
tive treatment for liver metastases from colorectal cancer 
(CLM). 60–70% of patients undergoing surgical treatment 
develop recurrent disease and about 30% of recurrences are 
in the liver. We analyzed intra-and postoperative outcome, 
recurrence and survival after primary (PR) and repeated (RR) 
hepatic resection for CLM to determine the value of this 
approach in patients with recurrent disease.
Materials and methods: From January 2000 to January 
2006, 298 liver resections for CLM in 245 patients were 
carried out at the Liver Unit HSR. 53 of these underwent RR 
and are the object of the study. PR and RR were compared 
in terms of type of hepatic resection, intraoperative blood 
loss, postoperative complications, hospital stay and mortality 
and fi nally overall survival (OS) and disease-free survival 
(DFS) were evaluated.
Results: There was no statistically signifi cant difference in 
terms of intra-and postoperative outcome between PR and 
RR. Minor resections were more frequently performed: 169 
in the PR group and 37 in the RR group. The 1.3 and 5 years 
OS has been 92%, 62% and 53% in the PR and 86%, 51% 
and 34% in RR group (P not signifi cant). The recurrence rate 
at 1, 3 and 5 years was respectively 40.5%, 56% and 61.2% 
in PR group and 44.6%, 60.5% and 64% in the RR.
Discussion: Our study confi rms the effectiveness of repeated 
hepatic resection in the treatment of recurrent liver metasta-
ses from colorectal cancer. The mortality, morbidity, and 
survival rates after repeated liver surgery are comparable 
with the results after the fi rst liver resection, and these data 
further underscore how new technological frontiers in 
surgery, radiology and oncology allow a progressive improve-
ment in the long term outcome of these patients, with no 
additional cost in terms of short-term outcome.
P0061L
EVALUATION OF STRESS RESPONSE IN 
LAPAROSCOPIC LIVER SURGERY: A 
PROSPECTIVE STUDY OF 
INFLAMMATORY PROFILE, 
COAGULATION HOMEOSTASIS AND 
CLINICAL OUTCOME
F. Cipriani, F. Ratti, M. Catena, M. Paganelli, G. Ferla and 
L. Aldrighetti
Department of Surgery – Liver Unit, Scientifi c Institute H 
San Raffaele, Vita-Salute San Raffaele University, Milano, 
Italy
Background: It is known that an infl ammatory response 
and hypercoagulability state develop after surgery, and its 
biological mediators have been recognized in infl ammatory 
cytokines. Laparoscopy has been introduced in clinical prac-
tice, but its application for liver resections is still in its 
infancy and its benefi ts remain to be demonstrated.
Aim: To perform a case-matched analysis about the clinical 
outcome, infl ammatory profi le and coagulation homeostasis 
of laparoscopic liver resections.
Patients: 32 hepatic resections have been enrolled in the 
study. 16 were assigned to the laparoscopic approach, while 
the further 16 to the traditional open procedure. Outcome 
measures were: operating time, intraoperative blood losses, 
blood transfusions, tumor exposure at the transection surface, 
minimal surgical margin, hospital stay, morbidity rate, time 
of mobilization, fasting and analgesic therapy duration, time 
of fi rst fl atus. Samples for liver function assessment were 
collected pre- and postoperatively. Levels of white blood 
cells count, C-reactive protein, IL6 and TNF were deter-
mined as markers of infl ammatory stress response. Levels of 
prothrombin time, platelets count, fi brinogen, antithrombin 
III and fi brin D-dimer were evaluated as markers of coagula-
tion homeostasis.
Results: Postoperative plasma levels of AST, ALT, WBC, 
CRP, IL-6, PT and XDP showed a lower rise in LPS group. 
Intraoperative blood losses, blood transfusions rate, analge-
sic therapy amount, time of mobilization, fasting duration, 
time of fi rst fl atus and overall morbidity resulted lower in 
LPS group. Decrease of PLT, ATIII and FG levels was lower 
in LPS group. Postoperative levels of BIL and TNF, operat-
ing time, tumor exposure at the transection surface and 
minimal surgical margins resulted comparable between the 
two groups.
Conclusions: The laparoscopic approach for liver resec-
tions seems to result in improved clinical outcome, lower 
stress response and lower coagulation alterations.
P0062L
ALVEOLAR ECHINOCOCCOSIS – A 
RARE BUT ‘MALIGNANT’ LIVER 
DISEASE
M. Roethlin and P. Renzulli
Surgical Dept, Kantonsspital, Münsterlingen, Switzerland
Introduction: Alveolar echinococcosis is a rare disease of 
the liver found in the southern part of Germany and northern 
Switzerland, parts of Canada and in Mongolia. The larvae of 
the fox tapeworm are transmitted by vegetables and fruit 
contaminated by fox excrements. The growing assimilation 
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and proximity of foxes in both urban and rural environments 
leads to an increase in new cases of this disease. Unlike the 
big cysts of the dog tapeworm, the tiny cysts of E. multilocu-
laris grow cancer-like in the liver tissue. The recommended 
treatment, therefore, is the radical resection of the involved 
liver tissue followed by a 2-year treatment with albendazol.
Patients: Between 2000 and 2010, 11 patients with this 
disease were treated at our institution. There were 6 males 
and 5 females aged 38 to 78 years (∅ 58 years). All but one 
patient underwent operation. These ranged fromatypical 
resections (n = 2) to segmentectomy (n = 2), hemihepatec-
tomy (n = 4), extended hemihepatectomy and hepaticojeju-
nostomy (n = 3). In 4 patients resections of extrahepatic 
disease occurred simultaneously (diaphragm, adrenal gland, 
thoracic wall). 5 patients were symptomatic with jaundice 
and/or upper right quadrant pain at presentation. All patients 
entered follow-up in a national database.
Results: Eight patients were resected radically, in one 
patients radicality was uncertain and 1 patient could not be 
completely resected. Complications were seen in 2 patients 
(bilioma) and one patient died of the disease without being 
operated on. All patients are presently free of recurrence after 
a median follow-up of 30 months. In 9 patients the postop-
erative medication could be terminated after 2 years in accor-
dance with protocol due to negative serological fi ndings.
Conclusion: The surgical therapy and postoperative chemo-
therapy with albendazol is a reliable and successful treatment 
of this rare disease. Early diagnosis of asymptomatic patients 
during imaging for other reasons helped improve results in 
recent years.
P0063L
RADIOFREQUENCY ABLATION (RFA) 
AND TRANSARTERIAL 
CHEMOEMBOLIZATION (TACE) IN THE 
MANAGEMENT OF HEPATOCELLULAR 
CARCINOMA (HCC)
S. Rohatgi, G. Sen, J. Rose, H. Reeves and D. M. Manas
Freeman Hospital, Newcastle Upon Tyne Hospitals, 
Newcastle, United Kingdom
Introduction: Radiofrequency Ablation and/or TACE, 
(alone or in combination), are now widely accepted as effec-
tive treatment options in the management of patients with 
cirrhosis who develop HCC’s.
Aim: To evaluate the effectiveness of these treatment 
modalities in the management of HCC in patients referred to 
our institution between 2001 and 2009.
Materials and methods: Case notes of 68 patients eligible 
for treatment with RFA and/or TACE, with a diagnosis of 
HCC based on the EASL criteria and/or histological evi-
dence of HCC were retrospectively reviewed. Treatment 
outcome was evaluated in conjunction with the MELD and 
Child-Pugh scores, tumor size and number, time to recur-
rence and number of treatments (RFA/TACE) given.
Results: Total of 68 patients were evaluated 52 male and 16 
female with median age of 69 yrs were included. Thirty six 
patients were Child A, 27 were Child B and 5 were Child C. 
51 patients received at least 1 treatment with TACE prior to 
RFA and 9 patients received TACE+RFA on the same day. 
At total of 88 tumors were treated in the 68 patients. Twenty 
lesions were equal too or larger than 4 cms and were ablated 
by multiple procedures (1.26 procedure/person). The mean 
size of the tumors ablated was 2.57 cms (0.5–4.5 cm). 
Median time of recurrence was 7.7 months and median sur-
vival was 16 months. Disease recurrence at the treatment site 
was seen in 20 lesions and de novo lesions were observed in 
20 patients remote from the RFA site. Complete response 
was achieved in 20 patients. 5 patients went on to liver 
transplantation.
Conclusion: RFA in conjunction with TACE provides a rea-
sonable survival with minimum complications. The indica-
tion of RFA in HCC needs to be well defi ned rather than 
using it indiscriminately which can skew the results as sug-
gested in the literature.
P0064L
ROLE OF RADIOFREQUENCY 
ABLATION (RFA) IN THE MANAGEMENT 
OF COLORECTAL LIVER METASTASIS 
(CRLM)
S. Rohatgi, G. Sen, M. Jacob, J. Rose, J. J. French, 
B. C. Jaques and D. M. Manas
Freeman Hospital, Newcastle Upon Tyne Hospitals, 
Newcastle, United Kingdom
Introduction: Publication of NICE guidelines in December 
2009 and promising result of CLOOC trial has triggered 
increased use of RFA in the management CRLM. AIMS &
Objectives: To evaluate the role of RFA in management of 
CRLM at our centre in last 8 years. Patients were subjected 
to Percutaneous, Laparoscopic, or Open RFA with or without 
liver surgery.
Methods: It is a retrospective analysis of prospectively col-
lected data of 60 patients. Case Notes with Serial CT/MRI 
scans were studied. Post procedure response was assessed by 
3–4 week CT Scan and regular follow up by 3 monthly CEA 
levels in secretors and CT scan in non secretors was done.
Results: The study revealed that the RFA use in 60 CRLM 
patients (42 male: 18 Female) had 78 tumour ablated with 
116 sessions (1.93 session/person). Mean tumour size of 
2.54 cms (0.4 cms–5.0 cms) ablated with median time to 
recurrence of 8.4 months and the median follow up was 14 
months (1 month–5.4 years). There were 36 synchronous 
lesions and 24 metachronus lesions in this study. 29/60 
patients had neoadjuvant chemotherapy and 6/60 went on to 
have chemotherapy post RFA. Patients were further divided 
in three subgroups: Percutaneous RFA, Surgery along with 
RFA and Open RFA without resection due to advanced 
disease. The overall median survival achieved with com-
bined modality was 23.8 months. There was minor morbidity 
in the form of basal atelectasis 4/60, pleural effusion-3/60, 
portal vein thrombosis 2/60 and bile leak in 1 patient was 
observed. There was no mortality attributed to RFA.
Conclusion: RFA is a safe and effective treatment espe-
cially in multiple liver metastasis and bilobar disease. 
Whether surgery or RFA at fi rst instance in certain situations 
can give equivalent results is yet to be proved. The survival 
achieved in this group merits a randomized controlled study 
for a defi nitive answer.
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P0065L
EFFECTS OF BODY MASS INDEX ON 
POSTOPERATIVE OUTCOMES OF LIVER 
RESECTIONS
K. Saribeyoglu, S. Pekmezci, E. Aytac, M. Kapan, 
H. Tasci, H. Kalafat, V. Durgun, S. Perek, E. Goksoy and 
M. Sariyar
Istanbul University, Cerrahpasa Medical Faculty, 
Department of Surgery, Division of Hepatopancreatobiliary 
Surgery, Istanbul, Turkey
Background/aim: It is widely known that increased levels 
of body mass index (BMI, kg/m2) are associated with high 
risks of health. Unfavorable effects of overweight and 
obesity have been reported in different fi elds of surgery but 
there are few data about the impact of BMI on patients 
undergoing liver resections.
Materials and methods: We retrospectively reviewed the 
medical records of 178 (100 women/78 men) consecutive 
adult patients who had underwent liver resection for various 
etiologies at our clinic. Medical fi tness of all patients had 
been suitable for major laparotomy.
The patients were divided into three groups according to 
their body mass indexes: normal weight (BMI < 25), over-
weight (25 ≤ BMI < 30), and obese (BMI ≥ 30). The liver 
resections were defi ned major (hemihepatectomy, trisectio-
nectomy) or minor (atypical resection, metastasectomy, seg-
mentectomy or bisegmentectomy). Demographics, surgical 
details, histopathological results and early post operative 
outcomes were evaluated. The parameters were evaluated by 
Kruskal-Wallis test for the statistical analysis.
Results: Mean age of the patients was 54 years (33–83). 
There were 45 right hemihepatectomy, 20 left hemihepatec-
tomy, seven right trisectionectomy, 34 segmentectomy/sec-
tionectomy, 36 atypical resection and 36 metastasectomy. All 
the patients underwent macroscopically R0 resection. There 
was no intraoperative mortality. The distribution of major 
and minor liver resections was summarized in table 1. There 
was no signifi cant difference between the groups for early 
period overall complication and mortality rates, duration of 
surgery, postoperative hospital stay, peroperative blood loss. 
Wound infection is the most common postoperative compli-
cation after liver resection for all groups.
Conclusion: Increased BMI is not a risk factor regarding 
the outcomes of liver resections.
Table 1 The distribution of major and minor liver resections between groups
18 ≤ BMI < 25 (kg/m2) 25 ≤ BMI < 30 (kg/m2) BMI ≥ 30 (kg/m2)
Major resections (n = 72) 35 26 11
Minor resections (n = 106) 51 36 19
Total (n = 178) 86 62 30
P0066L
A TRANSLATIONAL AND COMPARATIVE 
OVERVIEW OF ANIMAL MODELS FOR 
HEPATIC STEATOSIS
A. Schigt, M. Heger, H. Marsman and T. van Gulik
Academic Medical Center, Amsterdam, Netherlands
Background: Hepatic steatosis is characterized by exces-
sive triglyceride accumulation in the liver and might progress 
from simple steatosis to non-alcoholic steatohepatitis 
(NASH) and eventually to fi brosis, cirrhosis, and hepatocel-
lular carcinoma. It is associated with obesity and, because of 
the obesity epidemic, a higher incidence of hepatic steatosis 
is expected. Clinically representative animal models are 
imperative in conducting mechanistic and interventional 
investigations. The diet models used in this particular fi eld 
all have a different clinically relevant degree of representa-
tion. The aim of this study was to defi ne the most clinically 
representative diet model with respect to steatosis in obese 
patients.
Methods: A review of all relevant publications over the past 
10 years was conducted in Pubmed (rats, diet models, and 
steatosis) and the most frequently used models were com-
pared with respect to the following parameters: species, aim 
of study, dietary period, delta weight, calorie intake, diet 
composition, histological outcomes, hepatic function, lipido-
mics, and intrahepatic proteomic/genomic/metabolomic 
profi les.
Results: Preliminary results indicate that high fat (HF) 
diets, methionine-choline-defi cient (MCD) diets, and cho-
line-defi cient (CD) diets are used most frequently. Most of 
the models have been used to investigate therapeutic inter-
ventions, pathogenesis, or the model itself. Sprague-Dawley 
(SD) rats and Wistar rats are the most frequently used 
species. SDs have been used almost 3 times more than 
Wistars in HF diets, whereas Wistars have been used almost 
5 times more in MCD and CD diets. Steatosis induction 
period is signifi cantly higher in HF diets compared to MCD 
and CD diets. Comparison between as well as within diets 
indicate differences in histological steatosis degree, hepatic 
function, lipid profi les, protein and gene expression, and 
metabolomic parameters.
Conclusion: Experimental diet models used for research in 
the fi eld of human steatosis differ extensively and standard-
ization of investigational models is recommended.
P0067L
QUALITY OF LIFE OF PATIENTS WITH 
LIVER METASTASES COLORECTAL 
CANCER
V. Borrego-Estella, J. Montero-Martin and A. Serrablo
Miguel Servet University Hospital, Zaragoza, Spain
Introdution: Colorectal cancer (CRC) is third most fre-
quent in men in developed countries and second among 
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women, with approximately one million new cases per year 
throughout the world (550,000 men and 470,000 women), 
representing 14.6% and 15.2% respectively, of all malignant 
tumors diagnosed. Although much is known about the epi-
demiology, prognostic factors and treatment of CLM, nothing 
is known about the impact that surgery of liver metastases 
from colorectal cancer has on the QoL of these patients. 
Nevertheless, the most widely used version of these indica-
tors is the SF-36, which has a reduced version with only 12 
items and which has recently been validated for the Spanish 
population, but we used the SF-36 because is still the most 
widespread instrument.
Aim: To assess the quality of life of patients with liver 
metastases from colorectal cancer, before and 4 weeks after 
surgery.
Methods: From September 2008 to March 2009 we per-
formed a study of prospective cohorts by means of a con-
secutive sampling of patients undergoing liver resection for 
colorectal metastases (n = 30) and a positive control group 
(n = 30) formed by accompanying persons (relatives of the 
patients). Both groups fi lled in SF-36 questionnaires before 
the intervention and at 4 weeks after surgery. The groups 
were compared before and after treatment, using Student’s t 
test and a comparison of means in paired samples (paired t 
tests). We also calculated the effect of the intervention (effect 
size). ANOVA and Chi-squared tests were used to determine 
the modulating factors of the impact on quality of life.
Results: The mean age of our patients was 66.57 ± 10.85 
years. The proportion of men with respect to women was 
almost double, (63.3 vs. 36.7%). Regarding the location of 
the primary CRC, the primary location in the colon was 
76.7% vs. 23.3% with a rectal location. At the start, 36.7% 
of patients were not resectable. Before treatment the patients 
had a better quality of life in all dimensions than after treat-
ment and never attained that of the accompanying persons, 
either before or after treatment. The perception of pain was 
greater in the men but these showed a better mental wellbe-
ing with respect to the women. The main effect of the inter-
vention on the quality of life was perceived in the pain, 
mental and social dimensions. (Table 1)
Conclusions: Patients with liver metastases colorectal 
cancer the diagnosis and surgical treatment causes a decrease 
in their quality of life, above all in pain, mental and social 
SF-36 dimensions.
Table 1 Comparison of the QoL of patients and accompanying persons before and after surgery
Total Score 
among 
dimensions of 
the SF-36 health 
questionnaire
Patients 
pre-treatment 
score
n = 30
Accompanyng 
persons 
pre-treatment 
score
n = 30
Comparison of 
patients and 
accompanying 
persons before 
treatment 
(p-value)
Patients 
post-treatment 
score
n = 30
Accompanyng 
persons 
post-treatment 
score
n = 30
Comparison of 
patients and 
accompanying 
persons after 
treatment 
(p-value)
PHYSICAL 55.54 ± 24.66 66.32 ± 27.62 −10.78 (p = 0.12) 48.48 ± 22.42 66.44 ± 27.43 −17.99 (p < 0.01)
ROLE 0 75.55 ± 41.28 −75.55 (p < 0.00) 0 67.22 ± 39.99 −67.22 (p < 0.00)
PAIN 47.92 ± 18.59 56.67 ± 27.41 −8.75 (p = 0.15) 22.50 ± 15.18 56.67 ± 27.41 −34.17 (p < 0.00)
HEALTH 22.11 ± 5.46 42.05 ± 11.40 −19.94 (p < 0.00) 18.61 ± 5.38 41.22 ± 11.74 −22.61 (p < 0.00)
VITALITY 41.05 ± 5.65 44.11 ± 15.44 −3.06 (p = 0.32) 38.77 ± 5.25 41.50 ± 12.94 −2.72 (p = 0.29)
SOCIAL 51.25 ± 13.27 57.08 ± 25.57 −5.83 (p = 0.27) 41.25 ± 13.19 48.75 ± 21.11 −7.50 (p = 0.10)
EMOTIONAL 63.89 ± 41.07 19.44 ± 29.06 44.44 (p < 0.00) 49.44 ± 35.69 15.56 ± 23.95 33.89 (p < 0.00)
MENTAL 45.50 ± 3.41 40.63 ± 11.95 4.86 (p = 0.04) 42.10 ± 5.48 40.73 ± 10.15 1.37 (p = 0.52)
P0068L
THE P53, KI-67 AND NEW STEM CELLS 
CD44, CD133 AND CD166 MARKERS. 
‘CAN THEY BE CONSIDERED 
PROGNOSTIC FACTORS IN PATIENTS 
WITH LIVER COLORECTAL 
METASTASES?’
V. Borrego-Estella, C. Hördnler-Argarate and A. Serrablo
Miguel Servet University Hospital, Zaragoza, Spain
Introduction: The contribution of pathology concerning 
colorectal liver metastases cancer analysis has traditionally 
been to quantify the metastases number in order to correlate 
with radiological fi ndings, and to measure the surgical resec-
tion margin end in order to certify a distance equal or supe-
rior to 10 mm. considered optimal for oncology resection. 
But this approach is reductionist; the pathologist can provide 
more information both with the morphology and conven-
tional histology and with immunohistochemical techniques 
and molecular pathology, which can assist the treatment and 
prognosis.
Aim: To identify immunohistochemical markers p53, Ki-67 
as well as CD133, CD166 and CD44 markers in the stem 
cell, and also to estimate which of these markers are present 
or not and, if they are, their frequency in patients with 
colorectal liver metastases (MHCCR).
Material and methods: Retrospective data of 100 consecu-
tive patients (1-year minimum follow-up) who underwent 
any hepatic resection (HR 127) by MHCCR in HPB Surgical 
Unit and Multidisciplinary Team in tertiary hospital from 
January 2005 until April 2009. Immunohistochemical analy-
sis by using the tissue microarray technique (TMA or tissue 
microarrays), which allows simultaneous study of different 
immunohistochemical (molecular) markers and simultane-
ous monitoring and evaluation of large numbers of tumor 
samples in a single experiment, thus ensuring uniformity of 
techniques (histological, immunohistochemical and hybrid-
ization in situ (FISH)). We conducted three tissue microar-
rays, which consisted of 60–90 tumor fragments from the 
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most infi ltrating and representative areas of tumor. Through 
TMA, eosin haematoxylin staining techniques, which is a 
direct method, and, subsequently, immunohistochemical 
staining techniques appropriate for each of the markers iden-
tifi ed in our study (p-53, Ki-67, CD133-CD133/1-
AC133, CD44-EpCAMhigh-CD44+ and CD166-EpCA
Mhigh-CD166+). Correspondingly, the study has identifi ed 
signifi cant staining of each marker in the core (p-53 and 
Ki-67) in the cytoplasm (CD166) and the cell membrane 
staining (CD44 and CD166 CD133). DAKO automated 
staining system, which permits objective control of the tech-
nique and avoids random variations.
Results: Kaplan-Meier 1-3-5-year survival curves after 
hepatectomy: 92-48-30%, and 1-3-5-year disease-free sur-
vival rate after hepatectomy: 85-42-24%. The over-5-year 
survival rate in patients with high Ki-67 index and in those 
with a high mitotic index (mitosis number/mm.2 >10), which 
is another form of measuring the tumor proliferation index. 
58.7% of high Ki-67 index (threshold value >10%) showed 
a relation with mitosis number/mm.2 >10 (p = 0.023), 
whereas only 26.7% of low Ki-67 index (threshold value 
<10%) did, having been stated that both are good markers of 
cell proliferation.
Conclusions: Both p53 and Ki-67 indexes were not signifi -
cant prognostic factors, but expressed that patients with 
HCM have a more regulated cell cycle (low p53 index and 
low ki-67 index) and live longer. CD133 marker positivity 
implied having a lower index of tumor activity, and therefore 
stem-cell-rich carcinomas are made up of more undifferenti-
ated and immature cells than the ones that do not have a large 
number of stem cells. Patients with tumors containing 
CD44+ had higher survival rates that patients with tumors 
poor in CD44, with a difference of 15% at 5 years. The 
results that we obtained for the CD44 marker contradicts the 
theories that assume that the more stem cells which are 
present in the tumor, the worse survival rate. Increased 
5-year survival rate in those patients with tumors poor in 
CD133 and CD166 stem cell markers.
P0069L
MINIMALLY-INVASIVE SURGICAL 
TREATMENT FOR METASTATIC 
MERKEL CELL CARCINOMA TO THE 
LIVER AND ADRENAL GLAND: A CASE 
REPORT
J. Byrd, R. Swan, K. Lau, D. Sindram, K. Kercher, 
D. Iannitti and J. Martinie
Carolinas Medical Center, Charlotte, NC, United States
Introduction: Merkel cell carcinoma (MCC) is a rare and 
aggressive neuroendocrine skin cancer. Stage at presentation 
dictates prognosis, and one-third of patients have regional 
lymph node involvement (stage III) or distant metastasis 
(stage IV) at presentation. Metastasis occurs during the 
disease course in 75% to 83% of patients. Wide local exci-
sion (WLE) of skin lesions with sentinel lymph node biopsy 
(SLNB) is standard treatment; however, surgical treatment 
of metastatic lesions is not currently standard care due to the 
aggressive nature of the disease. We present a patient treated 
with WLE/SLNB for a MCC of the shoulder, followed by 
laparoscopic microwave ablation (MWA) of a liver metasta-
sis, followed later still by laparoscopic resection of an 
adrenal metastasis.
Methods: Review of the patients’ medical record, imaging, 
and pathology specimens.
Results: A 78 year-old female underwent WLE/SLNB for a 
MCC of the shoulder in December 2005 followed by regional 
radiation subsequent to a non-diagnostic SLNB. Metastases 
to the right liver and a retrocaval lymph node were discov-
ered in 2007 and chemotherapy was initiated. The hepatic 
lesion initially regressed and was non-apparent on PET scan, 
but recurred in 2008 and progressed to 5 cm in diameter 
despite additional chemotherapy. Laparoscopic MWA was 
performed, using a 3 antennae cluster at 45W to produce four 
overlapping ablations, and the retrocaval lymph node was 
resected. There were no adverse events and follow-up 
imaging confi rmed complete ablation. Eighteen months later, 
PET scan revealed a metastatic lesion in the left adrenal 
gland and she underwent a laparoscopic adrenalectomy in 
December 2009 without complication. There has been no 
recurrence of liver metastasis during 26 months of follow-up, 
and the patient remains free of disease since the 
adrenalectomy.
Conclusion: We present a patient with metastatic MCC to 
the liver and adrenal gland treated with systemic chemo-
therapy followed by laparoscopic MWA and adrenalectomy 
with no evidence of further disease. Minimally-invasive sur-
gical resection or ablation may offer a viable treatment 
option in select patients with metastatic MCC.
P0070L
FIBROLAMELLAR CARCINOMA OF THE 
LIVER: A CLINICAL REVIEW
M. Soloviy
1Lviv National University of Medicine, Lviv, Ukraine; 
2Lviv Regional Veterans Hospital, Lviv, Ukraine
Introduction: Fibrolamellar carcinoma (FLC) is a malig-
nant hepatic tumor that differs from hepatocellular carci-
noma (HCC) in some pathological and clinical features.
Aim: of the study was to investigate most commonly 
described pathological and clinical characteristics of the FLC 
of the liver.
Methods: Medline search for the words FLC was per-
formed. 151 abstracts and 23 full papers were identifi ed and 
studied for the period from 2000 to 2010.
Results: FLC is most commonly described as a rare disease 
of adolescents and young adults without gender predomi-
nance. Etiology is unknown and typical HCC risk factors 
such as viral hepatitis or cirrhosis are absent.
Typically FLC patients present with nonspecifi c abdomi-
nal pain, discomfort, malaise and weight loss or even can be 
asymptomatic and have their tumors revealed incidentally. 
The tumors are usually large, heterogenous lesions with well 
defi ned margins and areas of hypervascularity on CT scan. 
A triad of histological features is commonly used for diag-
nosis – tumor cells with eosinophilic cytoplasm, lamellar 
fi brosis and large vesiculated nucleoli.
Many studies report FLC to be less aggressive with better 
5-year survival reaching up to 76% in resected cases com-
pared to conventional HCC. One of the major explanation 
for this can be the absence of cirrhosis in FLC patients. 
However, several other studies state FLC to be aggressive 
tumor with 20% to 45% 5-year survival in resected cases, 
decreasing to 15% in patients with metastatic disease.
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Conclusions: FLC differs from HCC in demographics, con-
dition of the liver and prognosis. Although many studies 
emphasize the better survival in FLC compared to HCC, 
these results can be similar to that in HCC without cirrhosis, 
thus referring FLC to be though an aggressive neoplasms.
P0071L
CT DETECTS COLORECTAL LIVER 
METASTASES EARLIER AND IMPROVE 
RESECTION RATES
B. Hjelmeland1, K. Storli2, T. Bru3, I. Nesvik3, G. E. Eide1 
and K. Søndenaa2,4
1Haukeland University Hospital, Bergen, Norway; 
2Haraldsplass Deaconal Hospital, Bergen, Norway; 
3Stavanger University Hospital, Stavanger, Norway; 
4University of Bergen, Bergen, Norway
Introduction: We have examined patients diagnosed with 
liver metastases in community based patient populations to 
examine if extra diagnostic awareness and use of CT screen-
ing and surveillance, will increase the number of treated 
patients above the historic 3% margin.
Method: Three cohorts from two hospitals were examined: 
Rectal cancer (RC) patients treated between 1986 and 1992 
at hospital A, colon cancer (CC) patients treated in 2000 at 
hospitals A and B, and a cohort consisting of CC patients 
treated at hospital B between 2007 and 2009. Ultrasonography 
and chest x-ray have been part of work-up and follow-up for 
patients with colorectal cancer in our country. Follow-up in 
all cohorts was usually been systematic with 3–6 months 
intervals until 5 years postoperative. In Hospital B, CT was 
introduced as a routine screening and surveillance method in 
2007.
Results: RC was resected in 157 patients between 1986–92 
at hospital A. Hepatic metastases were seen in 24.2% of these 
patients. 11.5% were synchronous and 12.7% metachronous. 
Seven patients (18.4%) with hepatic metastases (4.5% of all) 
were operated. In the 2000 cohort of 169 resected patients at 
hospital A & B, 5.9% developed liver metastases during a 
six-year follow-up (F-U). Of these, 3.6% were synchronous 
and 2.4% were metachronous. 10% of the patients with liver 
metastases (0.6% of all) underwent liver resection. In the 
2007–2009 cohort at hospital B, 235 CC resections were 
carried out. 13.8% have developed liver metastases, synchro-
nous metastases in 12.6% of patients, and metachronous in 
1.2% with a mean F-U of 33 months (9–45). So far, 34.3% 
of patients with liver metastases (4.7% of all) have had liver 
resection.
Discussion: The detection of patients with CRC liver metas-
tases remained steady but the resection rate increased to the 
present day. CT may diagnose liver metastases earlier in the 
disease and thus assure an optimal time for intervention. So 
far it is uncertain if this leads to increased survival of patients 
with metastases.
P0072L
THE INFLUENCE OF PREOPERATIVE 
CHEMOTHERAPY ON THE INTRA- AND 
POSTOPERATIVE COURSE OF LIVER 
RESECTION FOR COLORECTAL 
CANCER METASTASES
L. Spelt, L. Hermansson, B. Tingstedt and R. Andersson
Dept of Surgery, Clinical Sciences Lund, Lund University, 
Lund, Sweden
Objective: To compare perioperative course and long-term 
mortality after liver resection for colorectal cancer (CRC) 
metastases between patients who were and who were not 
treated with preoperative chemotherapy.
Design: Retrospective cohort study.
Setting and participants: Patients who had undergone liver 
resection for CRC metastases at Lund University Hospital 
between January 1994 and December 2009. A group of 99 
patients who were treated with preoperative chemotherapy 
(group A) was compared with a group of 155 patients who 
were not (group B).
Main outcome measures: Intraoperative bleeding, compli-
cations and its staging according to Clavien’s classifi cation 
system, duration of postoperative hospital stay and mortality 
after 30 days and 1, 2 and 5 years. Statistical calculations 
were done using Pearson Chi-square, Fisher’s exact test and 
Mann-Whitney U test.
Results: The difference in mean intraoperative bleeding was 
not statistically signifi cant. Complications occurred in 63.6% 
in group A, comparable to the 66.5% in group B and the 
distribution amongst the Clavien’s classes was alike. There 
was a signifi cant difference (p < 0.05) in the occurrence of 
infection at the site of operation, which occurred in 10.1% 
and 3.2% in group A and B, respectively. The mean duration 
of hospital stay was comparable, being 9.8 and 10.1 days. 
Thirty days and 1 year mortality were 0% and 6.4% in group 
A, similar to the 1.3% and 8.6% seen in group B. Group A 
had a 31.3% and 82.5% mortality after 2 and 5 years, whereas 
this was 18.1% and 64.4% in group B (p < 0.05).
Conclusion: There were no signifi cant differences in peri-
operative outcome and short-term survival when comparing 
CRC patients with our without chemotherapy prior to liver 
resection, suggesting that preoperative chemotherapy does 
not negatively infl uence the perioperative course of liver 
resections. The difference in 2- and 5-year mortality presum-
ably can be attributed to other factors, like tumour location 
and need of downstaging therapy etc, infl uencing the indica-
tion for preoperative chemotherapy. Consequently, this study 
supports the safety of using preoperative chemotherapy 
before liver resection for CRC metastases if ‘downstaging’ 
is considered indicated.
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P0073L
A MULTICENTER TRIAL OF INVASIVE 
TREATMENT MODALITIES FOR 
HEPATOCELLULAR ADENOMAS: 
SELECTIVE ARTERIAL EMBOLISATION 
VERSUS RESECTION (SILVER TRIAL)
J. Stoot, M. De Jong, R-J. Coelen, R. Van Dam and 
K. Dejong
1Maastricht University Medical Centre, maastricht, 
Netherlands; 2Nutrim School for Nutrition, Toxicology and 
Metabolism, maastricht, Netherlands; 3Orbis Medical 
Centre, Sittard, Netherlands
Introduction: Hepatocellular adenomas (HCAs) are rare 
benign liver tumours mostly occurring in young females, 
particularly those using oral contraceptives. Due to the risk 
of rupture and malignant transformation, resection is 
suggested for HCAs > 5 cm. Recent studies showed that 
selective arterial embolisation of haemorrhaging and non-
haemorrhaging HCAs was effective as acute treatment but 
also decreased the size of the HCAs.
Method: The aim of the current study is to test the hypoth-
esis that minimally invasive embolisation of non-ruptured 
HCAs > 5 cm leads to a reduction of the post-treatment 
morbidity and mortality (i.e. any event with Clavien Grade 
≥3). Therefore, we designed a randomised controlled trial 
with a two-arm experimental design. Patients eligible for 
resection of the HCA will be randomised to either resection 
or selective arterial embolisation, therefore the two arms 
include the following groups: patients who are randomised 
to selective arterial embolisation (I) and patients who are 
randomised to surgical resection of the HCA (II).
The primary endpoint is the proportion of patients with 
treatment-related morbidity and mortality within 90 days 
after treatment. Secondary outcome parameters are func-
tional recovery, quality of life and post-treatment body-
image changes as well as direct and indirect medical costs. 
Moreover, patients who are not eligible for participating in 
the current trial will be enlisted and subsequently analysed 
in a supplementary observational study.
Discussion: This trial is a randomised controlled multi-
center trial that will provide evidence on the merits of selec-
tive arterial embolisation of HCAs > 5 cm.
P0074L
SELECTION FOR RESECTION OF 
PATIENTS OLDER THAN 75 YEARS, 
WITH LIVER METASTASES FROM 
COLORECTAL CANCER AT A LIVER 
SURGERY UNIT
C. Sturesson, K. Huld-Haraldsdottir and R. Andersson
Clinical Sciences, Lund, Sweden
Background and aims: An increasing number of elderly 
patients will present with liver metastases from colorectal 
cancer. The purpose of the present study was to describe the 
selection process of elderly patients with colorectal liver 
metastases for resection in a specialist hepatic surgical unit 
and to analyse the results of resection in this patient 
category.
Patients and methods: All patients older than 75 years with 
colorectal liver metastases referred to our institution between 
2002 and 2008 were included in the study. A total of 49 
patients were reviewed. Reasons for not accepting patients 
for resection were recorded and survival with and without 
resection were estimated.
Results: Of referred patients 28 (57%) were ultimately 
resected, none presenting with extrahepatic disease. Reasons 
for turning down patients for resection included unresectable 
liver tumours (33%) and concomitant extrahepatic disease 
(57%). Only two patients were not considered for resection 
due to reasons other than extensive colorectal metastatic 
disease. Median survival after diagnosis of liver metastases 
was 15 months without resection and more than 30 months 
with resection. Mortality and morbidity after resection was 
1 (4%) and 11 patients (39%), respectively
Conclusion: For elderly patients referred to our institution 
the extent of tumour burden and not general health deter-
mined operability and survival.
P0075L
THE ROLE OF LAPAROSCOPIC 
SURGERY IN TWO-STAGE 
HEPATECTOMY FOR BILOBAR 
COLORECTAL LIVER METASTASES
M. A. Hilal, F. Di Fabio, R. N. Whistance, S. Syed, 
N. W. Pearce, J. N. Primrose and P. Swan
Southampton University Hospitals NHS Trust, 
Southampton, Hampshire, United Kingdom
Background: The role of laparoscopy in the aggressive 
management of patients with bilateral colorectal liver metas-
tases (CRLMs) has not yet been investigated.
Methods: We reviewed a prospectively collected database 
of all patients undergoing two-stage hepatectomy at our insti-
tution between April 2007 and November 2009.
Results: Seven patients underwent two-stage hepatectomy 
for bilobar CRLMs (male n = 5, median age 64). The fi rst 
stage consisted of laparoscopic clearance of the left lobe with 
no postoperative morbidity and mortality. Six patients under-
went portal vein embolization. The median interval between 
fi rst and second stage hepatic resections was 89 days (range 
36–123 days). Second-stage hepatectomy with right lobar 
clearance (open n = 5, laparoscopic n = 2) was associated 
with no mortality and an operative morbidity rate of (43%). 
Complications included intra-abdominal collection (n = 2), 
and bleeding requiring re-operation (n = 1). Two patients 
(29%) died from disease recurrence. The fi rst death occurred 
16.5 months from diagnosis (12 months from second stage 
surgery) and was due to widespread extrahepatic metastases. 
The second fatal case survived for 30.5 months after diagno-
sis (22 months from second stage surgery) until death from 
intrahepatic recurrence. Of the remaining fi ve patients, four 
are disease-free at a median follow-up of 11.5 months (range 
8.5–15 months).
Conclusions: The well recognized advantages of laparos-
copy (e.g.: less intrabdominal adhesions and faster recovery) 
may play a favourable role in the aggressive management of 
patients with bilobar CRLMs who are candidates for a two-
stage resection. The fi rst-stage laparoscopic clearance of the 
left lobe should progressively become the ‘gold standard’.
98 Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
P0076L
SURGICAL MANAGEMENT OF BENIGN 
AND INDETERMINATE HEPATIC 
LESIONS IN THE ERA OF 
LAPAROSCOPIC LIVER SURGERY
M. A. Hilal, F. Di Fabio, M. J. Teng, J. N. Primrose, 
N. W. Pearce and P. Swan
Southampton University Hospitals NHS Trust, 
Southampton, Hampshire, United Kingdom
Background: The rapid expansion of laparoscopy for the 
surgical treatment of benign liver lesions has raised concerns 
regarding the risk of widening surgical indications and com-
promising safety, particularly when major hepatectomy are 
required. Large single-centre series focusing on laparoscopic 
management of benign liver lesions are still sporadic.
Methods: We reviewed a prospectively collected database 
of patients undergoing laparoscopic liver resection (LLR) for 
benign liver lesions. Prior to surgery, all cases were discussed 
at an open multidisciplinary team meeting with surgeons, 
pathologists, oncologists, gastroenterologists and 
radiologists.
Results: Forty-six patients underwent 50 LLRs for benign 
disease. Indications for surgery were: symptomatic benign 
lesions, preoperative diagnosis of adenoma or cystadenoma, 
and lesions with an indeterminate diagnosis. The preopera-
tive diagnosis was uncertain in 11 cases. Of these, histologi-
cal diagnosis was hepatocellular carcinoma in one (9%) and 
benign lesion in 10 patients (91%). Thirteen patients (28%) 
required major hepatectomy. One (2%) conversion occurred 
due to bleeding. Three patients (7%) developed postopera-
tive complications. Mortality was nil. The median postopera-
tive hospital stay following major and minor hepatectomy 
was 4 and 3 days respectively.
Conclusion: The laparoscopic approach represents a feasi-
ble and safe option for the management of benign and inde-
terminate liver lesions, even when major hepatectomy is 
required. This surgery should be only performed in special-
ized centres to ensure safety and strict adherence to orthodox 
surgical indication.
P0077L
ASSESSMENT OF ONCOLOGICAL 
EFFICIENCY OF LAPAROSCOPIC LIVER 
RESECTION FOR MALIGNANT DISEASE: 
SHORT- AND MID-TERM RESULTS
M. A. Hilal, F. Di Fabio, S. Cawich, M. Hamdan, A. Scio, 
N. W. Pearce and P. Swan
Southampton University Hospitals NHS Trust, 
Southampton, Hampshire, United Kingdom
Introduction: Laparoscopic liver resection is now gaining 
popularity. However, doubts regarding oncological effi -
ciency when dealing with malignant disease have been 
raised. Data from large single-centre series including major 
liver resections are required to provide adequate evidence.
Methods: We reviewed a prospectively collected database 
of 128 patients undergoing 133 pure laparoscopic liver 
resections for malignant disease. Two patients had 2-stage 
laparoscopic resections for bilobar colorectal liver metasta-
ses. Three patients had redo liver resection for recurrent 
colorectal liver metastases. Resection margins were classi-
fi ed into R0/R1 (microscopically more/less than 1 mm of 
clear margin respectively). Medium-term survival was ana-
lyzed in patients with colorectal liver metastases.
Results: Surgical indications were: colorectal liver metasta-
sis (n = 83), hepatocelluar carcinoma (n = 19), neuroendo-
crine tumour (n = 17), non-colorectal liver metastasis (n = 
11), lymphoma (n = 2), cholangiocarcinoma (n = 1). Forty-
one (31%) major hepatectomies were performed. Median 
operative time was 210 min (30–480 min). Median 
postoperative length of stay was 4 days (1–15 days) with a 
median of 1 day in the intensive care unit (0–10 days). 
Eleven cases (8%) were converted to open surgery. 
Fifteen patients (11%) developed signifi cant postoperative 
complications. One patient died in-hospital (0.7%). In the 
neuroendocrine group 6/17 patients (35%) had R1 resection. 
The majority of these underwent debulking/cyto-reductive 
surgery. R0 resection was obtained in the remaining 112/116 
resections (97%). No port site metastasis or peritoneal 
seeding was observed. Median follow-up for patients with 
colorectal liver metastases was 16 months (range 1–76 
months) and median overall survival has not yet been 
reached. Thirteen patients had recurrence of disease; only 
one of these was in proximity to the resection margins. We 
recorded a 72% 2-year survival.
Conclusion: Our data supports the safety and oncological 
effi ciency of pure laparoscopic liver resection for malig-
nancy. The minimally-invasive approach may be an effective 
alternative to open resection in selected cases. Extensive 
experience in hepatic and laparoscopic surgery is required.
P0078L
SAFELY EXTENDING THE CENTRAL 
HEPATECTOMY: THE ART OF SEGMENT 
SIX PRESERVATION
T-J. Tan1,2, K. Jawade1, C-Y. Lin3, C-Y. Liu1, C-L. Chen1 
and C-C. Wang1
1Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 
Taiwan; 2Khoo Teck Puat Hospital, Singapore, Singapore; 
3Ping Tung Christian Hospital, Ping Tung, Taiwan
Background and objective: Preservation of the venous 
outfl ow of Segment 6 (S6), can overcome the limitation of 
an insuffi cient future liver remnant (FLR) with traditional 
extended hepatectomies for large centrally located hepato-
cellular carcinomas (HCC) involving the hepatic veins.
Case presentations: We describe our approach to planning 
a S6 preserving procedure utilizing multimodality down-
staging followed by salvage surgery, existing RIHV drainage 
when present and venous outfl ow reconstruction with a 
Gore-Tex tube graft.
Case 1: A 62 year-old male patient with hepatitis B related 
liver disease was evaluated for an 11 cm centrally located 
HCC involving segment 4, 5 and 8, encroaching the bifurca-
tion of the portal vein and left hepatic duct. The patient 
underwent down-staging Hepatic Intra-arterial Chemotherapy 
(HAIC) with a low fi xed dose infusion of Cisplatin 10 mg, 
5-FU 250 mg and Leucovorin for 2 months followed by 
external beam radiotherapy. After partial response, tumor 
volume decreased by 50% allowing clearance from critical 
structures. S6 preservation based on RIHV drainage allowed 
safe resection with an FLR of 51% SLV compared to 29% 
for a conventional extended right hepatectomy.
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Case 2: A 56 year-old male with HBV related liver disease 
was evaluated for a bulky HCC of segments 4/8 involving 
the RHV and MHV. An extended right hepatectomy would 
leave a FLR of 21% SLV, but preservation of the S6, based 
on a thick 7 mm RIHV would provide 44% SLV. 
Intraoperatively, there was marked congestion of the S6 
despite RIHV preservation. Outfl ow reconstruction of S6 
with an 8 mm ringed Gore-Tex graft from the transected 
distal RHV to the RHV-caval stump resulted in immediate 
resolution of the congestion. Currently both patients remain 
well and disease free at 12 and 24 months.
Conclusion: The use of down-staging chemo-radiotherapy 
and living donor transplantation techniques for the calcula-
tion of the FLR of non-adjacent segments and for hepatic 
venous reconstruction can allow preservation of suffi cient 
hepatocyte mass in S6 to tip the scales in favor of curative 
resection with a greater margin of safety.
P0079L
MULTIPLE BILOBAR LIVER 
METASTASES FROM COLORECTAL 
CANCER – DOES THE EXTENT OF 
LIVER RESECTION INFLUENCE ON 
OUTCOME?
B. Tingstedt, L. Spelt, L. Mölve, T. Andersson and 
R. Andersson
Dept of Surgery, Clinical Sciences Lund, Lund University, 
Lund, Sweden
Objective: To compare perioperative course and long-term 
mortality after liver resection for bilobar colorectal cancer 
(CRC) metastases between patients subjected to ‘extensive’ 
liver surgery, i.e. a hemihepatectomy plus minor resection on 
the other lobe, and ‘minimal’ surgery, i.e. segmentectomies 
and minimal resections in both liver lobes.
Setting and participants: Patients who had undergone 
bilobar primary liver resection for CRC metastases at Lund 
University Hospital January 1994-December 2009. A group 
of 41 patients who underwent ‘extensive’ surgery (group A) 
was compared with a group of 30 patients who underwent 
‘minimal’ surgery (group B).
Main outcome measures: Intraoperative bleeding, opera-
tion time, radicality of resection, complications and its 
staging according to Clavien’s classifi cation system, duration 
of postoperative hospital stay and mortality after 30 days, as 
well as after 1, 2 and 5 years. Statistical calculations were 
done using Pearson Chi-square, Fisher’s exact test and 
Mann-Whitney U test.
Results: The difference in mean intraoperative bleeding and 
the radicality of resection were not statistically signifi cant. 
Complications occurred in 82.9% in group A, comparable to 
the 70.0% in group B and the distribution amongst the 
Clavien’s classes was alike. There was a signifi cant differ-
ence (p < 0.05) in the operation time, which was 507.0 and 
444.1 minutes in groups A and B, respectively. The mean 
hospital stay was 11.0 days in group A and 9.1 days in group 
B (p < 0.05). Mortality after 30 days and 1, 2 and 5 years 
was similar in both groups, being 2.4%, 10.0%, 24.3% and 
71.4% in group A and 0%, 3.3%, 15.4% and 63.2% in group 
B.
Conclusion: There were no signifi cant differences in peri-
operative outcome and long-term survival when comparing 
CRC patients who underwent ‘extensive’ or ‘minimal’ resec-
tion for bilobar liver metastases, except for a difference in 
operation time and postoperative stay, in favour of ‘minimal’ 
resection. ‘Minimalising’ resection does not seem to infl u-
ence on radicality The possible benefi ts of shortening opera-
tion time and hospital stay, as well as sparing liver 
parenchyma, support minimal liver surgery in bilobar CRC 
liver metastases, when possible.
P0080L
NEW WORK-UP STRATEGY INCREASES 
THE NUMBER OF RADICAL 
RESECTIONS IN LIVER SURGERY
C. van Kessel, M. van Leeuwen, R. van Hillegersberg and 
Q. Molenaar
University Medical Centre Utrecht, Utrecht, Netherlands
Background: The number of resections for malignant focal 
liver lesions is increasing. Resection outcome is strongly 
associated with prognosis, with 5-year survival rates of 
40–50% and 0–30% for radical (R0) and irradical (R1/R2) 
resections respectively. R0 resection was achieved in 80% of 
patients in the University Medical Center Utrecht (2007–
2009). The aim of our study was to increase the number 
of radical resections by intensifying the pre-operative 
work-up.
Methods: Apart from the regular multidisciplinary oncol-
ogy meeting, an additional one-week-pre-operative expert-
meeting, was introduced in March 2009. The operating 
surgeon and a hepatobiliary radiologist attend this meeting 
and evaluate the following items in a standardized manner: 
1. adequacy of the imaging (maximum time-interval of 6 
weeks until surgery), 2. number and nature of lesions, 3. 
portal, arterial and venous vasculature with relation to the 
lesions, 4. extrahepatic disease and 5. surgical resection strat-
egy. Furthermore, results from the intra-operative ultrasound 
and pathology were recorded with standardized score forms 
(reference standard).
Results: Between March 2009 and September 2010, a total 
of 58 patients were evaluated during the expert-meeting. The 
mean time-interval between imaging and surgery was 23.5 
days. Patients were diagnosed with colorectal liver metasta-
ses (n = 54), hepatocellular carcinoma (n = 2) or melanoma 
metastases (n = 2). Sensitivity and specifi city for lesion 
detection and characterization were 81.4% and 57.4% on a 
per lesion basis. Surgery was cancelled in fi ve patients due 
to additional information on the extent of lesions (n = 2), 
presence of extrahepatic disease (n = 2) or change in diag-
nosis (n = 1). Major changes in resection strategy due to 
additional fi ndings occurred in 10/51 patients. Surgical 
outcome (n = 53) was as follows: radical resection n = 45 
(84.9%), irradical resection n = 6 (11.3%) and intra-operative 
irresectability n = 2 (3.8%).
Conclusion: Intensifying the pre-operative work-up of 
patients with focal liver malignancies appears to increase the 
number of radical resections and can prevent per-operative 
irresectability.
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P0081L
DO ADDITIONAL LIVER RESECTIONS 
TO LAPAROSCOPIC LEFT LATERAL 
LIVER RESECTION INFLUENCE ON 
SHORT-TERM OUTCOME?
O. Villanger1, I. P. Marangos2, A. Kazaryan2, B. Røsok1, 
A. Rosseland1, Ø. Mathisen1 and B. Edwin1,2
1Division of Surgery, Oslo University Hospital, 
Rikshospitalet, Oslo, Norway; 2The Interventional Centre, 
Oslo University Hospital, Rikshospitalet, Oslo, Norway
Background: Left lateral sectionectomy (LLS) is the easiest 
anatomical liver resection suitable for laparoscopic tech-
nique and has been our preferred method since 1998. We 
wanted to study if additional local liver resection or simul-
taneous local liver ablation would infl uence on our results.
Aim: To compare the results of LLS alone and LLS accom-
panied by additional local liver resection (combined group).
Material: From January 1999 to August 2010 there were 31 
left lateral sectionectomies and 22 combined procedures per-
formed laparoscopically. The median age was 66 years 
(23–88) in the LLS group and 62 years (41–84) in the com-
bined group. Median ASA score were 2 in both groups, with 
range 1–3 in the LLS group and 2–4 in the combined group. 
Our material includes 25 malign and 6 benign tumors in the 
LLS group, and only malign tumors in the combined group.
Results: No perioperative mortality occurred. The median 
operation time was 165 minutes (100–357) after LLS and 
205 minutes (95–452) in the combined group. The median 
intraoperative bleeding was 200 ml (0–200) in the LLS 
group compared to 500 ml (0–3300) in the combined group. 
We experienced one patient with postoperative complication 
(urine retention) in LLS group. In the combined group four 
patients experienced postoperative complications in form of 
atelektasis (1), pneumonia (1), bile leakage/abscecc (1) and 
bleeding which required relaparotomy (1). None of the pro-
cedures were converted to open surgery. The median postop-
erative stay in hospital was 3 days (1–12) after LLS and 4 
days (2–26) in patients with the combined procedures.
Conclusion: Laparoscopic LLS for lesions of the liver is safe 
and feasible in experienced hands. Laparoscopic LLS can also be 
safely done in combination with additional local liver resection
P0082L
WORLDWIDE ADOPTION OF 
LAPAROSCOPIC LIVER SURGERY AND 
FAST TRACK RECOVERY 
PROGRAMMES. AN ONLINE SURVEY TO 
SUPPORT THE INTERNATIONAL 
ORANGE II – RCT
E. M. Wong-Lun-Hing, R. M. van Dam, T. M. Lodewick, 
J. H. M. B. Stoot, M. H. A. Bemelmans, 
S. W. M. O. Damink and C. H. C. Dejong
Department of Surgery, Maastricht University Medical 
Center, Maastricht, Netherlands
Background: Fast track recovery programmes and laparo-
scopic techniques are increasingly adopted in the fi eld of 
liver surgery. There is debate about the necessity of perform-
ing an international multicentre RCT comparing open and 
laparoscopic liver surgery (the ORANGE II – Trial) before 
worldwide adoption of the laparoscopic approach.
Methods/design: A 19 question electronic survey was send 
out to 811 HPB-surgeons worldwide. The current experience 
in liver resection, laparoscopic liver surgery, fast track recov-
ery programmes, willingness to participate in the randomized 
controlled ORANGE-II trial/registry and opinions on the 
necessity of such a RCT were assessed.
Results: 260 surgeons completed the survey. A median 
number of 50 (5–560) open and 9.5 (1–80) laparoscopic liver 
resections per surgical unit were performed annually. 205 
(78.8%) surgeons performed laparoscopic liver surgery as part 
of their daily practice with a median number of 13 (2–100) 
laparoscopic resections annually. 1 out of 4 (26.9%) surgical 
units has experience with an enhanced recovery (ERAS) or 
fast-track perioperative care programme in liver surgery. 
59.4% of all liver surgeons consider a RCT essential, 49.1% 
consider both a RCT and prospective multicentre registry nec-
essary before laparoscopic liver surgery can be further adopted 
worldwide. 82.9% of all HPB surgeons consider participation 
in the ORANGE II – trial if their surgical unit performs both 
open and laparoscopic left lateral sectionectomy. 82.8% would 
randomize between open and laparoscopic resection.
Conclusion: Laparoscopic liver resection is gradually being 
adopted worldwide and many centres perform liver surgery in 
absence of an enhanced recovery programme. Nearly 50% of 
responding liver surgeons consider a RCT and prospective 
multicentre registry necessary for further adoption of laparo-
scopic techniques in liver surgery. Liver surgeons are willing 
to randomize and to participate in the ORANGE II interna-
tional multicentre RCT comparing open and laparoscopic left 
lateral hepatic sectionectomy within an ERAS-programme.
P0083L
RESECTION OF HEPATOCELLULAR 
CARCINOMA ARISING IN NON-
CIRRHOTIC/NON-FIBROTIC LIVER
V. Yip, S. Fenwick, H. Malik, P. Ghaneh, G. Sarno, A. Wu, 
M. Terlizzo and G. Poston
University Hospital Aintree, Liverpool, United Kingdom
Background: HCC is uncommon in Western countries. It is 
even more uncommon in non-cirrhotic livers. The purpose 
of this study was to evaluate outcomes and prognostic factors 
after hepatectomy in our centre.
Material and methods: Between 1997 and 2008, patients 
undergoing hepatectomy for HCC were identifi ed from a 
prospectively maintained database. Pre-operative biochemi-
cal and haematological factors, intra-operative and post- 
operative clinical details, and tumour pathological fi ndings, 
were analysed against overall and disease-free survival.
Results: 47 consecutive patients underwent hepatectomy for 
HCC during the study period. Of the 43 eligible patients, median 
survival was 30 months (IQR: 10–44), with 3- and 5-year survival 
rates post resection of 46% and 33% respectively. After a median 
follow-up of 21 months (IQR: 5–38), 51% (n = 22/43) had recur-
rent disease. In univariate analysis, aspartate aminotransferase 
(AST) [p < 0.01 (survival), p < 0.02 (recurrent)] levels were 
factors affecting both survival and tumour recurrence, whereas 
pre-operative bilirubin (p < 0.01), the percentage of neutrophil 
count (p = 0.04) and neutrophil/lymphocyte ratio (p = 0.04) were 
factors related to long term survival. Social deprivation, type of 
hepatectomy, tumour size and histopathological characteristics 
were not signifi cant prognostic factors for survival or disease 
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recurrence. There was a non-signifi cant trend towards poorer 
survival for patients with poorly differentiated tumours (p = 0.07) 
compared to well and moderately differentiated tumours.
On multi-variate analysis, pre-operative AST (p = 0.04) 
and neutrophil counts (p = 0.03) were independent predictors 
for long term outcome.
Conclusions: Surgical resection offers the best chance of 
potential cure for HCC arising from non-cirrhotic livers. 
Pre-operative liver function has a role in contributing to the 
long term outcome of patients after HCC resection.
P0084L
ASTAXANTHIN, POWERFUL 
ANTIOXIDANT HELPS LIVER OF MICE 
TO OVERCOME THE ACUTE HEPATIC 
INJURY INDUCED BY TETRACHLORIDE 
CARBON
I. J. Yun
Konkuk University Hospital, Seoul, Korea
Introduction: Liver fi brosis is one of the biggest problems 
in human disease. Since now proper treatment for this disease 
is insuffi cient and ineffective. Liver fi brosis is induced from 
recurrent liver damage including viral infections, drugs and 
alcohol and on the way of injury oxidative stress induced by 
oxygen free radical seems to be the main pathway to fi brosis. 
So antioxidant treatment for liver injury can be the protection 
from process of liver fi brosis and many trials have been done. 
However, good candidates for drug for liver fi brosis are not 
yet discovered.
Material and methods: We have examined the effect of 
Astaxanthin which is the derivative of Carotenoids and 
potent antioxidant itself to the acute liver damage induced 
by tetrachloride on the mice. We have compared it with the 
non-treatment control group and other antioxidant groups 
(silymarin group, Vitamin E group).
Results: There are no statistically signifi cant differences in 
liver function test among groups. In AST and ALT, relatively 
low levels are showed in pure astaxanthin group, but no 
signifi cance. In MDA levels, liver shows no differences 
among groups even in control group. However, in lung 
MDA, all the antioxidant groups show lower levels than 
those of control group. In pathologic fi ndings, astaxanthin 
groups show relatively less invasion of necrosis.
Conclusions: Protective effect for the acute liver injury of 
Haematococcus extracts is not confi rmed. Also other antioxi-
dant groups could not show the hepatoprotective effect. 
However Astaxanthin groups show the possibility to have 
hepatoprotective effect concerning to results of ALT levels 
and pathologic fi ndings.
P0085L
HEPATIC RESECTION FOR HUGE 
(>15 CM) MULTINODULAR HCC WITH 
MACROVASCULAR INVASION
Y. Zeng1,5, J. Huang2,4, L. Yan3,5, H. Wu4,5 and Z. Chen5
1West China Hospital, Chengdu, China; 
2Sichuan University, Chengdu, China
Patients with huge (>15 cm), multinodular lesions and mac-
rovascular invasion (advanced-stage HCC patients) are not 
recommended for surgical resection because of high opera-
tive mortality, recurrence rate and dismal survival benefi t. A 
retrospective study of a single centre’s 10-year-experience 
was carried out for total 1425 patients (1245 met EASL/
AASLD resection criteria, EA group; 116 surgical treated 
advanced-stage HCC patients, SA group; 64 advanced- stage 
HCC patients received non-surgical treatments, NSA group). 
The 1-, 3-, 5-year survival rates were 79%, 71% and 61%, 
71%, 23% and 11%, and 23%, 0% and 0% for the 3 groups 
above respectively.
The SA group had a poorer survival than the EA group but 
a better one than the NSA group (p < 0.001, P < 0.001). And 
the 1-, 3-, 5-year recurrence-free survival rates were 61%, 
53% and 39% for the EA group and 48%, 16% and 4% for 
the SA group, respectively. Conclusion: Hepatic resection 
may still be suitable for the HCC patients with huge (>15 cm), 
multinodular and macrovascular invasion in selected cases. 
Advanced-stage HCC patients without liver cirrhosis and 
with a tumor-free resection margin could enjoy longer sur-
vival and lower recurrence. Pre-or/and post operative TACE 
represents no survival benefi ts.
P0086L
SURGICAL MANAGEMENT FOR GIANT 
LIVER HEMANGIOMA (>20 CM)
Y. Zeng, H. Jiang, Z. Chen, P. Prasoon and H. Wu
1West China Hospital, Chengdu, China; 
2Sichuan University, Chengdu, China
Aim: To investigate the primary experience of management 
for giant liver hemangioma larger than 20 cm.
Methods: Records of patients referred for evaluation of 
radiologically and/or histopathologically proven giant liver 
hemangiomas, from January 2007 to March 2010, were ret-
rospectively analyzed. Reason for referral, results of imaging 
studies, preoperative treatment, and surgical treatment and 
outcome were reviewed.
Results: Retrospective analysis had been done in 14 patients 
to diagnose the Giant hemangioma with the imaging and his-
topathological basis. All cases were diagnosed as giant liver 
hemangioma with at least one lesion larger than 20 cm in size. 
Abdominal discomfort was the main presenting complaint for 
referral in 9 patients (64.2%). Abdominal ultrasound estab-
lished the diagnosis in 12 patients (85.7%). 12 patients were 
undertaken liver resection, among which 2 patient underwent 
staging resection. Enucleation was performed in 2 patients. 
Selective transcatheter arterial embolization was implemented 
in 9 patients. Postoperative morbidity occurred in 3 patients 
(21.4%). No complications related to hemangiomas occurred 
during follow-up in all the cases.
Conclusions: Liver resection is indicated for giant liver 
hemangiomas with abdominal discomfort, especially for 
lesions larger than 20 cm. And staging operation is adopted 
for patients with multiple lesions. Preoperative selective 
transcatheter arterial embolization is good to alleviate pro-
gressive abdominal pain.
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P0001M
PRIMARY MUCINOUS CYSTIC TUMOR 
OF THE SPLEEN
B. Dube, G. R. Manoharan and S. S. Pillay
1Livingstone Hospital, Port Elizabeth, South Africa; 
2Walter Sisulu University, Port Elizabeth, South Africa
Introduction: Primary mucinous cystic tumors of the 
spleen are extremely rare. Only a few cases of such tumors 
arising from the spleen have been documented in literature. 
We present one such case from our surgical unit.
Clinical case: A 52 year old female presented to our surgical 
clinic with a 1 year history of pain in the left hypochondrium 
and associated weight loss. Abdominal examination revealed 
a mass in the left hypochondrium extending into the epigas-
tric and umbilical regions. Ultrasound scan reported a 27 cm 
× 16 cm multi-septated cystic mass most likely arising from 
the spleen. A follow up contrasted CT scan confi rmed these 
fi ndings and further reported the ovaries, appendix and pan-
creas as normal. At exploratory laparatomy a cystic lesion of 
the spleen and an incidental isolated cystic lesion on the 
anterior abdominal wall were seen. Splenectomy was done 
and the abdominal wall cyst was excised. Histology reported 
the splenic mass as an ‘intestinal type borderline mucinous 
cystic tumor’. The isolated abdominal wall cyst was a 
pseudo-myxoma.
Discussion: Primary mucinous neoplasms of the spleen are 
very rare. Mucinous cystadenomas commonly arise from the 
ovaries, pancreas and appendix. The exact histogenetic 
mechanism that gives rise to mucinous neoplasms of the 
spleen is unknown. Suggested theories range from develop-
mental misplacement of endodermal tissue to metaplastic 
transformation of intrasplenic mesothelium. There is a 
paucity of information regarding the natural history and man-
agement of this condition.
Conclusion: There are no established radiological criteria 
for diagnosis and therefore surgical exploration and histopa-
thology are essential. Advanced disease is generally reserved 
for multi-disciplinary management.
P0002M
LAPAROSCOPIC MANAGEMENT OF 
PERFORATED PEPTIC ULCER
Z. Koto, R. Jacks, M. Tai and B. Strobele
Wits University, Johannesburg, South Africa
Introduction: Despite major advances in the management 
of peptic ulcer disease, the complications have remains a 
major challenge. Minimally invasive surgery has become has 
become an integral part of the management of perforated 
peptic ulcer disease. We report our initial experience with 
laparoscopy in managing patients with perforated peptic 
ulcer disease.
Methods: The records of patients presenting with general-
ized peritonitis from perforated peptic ulcer disease were 
reviewed between Jan 2006 and October 2010. We included 
patients that were done in private as well. The patient’s 
demographics, clinical picture, operative procedure and out-
comes were looked at. All patients were resuscitated on 
admission and operated upon under general anesthesia. A 
three port technique was used in most cases and additional 
port would be inserted when necessary. The peritoneal cavity 
would be rinsed with copious amount of warm saline and the 
ulcer closed with a graham patch using absorbable suture.
drains was placed selectively.
Results: During this period 23 pts were seen (15 males and 
8 females) their mean age was 44 y (23–65 y). The average 
operative time was 55 min. the mean hospital stay was 3 
days. Complications were readmission with bleeding ulcer 
after 3 weeks. No was reported mortality in the series.
Conclusion: Laparoscopic surgery in perforated peptic 
ulcer is feasible and safe.
It results in shorter hospital stay and quicker recovery.
Short comings of the study.
Small sample size.
P0003M
PANCREATICODUODENECTOMY BY 
YOUNG TRAINEE
Y. Minami, H. Sekido, S. Harada, G. Nakayama, Y. Gyoda, 
S. Sato, M. Ichimanda, T. Shimizu, G. Matsuda and 
T. Takahashi
Department of Surgery, National Hospital Organization 
Yokohama Medical Center, Yokohama, Japan
Background: Our institution is a medium-scale hospital. 
We operate over ten cases of Pancreaticoduodenectomy (PD) 
per year. The young trainees also operate PD as well as the 
skilled surgeon.
Aim: To evaluate the suitability of PD by young trainee with 
short term outcome.
Method: Between 2006 and Jul.2010, 52 patients under-
went PD. Operators were guided by same advising doctor, 
and divided into two groups. Operators were within 6 years 
after graduate medical school is GroupI (n = 17), over 6 years 
is GroupII (n = 35). Operation time and estimated blood loss 
were compared between the two groups. As a short term 
outcome, complications and hospital stay after operation 
were compared between the two groups.
Result: Operation time in GroupI is 494 ± 81 min and in 
GroupII is 472 ± 70 min. Estimated blood loss in GroupI is 
1068 ± 685 ml and in GroupII is 854 ± 521 ml. There were 
no signifi cant differences between two groups. Pancreatic 
fi stula in GroupI was 2 cases (11.8%) and in GroupII was 4 
cases (11.4%), it was not signifi cant difference. Other com-
plications did not show signifi cant differences between two 
groups. Moreover, there was not a signifi cant difference in 
hospital stay after operation between the two groups (29.2 ± 
13.5 (range 12–60) vs. 23.8 ± 12.1 (range 11–54) days).
Conclusions: Our result shows there is no problem even if 
the PD underwent by young trainee. PD by young trainee is 
safe if there is appropriate guidance.
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P0004M
ISOLATED INTRAPARENCHYMAL 
SPLENIC METASTASIS OF SEROUS 
OVARIAN ADENOCARCINOMA
M. Serradilla1, N. Muñoz3, A. Serrablo2, E. Dabán1, L. 
Vázquez1, B. Sánchez1, A. Palomares1 and M. Medina1
1Complejo Hospitalario de Jaén, Jaén, Spain; 2Miguel 
Servet University Hospital, Zaragoza, Spain; 3Virgen de las 
Nieves University Hospital, Granada, Spain
Introduction: Splenic tumors are rare (0.002% of all 
patients with malignant tumors) and present a diagnostic 
dilemma. The differential diagnosis of splenic tumors 
includes hemangioma, lymphangioma, hamartoma, heman-
giosarcoma, malignant lymphoma and metastatic carcinoma. 
The primary tumors more frequently related with splenic 
metastasis are lung, breast, gynecological (specially ovarian 
tumors), colon, rectum and melanoma. Visceral metastases 
in patients with ovarian cancer represent hematogenous 
spread of the disease. Capsular involvement resulting from 
serosal and peritoneal seeding is the most common presenta-
tion. We present a patient with an isolated intraparenchymal 
splenic metatasis from serous ovarian adenocarcinoma.
Case presentation: 65-year-old woman underwent total 
hysterectomy and bilateral salpingo-oophorectomy, omen-
tectomy and appendectomy for bilateral ovarian papillary 
serous adenocarcinoma (T1b N0 M1, stage III) in 1999. 
Afterwards she received adjuvant chemotherapy. Recurrence 
of 2 cm in the vaginal cupola was diagnosed after 7 years 
with complete response to treatment with chemotherapy and 
radiotherapy. An increase of the serum CA-125 was detected 
in April 2010, and the abdominal CT revealed a mass in the 
spleen. A whole-body FDG-PET-CT showed an intense 
hypermetabolism area in the spleen as a unique fi nd. A soli-
tary splenic metastasis from ovarian cancer, even though 
very rare, was strongly suspected. Splenectomy with distal 
pancreatectomy was undertaken in May 2010. The patient 
was discharged on the fi fth postoperative day without com-
plications. Histopathological examination revealed a single 
splenic lesion of 6 cm compatible with intraparenchymal 
metastasis of papillary serous carcinoma of low grade 
with poorly differentiated solid areas extending to the 
splenic hilar. Currently free of disease after adjuvant 
chemotherapy.
Conclusions: Splenic metastases are uncommon and, 
further, if they are unique and intraparenchymal. Often 
asymptomatic, they used to be diagnosed in the context of a 
widespread disease. When there is only one lesion, as in case 
described, splenectomy is the treatment of choice. Median 
survival after diagnosis is 3 months, but seems to increase 
after surgery followed by chemotherapy.
P0005M
MANAGEMENT OF EPITHELIAL 
SPLENIC CYSTS
A. B. Szczepanik1, A. J. Meissner1, A. M. Szczepanik2 and 
A. Misiak1
1Department of General and Hematological Surgery, 
Institute of Hematology and Transfusion Medicine, 
Warsaw, Poland; 2Praski Municipal Hospital, Warsaw, 
Poland
Background: Recognition the importance of preserving the 
spleen for its immunologic function, the spleen parenchyma 
saving procedures have recently been recommended in 
splenic cysts. The aim of the study was to present our surgi-
cal strategy in the management of epithelial splenic cysts 
(ESC).
Methods: From 2003 to August 2010, 22 patients were sur-
gically treated for ESC. Patients with splenic cysts consti-
tuted 4.8% of all 456 patients subjected to splenectomy 
during the study period. The study group included 14 women 
and 8 men, aged 17–57, 33.8 years in average. In all patients, 
splenic cysts were diagnosed by means of ultrasonography 
and confi rmed by computed tomography scan. The size and 
location of the cyst, its relationship to hilar vessels and 
dimension of normal splenic parenchyma were determined. 
The indication for operation were a splenic cysts of diameter 
larger than 5 cm, and rapidly growing cysts. Type of surgery 
depended on cyst location as well as intraoperative anatomi-
cal and technical conditions.
Results: In 16 patients cysts were located in the upper 
splenic pole, in 3 in the lower pole and in 3 centrally in the 
splenic hilus. In 20 patients cysts were single, in 2 multiple. 
The mean diameter of the treated cysts was 9.3 cm (range 
5–17 cm). In 15 patients open partial splenectomy, in 5 open 
total splenectomy and in 2 laparoscopic total splenectomy 
were performed. All patients survived the operation. The 
mean operation time was 93 min (range 70–160) for partial 
splenectomy, 77 min (55–100) for open total splenectomy 
and 55 min (45–65) for total laparoscopic splenectomy. In 
two patients bleeding from transected spleen parenchyma 
was observed, which required laparotomy and removing of 
splenic remnant. There were no other postoperative compli-
cations or deaths after surgery. Pathological examination 
showed epithelial (true) cysts in all patients. The mean hos-
pital stay was 9.7 days (range 7–12) after partial splenec-
tomy, and 6.6 days (3–8) after total splenectomy.
Conclusion: We consider partial splenectomy as the method 
of choice in the management of ESC. Total splenectomy 
should be performed only in centrally located and multiple 
cysts.
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P0001P
THE VALUE OF ENDOSCOPIC 
ULTRASOUND AND ENDOSCOPIC 
ULTRASOUND GUIDED FINE NEEDLE 
ASPIRATION IN THE DIAGNOSIS AND 
ASSESSMENT OF RESECTABILITY 
OF MASS LESIONS IN THE HEAD 
OF PANCREAS
S. Akwei, W. Al-Khyatt, R. Malhotra, F. Whiting, T. 
Boyce, D. Hammouche and I. Beckingham
Queens Medical Centre, Nottingham, United Kingdom
Background: Mass lesions of the head of the pancreas 
(MoHP) may represent benign or malignant neoplasms. 
Endoscopic ultrasound (EUS) and EUS guided fi ne-needle 
aspiration (FNA) is increasingly used to assess pancreatic 
lesions, obtain tissue diagnosis and determine local resect-
ability. Our aim was to review the clinical utility of EUS and 
EUS-guided FNA in diagnosing and staging MoHP.
Methods: Restrospective analysis of 123 consecutive 
patients (64M : 59F) undergoing pancreaticoduodenectomy 
for malignant MoHP at a university hospital from August 
2006 to October 2009. We assessed the contribution of EUS 
in obtaining preoperative tissue diagnosis and assessing local 
resectability.
Results: Fifty-nine of the 123 patients underwent preopera-
tive EUS. Indications for EUS were: to identify MoHP, 
inability to obtain tissue for diagnosis by other methods, and 
questionable resectability on computed tomography. Fifty-
six percent (33/59) undergoing preoperative EUS were 
successfully resected. The commonest reason for being non-
resectable after pre-operative EUS was vessel encasement, 
61.5% (16/26). Preoperative EUS had suggested clear vessels 
in 50 patients, of whom 37 were confi rmed clear but 13 had 
involved vessels at operation. EUS fi ndings for vessel 
involvement were equivocal in 9 patients, however 5/9 
(56%) of these patients were resectable. Sensitivity of EUS 
for identifying MoHP was 94%, and adequate tissue sam-
pling via EUS FNA was successful in 37/38 (97%) requiring 
tissue diagnosis. The sensitivity for diagnosing malignancy 
with EUS FNA samples was 69%. Preoperative EUS 
however, prolonged the time between presentation and 
surgery by 1.7 weeks [EUS group 8.05 wks vs non EUS 
group 6.34 wks, p = 0.013].
Conclusion: While EUS is valuable in identifying mass 
lesions and achieving a tissue diagnosis, its reliability in 
determining surgical resectability is less robust. In patients 
with vessels thought to be clear on EUS 26% were involved 
(and inoperable) and in patients with threatened vessels 56% 
were resectable at surgery mandating surgical exploration in 
this group.
malignancy with EUS FNA samples was 69%. Preoperative 
EUS however, prolonged the time between presentation and 
surgery by 1.7 weeks [EUS group 8.05 wks vs non EUS 
group 6.34 wks, p = 0.013].
P0002P
SOLID PSEUDOPAPILLARY NEOPLASIA 
OF THE PANCREAS: CASE REPORTS
T. Artis1, Z. Yilmaz1, M. Celikbilek3, K. Deniz2 and 
A. Akay1
1Erciyes University Medical School Department Of 
General Surgery, Kayseri, Turkey; 2Erciyes University 
Medical School Department Of Pathology, Kayseri, 
Turkey; 3Erciyes University Medical School Department Of 
Gastroenterology, Kayseri, Turkey
Background: Solid pseudopapillary tumor (SPT) of the 
pancreas is a relatively rare neoplasm with low malignant 
potential, fi rst described by Frantz in 1933 and representing 
less than 3% of all exocrine tumors. SPT is rare in children, 
accounting for 6% of all cases and shows different clinical 
features compared with adults. The natural history is poorly 
defi ned. Herein we report two SPT patients occurred in 
young adulthood.
Case reports: Two young adult females, one is 16-year-old 
and the other 17-yearl with solid mass growing from the head 
of pancreas was referred for surgical treatment. Both patients 
had no complaint other than right upper quadrant discomfort. 
Bloodwork including tumor markers were in normal limits. 
Radiological study revealed a well-demarcated mass which 
was composed of a solid-cystic portion. Tumor diameters 
were 10 × 8 × 7 cm and 12 × 9 × 8 cm respectively. 
On post-contrast CT, the solid portions could be 
enhanced whereas the cystic parts remained unenhanced. 
Pancreaticoduodenectomy was performed on both patients. 
Histopathological examination revealed that the tumor was 
a 10-cm well-circumscribed solid mass, with pseudopapil-
lary cell architecture, showing strong cellular immunoreac-
tivity for alpha-1 antitrypsin, vimentin, neurone-specifi c 
enolase, and in part to CD10 and CAM 5.2, but not to sin-
aptofi sin and chromogranin. Postoperative courses were 
uneventful for the both patients. A 12-month and 9 months 
post-surgical follow-up after successful surgical resection 
showed no evidence of recurrent disease.
Conclusion: In combination with clinical fi ndings, radio-
logical features of SPT may help to make the correct diag-
nosis and differentiation from other pancreatic neoplasms. 
Particularly in young women with pancreatic mass SPT 
should be considered. Once diagnosed, given the excellent 
prognosis and low-grade malignancy, surgical resection of 
the primary lesion is proposed.
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P0003P
DAMAGE CONTROL PRINCIPLES FOR 
HEMORRHAGING PATIENTS 
UNDERGOING OPERATIVE 
DEBRIDEMENT FOR NECROTIZING 
PANCREATITIS
C. Ball1,2, C. Correa-Gallego2, T. Howard2, N. Zyromski2, 
M. House2, A. Nakeeb2, E. Dixon1, C. M. Schmidt2, H. 
Pitt2 and K. Lillemoe2
1University of Calgary, Calgary, Alberta, Canada; 2Indiana 
University, Indianapolis, Indiana, United States
Introduction: Damage control resuscitation (DCR) involves 
(1) early transfusion of blood products, (2) reduced admin-
istration of crystalloid fl uids, (3) immediate hemorrhage 
control and (4) a structured, team-based system that func-
tions independent of patient location. While DCR was ini-
tially described for injured patients, surgery for necrotizing 
pancreatitis represents another high risk scenario that may 
necessitate this philosophy. The primary goal of this study 
was to evaluate the frequency and delivery of DCR in a 
mature pancreatitis practice.
Methods: The Indiana University Hospital pancreatitis reg-
istry was retrospectively evaluated for cases requiring DCR 
concurrent to operative procedures (2003 to 2007). Standard 
statistical methodology was employed.
Results: Of 1290 patients with acute pancreatitis, 238 
(18%) displayed a necrotizing variant. Of these, 178 (75%) 
required operative debridement with 6 (3.4%) necessitating 
initiation of DCR for massive ongoing hemorrhage. Each of 
these patients displayed concurrent intraoperative physio-
logic exhaustion (mean base defi cit = −18; mean pH = 7.14; 
mean temperature = 35°C). These patients received an 
average of 17 units of packed red blood cells, 13 units of 
plasma, and 6.1 liters of crystalloid fl uid. Factor VIIa was 
not utilized. Among the 4 (67%) survivors, the median time 
to abdominal wall closure was 6.9 days. One patient required 
initial skin graft coverage and interval component separation 
reconstruction for a persistently open abdomen. Six (3.4%) 
additional non-DCR patients also required an open 
abdomen with a temporary abdominal closure to allow serial 
access to the peritoneal cavity for repeat pancreatic 
debridements.
Conclusions: The risk of exsanguinating hemorrhage 
requiring DCR in patients undergoing operative debridement 
for necrotizing pancreatitis approximates 3% in a high 
volume pancreas referral center. This technique can be life 
saving, but should be reserved for patients who display con-
current physiologic exhaustion.
P0004P
WELL-DIFFERENTIATED PANCREATIC 
ENDOCRINE TUMORS: FACTORS 
INFLUENCING DISEASE-FREE SUVIVAL
R. Cherif, S. Gaujoux, A. Couvelard, S. Dokmak, B. 
Aussilhou, P. Ruszniewski, J. Belghiti and A. Sauvanet
Hopital Beaujon, Clichy, France
Objectives: Well-differentiated pancreatic endocrine tumors 
(PET) are resected even if they are metastatic to the liver or 
nonfunctioning. The aim of this study was to assess factors 
infl uencing disease-free suvival after PET resection.
Methods: From 1995 to 2008, 118 patients (H/F = 0.71, 
median age 51 years) underwent PET resection (37 pancre-
aticoduodenectomy [PD], 43 left pancreatectomy [LP], 27 
enucleation [EN], 10 median pancreatectomy [MP] and 1 
total pancreatectomy), associated with hepatic metastasis in 
21 (18%), resected in 19 (16%). Disease-free survival (DFS) 
was evaluated using Kaplan -Meier and compared with Log 
rank test. Multivariate analysis with Cox regression model 
was used to identify prognostic factors.
Results: 83% of PET were sporadic and 75% nonfunction-
ing. Postoperative mortality was 1.7% (1 EN, 1 MP). 
According to WHO classifi cation, 24% were benign lesions 
(B), 25% of uncertain behavior (UB) and 51% carcinomas 
(N+ = 45, M+ = 21). After a median follow-up of 51.5 
months, 5 years DFS was 72% (B = 100%, UB = 94% and 
carcinomas = 57%). Recurrence in UB tumors occurred in 4 
of 5 cases after the 7th year. In the 32 (72%) nonfunctional, 
less or equal to 2 cm, without radiologic metastatases PET, 
23 (72%) were B, 6 (19%) were UB and 3 (9%) were carci-
noma (N+). For this group, the 5 and 10 years DFS was 
100% and 80% respectively (2 recurrences at 85 and 130 
months).
Conclusions: Nonfunctioning tumors less or equal to 2 cm 
are malignant in only 9% of cases and their recurrences are 
rare and late. Postoperative mortality is not nil even if for 
limited resections, and the benefi t/risk balance should be 
discussed case by case. Surgery for functioning, or >2 cm, 
or PET metastatic to the liver is justifi ed by the low mortality 
and a 5 years DFS of 63%.
P0005P
LAPAROSCOPIC AND OPEN DISTAL 
PANCREATECTOMY FOR LEFT-SIDED 
PANCREATIC LESIONS
G. Belli, P. Limongelli, A. D’Agostino, C. Fantini, L. 
Cioffi , A. Belli and G. Russo
Department of General and Hepato-Pancreato-Biliary 
Surgery S.M. Loreto Nuovo Hospital, Naples, Campania, 
Italy
Introduction: Laparoscopic distal pancreatectomy has pro-
gressively gaining popularity with several studies reported 
on feasibility and safety of the procedure.
Aim: To report our experience with Laparoscopic distal 
pancreatectomy and retrospectively compare postoperative 
outcomes in patients undergoing either laparoscopic or open 
distal pancreatectomy.
Material and methods: The short term result of patients 
undergoing laparoscopic distal pancreatectomy were ana-
lyzed and compared to patients operated by the open 
approach.
Results: From January 2000 to January 2010, 65 patients 
underwent distal pancreatectomy (DP) Forty-nine patients 
were operated on by the open approach (ODP) whereas 16 
by laparoscopy (LDP) in the last 3-years (2007–2010) of the 
study. Mean age, sex ratio and BMI did not differ between 
ODP and LDP patients. Indications to laparoscopy were 
cystic tumor of the pancreas (n = 6), neuroendocrine tumor 
(n = 4); chronic pancreatitis (n = 2), ductal adenocarcinoma 
(n = 2) IPMN (n = 1) and metastasis (n = 1). The mean 
operative time was statistically longer for the LDP group 
(LDP, 194 min; OH, 160 min; p 0.0001), whereas intraopera-
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tive blood loss (LDP, 160 ml; ODP, 365 ml; p = 0.0001) and 
length of hospital stay (LDP, 6 days; ODP, 8 days; p = 
0.0001), were signifi cantly greater in the ODP group. There 
was no statistically signifi cant difference in postoperative 
pancreatic leak (LDP 18%; ODP 20%; p = 0.617) and overall 
complications (LDP, 25%; ODP, 41%; p = 0.202).
Conclusion: In selected patients, LDP is associated with 
lower intraoperative blood loss and shorter length of hospital 
stay than ODP. Pancreatic leak rates were similar for LDP 
and ODP. LDP is appropriate for selected patients with left-
sided pancreatic lesions.
P0006P
ENUCLEATION OF INSULINOMA 
PANCREATIC CANCER (CASE REPORT)
F. Bersano, G. Moriconi, J. Iniesta, M. Lenz and J. Pekolj
Hospital Italiano de Buenos Aires, Capital Federal-Buenos 
Aires, Argentina
Introduction: Neuroendocrine tumors usually originate in 
proximity to the pancreas, 8% of these tumors secrete bio-
logically active substances that produce specifi c clinical syn-
dromes. Insulinomas are the most common type of horm1 
secreting tumors (60% of all pancreatic endocrine tumors). 
Tumor resection is the only potentially curative treatment 
and it is important for the attenuation of signs and symptoms 
related to excessive hormone production or to tumor 
mass.
Description and contents: We present a case of a 48-years-
old male, with no previous history of known disease, who 
presented with symptoms suggestive of neuroglycopenic 
syndrome: dizziness, lightheadedness, sweating, blurred 
vision, fainting. Laboratory prompted Fasting blood glucose 
<40, Insulinemia > 6 UI/mL. Suspecting a functioning pan-
creatic endocrine tumor, the following examination was 
requested: Abdominal CT scan: Solid Nodule in the head of 
de pancreas in contact with SMV. To confi rm the diagnosis 
and tumor topography the following studies were performed: 
Abdominal angiography with calcium gluconate stimulus 
test, a nodular lesion of about 10–12 mm in diameter was 
identifi ed, in the territory of the gastroduodenal artery. After 
the insulinoma was diagnosed, an exploratory laparotomy 
was carried out:
– Bilateral subcostal incision.
– Extended Kocher maneuver.
– Dissection of the inferior border.
– Location of tumor lesion 2 cm in diameter, on right lateral 
SMV.
– Intraoperative Ultrasound: to confi rm patency of the pan-
creatic duct and the non-existence of not detected or previ-
ously unsuspected occult tumors.
– Enucleation of the tumor.
– Hemostasis and drainage of the residual cavity.
The patient had good postoperative course, normalized blood 
glucose values and was discharged 6 days after surgery, 
without complications.
Observations and/or comments: When an insulinoma is 
suspected, CT or MRI should be performed to try to identify 
it. To confi rm diagnosis and tumor topography with abdomi-
nal angiography (sensitivity reported for detection of primary 
tumors of 28–70%). The latter may be accompanied by arte-
rial stimulation with secretagogues substances into the arter-
ies of the pancreas (89% sensitivity). Enucleation is the 
treatment of choice for patients with insulinomas, since they 
are encapsulated tumors, which allow the surgeon to remove 
the tumor from the surrounding pancreas. Only 5–10% of the 
insulinomas are malignant.
P0007P
ENDOSCOPIC DRAINAGE OF 
PANCREATIC PSEUDOCYSTS
N. Y. Bhorat, S. Thomson, F. Anderson, L and Ferndale
Nelson Mandela School of Medicine, Durban, South Africa
Background: Endotherapy is a well established and evolv-
ing initial treatment modality for symptomatic pancreatic 
pseudocysts at our institution. We present our experience 
with endotherapy to benchmark the outcome in our 
setting.
Patients and methods: Patients undergoing visual directed 
ERCP pseudocyst drainage were reviewed in the period 
1998–2010. Demographic data, mode of drainage, complica-
tions and outcomes were noted.
Results: During this period 40 patients were identifi ed, 9 
females and 31 males, within the ages 18 months to 64 years. 
Etiologies of the pseudocysts were: Acute alcoholic pancre-
atitis 16, trauma 6, gall stone pancreatitis 7, dyslipadaemic 
pancreatitis 1 patient and unknown in 10. Endotherapy 
evolved, but all techniques entailed needle knife transent-
eric entry or transampullary access and plastic stenting. 
Endotherapy was successfully performed in 30 (75%) of 
patients comprising transgastric drainage 21 (70%), trans-
duodenal 5 (17%) and trans-ampullary 4 (13%). The morbid-
ity was 5.0% with 1 patient having a gastric perforation and 
a second had a stent passed completely into the pseudocyst. 
The mortality was 5.0% with 1 patient with portal hyperten-
sion exsanguinating and another demised from unrelated 
sepsis. Failure rate was 25%, the commonest reason been an 
absence of a bulge on endoscopy. Follow-up was poor with 
7 patients having no follow-up and only 6 patients had fol-
low-up for >6 months with the longest been 3.5 years. The 
remaining 17 patients with short-term follow-up were docu-
mented to be asymptomatic with 9 patients having radiologi-
cal evidence of resolution of the pseudocysts. Repeat ERCP 
with balloon dilatation of the cystgastrostomy tract was 
required in 3 patients.
Conclusions: Endoscopic cyst drainage is a technically fea-
sible and a therapeutically successful modality for the major-
ity of pseudocysts independent of aetiology. Morbidity is 
usually minor and mortality low. EUS may extend the role 
for smaller less accessible pseudocysts that do not bulge into 
the stomach.
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P0008P
PANCREATECTOMIES ASSOCIATED TO 
VASCULAR RESECTION (PVR): A 
SINGLE INSTITUTION EXPERIENCE
M. Del Chiaro1, N. De Lio1, F. Costa1, V. G. Perrone1, S. 
D’Imporzano1, S. Signori1, C. Croce1, F. Vistoli1, F. Mosca2 
and U. Boggi1
1Pisa University Hospital – Division of General and 
Transplant Surgery, Pisa, Italy; 2Pisa University Hospital 
– First Division of General Surgery, Pisa, Italy
Background: In the last years the number of published 
reports on PVR is increased.
Aim: The aim of this study is to analyze a large single center 
experience retrospectively.
Methods: From November 1987 to March 2010, 231 PVR 
were performed at Pisa University Hospital. There were 126 
men (54.5%) and 105 females (45.5%). The mean age was 
64.6 yrs. Vein resection alone (VRA) were performed in 167 
patients (72.4%), artery resection alone (ARA) in 25 (10.8%) 
and combined artero-venous resections (AVR) in 39 (16.8%). 
The fi nal diagnosis was ductal adenocarcinoma (DA) in 173 
cases (74.9%), chronic pancreatitis in 3 (1.3%) and other 
tumor types (OTT) in 55 (23.8%).
Results: The overall morbidity rate was higher in patient 
treated for kinds of tumors different from DA on respect to 
DA (60% vs 38.1%; p = 0.05). No differences were found in 
post-operative mortality in the same groups (12.7% vs 5.7%). 
The overall 1.3 and 5 yrs survival for patients with OTT was 
higher on respect to patient diagnosed with DA (86.7%, 
59.6% and 49.6% vs 56.9%, 15.6% and 7.6%; p < 0.0001). 
In the DA group, no statistically signifi cant differences in 
survival rates were found comparing VRA vs ARA vs AVR, 
comparing patients with post-operative complications to 
uneventfull post operative course patients, comparing 
patients with histologically confi rmed vascular involvement 
to patient without confi rmed vascular involvement. A statisti-
cally signifi cant difference was found comparing 1, 3 and 
5 yr survival rate of patients with one single vessel resection 
to patients with multiple vessels resection (61.6%, 18.1% 
and 10.8% vs 40.9%, 10.9% and 0; p = 0.02).
Conclusions: PVR are feasible procedures. Patients with 
OTT seems to have an increased risk of post-operative com-
plication than patients with DA. However this group of 
patients has a longer survival time compared to the DA 
group. In the DA group the number of resected vessels seems 
to be the most important prognostic factor, probably as 
marker of ‘real’ locally advanced tumors.
P0009P
TOTAL PANCREATECTOMY AND AUTO 
ISLET TRANSPLANTATION FOR 
CHRONIC PANCREATITIS
J. Botha, B. Stevens, T. Rigley, J. Skorupa, D. Mercer, 
W. Grant and A. Langnas
University of Nebraska medical Center, Omaha, Nebraska, 
United States
Background: For patients with severe chronic pancreatitis 
refractory to conventional therapy, total pancreatectomy with 
islet cell auto transplantation can alleviate pain while at the 
same time avoid the complications of diabetes.
Methods: Between 2006 and 2010, 5 patients underwent 
either total pancreatectomy and splenectomy (n = 4) or 
splenic preserving total pancreatectomy (n = 1), with islet 
cell auto transplantation. Pain relief, glycemic control and 
insulin requirements were assessed post operatively, The 
pancreas was excised and placed into chilled RPMI 1640 
tissue culture medium followed by decontamination with 
povidone iodine and saline, followed by intraductal perfu-
sion with a solution of collagenase and neutral protease and 
then transferred to a heated vessel for digestion. Collection 
of tissue fragments (including free islets) began after 20 
minutes and continued 30 minutes longer. The pancreatic 
fragments were washed, combined, and assessed for islet 
number, size, quality, and total tissue volume. Islets were 
placed into RPMI with heparin and returned to surgery for 
infusion through a 5 Fr. intraportal catheter.
Results: The etiology of pancreatitis was: pancreas 
divisum (2), autoimmune (1), and idiopathic (2). Mean islet 
yield was 3339 islet equivalents/gm of pancreas (I.E.)/gm, 
(range 556 to 11,310 (I.E.)/g pancreas). Infusion was inter-
rupted at intervals to allow monitoring of portal pressure, 
which gradually rose as more tissue was infused. Infusion 
was discontinued when portal pressures became stable at 
20–25 mm/Hg. Because the volume of tissue infused was 
limited by portal pressure rise, an average of 61% of each 
patient’s islets could be infused. In all cases, robust graft 
function gradually developed between two and 8 weeks, 
mean C-peptide levels at 1 month and 6 months were 1.74 
and 4.0 respectively, complete insulin independence was 
achieved in 4 patients. Although one patient continued to 
suffer from severe intercurrent disease (Lupus, renal failure, 
sepsis), four patients reported signifi cant or complete pain 
relief and were completely weaned from narcotic 
analgesia.
Conclusion: Total pancreatectomy with islet auto transplan-
tation should be considered as an early therapeutic option for 
patients with chronic pancreatitis to alleviate abdominal pain 
while preserving endocrine function.
P0010P
PHD3 REGULATES DIFFERENTIATION, 
TUMOR GROWTH AND ANGIOGENESIS 
IN PANCREATIC CANCER
Y. Su3, M. Loos1, N. Giese2, M. Büchler2, A. Kornberg1, H. 
Friess1 and P. Büchler1
1Klinikum rechts der Isar, Technische Universität München, 
München, Germany; 2Department of General Surgery, 
University of Heidelberg, Heidelberg, Germany; 
3Department of Surgery, Zhongda Hospital, Nanjng 
Southeast University, Nanjing, China
Purpose: Tumor hypoxia activates hypoxia-inducible 
factor-1 (HIF-1) and indluences angiogenesis, cell survival 
and invasion. Prolyl hydroxylase-3 (PHD3) regulates degra-
dation of HIF-1α. The effects of PHD3 in tumor growth are 
largely unknown.
Experimental design: PHD3 expression was analyzed in 
human pancreatic cancer tissues and cancer cell lines by 
real-time quantitative PCR and immunohistochemistry. 
PHD3 overexpression was established by stable transfection 
and downregulation by siRNA technology. VEGF was quan-
tifi ed by ELISA. Matrigel invasion assays were performed 
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to examine tumor cell invasion. Apoptosis was measured by 
annexin-V staining and caspase-3 assays. The effect of 
PHD3 on tumor growth in vivo was evaluated in an estab-
lished orthotopic murine model.
Results: PHD3 was upregulated in well differentiated 
human tumors and cell lines and regulated hypoxic VEGF 
secretion. PHD3 overexpression mediated tumor cell growth 
and invasion by induction of apoptosis in a NGF dependent 
manner via activation of caspase-3 and phosphorylation of 
focal adhesion kinase HIF-1 independently. In vivo, 
PHD3 inhibited tumor growth by abrogation of tumor 
angiogenesis.
Conclusion: Our results indicate essential functions of 
PHD3 in tumor growth, apoptosis and angiogenesis and 
through HIF-1 dependent and HIF-1 independent 
pathways.
P0011P
LAPAROSCOPIC VS OPEN DISTAL 
PANCREATECTOMY: A CASE 
CONTROL COMPARISON
M. Howard, T. Bradish, J. O’Connell, R. Charnley, 
S. White and J. French
Dept HPB Surgery, Freeman Hospital, Newcastle, United 
Kingdom
Introduction: Distal pancreatectomy has traditionally been 
performed as an open procedure. In an attempt to improve 
patient outcome such procedures have recently been per-
formed utilising a laparoscopic technique. The aim of this 
study was to compare patients undergoing distal pancreatec-
tomy via either the open or laparoscopic technique.
Methods: 15 consecutive patients undergoing laparoscopic 
distal pancreatectomy at the Freeman Hospital HPB unit 
were identifi ed for study from a prospectively managed data-
base (group 1). These patients were matched with 15 histori-
cal patients who underwent open procedures, but would have 
been suitable for laparoscopic surgery (group 2). Data was 
collected from patients’ medical records and trust databases. 
Parameters studied included indication, size of lesion, resec-
tion margin, mortality, morbidity, operative time, blood loss, 
post-operative analgesia and time to mobilisation, hospital 
stay, and total cost.
Results: There was no statistical difference in indication, 
size of lesion, margin, or splenectomy rate between each 
group. There was no mortality in either group. Lower mor-
bidity was seen in the group 1 (p = 0.03). Post operative 
analgesia and total hospital stay were both signifi cantly less 
in group 1 (p = 0.02). Median intra-operative blood loss was 
lower in group 1 (200 vs 600 mls, p = 0.047), and median 
post-operative mobilisation was faster both for sitting in a 
chair (p = 0.0005) and aided walking (0.0096). Group 1 had 
a longer median operative time (315 vs 250 mins, p = 
0.0288). Total hospital stay was shorter (p = 0.004) and total 
cost less (p = 0.001) in group 1.
Conclusions: In anatomically favourable patients, and in 
centres supporting advanced laparoscopic techniques, lapa-
roscopic distal pancreatectomy should be offered as the 
method of resection.
P0012P
TWO LAYER OPEN 
PANCREATICOGASTROSTOMY. 
TOWARD AN EASY AND SAFE 
ANASTOMOSIS? 
PRELIMINARY EXPERIENCE
R. D. Valle and Nicola de’Angelis
University of Parma, Parma, Italy
Background: Pancreatic fi stula (PF) is the main cause of 
morbidity and mortality after pancreaticoduodenectomy 
(PD). It mostly occurs when anastomosis is performed in soft 
pancreatic tissue. Pancreaticogastrostomy (PG) seems actu-
ally to be preferred to Pancreaticojejunostomy (PJ) in pres-
ence of soft residual parenchyma. Aim: Compare the PG and 
PJ in a consecutive series of patients submitted to PD.
Methods: From January 2008 to September 2010 48 patients 
were randomized to two different surgical reconstructive 
technique, PG and PJ. 26 patients received PJ (duct to 
mucosa pancreaticojejunostomy) and 22 PG (two layer 
open pancreaticogastrostomy). All the procedures were per-
formed by the same surgeon. PF was defi ned in according to 
the International Study Group on Pancreatic Fistula 
Classifi cation. 41 patients underwent a Whipple procedure 
whereas 7 patients were submitted to a pylorus-preserving 
operation.
Results: In the PJ group (16 male/10 female, average age 
69 years) we observed 5 PF (19%), 3 grade A (11%), 1 grade 
B (4%) and 1 grade C (4%). This latter case required a 
relaparotomy for completion pancreatectomy. In all these 5 
PF the residual parenchyma was soft. In the PG group (14 
male/8 female, average age 68 years) we registered 3 grade 
A PF (13%) all in presence of soft pancreatic tissue. In this 
group of patients we observed also 1 bleeding from the 
pancreatic anastomosis and 1 postoperative pancreatitis with 
a minimal leak of the gastrojejuneal anastomosis. All com-
plications were treated conservatively. In the two groups 
mortality were 0%. The mean hospitalization time was 15.6 
days in PJ group and 12.2 days in PG group. Histological 
examination led to the diagnosis of 28 ductal adenocarcino-
mas, 10 carcinomas of the papilla, 6 duodenal carcinoma, 3 
chronic pancreatitis and 1 duodenal polyposis (Spigelmann 
stage IV). Conclusion: In our initial experience the incidence 
of PF seems to be lower in the PG group especially in pres-
ence of soft pancreatic tissue. The anterior gastrotomy makes 
easier the anastomosis whereas the two layer technique 
increases its safety. These initial results appear encouraging 
but must be confi rmed in a larger group of patients.
P0013P
INCIDENCE, TREATMENT, AND 
PROGNOSIS OF PERITONEAL 
CARCINOMATOSIS OF PANCREATIC 
ORIGIN: A POPULATION-BASED STUDY
I. De Hingh1, Y. van Gestel2, S. Nienhuijs1, V. Verwaal3 and 
V. Lemmens2
1Catharina Hospital, Eindhoven, Netherlands; 2Eindhoven 
Cancer Registry, Eindhoven, Netherlands; 3National 
Cancer Institute, Amsterdam, Netherlands
Introduction: Peritoneal carcinomatosis (PC) is an impor-
tant cause of morbidity and mortality among patients with 
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pancreatic cancer. However, data on the incidence, treatment, 
and prognosis of this condition are very scarce in 
literature.
Methods: All patients diagnosed with non-endocrine pan-
creatic cancer diagnosed between 1995 and 2008 in the area 
of the Dutch Eindhoven Cancer Registry (comprising 2.3 
million inhabitants) were included. Follow-up was complete 
until January 1st 2010. Median survival of patients diag-
nosed in 1995–2001 was compared with 2002–2008.
Results: In total, 2627 patients were diagnosed with pancre-
atic cancer between 1995 and 2008. Of these, 227 (10%) 
presented with PC, of which 130 (6% of total) also had other 
systemic metastases. None of the patients with PC underwent 
resection of the primary tumour. Only a small proportion of 
patients with PC received chemotherapy and this did not 
increase signifi cantly over time (14% vs. 20%).
Median survival in the presence of PC is extremely poor. 
Whereas survival was 26 weeks (24–30) for non-metasta-
sised patients in the most recent period, survival was only 5 
weeks (4–7) in the presence of PC with other metastases. For 
patients with PC only, median survival was 8 weeks (5–12). 
No improvement in survival was seen over time.
Conclusion: Prognosis in the presence of PC is extremely 
poor with a median survival of 8 weeks, decreasing to 5 
weeks if concomitant metastases on other localizations are 
present. No improvements have been achieved in the last 15 
years. There are no surgical options and only a small propor-
tion of patients receive chemotherapy. Thus, effective treat-
ment for these patients is much needed but so far promising 
results by using new chemotherapeutic regimens or intra-
peritoneal administration have been shown in case reports 
only.
P0014P
PANCREATICODUODENECTOMY AFTER 
RADIOCHEMOTHERAPY FOR LOCALLY 
ADVANCED ADENOCARCINOMA OF 
THE PANCREATIC HEAD
Q. Denost1,2, C. Laurent1,2, A. Jacquin1,2, J-P. Adam1,2, M. 
Capdepont1,2, D. Smith1,2, V. Vendrely1,2, G. Belleannee1,2, 
B. Masson1,2, D. Collet1,2 and A. Sa-Cunha1,2
1Haut Leveque Hospital, Digestive surgery unit, Pessac, 
France; 2Victor Segalen University, Bordeaux, France
Introduction: The aim of the study was to compare onco-
logical results of patients treated by duodenopancreatectomy 
for adenocarcinoma of the pancreatic head with or without 
preoperative radiochemotherapy.
Methods: From 2004 to 2009, patients treated by duodeno-
pancreatectomy for adenocarcinoma of the pancreatic head 
were included in a retrospective comparative study. Patients 
with locally advanced adenocarcinoma were treated with 
preoperative radiochemotherapy (total dose, 45 Gy at 1.8 Gy, 
5 d/wk) and were compared to those treated by surgery 
alone. Global survival and disease free survival were assessed 
by Kaplan Meier method and compared by Log Rank test.
Results: One hundred eleven patients were included: 72 
patients treated by surgery alone were compared to 39 
patients treated by preoperative radiochemotherapy. The 
median follow-up was 21 months. Patients with preoperative 
radiochemotherapy were younger and had a more advanced 
tumoral status. There was no difference of surgical morbidity 
between the two groups. Microscopic resection rate was 
similar but nodal status and vascular or lymphatic embolus 
was lower in the radiochemotherapy group. At 3 years, 
global survival rate (36% vs. 51%; p = 0.10) and disease-free 
survival (26% vs. 37%) were similar between surgery or 
radiochemotherapy group.
Conclusion: Preoperative radiochemotherapy for pancre-
atic head adenocarcinoma allow obtaining the same survival 
rate than patients treated by surgery alone who had initially 
a better prognosis.
P0015P
ANALYSIS OF MIR-143 AND MIR-21 
EXPRESSION LEVELS IN DIFFERENT 
HISTOLOGICAL TYPE OF PANCREATIC 
CANCER
F. F. di Mola1, F. Tavano1, A. Piepoli2, A. Panza2, L. Festa1, 
T. Latiano3, M. Copetti4, A. Andriulli2, E. Maiello3 and 
P. Di Sebastiano1
1Dept Surgery IRCCS Casa Sollievo Sofferenza Hospital, 
San Giovanni Rotondo, Italy; 2Unit of Gastroenterology 
IRCCS Casa Sollievo Sofferenza Hospital, San Giovanni 
Rotondo, Italy; 3Dept Oncology IRCCS Casa Sollievo 
Sofferenza Hospital, San Giovanni Rotondo, Italy; 4Unit of 
Biostatistics IRCCS Casa Sollievo Sofferenza Hospital, San 
Giovanni Rotondo, Italy
Introduction: Pancreatic cancer is an aggressive malig-
nancy with an extremely poor prognosis. Despite advances 
in the clinical management of pancreatic cancer there is a 
lack of improvement in its early detection, diagnosis and 
treatment strategies. MicroRNAs (miRNAs) are a new class 
of small, non-coding RNAs that modulate expression of spe-
cifi c genes target at post-transcriptional level. It is becoming 
increasingly clear that altered miRNAs expression contrib-
utes to pathogenesis of cancer by promoting the expression 
of proto-oncogene or by inhibiting the expression of tumour 
suppressor gene.
Materials and methods: qRT-PCR was used to determined 
the relative expression levels of mature miR-143 and miR-21 
in the 17 tissue samples obtained from patients with pancre-
atic head ductal adenocarcinoma (PDAC; n = 10), ampullary 
cancer (PVAC; n = 4), extra-hepatic cholangiocarcinoma 
(EH-CCA; n = 2) and MEN1-associated pancreatic endo-
crine tumour (PET; n = 1). MiRNAs expression levels were 
correlated with patients clinic pathologic features to identify 
new elements with potential prognostic and diagnostic value 
for pancreatic cancer.
Results: We observed miR-143 and miR-21 over-expression 
in all cancer compared to normal adjacent tissue samples, 
except for MEN1-associated PET and moderately differenti-
ated EH-CCA samples where miR-143 and mi-R21 were 
found respectively down-regulated. In PDAC/PVAC samples 
miR-143 expression was inversely correlated with the degree 
of lymph nodes involvement while expression of miR-21 was 
correlated with the grade of tumour differentiation and pan-
creatic cancer histological type. The high over-expression of 
both miRNAs was associated to dysphasic tumour stage in 
EH-CCA.
Conclusions: Our data suggest the potential prognostic 
value of miR-143 and miR-21 in PDAC and PVAC. The 
signifi cant over-expression of both miRNAs in EH-CCA 
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sample indicates the potential importance of these molecules 
for EH-CCA early detection. Furthermore data on miR-143 
e miR-21 down-regulation in specifi c pancreatic cancer 
sample types may refl ect histological features and different 
behaviours of pancreatic tumours.
P0016P
NEUTRAL ENDOPEPTIDASE PATHWAY 
IS ALTERATED IN CHRONIC 
PANCREATITIS
F. F. di Mola1, F. Tavano1, G. Mascetta1, C. Bassi6, R. 
Barbano3, P. Parrella3, M. Büchler2, H. Friess5, M. Carella4 
and P. di Sebastiano1
1Dep Surgery IRCCS Casa Sollievo della Sofferenza, San 
Giovanni Rotondo, Italy; 2Department of General Surgery, 
University of Heidelberg, Heidelberg, Germany; 
3Laboratory of Oncology, IRCCS Hospital Casa Sollievo 
della Sofferenza, San Giovanni Rotondo, Italy; 4Unit of 
Genetic, IRCCS Hospital Casa Sollievo della Sofferenza, 
San Giovanni Rotondo, Italy; 5Department of Surgery, 
Technische Universität of München, Klinikum rechts des 
Isar, Munich, Germany; 6Department of Surgery University 
of Verona, Verona, Italy
Aim: The mechanisms of pain in chronic pancreatitis (cp) 
are still not completely understood. A role for neuropeptides 
such as substance p (sp) and the neuroimmune interaction 
has been suggested in the infl ammatory process of the pan-
creas. Sp degradation is mediated by the endogenous extra-
cellular metalloenzyme called neutral endopeptidase (nep). 
Further studies failed to detect nep in patient with pancreatic 
disorders while increased expression of sp was detected. In 
the present study we investigated nep pathway to better 
evaluate the sp pathway in cp patients.
Methods: SP and NEP mRNA levels were analyzed by 
quantitative real time polymerase chain reaction (RT-PCR) 
in pancreatic tissue specimens from patients undergoing pan-
creatic resection for CP and healthy organ donors. NEP gene 
mutation analysis, NEP methylation assay and miR-128a 
expression was also performed.
Results: Quantitative RT-PCR demonstrated increased SP 
mRNA expression in CP tissues (P < 0·05) compared to 
controls, while NEP mRNA showed no signifi cant changes 
between CP and healthy controls. Screening did not reveal 
any mutation of interest but only the presence of seven 
intronic polymorphisms located downstream or upstream of 
several exons. MSP analysis suggests a light tendency to 
NEP hypermethylation for one promoter CpG islet in about 
half of chronic pancreatitis samples when compared with 
donor group meanwhile NEP loos of function was associated 
to mir-128a signifi cant over-expression in CP patients.
Conclusions: The present data show that expression of SP 
is increased during chronic infl ammation of the pancreas and 
that tissue levels of NEP are unaltered. In the SP pathway, it 
would appear that NEP is unable to suffi ciently degrade the 
increased amount of SP, which may in part explain the per-
petuation of pancreatic infl ammation, due to mir-128a 
over-expression.
P0017P
CONVENTIONAL AND PANCREAS-
PRESERVING SURGERY OF THE 
DUODENAL DYSTROPHY
V. Egorov, I. Kozlov, A. Vankovich and N. Yashina
The Vishnevsky Institute of Surgery, Moscow, Russian 
Federation
Background: Duodenal dystrophy (DD) is infrequent 
disease, characterized by the chronic infl ammation of the 
aberrant pancreatic tissue in the duodenal wall. DD manage-
ment remains a topic of discussion and pancreaticoduode-
nectomy (PD) is currently a method of choice when 
conservative treatment fails.
Objective: To compare the results of standard and pancreas-
preserving surgery of DD.
Methods: Prospective analysis of the demographic, clinical 
and instrumental data (37 pts), and results of surgical treat-
ment of 26 patients with cystic forms of DD (2005–2009).
Results: Constant or relapsing abdominal pain was revealed 
in 100%, weight loss in 51%, vomiting in 26% and jaundice 
in 20% of cases. The most precise diagnostic methods were 
CT, MRI and endoUS. Twenty two patients were operated 
on by pancreatico – and cystoenterostomy (4), PD (11), 
Nakao procedure (3), duodenum-preserving pancreatic head 
resection (2) and partial gastrectomy (1). In fi ve cases pan-
creas-preserving technique was used: resection of the second 
part of the duodenum (RSPD) with direct duodeno-duodeno-
anastomosis (2), RSPD with jejunal interposition (2) and 
subtotal dudenectomy (1). Postoperative lethality was zero. 
Full pain control and all symptoms disappearance were 
achieved after pancreas-preserving procedures, in 91% of 
cases after PD and in 16% of cases after the pancreatic head 
resections and draining procedures. In two cases of severe 
chronic ‘orthotopic’ pancreatitis the disturbance of glucose 
tolerance was detected after PD.
Conclusion: In case of mild changes of the orthotopic gland 
pancreas-preserving procedures can be the optimal methods 
for duodenal dystrophy surgery and real alternative to PD.
P0018P
SPLEEN-PRESERVING DISTAL 
PANCREATECTOMY WITH SPLENIC 
VESSELS RESECTION. CAN WE RELY 
ON THE SHORT GASTRICS?
V. Egorov, N. Yashina, T. Zhurenkova, M. Petukhova and 
K. Dmitrieva
1The Vishnevsky Institute of Surgery, Moscow, Russian 
Federation; 2The Russian State Medical University, The 
Vishnevsky Institute of Surgery, Russian Federation
Background: The knowledge of spleen collaterals is impor-
tant as for distal spleen-presrving pancreatectomy with 
splenic vessels resection (DSPPSVR), so as for possible 
upper GI surgery for this patients.
Objective: To clarify the sources of spleen blood supply 
after DSPPSVR.
Methods: Perfusion of the cadaveric left gastric artery with 
a colouring agent after the occlusion of all arteries except for 
the short gastrics (n = 10); Intraoperative Doppler ultrasound 
(IDU) for the evaluation of the splenic blood fl ow during 
distal pancreatectomy (n = 18) after the splenic artery clamp-
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ing, following the clamping of the splenic and the left gastro-
epiploic arteries and after the clamping of the splenic and the 
short gastric arteries; CT-angiography (CTA) of gastric and 
splenic vessels before and after DSPPSVR (n = 10).
Results: The perfusion of cadaveric arteries after the occlu-
sion of all the arteries except for the short gastrics never only 
once revealed a dyestuff in the spleen (through the accessory 
left gastric artery); IDU never detected any blood fl ow in the 
splenic hilus after the clamping of the splenic and the left 
gastro-epiploic arteries; CTA after DSPPSVR never delin-
eated short gastric vessels supplying the spleen.
Conclusion: Experimental, intra- and postoperative instru-
mental investigations have not revealed more or less signifi -
cant involvement of the short gastric arteries in the blood 
supply of the spleen after DSPPSVR. The left gastro-epiploic 
artery is the ‘main player’ after DSPPSVR and must be care-
fully preserved.
P0019P
CREATION OF A REFERENCE CENTER 
FOR PANCREATIC SURGERY BY TEAM 
RELOCATION – IS SURGICAL 
EXPERTISE TRANSFERABLE?
M. Erkan, C. Reiser-Erkan, C. Michalski, R. Gertler, M. 
Hartel, H. Friess and J. Kleeff
Department of Surgery, Klinikum rechts der Isar, 
Technische Universität München, Munich, Germany
Background and aims: Pancreatic resection for malig-
nancy can be performed with low morbidity and mortality in 
tertiary reference centres with a case load more than 100 
patients per year. To analyze if such results are transferable 
by surgical team relocation; fi rst 3 years of the new team 
experienced in pancreatic surgery was compared with a) 
publications of other tertiary reference centres world-wide, 
b) with the last 3 years of the same university clinic before 
specialization in pancreatic surgery.
Methods: All operations were performed in Klinikum 
rechts der Isar – Technische Universität München (TUM). 
Data registered prospectively into a database was analyzed 
retrospectively. All operations were performed by three 
senior surgeons trained previously in a tertiary reference 
centre for pancreatic surgery. Frequency of major morbidi-
ties (MM: fi stula/abscess or bleeding), re-operation and mor-
tality were endpoints.
Results: According to literature, MM and mortality rates 
less than 10% and 4%, respectively can be achieved in ter-
tiary reference centres. In the fi rst period (01.07.2004–
30.06.2007), 104 pancreatic tumor resections were per-
formed in TUM. These operations included 56 classical 
Whipples, 34 pylorus preserving Whipples, 11 left pancreatic 
resections and 3 total pancreatectomies. Pancreatic tumor 
resections almost tripled in the second period (01.07.2007–
30.06.2010) with 293 operations. These operations included 
14 classical Whipples, 144 pylorus preserving Whipples, 73 
left pancreatic resections and 39 total pancreatectomies. In 
addition, in the second period rare pancreatic operations like 
ampullectomy (3), segmental pancreatectomy (5), and pan-
creas preserving duodenum resection (3) as well as multivis-
creal- (30) and vascular-resetions (37) were routinely 
performed. MM was 12.3% and 7% for the fi rst and the 
second periods. Reoperations were 7% and 7.5%, respec-
tively and mortality was 2.1% and 2.4%, respectively.
Conclusion: Pancreatic reference centres with a high case 
load performing routine and complicated pancreatic resec-
tions with low morbidity and mortality rates can be created 
by surgical team relocation.
P0020P
OBSTRUCTIVE JAUNDICE AFTER 
PANCREATODUODENECTOMY – 
INCIDENCE AND MANAGEMENT
W. Eshuis, O. Busch, T. Van Gulik and D. Gouma
Academic Medical Center, Amsterdam, Netherlands
Background: Obstructive jaundice after pancreatoduode-
nectomy (PD) may be the fi rst indication of recurrent or 
progressive disease.
Aim: To describe the incidence, cause, treatment and 
outcome of obstructive jaundice after PD.
Methods: We identifi ed patients with readmissions for 
obstructive jaundice after PD from a prospectively recorded, 
consecutive series of 851 PDs. Diagnosis at pathology in this 
series was pancreatic adenocarcinoma in 35%, ampullary 
adenocarcinoma in 24%, distal common bile duct adenocar-
cinoma in 13%, other (pre)malignant lesions in 14% and 
benign lesions including chronic pancreatitis in 15%. The 
cause, presentation, treatment and outcome of readmissions 
for obstructive jaundice were analyzed.
Results: We identifi ed 43 patients (5%) who were readmit-
ted for obstructive jaundice. Diagnosis at pathology of these 
patients was pancreatic adenocarcinoma in 25 (58%), distal 
common bile duct adenocarcinoma in 7 (16%), ampullary 
adenocarcinoma in 5 (12%), other premalignant lesions in 1 
(2%) and benign lesions including chronic pancreatitis in 5 
(12%). Median time from PD to presentation with obstruc-
tive jaundice was 11 months (range, 4–44). At presentation, 
cholangitis was present in 20 patients (47%). Causes of the 
obstructive jaundice were progressive or recurrent malignant 
disease in 37 patients (86%), stenosis of the hepaticojejunos-
tomy in 4 (9%) and progression of primary sclerosing chol-
angitis in 2 (5%). The initial treatment was drainage (mostly 
external) at percutaneous transhepatic cholangiography 
(PTC) in 31 patients (72%). 9 Patients (21%) were treated 
conservatively and 3 patients (7%) underwent surgical treat-
ment. Median survival after operation in this patient group 
was 16.2 months. Median survival after presentation with 
obstructive jaundice was 2.5 months.
Conclusions: Readmissions for obstructive jaundice after 
pancreatoduodenectomy occurred in 5% of patients, and 
were mostly due to progressive or recurrent malignant 
disease. Patients were mostly treated by drainage at PTC or 
conservative management. Survival after presentation was 
very limited.
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P0021P
ROUTE OF GASTROENTERIC 
ANASTOMOSIS IN 
PANCREATODUODENECTOMY AND 
DELAYED GASTRIC EMPTYING – A 
RETROSPECTIVE ANALYSIS
W. Eshuis, J. W. Van Dalen, O. Busch, T. Van Gulik and 
D. Gouma
Academic Medical Center, Amsterdam, Netherlands
Background: Delayed gastric emptying (DGE) is a frequent 
complication after pancreatoduodenectomy (PD). Some authors 
suggest that an antecolic (compared to retrocolic) route of the 
gastroenteric (GE) anastomosis lowers the incidence of DGE.
Aim: To investigate the relation between route of 
GE-anastomosis and the incidence of DGE after PD.
Methods: In a consecutive series of 203 prospectively recorded 
PDs, the route of GE-anastomosis was established by reviewing 
operation reports. Hospital course and follow-up were prospec-
tively recorded. Patients with antecolic and retrocolic 
GE-anastomosis were compared. Main outcome measure was 
the incidence of DGE according to the International Study 
Group of Pancreatic Surgery criteria. Secondary outcome mea-
sures were other complications and hospital stay.
Results: In 47 patients the route of GE-anastomosis could 
not be determined. Two patients were excluded because they 
had Roux-en-Y reconstruction. Of the remaining 154 
patients, 77 had a retrocolic anastomosis and 77 had an 
antecolic anastomosis. In the retrocolic group, DGE occurred 
in 58% of patients (grades: A, 25%; B, 17%; C, 17%). In the 
antecolic group, 52% had DGE (grades: A, 21%; B, 16%; C, 
16%) (not signifi cant). ‘Primary’ DGE (not due to other 
intra-abdominal complications) occurred in 36% of the ret-
rocolic group and 20% of the antecolic group (p 0.02). 
‘Primary’ clinically relevant DGE (grade B/C) occurred in 
18% and 10%, respectively (p 0.17). There was no difference 
in need for (par)enteral nutritional support, other complica-
tions, mortality or length of stay.
Conclusions: The route of GE-anastomosis had no infl u-
ence on the overall incidence of DGE. Clinically relevant 
DGE (overall and ‘primary’) was not different between the 
retrocolic and antecolic group. ‘Primary’ DGE (any grade) 
was more frequent in the retrocolic group, mainly due to a 
higher incidence of DGE grade A. The preferred route for 
GE-anastomosis in PD remains to be confi rmed in a well-
powered randomized trial.
P0022P
ABDOMINAL WALL METASTASIS FROM 
PANCREATIC CARCINOMA TREATED 
WITH ELECTROCHEMOTHERAPY 
(ECT): REPORT OF TWO CASES
A. Giardino1, I. Frigerio1, R. Girelli1, R. Salvia2,1, P. T. 
Martini3, E. Barbi3 and C. Bassi2,1
1HPB Unit-Casa Di Cura Pederzoli, Peschiera Del Garda, 
Italy; 2Surgical and Gastroenterological Department, 
University of Verona, Verona, Italy; 3Radiology 
Department-Casa Di Cura Pederzoli, Peschiera Del 
Garda, Italy
Introduction: The standard therapy for many unresectable 
solid tumors is Chemo-Radiotherapy (CTRT). The major 
problem of citolitic agents with intracellular site of action is 
the correct penetration of the drug through membrane. ECT 
is a new ablation modality which provides delivery of the 
non- permeant drugs into cell by local application of short 
and intense electric pulse that transiently increases mem-
brane permeability (electroporation). In literature there are 
few studies regarding its application in case of melanoma, 
mammarian cancer relapse and other cutaneous carcinomas. 
We report two cases of abdominal wall metastasis of pancre-
atic carcinoma treated with ECT.
Case report: Case 1: A 68 yo woman previously treated 
with Radiofrequency Ablation of stage III pancreatic head 
carcinoma presented, 8 mts after surgery, complaining the 
onset of a small nodule under the surgical scar. US and FNA 
showed a 3.2 cm metastatic carcinoma. The patient was 
treated under sedation with intravenous injection of 24 mg 
of Bleomicin (15000 U/m²) followed by 8 applications of 
electroporation (EP). US in the fi rst post-operative day 
showed subcutaneous oedema with micro bubbles of air. The 
post-operative course was uneventful and the patient was 
discharged after 2 days.
Case 2: A 81 yo woman previously treated with distal pan-
createctomy and splenectomy for stage II pancreatic tail car-
cinoma (T2N1, G2), complained, 4 mts later, the onset of a 
small subcutaneous nodule in the upper left abdominal wall. 
US and FNA showed a 2 cm metastatic nodule. The patient 
was treated under sedation with intravenous injection of 
22 mg of Bleomicin (15000 U/m2) followed by 5 applica-
tions of EP. US in fi rst post-operative day showed oedema 
with micro bubbles of air. The post-operative course was 
uneventful and she was discharged after 2 days. In both cases 
1 month follow-up with US and MRI showed partial reduc-
tion of the treated nodule.
Conclusions: ECT is an innovative procedure potentially 
useful for pancreatic cancer. We report the fi rst two cases 
applied to pancreatic carcinoma metastasis in order to test 
the sensitivity to Bleomicin of pancreatic cancer cells. 
Further studies are needed to test ECT in unresectable pan-
creatic cancer.
P0023P
DOWNSTAGING AFTER 
RADIOFREQUENCY ABLATION OF 
STAGE III PANCREATIC CANCER CAN 
LEAD TO R0 RESECTION
I. Frigerio1, G. Alessandro1, R. Girelli1, R. Salvia2,1, 
P. Capelli3 and C. Bassi2,1
1HPB Unit, Casa di Cura Pederzoli, Peschiera del Garda, 
Italy; 2Surgical and Gastroenterological Department, 
University of Verona, Verona, Italy; 3Pathology 
Department, University of Verona, Verona, Italy
Introduction: downstaging in Stage III pancreatic carci-
noma (LAPC) is an event which occurs in 10–20% of patients 
after standard chemo-radiotherapy. Radiofrequency ablation 
(RFA) has been recently demonstrated as safe and feasible 
in non-methastatic and non-resectable ductal carcinoma.
Patients and methods: all patients with LAPC encounting 
inclusion criteria were enrolled for the study and received 
RFA, during laparotomy, associated with palliative surgery 
when needed. All patients were sent to the oncologist to 
complete the treatment with chemo-radiation and follow up 
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(FU) was carried on with CT scan, MRI and Ca19.9 every 3 
months. If radiological signs of signifi cative downstaging 
were detected a second look was proposed.
Results: Between February 2007 and June 2010 one 
hundred patients were treated with RFA and palliative 
surgery (50 pts) or alone (50 pts) and then sent to the oncolo-
gist. In ten cases, because of a signifi cative radiological 
reponse, a re-laparotomy was proposed. In 6/10 patients 
resection was not carried out due to massive fi brosis whereas 
no signs of residual tumour were detected: in these patients 
a second RFA was an alternative option. In the other 4 cases 
resection was completed: pancreaticoduodenectomy in 3 pts 
and distal pancreatectomy in one patient. Median interval 
between RFA and resection was 10 months. In three out of 
four cases a R0 resection was obtained. Post operative TNM 
reduced from T4 neoplasms to T1 (2 cases), T2 (1 case) and 
T0 (1 case). One patient died for disease after 26 months 
from RFA. One patient is alive with hepatic progression 38 
months after RFA and 24 months after resection. Two patients 
are alive disease free 37 and 20 months after RFA and 22 
and 12 months after resection respectively. Median survival 
of resected patients is 31 months.
Conclusions: RFA may be part of the multidisciplinary 
treatment for Stage III ductal pancreatic carcinoma. 
Downstaging of disease is a possible event occurring after 
RFA but the surgeon must know that RFA induced fi brosis 
may become an signifi cant obstacle to gain resection. This 
is the fi rst report where histology of surgical specimen of 
RFA-treated tumor has been analysed.
P0024P
ONE HUNDRED CONSECUTIVE 
PATIENTS TREATED WITH 
RADIOFREQUENCY ABLATION FOR 
STAGE III PANCREATIC CANCER: 
RESULTS FROM A SINGLE INSTITUTION
R. Girelli1, I. Frigerio1, A. Giardino1, R. Salvia2,1, C. 
Bassi2,1 and P. Pederzoli2
1HPB Unit, Pederzoli Clinic, Peschiera Del Garda, Italy; 
2Surgical and Gastroenterological Unit, University of 
Verona, Verona, Italy
Introduction: Radiofrequency ablation (RFA) is a local 
ablative method which use radiofrequency wave to apply 
high temperature inside a tumor to cause thermal coagulation 
and protein denaturation. In a recent publication we demon-
strated feasibility and safety of RFA in stage III pancreatic 
cancer (PC). Here we present our series of patients consecu-
tively treated with RFA.
Patients and methods: Patients with Stage III PC were 
prospectively enrolled for the study. RFA was performed 
during laparotomy and associated to palliative surgery when 
needed. Pancreatic fi stula, duodenal injuries and thrombosis 
of portal vein or superior mesenteric vein were considered 
as RFA-related complications. After surgery all patients were 
sent to the oncologist to receive chemo and radiotherapy 
(CTRT) and follow up was updated every 3 months.
Results: Between February 2007 and March 2010, 100 
patients with stage III PC were consecutively treated with 
RFA in our institution. M/F ratio was 55/45 and the median 
age was 64 yrs. Tumor was located in the head/uncinate 
process in 64 cases. The other 52 patients underwent neoad-
juvant therapy. During RFA 54 patients had associated 
surgery. Postoperative course was uneventful in 74 cases. 
Systemic complications occurred in 2 pts and abdominal in 
24 pts; 15 of which were related to RFA and 9 related to 
associated surgery. Mortality was 2%. At present follow up 
38 pts died for tumor progression and 4 pts due to unknown 
causes. Eighteen patients are alive with progression, 36 are 
progression free.
Conclusions: RFA might be a new option to treat patients 
with Stage III PC and must be associated with chemo and 
radiotherapy. Further studies are needed to investigate its 
possible role as part of a multimodal adjuvant treatment.
P0025P
THE ROLE OF LIVER RESECTION OF 
METASTASES FROM GASTRIC 
CARCINOMA: EVIDENCE BASED OR 
JUST INDIVIDUAL CASE DECISIONS. A 
SYSTEMATIC REVIEW AND META-
ANALYSIS FROM 1990 TO 2010
M. M. E. Coolsen1, R. M. van Dam1, A. A. van der Wilt1, 
L. J. H. van Wersch1, L. P. S. Stassen1, I. H. de Hingh3, U. 
P. Neumann2, C. H. C. Dejong1 and L. A. Heijnen1
1Dept. of Surgery Maastricht UMC, Maastricht, 
Netherlands; 2Dept. of Surgery Universitatsklinikum 
Aachen, Aachen, Germany; 3Dept. of Surgery Catharina 
Hospital Eindhoven, Eindhoven, Netherlands
Introduction: Prophylactic abdominal drainage after pan-
creaticoduodenectomy has been standard of care for many 
years. However, recent studies assessing the effi cacy of such 
drains show these drains seem to have no advantage over 
avoiding prophylactic postoperative drainage or show that 
the use of such drainage may even be harmful.
Methods: The PANDA trial is a multicentre, randomized 
controlled trial comparing prophylactic postoperative 
drainage versus a no drain policy within an Enhanced 
Recovery After Surgery pathway for patients undergoing 
pancreaticoduodenectomy.
Endpoints: Primary outcome is the number of (re-)inter-
ventions, specifi cally for pancreaticojejunostomy-, gastroje-
junostomy- or hepaticojejunostomy related complications as 
leakage, abscess, intra-abdominal fl uid collections and post-
operative haemorrhage. Re-interventions are defi ned as the 
administration of antibiotics, endovascular coiling or stent-
ing, ultrasound or CT guided drainage or relaparotomy.
The secondary outcomes are time to recovery, reasons for 
delay in discharge, complications, readmissions, mortality 
and total length of hospital stay.
Discussion: Recent studies suggest the use of prophylactic 
abdominal drainage after pancreaticoduodenectomy may be 
abandoned. The PANDA trial will provide more evidence on 
the value of prophylactic abdominal drainage after 
pancreaticoduodenectomy.
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P0026P
PROPHYLACTIC 
GASTROENTEROSTOMY FOR 
UNRESECTABLE ADVANCED 
PANCREATIC CANCER – A SYSTEMATIC 
REVIEW AND META-ANALYSIS
N. Hüser, C. Michalski, J. Kleeff and H. Friess
Klinikum rechts der Isar, Munich, Germany
Background: The value of a prophylactic gastroenteros-
tomy (usually combined with a biliary bypass) in patients 
with unresectable cancer of the pancreatic head is a subject 
of controversy.
Methods: A systematic review of the literature (retro- and 
prospective studies) and a meta-analysis of the prospective 
studies on the use of prophylactic gastroenterostomy for 
unresectable pancreatic cancer were performed.
Results: Analysis of retrospective studies did not reveal a 
clear advantage/disadvantage for a prophylactic gastroenter-
ostomy. Three prospective studies comparing a prophylactic 
gastroenterostomy plus biliodigestive anastomosis versus no 
bypass or a biliodigestive anastomosis alone were identifi ed 
(altogether 218 patients). In the group of patients with a 
prophylactic gastroenterostomy, the chance of gastric outlet 
obstructions during follow-up was signifi cantly lower (odds 
ratio, OR = 0.06, 95%-confi dence interval, CI = 0.02 to 0.21, 
p < 0.001), whereas the rates of postoperative delayed gastric 
emptying were comparable (OR = 1.93, 95%-CI = 0.57 to 
6.53, p = 0.290). There were no signifi cant differences in 
morbidity and mortality. The length of hospital stay follow-
ing prophylactic gastroenterostomy was estimated to be 3 
days longer than for patients without bypass (weighted mean 
difference = 3.1, 95%-CI = 0.7 to 5.5; p = 0.010).
Conclusion: Prophylactic gastroenterostomy should be per-
formed during the exploration of patients with unresectable 
pancreatic head tumors because it reduces the incidence of 
long-term gastroduodenal obstruction without impairing 
short-term outcome.
P0027P
PANCREATICODUODENECTOMY WITH 
EXTENDED LYMPHADENECTOMY VS. 
PYLORUS-PRESERVING 
PANCREATICODUODENECTOMY WITH 
STANDARD LYMPHADENECTOMY IN 
THE SURGICAL TREATMENT OF 
PANCREATIC HEAD CARCINOMA
I. Ignjatovic, D. Knezevic and S. Knezevic
Clinical Center of Serbia, belgrade, Serbia, Serbia
Objectives: The aim of this study was to register and 
compare postoperative mortality and morbidity rates as well 
as long-term survival in patients after classic (Whipple) pan-
creaticoduodenectomy with extended lymphadenectomy and 
pilorus-preserving pancreaticoduodenectomy with standard 
lymphadenectomy.
Materials and methods: Study was conducted at Clinic for 
Digestive Surgery in the Clinical Center of Serbia, Belgrade, 
from January 2003 until December 2009. We have operated 
on 60 patients with pancreatic head carcinoma. All patients 
underwent radical surgery which assumed pancreaticoduo-
denectomy-PD. Patients were divided into 2 groups with 30 
patients in each group. First group of patients underwent 
classic PD (Whipple’s procedure) with extended lymphade-
nectomy (EL). Patients in the second group underwent pilo-
rus-preserving PD (PPPD) with standard lymphadenectomy 
(SL).
Results: The rates of postoperative complications were 
higher in a group of patients which underwent classic PD 
with EL. Overall morbidity in this group was 40% compared 
to 16% in a group which underwent PPPD with SL (p < 
0.05). Postoperative mortality rates were similar between 
groups with 2 postoperative deaths in PD-EL and 1 postop-
erative death in PPPD-SL group. 5-year survival in PD-EL 
group was 7.1% compared to 6.9% in PPPD-SL group 
(p > 0.05).
Conclusion: Extended lymphadenectomy does not improve 
long-term survival but it carries a greater risk of postopera-
tivne complications such as DGE or postoperative hemor-
rhage. PPDP and classic PD are in every way equally 
adequate procedures. Therefore, PPDP with standard lymph-
adenectomy should be a gold standard in the surgical treat-
ment of pancreatic head carcinoma.
P0028P
PERIOPERATIVE AND LONG-TERM 
RESULTS OF LAPAROSCOPIC SPLEEN 
PRESERVING DISTAL 
PANCREATECTOMY WITH 
OR WITHOUT SPLENIC VESSELS 
RESECTION
M. Inama, G. Butturini, G. Malleo, R. Manfredi, G. 
Melotti, S. Perandini, A. Cavallini, P. Pederzoli and 
C. Bassi
Medical University of Verona, Verona, Italy
Context: Growing interest in the immunological role of the 
spleen, led surgeons to avoid splenectomy during Distal 
Pancreatectomy for benign tumors. Surgical techniques for 
spleen-preserving distal pancreatectomy (SPDP) include 
conservation of the splenic vessels (SPDP-SVP) or their 
resection with preservation of the short gastric vessels 
(SPDP-SVR).
Objective: To describe our experience with laparoscopic 
SPDP and to compare perioperative and long-term outcome 
of patients who underwent SPDP-SVP and SPDP-SVR.
Methods: We retrospectively analyzed demographic, 
pathology, surgical details and long-term outcomes of 
patients who underwent laparoscopic SPDP from January 
1999 to December 2007 at our. 
Institution: Follow-up included a thorough medical exami-
nation, routine blood tests, and a contrast-enhanced CT-scan 
or a magnetic resonance imaging at 1 year from the index 
operation. Follow-up was stopped in October 2009.
Results: We performed 43 SPDP for benign tumors. 
Mortality was nil. Median operative time was 160 minutes 
(75–310). The rate of abdominal complications and of pan-
creatic fi stula was 51.1% and 32.5% respectively. SPDP-SVP 
were 36, SPDP-SVR were 7. No signifi cant differences were 
observed between the two techniques as per demographic 
and surgical details. One patient in SPDP-SVR group 
required splenectomy on postoperative 10 for splenic infarc-
tion. In SPDP-SVP group 3 patients needed reoperation. In 
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particular, a splenectomy for splenic infarction and two 
drainage operations for infected collections were performed. 
17 patients accepted the follow-up protocol (4 in SPDP-SVR 
and 13 in SPDP-SVP group). At 12 months, perigastric 
varices were found in 3 patients (75.0%) after SPDP-SVR 
and in 2 patients (15.3%) after SPDP-SVP (p = 0.052). No 
gastrointestinal bleeding was observed at a median follow-up 
of 44 months (31–102).
Conclusion: SPDP is safe, either with SVP and SVR. 
However, a moderate risk of postoperative splenic infarction 
has to be taken into account. The formation of perigastric 
varices has to be interpreted as a paraphysiologic phenom-
enon after SVR.
P0029P
CYSTIC TUMOR OF THE PANCREAS. 
CASE REPORT
J. Iniesta, F. Bersano, G. Moriconi, M. Lenz and J. Pekolj
Hospital Italiano de Buenos Aires, Capital Federal-Buenos 
Aires, Argentina
Introduction: Mucinous cystic neoplasm is composed of 
mucin-producing epithelial cells, associated with an ovarian-
type stroma. Most originate in women (95%), although there 
are documented cases in men, as is ours. Mean age 45, the 
most frequent symptoms are due to the size of the intra-
abdominal mass.
Materials and methods: Male, 53 years old. Admitted to 
the hospital with sings and symptoms of acute cholangitis.
Pathological background: diabetes, hypothyroidism, acute 
gallstone pancreatitis and pancreatic pseudocyst (2000). 
Surgical history: cholecystectomy and cyst-jejunal anasto-
mosis (2000). Lab tests and serum tumor markers within 
normal limits.
CT scan 64 slices CT scan 64 slices: Cystic neoplasm of 
96 × 93 mm with internal septums and contrast enhanced 
walls, in contact with the aorta, left renal vein and Inferior 
Vena Cava. Superior mesenteric vein compressed and dis-
placed to the left with preservation of the superior mesenteric 
artery. Choledochal stenosis by extrinsic compression. Total 
pancreatoduodenectomy with vascular resection (superior 
mesenteric-portal vein confl uence) + partial gastrectomy, 
with porto – superior mesenteric vein anastomosis + hepati-
coyeyunostomy + feeding jejunostomy.
Evolution: Re-laparotomy at postoperative day 5 because 
of intestinal occlusion due to jejunostomy volvulous. 
Discharged at Postoperative day 16. Histopathology: 
Mucinous adenocarcinoma of the pancreas. T3N0Mx. Satage 
IIB.
Comments: One third of the mucinous cystic neoplasms of 
the pancreas are associated with invasive carcinoma. 
Complete surgical resection is the only way to determine 
whether a mucinous cystic neoplasm is benign or malignant. 
The survival rate is approximately 67% at 2 years and 50% 
at 5 years after surgical treatment.
P0030P
INTEGRATED PET/CT IN DIAGNOSTIC 
WORKUP OF PANCREATIC AND 
BILIARY TRACT CANCER
R-L. Jacobsen1,2, A. C. Larsen1, R. V. Fisker2, M. Kubik2, 
M. Sall1, V. W. Iyer2 and O. Thorlacius-Ussing1
1Department of gastroenterological surgery, Aalborg 
Hospital, Aarhus Universityhospital, Aalborg, Denmark; 
2Department of nuclear medicine, Aalborg hospital, Aarhus 
University Hospital, Aalborg, Denmark
Introduction: More studies demonstrate that Positron 
Emission Tomography/Computed Tomography (PET/CT) is 
useful in diagnosing gastrointestinal cancer. PET/CT is 
optional to use in standard diagnostic workup of pancreatic 
or biliary tract cancer and it remains to be demonstrated that 
PET/CT is indicated in the primary diagnosis of these 
cancers.
The present study evaluated the additional information 
from PET/CT by comparing with the CT component of PET/
CT.
Methods: From January 2008 to February 2010 123 patients 
admitted to the Department of Surgical Gastroenterology 
with a tentative diagnosis of pancreatic or biliary tract cancer 
underwent integrated thoracic-abdominal PET-CT. Scans 
were interpreted by an experienced nuclear medicine physi-
cian and a radiologist.
Results: Nine patients had inconclusive scans and were 
excluded. In 114 patients 63 got a defi nitive diagnosis of 
pancreatic or biliary tract cancer made by biopsy, resection 
or 6 months of clinical follow up. PET/CT demonstrated a 
malignant tumor in 55 of the 63 patients (87%), whereas the 
CT scan demonstrated a malignant tumor in 51 of the 63 
patients (81%).
Furthermore PET/CT incorrectly demonstrated a malig-
nant tumor in 11 patients and CT in 9 patients.
Sensitivity of PET/CT was 87% and specifi city 78% with 
a positive predictive value (PPV) of 83% and a negative 
predictive value (NPV) of 83%. Sensitivity of CT was 81% 
and specifi city 82%. PPV of CT was 85% and NPV 78% In 
109 out of 114 Clinical TNM staging was possible. Metastasis 
was seen in 41 out of 109 patients. Overall PET/CT demon-
strated correctly 25 out of 41 to have disseminated cancer 
and 65 correctly not to have cancer. 16 with disseminated 
cancer were not found and 3 were suspicious of metastasis 
but proven not to have it. Sensitivity for metastasis was 61% 
and specifi city 96%. PPV of PETCT proving metastasis was 
89% and NPV was 80%.
Conclusion: PET/CT has a small positive contribution in 
demonstrating primary malignant tumor of the pancreas or 
biliary tract compared to CT alone. PET/CT seems to add 
information in staging of these cancers.
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P0031P
CPX (CARDIOPULMONARY EXERCISE 
TESTING) AS A MEANS OF PRE-
OPERATIVE RISK ASSSESSMENT PRIOR 
TO PANCREATICODUODENECTOMY
M. Junejo1, A. Sheen1, D. Atkinson2, J. Moore2, P. Foster2, 
M. Parker2 and A. Siriwardena1
1The Manchester Hepato-Pancreato-Biliary Centre. 
Manchester Royal Infi rmary., Manchester, United 
Kingdom; 2Department of Anaesthesia and Critical Care, 
Manchester Royal Infi rmary, Manchester, United Kingdom
Introduction: Pancreaticoduodenectomy (PD) is the stan-
dard of care for non-metastatic tumours confi ned to the pan-
creatic head and can be undertaken with low in-hospital 
mortality. As pancreatic cancer is predominantly a disease of 
later life, many with the disease have considerable cardio-
vascular co-morbidity and this is likely an increasing trend. 
CPX offers a dynamic, combined, functional test of cardio-
pulmonary reserve. This study evaluates CPX for cardiopul-
monary risk assessment test prior to PD.
Methods: In the 28 months from 1st September 2007 to 31st 
December 2009, 83 patients underwent pancreaticoduode-
nectomy. Patients with known co-morbidity and those aged 
over 65 were evaluated preoperatively with CPX. 44 (53%) 
underwent CPX prior to surgery and 41 of these underwent 
PD (3 patients had advanced disease at operation). Median 
age in CPX patients was 66 (45–78) and in the non-CPX 42 
patients median age was 50 (37–74) [P < 0.0001 Mann-
Whitney U-test]. There was 1 death in the CPX group and 2 
in the non-CPX group (overall mortality 3.6%).
Results: Anaerobic threshold (AT) did not predict cardio-
vascular complications, post-operative morbidity or outcome 
(for comparison, neither did revised cardiac risk index). 
However a pre-operative VE/VCO2 > 34 was strongly pre-
dictive of post-operative death with a receiver operator curve 
area under curve of 0.974. VO2/HR was predictive of High 
Dependency Unit stay (p 0.039).
Conclusion: Contemporary perioperative assessment must 
offer accurate risk assessment to address the high morbidity 
in a low mortality operation. These preliminary data suggest 
that CPX may offer an objective test of peri-operative risk 
for pancreaticoduodenectomy.
P0032P
DISTAL PANCREATECTOMY – THE 
SIGNIFICANCE OF 
PANCREATOENTERAL ANASTOMOSIS 
VERSUS DIRECT CLOSURE OF THE 
PANCREATIC REMNANT
F. Klein, M. Glanemann, G. Puhl, P. Neuhaus and 
M. Bahra
Department of General, Visceral, and Transplantation 
Surgery, Charité Campus Virchow, Universitätsmedizin, 
Berlin, Germany
Background: A major complication of distal pancreatec-
tomy is the formation of postoperative pancreatic fi stula. 
Despite numerous surgical techniques the incidence of pan-
creatic fi stula could not be reduced. The aim of this study is 
to compare the performance of a pancreatoenteral anastomo-
sis (PE) versus a direct closure of the pancreatic stump (DC) 
with the main focus on postoperative morbidity and 
mortality.
Methods: 198 patients, who underwent a distal pancreatec-
tomy between 2002 and 2010 were retrospectively analyzed 
for postoperative morbidity (according to Clavien) and 
mortality.
Results: In 151 patients (76.3%) the pancreatic remnant was 
closed. In 47 patients (23.7%) a pancreatoenteral anastomo-
sis was performed either as a pancreatojejunostomy or as a 
pancreaticogastrostomy. The incidence of a pancreatic fi stula 
was signifi cantly higher in the DC-group than in the PE-group 
(21.9% vs. 10.6%), whereas the rate of postoperative hemor-
rhage was signifi cantly higher in the PE-group (10.6%) then 
in the DC-group (7.3%). After direct closure of the pancre-
atic remnant a signifi cant higher incidence of major postop-
erative complications > Clavien II was observed than in the 
PE-group (25.83% vs. 17.02%). The median hospital stay, 
the operation time, the rate of reoperations and the postopera-
tive mortality rate did not differ between the groups.
Discussion: The incidence of postoperative pancreatic 
fi stula formation can be signifi cantly reduced by the perfor-
mance of a pancreatoenteral anastomosis. Also especially the 
pancreatogastrostomy is distinguished by a good learn ability 
and feasibility as well as by the endoscopic accessibility of 
the anastomosis. Therefore the performance of a pancreato-
enteral anastomosis after distal pancreatectomy should be 
individually evaluated to reduce the incidence of postopera-
tive pancreatic fi stula formation.
P0033P
SURGERY REMAINS THE BEST OPTION 
FOR THE MANAGEMENT OF PATIENTS 
WITH CHRONIC PANCREATITIS: A 
SYSTEMATIC REVIEW
C. Kyriakides1, A. E. Frampton1, P. Limongelli1, D. 
Westaby2, P. Vlavianos2 and L. R. Jiao1
1HPB Surgical Unit, Dept. of Surgery & Cancer, Imperial 
College, London, United Kingdom; 2Dept. of 
Gastroenterology, Imperial College NHS Trust, London, 
United Kingdom
Objective: Controversy related to endoscopic or surgical 
management of patients with chronic pancreatitis (CP) 
remains due to the lack of adequately powered randomized 
control trials. A systematic review of the published data was 
carried out to address issues related to the outcome and 
choice of treatment for CP.
Methods: A search of published articles on the endoscopic 
or surgical treatment of CP from January 1994 to December 
2009 was performed. Search engines of MEDLINE, 
EMBASE and the Cochrane Collaboration database were 
used with keywords such as CP, endoscopic, stenting, surgi-
cal, drainage, resection, pancreaticojejunostomy, Whipple in 
various combinations. Meta-analysis was performed on 
studies fulfi lling the selection criteria with data on morbidity, 
mortality and pain control.
Results: A total of 19 articles were included in the statistical 
analysis which fulfi lled the selection criteria. Only two arti-
cles were randomized trials (RCT). Analysis of these two 
RCTs (n = 179) revealed that surgical treatment was signifi -
cantly better than the endoscopic option for either complete 
pain resolution or partial pain resolution (P < 0.0001). 
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Seventeen non-RCT publications with a total of 2496 patients 
were identifi ed. Analysis of the pooled data showed that 
complete and partial pain control was achieved in the surgi-
cal group in 58.3% and 21.7% patients respectively whilst in 
the endoscopic group in 64.0% and 8.5% respectively. 
Complications were higher (19.3%) in the surgical group 
compared to the endoscopic group (12.8%) including chole-
cystitis, pancreatitis, bleeding, leakage, infection and death.
Conclusion: Surgery remains the most effective treatment 
for CP, with a higher proportion of patients achieving lasting 
pain relief.
P0034P
HEMOBILIA AS ONE OF THE 
PRESENTATION OF HEMORRHAGE 
AFTER PANCREATODUODENECTOMY
T. J. M. Lalisang, Y. Mazni, R. Y. Saunar, A. Nugroho, B. 
Philippi and A. Simanjuntak
Division of Digestive Surgery, Department of Surgery, 
Faculty of Medicine, University of Indonesia/Cipto 
Mangunkusumo Hospital, Jakarta, Indonesia
Background: Postoperative hemorrhage, particularly early 
or delayed hemorrhage after pancreatoduodenectomy (PD), 
is a serious complications and one of the leading cause of 
mortality. The purpose of this study was to analyze the inci-
dent, presentation and management of post PD hemorrhage, 
to better defi ne treatment options in the future.
Methods: From January 2007 to April 2010, 45 patients 
underwent PD and were analyzed with regard to postopera-
tive hemorrhage.
Results: Hemorrhage occurred in 9 patients (20%), all with 
delayed phase. The bleeding sources were at the raw surface 
of pancreas in 2 patients and exactly 2 hemobilia cases were 
detected. Portal vein bleeding on 2 cases, 2 at the gastroje-
junostomy side and one at the abdominal wall. Five patients 
underwent relaparotomy and 4 patients had successfuly 
treated conservatively. 7 mortal cases occur and mostly after 
reoperation.
Conclusion: Hemobilia, as one of the presentation of hem-
orrhage after PD, is associated with a high mortality, if fol-
lowed with reoperation.
P0035P
HOW TO PREVENT AND MANAGE THE 
PANCREATIC ANASTOMOTIC LEAKAGE 
IN PANCREATIC SURGERY
T. J. M. Lalisang, Y. Mazni, R. Y. Saunar, A. Nugroho, 
B. Philippi and A. Simanjuntak
Division of Digestive Surgery, Department of Surgery, 
Faculty of Medicine, University of Indonesia/Cipto 
Mangunkusumo Hospital, Jakarta, Indonesia
Pancreatic leak was one of the common complications 
leading to death if not managed adequately. The incidence 
of this leak was stable around 7–10% worldwide even in top 
center. The objective of this study were to know how to 
prevent and manage pancreatic leak.
Our data recorded 20 pancreatic fi stula out of 106 pancreti-
coduodenal resection, in the fi rst 50 cases, 16 pancreatic fi stula 
occur, in which 14 of them healed spontaneously within 14–21 
days and the rest 2 cases underwent reoperation. In the last 6 
cases, only two cases needed reoperation. The anastomosis 
was performed to the proximal end raw surface of the pan-
creas, directly with the pancreatic duct if it is small. Double 
layer suture techniques with PDS 3-0 and without tension 
approximation were done. Stent to pancreatic duct were used 
very seldom at the beginning but nowadays never been used. 
Single drainage tube were put near the anastomosis side which 
guaranty an adequate drainage of pancreatic fl uid or blood. 
Medical therapy was never been used to depress the pancreatic 
exocrine functions in the last 50 cases.
In conclusion, good haemostatic, double layer anastomo-
sis and loose jejunal loop with adequate preparation of the 
pancreatic remnant will decrease the anastomosis leak. 
Adequate and good drainage of the pancreatic leak fl uid will 
also prevent the worsening of the leakage that might end up 
with increase mortality.
P0036P
THE INFLUENCE OF ERCP IN THE 
INTERPRETATION OF INTEGRATED 
PET-CT IN PANCREATIC AND BILE 
DUCT CANCERS
A. C. Larsen1, R-L. Jacobsen1, M. Kubik2, R. V. Fisker2, P. 
Ejstrud1, V. W. Iyer2 and O. Thorlacius-Ussing1
1Department of gastroenterological surgery, Aalborg 
Hospital, Aarhus University Hospital, Aalborg, Denmark; 
2Department of nuclear medicine, Aalborg hospital, aarhus 
University hospital, Aalborg, Denmark
Background: Integrated Positron Emissions Tomography 
and Computer Tomography scanning (PET-CT) is effective 
in demonstrating recurrence of various cancers. In Denmark 
PET-CT is optional in the primary diagnostic work up of 
Pancreatic Cancer (CP) and Bile Duct Cancer (BDC). These 
patients often undergo therapeutic endoscopic retrograde 
cholangiopancreatography (ERCP) where strictures in the 
common bile duct are treated with stenting. The periductal 
infl ammation caused by these stents may infl uence on inter-
pretation of the PET-CT.
Material: From January 2008 to February 2010 123 patients 
suspicious of CP or BDC, where diagnosed and staged with 
PET-CT, upon referral to hospital. Nine inconclusive cases 
where excluded and among the rest 65 had cancer (biopsy 
proven, resection or clinically follow in 6 months). The 
remaining suffered from other cancers or benign disorders. 
31 had primarily ERCP with stent before the PET-CT.
Results: In the group with stenting before PET-CT (N = 31), 
18 CP or BDC was correctly diagnosed and 4 as not being 
one of these cancers. Four cancers were not detected. 
Sensitivity was 81.8% and specifi city 45.0%. Positive pre-
dictive value (PPV) was 78.3% and negative predictive value 
was 50.0%.
PET-CT correctly diagnosed 37 CP or BDC in the other 
group with primarily PET-CT (N = 83) and correctly diag-
nosed 36 as other cancers or benign disorders. Six cancers 
were no detected. Sensitivity in absence of a bile duct stent 
was 90.2% and specifi city 86.0%. PPV was 86.1% and NPV 
90.0%.
Conclusion: This small material shows a benefi t of PET-CT 
before ERCP with bile stent in the primarily staging of 
Pancreatic Cancer or Bile Duct Cancers.
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P0037P
PANCREATIC DEBRIDEMENT: HAVE 
RESULTS IMPROVED?
K. Lee, D. Yadav, J. Moser and H. Zeh
University of Pittsburgh, Pittsburgh, PA, United States
Introduction: Pancreatic debridement (PD) procedures 
have been associated with signifi cant mortality and morbid-
ity. We reviewed a ten-year experience with PDs to deter-
mine contemporary outcomes from such procedures.
Methods: All patients undergoing PDs in a tertiary medical 
center between 1/1/00 and 9/9/09 were identifi ed from an 
electronic database.
Results: 99 patients ranging in age from 21 to 85 years 
(median 57) underwent PDs. The most frequent etiologies of 
the pancreatitis were gallstones (52), alcohol (13), post-
ERCP (6), hypertriglyceridemia (3), and indeterminate (16). 
The most frequent Indications for surgery were infected 
necrosis (75), multiorgan system failure (9), and other 
intraabdominal infections or perforated viscus (5). The inter-
val between onset of pancreatitis and the PD ranged from 0 
to 120 days. Debridements for infected necrosis were per-
formed as early as 4 days and as late as 120 days after onset 
of pancreatitis (median 40 days). Seven patients underwent 
surgical debridement after failing prior treatment with per-
cutaneous drains. 59 patients underwent additional debride-
ment procedures (range 1–10, median 1). Eleven patients 
(11%) died. Sixty seven patients required extended post dis-
charge care (long term acute care, inpatient rehabilitation, or 
skilled nursing) and 20 patients were discharged to home. A 
shorter interval between onset of pancreatitis and surgery 
was associated with a need for multiple debridement proce-
dures (28 vs. 45 days; p < 0.05) and extended care (31 vs. 
45 days; p < 0.05).
Conclusions: PD procedures are associated with encourag-
ing mortality rates, although morbidity remains substantial 
and postoperative recovery remains lengthy. Current non-
operative treatment of pancreatitis may prevent or delay the 
timing of such procedures. If surgery then becomes neces-
sary, such delays may be benefi cial as operative management 
and patient recovery may be facilitated.
P0038P
FIBRIN GLUE MAY REDUCE 
PANCREATIC LEAK FOLLOWING 
WHIPPLE’S 
PANCREATICO-DUODENECTOMY
R. Lochan and B. Jaques
Department of Hepato-Pancrea-Biliary Surgery, Freeman 
Hospital, Newcastle Upon Tyne, United Kingdom
Aim: Leakage from the pancreatic anastomosis is a major 
contributor of morbidity following Whipple’s operation. 
Numerous methods of minimising this risk have been 
explored. We sought to assess the utility of fi brin glue sealant 
as an adjunct to a sutured pancreatico-jejunostomy.
Methods: Our hospital acts as a tertiary referral centre for 
elective and emergency hepato-pancreato-biliary surgery. 
The unit performs over 100 elective pancreatic resections 
annually. Pancreatico-jejunostomies performed as part of 
Whipple’s pancreatico-duodenectomy under the care of a 
single consultant surgeon were either sealed with fi brin glue 
or washed with saline on an alternate basis following 55 
consecutive Whipple’s performed from October 2008–2010. 
All Pancreatico-jejunostomies were fashioned uniformly 
using 4-0 PDS suture. Every patient had 3 surgical drains 
placed in the same anatomical locations and drain effl uent 
analysed for amylase daily following operation from the 3rd 
post operative day. Drains were routinely removed on day 8 
post operation. All care was standardised and all complica-
tions recorded prospectively. Pancreatic leak has been 
defi ned as a drain amylase more than 3 times normal serum 
levels in any drain measured up to the 8th postoperative day. 
Complications have been graded according to the Clavien 
classifi cation and International Study Group on pancreatic 
Fistula (ISGPF).
Results: 3 of 28 (10.7%) of anastomoses which were sealed 
with fi brin glue leaked, whereby 5 of 27 (18.5%) in the saline 
group displayed pancreatic leaks. In the group that were 
sealed, 1 patient required treatment with Octreotide (Clavien 
2, ISGPF B) and the other 2 were treated conservatively 
(Clavien 1, ISGPF A). In the non-glue group, 4 of the leaks 
were Clavien A and the 5th required surgical treatment 
(Clavien 4, ISGPF C). There were no mortalities.
Conclusion: Fibrin glue can be used easily as an adjunct to 
sutured pancreatico-jejunostomy and may reduce the occur-
rence of pancreatic leak. The severity of leak as graded by 
Clavien does not appear affected by the use of fi brin 
glue.
P0039P
ENDOSCOPIC TRANSMURAL DRAINAGE 
OF PSEUDOCYSTS ASSOCIATED WITH 
PANCREATIC RESECTIONS OR 
PANCREATITIS: A COMPARATIVE 
STUDY
A. Cavallini, G. Malleo, G. Butturini, G. Angelini and 
C. Bassi
Department of Surgery, G.B. Rossi Hospital, University of 
Verona, Verona, Italy
Background: Endoscopy has been regarded as an effective 
modality for draining pancreatic collections, pseudocysts 
and abscesses. This study analyzes our experience with endo-
scopic transmural drainage of pancreatic pseudocysts and 
compares the outcomes in patients with post-surgical and 
pancreatitis-associated ones.
Methods: Patients who underwent endoscopic drainage of 
a pancreatic pseudocyst from January 1999 through June 
2008 were included in this retrospective analysis. The spe-
cifi c indication for attempting the procedure was the pres-
ence of a direct contact between the pseudocyst and the 
gastric wall. All the drainages were carried out via a trans-
gastric approach, one or two straight plastic stents (10 or 11.5 
French) were positioned. A comparative analysis of short- 
and long-term results was made between patients with post-
operative pseudocysts (group A) and patients with 
pancreatitis-associated pseudocysts (group B).
Results: 55 patients were included in the study, 25 in group 
A and 30 in group B. Overall, a single stent was inserted in 
84.0% of patients, while in the remaining 16.0% two stents 
were needed. The technical success rate was 78.2%, whereas 
procedure-related complications were 16.4%. Complications 
included pseudocyst superinfection and major bleeding, and 
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were mainly managed by surgery. Mortality was 1.8% (1 
patient). There were no signifi cant differences in technical 
success rate and procedure-related complications between 
the two groups (p = 0.532 and p = 0.159 respectively) 
Recurrences were 13.9% and signifi cantly more common in 
group B (p = 0.021). In such cases, a second endoscopic 
drainage was successfully attempted.
Conclusion: Transmural endoscopic treatment of pancreatic 
pseudocysts has a technical success rate of 78.2%, without 
differences related to the pseudocyst etiology. Recurrences 
are more common in patients with pancreatitis. Given the 
severe complications that may occur after the procedure, we 
recommend endoscopic drainage to be carried out in tertiary-
care centers with specifi c expertise in pancreatic surgery.
P0040P
HISTOPATOLOGIC REVIEW OF 
RESECTED BRANCH-DUCT IPMNS OF 
THE PANCREAS. CORRELATION WITH 
PREOPERATIVE DETAILS IN 51 PATIENTS
G. Malleo1, A. Pea1, G. Zamboni2, P. Pederzoli1, C. Bassi1 
and R. Salvia1
1Department of Surgery, University of Verona, Italy; 
2Department of Pathology, University of Verona, Italy
Background: According to the current guidelines, indica-
tions for surgical resection for pancreatic branch-duct intra-
ductal papillary mucinous neoplasms (BD-IPMNs) include a 
diameter > 3 cm, the presence of mural nodules at imaging 
and the presence of symptoms. Little is known about the 
different histotypes of BD-IPMNs and their association with 
clinical and radiological manifestations.
Aims: In the present study we retrospectively reviewed all 
the histologic specimens of patients who underwent pancre-
atic resections for BD-IPMNs between 1993 and 2009. 
Tumors were classifi ed according to the degree of dysplasia 
and histotype (mainly gastric and intestinal). Correlations 
with clinical and radiological details were investigated using 
uni- and multivariate models.
Results: 54 patients underwent resection for pancreatic 
BD-IPMNs. Immunohistochemical analysis was possible 
only in 51 specimens. Mild dysplasia (adenoma) was found 
in 23 pazients (42.6%), moderate (Borderline) in 24 (44.4%), 
and severe in 7 (13.7). Of these, 3 were in situ carcin-
omas (5.8%) and 4 infi ltrating carcinomas (7.8%). 
Immunohistochemical analysis showed a gastric hystotype 
in 36 specimens (70.6%), and an intestinal one in 14 (27.4%). 
A pancreatobiliary and oxyphil hystotypes were found in one 
case (1.8%). Dysplasia and hystotype were dichotomized 
and used as dependent variables for uni- and multivariate 
analysis.
Preoperative pain was found to be an independent risk 
factor for an ‘unfavorable’ hystotype (intestinal/pancreatobi-
liary/oxyphil), whereas a dilatation of the main pancreatic 
duct was found to be a risk factor for moderate to severe 
dysplasia. At a median follow-up of 186 months, disease-
specifi c survival was 100%. Of note, 21 patients (38.9%) 
developed an extrapancreatic tumor, in nine cases (16.6%) it 
was malignant. Five patients died of other diseases, of these 
three died of a malignant disease.
Conclusion: Rewiev of specimens of resected BD-IPMNs 
confi rms that degeneration is uncommon. However, the pres-
ence of a dilated pancreatic duct at imaging may lead to a 
more strict follow-up. Follow-up for other malignancies is 
also necessary.
P0041P
MOLECULAR MECHANISMS OF 
L-ARGININE-INDUCED EXPERIMENTAL 
ACUTE PANCREATITIS
O. Masood1,2, A. Siriwardena1 and J. Bruce2
1The Manchester Hepato-Pancreato-Biliary Centre, 
Manchester Royal Infi rmary, Manchester, United Kingdom; 
2Faculty of Life Sciences, University of Manchester, 
Manchester, United Kingdom
Introduction: Impairment of cytosolic calcium ([Ca2+]i) 
signaling and in particular calcium overload has emerged as 
a possible mechanism for precipitating acute pancreatitis 
(AP.)
In the L-arginine (Larg) experimental model of AP, nitric 
oxide (NO) has been implicated however the disease pro-
gression is largely unaffected by nitric oxide synthase (NOS) 
inhibitors. Additionally, L-ornithine (Lorn), a NOS-
independent metabolite of Larg, has been shown to be potent 
at inducing AP. Both Larg and Lorn activate calcium-sensing 
like receptors (CaSR) such as the GPRC6A which may be 
responsible for initiating the [Ca2+]i overload.
Methods: Whole pancreata were harvested from male 
Sprague Dawley rats. Pancreatic acinar cells were isolated 
by collagenase digestion. [Ca2+]i was measured using fura-2 
imaging, and cell viability assessed using physiological 
CCK. Oxidative stress was measured in dichlorofl uorescein 
(DCF) and cell death was quantifi ed using trypan blue 
exclusion.
Results: Larg and Lorn (100 mM) induced spike-like, 
reversible increases in [Ca2+]i in 46% and 74% of cells 
and Ca2+ overload in 11% and 26% respectively. At 
500 mM both induced Ca2+ overload in all cells however this 
was also seen with the osmotic control, mannitol. Isosmotic 
Larg and Lorn (100 mM) induced only reversible increases 
in [Ca2+]i.
Neither Larg nor Lorn had signifi cant effects on CCK-
evoked [Ca2+]i oscillations. Both Larg and Lorn induced sig-
nifi cant oxidative stress responses (22% and 37% of a 
maximum response seen with 3 mM H202., respectively.) 
Both Larg and Lorn caused cell death in 76% ± 4 and 89% 
± 7 at 3 hours respectively, compared to 35% ± 4 and 40% 
± 3 with controls (Hepes, Glycine).
Conclusion: These data suggest that changes in [Ca2+]i, oxi-
dative stress and cell death were induced by both Larg and 
Lorn. The large concentrations used experimentally do not 
exclude osmotic effects of these agents.
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P0042P
CELLULAR MECHANISMS OF 
L-ARGININE INDUCED EXPERIMENTAL 
ACUTE PANCREATITIS
O. Masood1,2, A. Siriwardena1 and J. Bruce2
1Manchester Royal Infi rmary, Manchester, United 
Kingdom; 2University of Manchester, Manchester, United 
Kingdom
Introduction: Impairment of cytosolic calcium ([Ca2+]i) 
signaling and in particular calcium overload has emerged as 
a possible unifying mechanism for precipitating acute 
pancreatitis (AP.)
Methods: In the L-arginine (Larg) experimental model of 
AP, nitric oxide (NO) has been implicated however the 
disease progression is largely unaffected by nitric oxide syn-
thase (NOS) inhibitors. Additionally, L-ornithine (Lorn), a 
NOS-independent metabolite of Larg, has been shown to be 
potent at inducing AP. Both Larg and Lorn activate calcium-
sensing like receptors (CaSR) such as the GPRC6A which 
may be responsible for initiating the [Ca2+]i overload.
Whole pancreata were harvested from male Sprague 
Dawley rats. Pancreatic acinar cells were isolated by colla-
genase digestion. [Ca2+]i was measured using fura-2 imaging, 
and cell viability assessed using physiological CCK. 
Oxidative stress was measured in dichlorofl uorescein (DCF) 
and cell death was quantifi ed using trypan blue exclusion.
Results: Larg and Lorn (100 mM) induced spike-like, 
reversible increases in [Ca2+]i in 46% and 74% of cells and 
Ca2+ overload in 11% and 26% respectively. At 500 mM both 
induced Ca2+ overload in all cells however this was also seen 
with the osmotic control, mannitol. Isosmotic Larg and Lorn 
(100 mM) induced only reversible increases in [Ca2+]i.
Neither Larg nor Lorn had signifi cant effects on CCK-
evoked [Ca2+]i oscillations. Both Larg and Lorn induced sig-
nifi cant oxidative stress responses (22% and 37% of a 
maximum response seen with 3 mM H202., respectively.) 
Both Larg and Lorn caused cell death in 76% ± 4 and 89% 
± 7 at 3 hours respectively, compared to 35% ± 4 and 40% 
± 3 with controls (Hepes, Glycine).
Conclusion: The data suggests that the Larg and Lorn 
causes signifi cant increase in oxidative stress and cell death. 
The data suggests that although changes in [Ca2+]i were 
induced by both L-arg and L-orn the large concentrations 
used experimentally are likely to induce signifi cant osmotic 
effects.
P0043P
LAPAROSCOPIC TREATMENT OF 
ACUTE PANCREATIC PSEUDO CYSTS
O. Mazza, J. Iniesta, C. Salas, G. Moriconi, F. Bersano, R. 
S. Clariá and J. Pekolj
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background: Acute pancreatic pseudocysts may be treated 
in different therapeutic approaches: endoscopic, percutane-
ous drainage, open and laparoscopic surgery. Open surgery 
remains as Gold Standard treatment, and such goals should 
be considered at the moment of choosing a therapeutic 
approach.
Objective: To describe technical aspects and results of lapa-
roscopic treatment of acute pancreatic pseudocysts.
Setting: Community private hospital.
Design: Case series.
Material and methods: Between November 1996 and June 
2009, 42 patients with 47 acute pancreatic pseudocysts were 
treated at the hospital. 22 patients with 23 pseudocysts after 
acute biliary pancreatitis were operated on by laparoscopic 
approach. Mean age of the population was 55 years (r 
31–77), and 13 of them were male. Mean evolution time until 
surgery was 12 weeks (r 8–16), with an average size of the 
cyst of 11.3 cm (r 5–18): Laparoscopic ultrasound was rou-
tinely performed.
Results: We performed Y Roux cystojejunostomy in twelve 
patients, cystogastrostomy in three, external drainage in two 
infected cysts, one double cystojejunostomy and one distal 
pancreatectomy. Three patients were converted to open 
surgery.
Additional procedures were twelve laparoscopic cholecys-
tectomies, one laparoscopic common bile duct exploration, 
and one umbilical hernioplasty. Mean operating time was 
258 minutes (r 90–360) with an average in postoperative 
hospitalization of 3.8 days (r 2–5). All patients are free of 
recurrence after 30.3 months of follow up (r 6–71). We had 
no mortality.
Conclusions: We could perform all maneuvers as we used 
in open surgery. Complete necrosectomy was achieved in all 
cases. Biliary pathology, when needed, was treated in the 
same surgical session. Laparoscopic approach is fi rst thera-
peutic approach at our institution for patients suitable for 
surgery.
P0044P
SINGLE SURGEON EXPERIENCE OF 
DISTAL PANCREATECTOMY
K. Bowers1, S. McKay2, S. Pericleous2 and R. Hutchins1,2
1The Royal London Hospital, London, United Kingdom; 
2London Bridge Hospital, London, United Kingdom
Aim: To analyse our experience of distal pancreatectomy.
Method: Retrospective analysis of 37 consecutive distal 
pancreatectomies performed by a single HPB consultant 
surgeon between 2003 and 2010.
Results: The median age was 54(range 22–80). Male to 
female ratio was 1.1:1. Preoperative diagnosis was cystic 
neoplasm 15(41%), solid neoplasm 9(24%), GIST 3(8%), 
neuroendocrine tumour 2(5%), metastatic renal cell carci-
noma 1(3%), acute pancreatitis with duct disruption 4(11%), 
chronic pancreatitis 2(5%), and trauma 1(3%). In 8 patients 
(22%) histopathology signifi cantly differed from preopera-
tive diagnosis. 5 patients (14%) with presumed neoplastic 
tumours had non neoplastic lesions on histopathology. 
34(92%) were performed as open procedures, 2 were lapa-
roscopic and 1 laparoscopic converted to open. The pancre-
atic stump was stapled and oversewn in 62%, stapled in 8%, 
oversewn in 19%, and oversewn with separate suturing of 
the pancreatic duct in 11%. The spleen was preserved in 
7(19%). 13 concurrent procedures were performed (7 partial 
gastrectomies, 2 transverse colectomies, 2 liver resections, 1 
liver RFA, and 1 cholecystectomy. Median operative time 
was 3 hrs (range 1–5 hrs). 48% received a blood transfusion 
(median 3 units in these patients). Overall median blood 
transfusion was 0 units. Morbidity was 49%, with no mortal-
ity. Pancreatic leak occurred in 12(32%). Median length of 
stay was 11 days (range 6–30 days). Median follow up was 
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26 mths (range 2–92 mths). 10 patients (27%) developed 
new onset diabetes and 2(5%) pancreatic exocrine 
insuffi ciency.
Conclusion: In our experience of distal pancreatectomies, 
the majority of resections were performed for suspected 
tumours with half of these cystic neoplasms. There was a 
signifi cant discrepancy between preoperative diagnosis and 
fi nal histopathology in 22% of patients. Morbidity was sig-
nifi cant, predominantly pancreatic leak in almost 1/3, and 
new onset diabetes in over 1/4. A low mortality can be 
achieved, with no perioperative deaths in this series.
P0045P
TRIF-DEPENDENT TYPE I IFN 
INDUCTION CONSTRAINS 
INFLAMMATORY INJURY IN MURINE 
ACUTE PANCREATITIS
C. W. Michalski, S. Rieder, M. Erkan, H. Friess and 
J. Kleeff
Dept. of Surgery, TU Munich, Munich, Germany
Background: TLR signaling is mediated primarily by 
MyD88 and Toll–IL-1 receptor domain–containing adaptor 
inducing IFN-β (TRIF). Besides their well-described role in 
innate immunity, TLRs are believed to play an important role 
in the recognition of endogeneous danger associated molecu-
lar patterns (DAMPs). The MyD88-dependent activation of 
NF-kappaB results in the induction of infl ammatory genes 
such as TNF, IL-6, and IL-1β. The TRIF-dependent pathway 
involves the induction of type I IFNs and secondary response 
genes activated by type I IFNs in an autocrine or paracrine 
manner.
Materials and methods: Acute pancreatitis was induced by 
the cholecystokinin analogue cerulein in wild-type mice and 
in animal’s defi cient for TRIF, IFNAR and STAT1. Severity 
of the disease was assessed using standardized assays (i.e. 
histology, serum amylase/lipase, cytokine and chemokine 
levels).
Results: We demonstrate that the extent of acinar cell injury 
is constrained by TRIF-dependent type I IFN production and 
activation of its down-stream targets. Mice with defects in 
TRIF, type I IFN receptor (IFNAR), or STAT1 developed 
more severe acute pancreatitis. Notably, these mice exhibited 
marked pancreatic tissue damage, as demonstrated by histo-
pathology and increased serum amylase and lipase levels. In 
addition, TRIF- and IFNAR-dependent downstream targets 
were essential for regulating the cytokine and chemokine 
response in the acutely infl amed pancreas. Furthermore, 
immune cell infi ltration was markedly increased in TRIF, 
IFNAR, and STAT1 global knock-out mice.
Conclusion: Together, our fi ndings demonstrate a regula-
tory role for DAMP-dependent type I IFN induction and its 
downstream targets in limiting sterile pancreatic infl amma-
tion. Cell compartment-specifi c manipulation of gene expres-
sion (both in vitro and in vivo) is currently conducted to 
determine the contribution of different cell lineages to the 
observed results.
P0046P
PHASE II TRIAL OF URACIL/TEGAFUR 
PLUS LEUCOVORIN AND CELECOXIB 
COMBINED WITH RADIOTHERAPY 
IN LOCALLY ADVANCED PANCREATIC 
CANCER
M. Morak1, D. Richel2, C. van Eijck1, J. Nuyttens1, 
A. van der Gaast1, W. Vervenne2, E. Padmos2, E. Schaake2, 
O. Busch2 and G. J. van Tienhoven2
1Erasmus Medical Center, Rotterdam, Netherlands; 
2Academic Medical Center, Amsterdam, Netherlands
Background and purpose: To investigate the effi cacy and 
toxicity of a short intensive Uracil/Tegafur (UFT) based 
chemoradiotherapy scheme combined with Celecoxib in 
locally advanced pancreatic cancer.
Material and methods: The Academic Medical Centre, 
Amsterdam and the Erasmus Medical Centre, Rotterdam 
enrolled eighty-three eligible patients with unresectable pan-
creatic cancer in a prospective multicentre phase II study. 
Median age was 62 years, median tumour size 40 mm and 
the majority of the patients (85%) had pancreatic head 
cancers. Treatment consisted of 20 × 2.5 Gy radiotherapy 
combined with UFT 300 mg/m2 per day, Leucovorin (folinic 
acid) 30 mg and Celecoxib 800 mg for 28 days concomitant 
with radiotherapy. Four patients were lost to follow-up.
Results: Full treatment compliance was achieved 55% of 
patients, 80% received at least 3 weeks of treatment. No 
partial or complete response was observed. Median survival 
was 10.6 months and median time to progression 6.9 months. 
Toxicity was substantial with 28% grade III-IV gastrointes-
tinal toxicity and two early toxic deaths.
Conclusions: Based on the lack of response, the substantial 
toxicity of mainly gastro-intestinal origin and the reported 
mediocre overall and progression free survival, we can not 
advise our short intensive chemoradiotherapy schedule as 
standard treatment.
P0047P
NATURAL HISTORY OF ASYMPTOMATIC 
PANCREATIC CYSTIC NEOPLASMS
G. Morris-Stiff, G. Lentz, S. Chalikonda and M. Walsh
Cleveland Clinic Foundation, Cleveland, Ohio, United 
States
Background: Management of asymptomatic pancreatic 
cysts is controversial, with need for excision based on pathol-
ogy and natural history.
Aims: To examine the outcome of asymptomatic lesions 
using our protocol based on size and cyst fl uid analysis.
Methods: A prospective database was queried to identify 
asymptomatic pancreatic cysts. Sequential cross-sectional 
imaging studies were assessed, and for those ≥1.5 cm, results 
of endoscopic ultrasound-guided aspiration were co-anal-
ysed. Defi nitive histopathology was available for resected 
specimens.
Results: During the period 1998–2008, 338 patients under-
went evaluation (228 females) with a median age of 67 years 
(IQR [Inter-quartile range]: 57–75). 84 cysts were <1.5 cm 
and 254 were ≥1.5 cm in diameter. Median patient follow-up 
was 5.1 years (IQR: 4.1–6.9). In the <1.5 cm group, median 
cyst size at presentation was 1 cm (IQR: 0.6–1.2) increasing 
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to 1.2 cm (0.7–1.6) during follow-up. 5 (6.0%) patients 
underwent resection, all within 2 months of presentation, 4 
of these also underwent cyst aspiration which was positive 
for mucin. In the ≥1.5 cm group, the median cyst size at 
presentation was 2.5 cm (IQR: 2.0–3.4) increasing to 2.7 cm 
(IQR: 3.0–4.2). 63 (24.8%) patients underwent resection. 53 
(84.1%) cases were performed within 2 months, 4 (6.3%) 
within 12 months, and 6 (9.6%) >12 months post presenta-
tion. Histopathology of resected specimens revealed 71% 
were malignancies or had malignant potential.
Conclusions: Asymptomatic cysts <1.5 cm can safely be 
followed only by imaging with little change expected. A 
quarter of all asymptomatic cysts ≥1.5 cm are appropriately 
resected based on imaging and cyst fl uid analysis.
P0048P
INCIDENCE AND IMPLICATIONS OF 
IMPAIRED GLYCEMIC CONTROL 
FOLLOWING DISTAL PANCREATECTOMY
M. Cadd-Rogers, G. Morris-Stiff, S. Chalikonda and 
M. Walsh
Cleveland Clinic, Cleveland, Ohio, United States
Background: Impaired glycemic control is an important 
long-term consequence of distal pancreatectomy partially 
due to preferential β cell location in the body and tail, and 
nature of underlying pancreatic disease.
Aims: To defi ne the prevalence of, and risk factors for this 
complication.
Methods: All patients who had undergone a distal pancre-
atectomy were identifi ed and demographic data, medication 
requirements for glycemic control, histopathology, and 
resection volumes collected.
Results: 137 were identifi ed including 26 (19%) that were 
diabetic preoperatively. New-onset diabetes (DM) was iden-
tifi ed in 27/111 patients (24.3%) with a mean time of onset 
of 6.4 months and median follow-up of 25 months. DM was 
more common in patients with chronic pancreatitis (5/13; 
38.5%) and adenocarcinoma (7/22, 31.8%). Patients devel-
oping DM were older (63.4 vs. 55.1, p = 0.01) but there was 
no difference in gender or ethnic distributions. The develop-
ment of DM was not linked to the volume of parenchyma 
resected: resection volumes were lower in those with diabe-
tes (119.2 cm3 vs 192.7 cm3; p = 0.314); or related to patient 
body mass index (29.3 KgM−2 vs 28.1 KgM−2; p = 0.51). Of 
the 26 patients with pre-resection DM, 9 were taking insulin. 
In the remaining 17, 8 (47%) deteriorated and required 
insulin postoperatively. The development of postoperative 
impaired glycemic control was associated with prolonged 
hospital stay (12.6 days vs. 7.7 days; p = 0.001).
Conclusion: Impaired glycemic control is common follow-
ing distal pancreatectomy, especially in those resected for 
chronic pancreatitis or cancer. In patients requiring distal 
pancreatectomy for chronic pancreatitis, improved outcome 
may include islet replacement.
P0049P
EVALUATION OF THE GUIDELINES FOR 
MANAGEMENT OF PANCREATIC 
BRANCH-DUCT INTRADUCTAL 
PAPILLARY MUCINOUS NEOPLASM
S. Murcia, C. Laurent, C. Cassinoto, G. Belleannée, B. 
Masson, D. Collet and A. S. Cunha
Chu Bordeaux, Pessac, France
International Consensus Conference of 2006 recommended 
surgical resection for IPMT secondary channels of diameter 
greater than 30 mm and there are mural nodules. The purpose 
of this study was to evaluate retrospectively the relevance of 
these recommendations in patients supported for IPMT sec-
ondary channels.
Methods: Patients supported for IPMT secondary canals 
were selected from a prospective database. Radiological data 
(lesion size, presence of mural nodules) were correlated with 
histology.
Results: From September 1996 to December 2008, 94 
patients were supported for IPMT, 41 patients had IPMT 
secondary channels. 18 patients were operated and 23 
patients were monitored. According to the consensus confer-
ence, 13 patients had radiological criteria for resection, 12 
underwent surgery, 9 had benign and 3 malignant lesions. 28 
patients had radiological criteria for simple monitoring, 6 
patients underwent surgery and had benign lesions. None of 
the patients monitored had developed malignancy in the 
follow-up. Radiological criteria had a sensitivity of 100%, a 
specifi city of 70%, and positive predictive value of 25% and 
a negative predictive value of 100%. Eight patients had 
IPMT > 30 mm without mural nodules, none had malignancy 
on histological examination.
Conclusion: Using criteria of the consensus conference to 
indicate resection of IPMT secondary channels enabled the 
resection of all malignant lesions. Monitoring of patients 
with IPMT > 30 mm without mural nodules would reduce 
the number of resections for benign lesions.
P0050P
LAPAROSOCPIC MANAGEMENT OF 
CYSTIC NEOPLASM OF PANCREAS
M. Narasimhan, S. Kurhade, P. Swaminathan and 
R. Ardhanari
Meenakshi Mission Hospital and Research centre, 
Madurai, Tamilnadu, India
Introduction: Laparoscopic pancreatic resections for cystic 
neoplasms of pancreas are limited to small retrospective case 
series as these neoplasms are rare. We critically analyzed the 
indications for and outcomes after laparoscopic resection of 
pancreatic cystic neoplasm a tertiary referral centre in South 
India over 8 year period.
Methods: A retrospective analysis of data collected on per-
tinent pre-operative factors, intraop & post operative course 
with a short term follow up was done.15 selected cases were 
successfully completed laparoscopically.
Results: Majority of patients were females (86%) and all 
were symptomatic at presentation. Abdominal Pain was com-
monest symptom. 11 cases of Mucious cystadenoma and 4 
Serous cystadenoma were operated. 11 Distal pancreatec-
tomy with and without splenectomy, 2 central pancreatec-
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tomy and 2 enucleation were done. Mean operating time was 
130 minutes. There were no conversions or blood transfu-
sions. Mean tumor size was 8.5 cm. Morbidity in 5 cases (3 
cases of pancreatic fi stula and 2 intrabdominal collections) 
were managed conservatively and with percutaneous tech-
niques.mean hospital stay was 6.4 days.
Conclusions: Laparoscopic pancreatic resections for cystic 
pancreatic neoplasms is feasible and safe and can be offered 
to selected patients. Morbidity of surgery reduces with surgi-
cal experience in advanced laparoscopic techniques.
P0051P
AN UNUSUAL TREATMENT OF 
ABDOMINAL COLLECTIONS AFTER 
DISTAL PANCREATECTOMY
A. Neri, R. Rossini, M. Inama, G. Butturini, C. Bassi and 
P. Pederzoli
General Surgery Department of Medical University, 
Verona, Italy
Context: Pancreatic Fistula and abdominal collections are 
frequent and severe post-operative complications after pan-
creatic resection. Endoscopic drainage and placement of 
pancreatic endoprosthesis may be a treatment of abdominal 
fl uid collection.
We here report a case of 67 year-old female who under-
went distal pancreatectomy in November 2008 for an intra-
ductal papillary moucinous neoplasm. The patient had an 
uneventful postoperative course and she was discharged after 
10 days. One month later a routine US detected a large fl uid 
collection in pancreatic compartment. MS-CT scan con-
fi rmed a 16 × 7 × 8 cm fl uid collection with thick wall and 
gas bubbles with anterior dislocation of stomach. The patient 
was completely asymptomatic.
The patient underwent an endoscopic procedure with sfi n-
terotomy and cannulation of minor papilla and subsequent 
placement of a 10 cm plastic prosthesis in communication 
with the collection. Fever and lymphocitosis appeared after 
the procedure. The patient was treated with intra-venous 
antibiotic and Enteral Nutrition (EN) with resolution of 
symptoms. Serial CT scans detected progressive reduction of 
the collection (from 16 to 11 cm).
After 2 weeks another endoscopic procedure was under-
taken and a naso-cystic tube was placed parallely to the 
prosthesis in order to perform irrigations and to complete the 
evacuation of the collection. A CT scan performed 1 week 
after the second endoscopic procedure showed a complete 
reduction of the collection and the naso-cyst tube drain was 
accordingly removed. We stopped the EN and the patient 
started oral feeding successfully without any gastrointestinal 
symptoms. The patient was discharged after 1 month from 
the admission.
Conclusion: The result of this endoscopic procedure sug-
gests a novel treatment of pancreatic collection with cannula-
tion of minor pancreatic duct.
P0052P
IS THERE A CHANGE IN THE NEED 
FOR SURGICAL BYPASS IN PATIENTS 
WITH NON-RESECTABLE 
PANCREATIC CANCER?
C. Fristrup, L. Poulsen, H. O. Nielsen and 
M. B. Mortensen
Odense University Hospital, Odense, Denmark
Background: Gastroduodenal obstruction due to malig-
nancy can be diffi cult to palliate. The optimal method of 
palliation for patients with unresectable pancreatic and peri-
ampullary cancer remains controversial. Patency of the stents 
remains a disadvantage of endoscopic stenting, especially in 
patients with longer life expectancy. Improvement in sup-
portive care and the introduction of palliative chemotherapy 
could change the need for surgical bypass.
Aim: To evaluate the need for surgical bypass in patients 
with non-resectable pancreatic cancer.
Method: Retrospective analysis of patients with non-resect-
able pancreatic cancer in the period 1996–2001 (group I) and 
2002–2006 (group II).
Results: A total of 694 patients with pancreatic cancer were 
treated in the period 1996 to 2006. Of these 545 (78%) were 
found to be non-resectable by CT and/or EUS. The number 
of patients increased during the study period with 222 in 
group I and 323 patients in group II. Surgical bypass was 
performed, if endoscopic palliation was either impossible or 
had failed. In total 117 (21%) surgical palliations was per-
formed. In group I there was need for surgical palliation in 
68 (31%) patients, compared with 49 (15%) patients in group 
II (p < 0.01). In total 20 (17%) patients were treated for 
complication after surgical palliation, of these 13 required 
surgical or endoscopic intervention. The average time to 
discharge was 10.3 days (range 2–71). There was no differ-
ence with regard to gender, age, and numbers with metastatic 
disease between patients with and without surgical palliation, 
and there was no signifi cant difference in survival. The 
median survival was 5.6 months (95%-CI 4.1–6.4) and 4.2 
(95%-CI 3.6–4.7) for patients with and without the need of 
surgical palliation.
Conclusion: We found that the need for surgical palliation 
had declined in recent years. We found no signifi cant differ-
ence in survival between patients with and without surgical 
palliation.
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P0053P
OUTCOME OF SURGERY IN THE 
TREATMENT OF PANCREATIC CANCER, 
RECORDED AS POSTOPERATIVE 
MORTALITY, MORBIDITY AND 
QUALITY OF LIFE (QOL)
T. Nordby1,7, T. Heiberg1,6, K. J. Labori1, A. Waage1, B. A. 
Bjoernbeth1, E. Trondsen1, G. Wiedswang1, T. Hauge2,7, K. 
Aanonsen2, I. M. B. Lothe3, B. Edwin5, T. Ikdahl4, 
E. Kure4 and T. Buanes1,7
1Department of Gastroenterological surgery, Oslo 
university Hospital (OuH), Ullevaal, Oslo, Norway; 
2Department of Gastroenterology, Oslo university Hospital, 
Ullevaal, Oslo, Norway; 3Department of Pathological 
Anatomy, Oslo university Hospital, Oslo, Norway; 
4Department of Oncology, Oslo university Hospital, Oslo, 
Norway; 5Interventional Center, Oslo university Hospital, 
Gaustad, Oslo, Norway; 6Lovisenberg Diakonal College, 
Oslo, Norway; 7Medical Faculty, Institute of Clinical 
Medicine, Oslo, Norway
Introduction: Only about 20% of patients investigated for 
pancreatic cancer (PC) are resectable at the time of diagnosis 
and surgery is the only treatment with curative potential. But 
pancreatic surgery may also be associated with serious com-
plications, signifi cantly infl uencing postoperative QoL. The 
objective of the present study was to investigate the relation-
ship between postoperative morbidity/mortality and health 
related QoL after pancreatic surgery.
Method: All patients referred to our hospital with suspected 
malignant periampullary lesions, were included in Thematic 
Pancreatic Tumor Project (TPTP) from September 2008. All 
together 257 patients are included, 127(49%) underwent 
laparotomy. Preoperative histological diagnosis was not 
required. Eighty patients underwent pyloric preserving pan-
creaticoduodenectomy (PPPD), 12 classical Whipples proce-
dure. Total pancreatectomy was performed in 2 patients, 
distal pancreatectomy in 15 (10 of these laparocopically) and 
one open Bilroth I. QoL was recorded longitudinally with 
monthly collection of Edmonton Symptom Assessment 
System (ESAS) forms.
Results: Irresectable tumor was recognized during laparot-
omy in 17(13%). The residual 110 histological diagnosis 
were pancreatic adenocarcinoma in 48, papillary carcinoma 
in 32, endocrine carcinoma in 8, IPMN in 5 and distal chol-
angiocarcinoma in 6. Five cystadenoma were resected lapa-
roscopically. Six patients (5%) had benign histology. 
Postoperative mortality was zero in PC patients, total mor-
bidity 23%. Delayed gastric emptying was the most frequent 
complication, 10%. The R0 resection rate was 21(41%). 
Follow up was median 9.5, range 1–23 months. The preop-
erative ESAS score was regained or improved, for pain after 
3 months, fatigue 2 months, nausea 1 month and global 
health 2 months.
Conclusion: Pancreatic resection can be performed safely 
as an open Whipple procedure as well as laparoscopic distal 
resection with zero mortality and low postoperative morbid-
ity. Clinical outcome recorded as QoL, reveal that preopera-
tive symptom score is regained or improved during 2–3 
months.
P0054P
MINIMALLY INVASIVE 
RETROPERITONEAL PANCREATIC 
NECROSECTOMY: THE CHRIS HANI-
BARAGWANATH EXPERIENCE
J. Omoshoro-Jones1,2, A. Spaaco1,2 and M. Smith1,2
1Chris Hani-Baragwanath Hospital, Johannesburg, South 
Africa; 2University of the Witwatersrand, Johannesburg, 
South Africa
Introduction: Infected pancreatic necrosis remains a 
dreaded complication of acute severe pancreatitis. A mini-
mally invasive retroperitoneal surgical approach has proved 
useful in improving the previously associated dismal outcome 
with open surgery. This report presents a South African expe-
rience with the minimal access retroperitoneal procedure.
Patients and method: Between January 2006 and August 
2010, an analysis of patients with severe acute pancreatitis 
and infected necrosis who underwent a minimally invasive 
retroperitoneal necrosectomy (MIRP) was performed. The 
procedure was performed by the establishment of continuous 
lavage of the cavity through the necrosectomy tract. This 
presentation describes the experience of a regional South 
African unit with this procedure. Operative time, related 
complications, mortality and hospital stay are analysed.
Results: Seventeen patients (13 males, 4 females), median 
aged 38 (29–65) years underwent MIRP. Medan time from 
pain onset to time of intervention was 8.5 (3–34) weeks. 
Median procedure per patient was 3 (2–5). Median operation 
time and blood loss were 2.5 (1.2–4.5) hours and 300 (100–
450) mls respectively. Four patients developed mild pancre-
atic fi stulae, 2 resolved spontaneously and two required 
endoscopic therapy. Two patients died (one from pulmonary 
embolism, one from irreversible multiple organ dysfunction 
after conversion to open surgery). Median ICU/HCU and 
hospital stays were 18 (6–39) days and 46 (40–80) days 
respectively.
Conclusion: In this initial experience, MIRP appears safe 
and effective in treating infected pancreatic necrosis with 
low morbidity and mortality.
P0055P
SPECTRUM OF PANCREATITIS 
PRESENTING TO A REGIONAL HPB 
UNIT IN SOUTH AFRICA
J. Omoshoro-Jones1,2, A. Sparaco1,2 and M. Smith1,2
1Chris Hani-Baragwanath Hospital, Johannesburg, South 
Africa; 2University of the Witwatersrand, Johannesburg, 
South Africa
Introduction: Pancreatitis is about 35–800 times more 
common in the HIV/AIDs population. Reported incidence 
varies between 3.2% and 46% in large series. Highly active 
anti-retroviral therapy (HAART), particularly combinations 
with nucleoside analogues, protease-inhibitors, non-reverse 
transcriptase, hydoxyureas, are the usual etiological agents. 
However, HI virus itself, other pancreotoxic agents like anti-
tuberculous drugs, opportunistic infections, chronic liver and 
biliary diseases, use of illicit substances, hypertriglyceride-
mia of HAART may play varying roles in the genesis of 
pancreatitis in the HIV infected patient. Although sub-saha-
ran Africa is heavily impacted by the HIV/AIDs pandemic, 
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there is a paucity of data on pancreatic disorders in the large 
HIV/AIDs population within the continent. This report pres-
ents a regional South African Hepatopancreatobiliary (HPB) 
unit’s experience.
Methodology: Retrospective analysis of prospectively col-
lected data of all HIV positive individuals presenting with 
acute pancreatitis to the HPB Unit at the Chris Hani-
Baragwanath Hospital, South Africa, from January 2006 
to August 2010. Demographic, clinical, investigational, 
management and outcome data are presented herein. 
Stratifi cation of HIV status was according to CDC classifi ca-
tion. Severity of pancreatitis was stratifi ed according to the 
International Hepatopancreatobiliary Association’s (IHPBA) 
classifi cation.
Results: Twenty four individuals (14 men, 10 women; 
median age 39 years, range 26–63 yrs) with HIV or HIV/
AIDs were managed for pancreatitis in the unit during the 
reference period. Thirteen (13) presented with mild pancre-
atitis, eight (8) with severe acute pancreatitis and three (3) 
with predicted severe pancreatitis. Acute pancreatitis 
occurred following commencing stavudine-containing anti-
retroviral combinations in 16 individuals, protease inhibitors 
in combination with stavudine or didanosine in 8. Other 
associated agents in 13 individuals include anti-tuberculous 
agents (5), gall stones (3), opportunistic infections (2), sul-
phonamide-trimethoprim (3). Acute pancreatitis occurred 
within 2 months of commencing ARVs in 7 individuals, 
within 6 months in 8, twelve months in 5, more than twelve 
months in 4 individuals. Median CD4 levels in the cohort 
was 248 (155–658). Symptomatic pseudocyst requiring 
endoscopic and minimal access drainage and/or debridement 
occurred in 9 individuals. Three patients died of MODS in 
the severe group, whilst all the others survived. The median 
hospital stay was 3 (2–28) weeks.
Conclusion: Acute pancreatitis was mild in most of the HIV 
positive individuals in this analysis. Stavudine, didanosine 
and pentamidine-containing combinations remains the com-
monest etiologic agents for pancreatitis in this cohort. Severe 
pancreatitis remains highly fatal in this group as reported by 
others. Local pancreatic complications can easily be managed 
by minimally invasive means. Acute pancreatitis in the HIV/
AIDs individual can however be adequately managed as in 
the non-HIV positive population.
P0056P
GLASGOW PROGNOSTIC SCORE (GPS), 
CA19-9 AND PLATELET-LYMPHOCYTE 
RATIO (PLR) AS SURROGATE 
MARKERS FOR RESECTABILITY IN 
PANCREATIC MALIGNANCY
C. Macutkiewicz, R. Deshpande, N. de’ Liguori Carino, B. 
Ammori, D. Sherlock and D. O’Reilly
North Manchester General Hospital, Manchester, United 
Kingdom
Staging laparoscopy (SL) is currently controversial for 
staging of intra-abdominal malignancies due to the accuracy 
of high resolution computed tomography (CT) scans. 
Platelet-lymphocyte ratio (PLR) and carbohydrate antigen 
19-9 (CA19-9) have been used to determine patient selection 
for SL in pancreatic cancer. The Glasgow Prognostic 
Score (GPS) is an infl ammation-based scoring system. The 
aim of this study was to use a scoring system to allow target-
ing of SL to the highest risk groups and predict 
resectability.
A prospectively maintained pancreatic database was 
reviewed and patients identifi ed who underwent pancreato-
duodenectomy. Preoperative CA19-9, C-Reactive protein 
(CRP), carcinoembryonic antigen (CEA), and PLR values 
were obtained and used to stratify patients into low-risk and 
high-risk groups based on CA19-9 and PLR values.
From 130 patients: 12 were found to be inoperable at lapa-
roscopy, 36 were inoperable at laparotomy and 82 underwent 
pancreatoduodenectomy. The median CA19-9 was signifi -
cantly raised in the unresectable group (363 vs 94 kU/l, P = 
0.005). The median PLR was signifi cantly higher in the unre-
sectable group (223.0 vs 172.0, P = 0.0027). The CEA and 
CRP were not signifi cantly different in either group. The 
GPS was signifi cantly higher in the unresectable group 
(1.621 vs 1.089, P = 0.004). The positive and negative pre-
dictive values for resectability, sensitivity and specifi city for 
CA19-9 levels ≤150 kU/l were 76.6%, 47.2%, 65.5% and 
60.7% respectively. For PLR ≤ 150, these levels were 76.2%, 
45.7%, 45.7% and 76.2%, respectively. Combining CA19-9 
and PLR ≤ 150 increased both positive predictive values 
(90%) and specifi city (94.7%). Combining CA19-9 and PLR 
≤ 150 and GPS ≤ 1 increased both positive predictive value 
(100%) and specifi city (100%) for resectability. Patients in 
the low-risk group would have avoided 12% of laparoscopies 
and missed no unresectable tumours.
CA19-9 and PLR are signifi cantly raised in advanced pan-
creatic malignancy and are therefore useful markers in pre-
operatively assessing the need for SL. GPS is signifi cantly 
raised in unresectable patients and combined with CA19-9 
and PLR has a high predictive value for resectability. 
Stratifying patients into low- and high-risk groups has the 
potential of sparing patients the need for SL and increases 
cost-effectiveness.
P0057P
EARLY POSTOPERATIVE OUTCOMES 
OF PANCREATICODUODENECTOMY IN 
ELDERLY PATIENTS
S. Pekmezci, K. Saribeyoglu, E. Aytac, M. Kapan, 
H. Tasci, H. Kalafat, V. Durgun, S. Perek, E. Goksoy and 
M. Sariyar
Istanbul University, Cerrahpasa Medical Faculty, 
Department of Surgery, Division of Hepatopancreatobiliary 
Surgery, Istanbul, Turkey
Introduction: Cancers of the pancreas, distal common bile 
duct and duodenum are relatively more common in the aged 
patients. In this study, we aimed to evaluate the early period 
postoperative outcomes of pancreaticuduodenectomy in 
elderly patients.
Materials and methods: We retrospectively reviewed the 
medical records of 164 (64 women/103 men) consecutive 
adult patients who had underwent pancreaticoduodenectomy 
at our clinic. The patients were separated into two groups 
according to their age; Group 1: <65 years old, Group 2: 65 ≥ 
years old. The demographics, histopathology of the tumors 
and early postoperative outcomes were evaluated. Mann-
Whitney U test and x2 test (Fisher’s Exact Test) were used for 
the continuous and the categorical variables respectively.
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Results: There were 50 patients in group 2. There was no 
perioperative mortality in both groups. Duration of the 
surgery, perioperative blood loss, postoperative hospital stay, 
mean harvested lymph node number, early period postopera-
tive mortality rate and overall complication rates were not 
signifi cantly different between the groups.
Conclusion: Whenever indicated, pancreaticoduodenec-
tomy should be taken into account regardless of the 
age.
P0058P
PANCREATIC CARCINOID TUMOR
A. L. Pierini, L. Pierini, H. Imhof, E. A. Meza and 
L. Gianinetti
Hospital J. B. Iturraspe, Santa Fe/Santa Fe, Argentina
Introduction: Although the pancreatic location of carcinoid 
tumors is infrequent, the number of reported cases has 
increased. The majority of them are asymptomatic with 
normal levels of serotonin and metabolites in plasma and 
urine. Nevertheless, in some cases an atypical carcinoid syn-
drome with abdominal pain, diarrhea, weight loss and less 
frequently, facial redness has been shown. They are consid-
ered malign tumors by the classic literature and at the time 
of diagnosis the majority shows remote metastasis with a 
poor survival up to 5 years.
Case presentation: Female 58-year-old patient that attended 
the consultation with an atypical left iliac fossa pain. The 
urinal levels of 5-HIIA and the seric serotonin levels showed 
normal fi gures. However, imaging studies (Multislice 
Computed Tomography and Ultrasound) showed a pancre-
atic formation that defi ned the surgical procedure: a VATS 
splenopancreatectomy, which had a successful follow-up and 
control at 6 months after the surgery.
Conclusion: It is a malign tumor, generally asymptomatic, 
which retards the diagnosis and darkens the prognosis. A 
radical resection along with lymphadenectomy can lead to 
an accurate histological description of the tumor and the 
detection of hidden metastasis in lymphatic nodes in the 
case of pancreatic tumors without evidence of remote 
metastasis.
P0059P
CHOOSING THE METHOD OF 
OPERATUVE INTERVENTION IN THE 
EVENT OF PANCREAS TRAUMAS
B. Rakhimov, I. Galkin, J. Korymasov and V. Baranov
Clinik hospital No5, Togliatti Samara region, Russian 
Federation
Objective: To put forward an algorithm that facilitates 
choosing the method of surgery with patients having pan-
creas injuries.
Material and methods: During the period of 1989–2008 
the examination of medical treatment of 41 patients with 
pancreas traumas was carried out. The patients were broken 
down by sex and age as follows: male – 34, female – 7. The 
patients’ age fl uctuated from 20 to 67 year old.
The patients were divided into two groups. The fi rst group 
that included 27 patients was examined from year 1989 to 
year 1999 and the second one that included 14 patients – 
from year 2000 to year 2008. During the diagnostics, helical 
computer tomography data and ultrasonic scanning data 
were taken into consideration. Various laboratory factors 
were also used. There were no big differences in terms of 
severity of trauma and concomitant injuries in compared 
groups. Till year 2000 all the patients underwent surgical 
operations, without type and severity of organ injury being 
taken into consideration. Beginning from year 2000, on 
choosing the method of operation, the severity of organ 
injury, its ductal system, the condition of the duodenal wall 
and bile-excreting ducts have been taken into account in a 
mandatory manner.
Outcome: In the fi rst group of 27 patients 8 patients died; 
the cause of death in four cases was acute blood loss, in 
four remaining cases – suppurative-septic complications. 
The lethality was affected essentially by the nature of 
adverse factor – in case of a gunshot wound, 2 injured 
persons out of 3 died, in case of knife wound, 4 injured 
persons out of 9 died., in case of closed injury, 2 persons 
out of 29 died. On investigation of lethality, depending on 
the type of the operative intervention, the following data 
were obtained: 5 persons died out of 17 patients that under-
went pancreas wound closure and complications were 
observed with 9 patients. Beginning from year 2000 the 
application of the algorithm based on evaluation of the sever-
ity of the organ injury, its ductal system, as well as the 
adjacent organs made it possible to single out 4 groups of 
injured persons and apply only three types of operative inter-
vention: external drainage of the zone of injury, distal resec-
tion of the pancreas and pancreatoduodenectomy in some 
special cases. With the use of the proposed algorithm 14 
patients have been operated on without lethal termination 
and serious complications.
Conclusion: The proposed algorithm makes it possible to 
simplify and justify the choice of the method of the operative 
treatment in case of pancreatic gland injuries.
P0060P
ENDOSCOPIC INTRAMURAL DRAINAGE 
OF PANCREATIC PSEUDOCYST WITH 
AND WITHOUT 
ENDOULTRASONOGRAPHY GUIDANCE: 
A SYSTEMATIC REVIEW
M. S. Sajid, K. Ray, K. Hutson, M. Sayegh and K. Singh
Worthing Hospital, Worthing, West Sussex, United 
Kingdom
Objective: To systematically analyze published trials on the 
effectiveness of endoultrasonography guided endoscopic 
drainage (EUS-ED) versus non-endoultrasonography guided 
endoscopic drainage (NUS-ED) of pancreatic pseudocyst 
(PP).
Methods: Trials on the effectiveness of EUS-ED and 
NUS-ED were selected according to specifi c criteria and 
analyzed to generate summative data [expressed as odds ratio 
(OR), and mean difference (MD)] by using RevMan 5.0.
Results: Four studies (Two randomized trails and two non-
randomized trials) encompassing 239 patients of PP were 
analyzed systematically. There were 112 patients in EUS-ED 
group and 127 patients in NUS-ED group. There was a sig-
nifi cant heterogeneity among trials. Therefore, in the random 
effects model the risk of technical failure [OR, 3.17; 95% 
CI, 0.56–17.90; z = 1.31; p < 0.19), and peri-procedure 
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complications (OR, 0.63; 95% CI, 0.28, 1.43; z = 1.11; p < 
0.27) following both approaches are statistically comparable. 
Clinically EUS-ED is as effective as NUS-ED in terms of 
successful treatment and procedure time. However, EUS-ED 
is associated with shorter length of stay in hospital. On sub-
group analysis of the randomized trials, the risk of technical 
failure is higher in NUS-ED (OR, 3.17; 95% CI, 0.56–17.90; 
z = 1.31; p < 0.19) group but treatment success rate for both 
short-term and long-term outcomes, complications rate and 
procedure time is comparable between EUS-ED versus 
NUS-ED groups.
Conclusion: EUS-ED of PP is as effective as NUS-ED in 
terms of treatment success rate, technical success rate, peri-
procedure complications, and procedure time. EUS-ED is 
associated with shorter length of stay in hospital as compared 
to NUS-ED. However, signifi cant heterogeneity (clinical and 
methodological diversity) among included studies renders 
this conclusion weaker and deplorable. Further trials on 
higher number of patients involving multiple specialist units 
are required in order to obtain a stronger and reliable 
conclusion.
P0061P
PROGNOSTIC MOLECULAR IMAGING 
IN PANCREATIC CANCER THROUGH 
ANALYSIS OF THE STROMAL ACTIVITY
C. Reiser-Erkan1, M. Erkan1, A. Fingerle2, J. Gaa2, C. 
Michalski1, H. Friess1 and J. Kleeff1
1Department of General Surgery, Technische Universität 
München, Munich, Germany; 2Department of Radiology, 
Technische Universität München, Munich, Germany
Aims: To identify tumor specifi c stromal changes in pancre-
atic cancer using MRI-imaging coupled with quantitative 
image analysis and immunohistochemistry.
Methods: Postoperative high resolution MRI imaging of the 
resected specimens using standard and diffusion-weighted 
sequences was carried out in 6 patients with chronic pancre-
atitis and 12 patients with pancreatic ductal adenocarcinoma. 
Stromal activity was assessed by IHC and quantitative image 
analysis in terms of α-smooth muscle-actin, CD31, collagen 
and periostin expression of the stromal tissue. Prognostic 
value of the identifi ed stromal factors was tested separately 
on a cohort of 113 pancreatic cancer patients. Survival analy-
sis was performed using the Kaplan–Meier and Log-Rank 
analyses. Prognostic factors were determined in a multivari-
able analysis using a Cox proportional hazards model.
Results: Postoperative high resolution T2-scanning corre-
lated accurately with the histomorphological data. Among 
analyzed factors only periostin expression was signifi cantly 
different in pancreatic cancer tissues compared to chronic 
pancreatitis tissues (lower in cancer, p = 0.01). Collagen 
expression correlated negatively (p = 0.03) whereas periostin 
expression correlated positively (p = 0.002) with the 
microvessel density of the tumors. Pancreatic cancer patients 
with higher periostin expression survived signifi cantly longer 
than the ones with low expression (29.7 months vs. 15.8 
months, p = 0.01). High periostin expression was an inde-
pendent prognostic marker among pancreatic cancer patients 
(p = 0.017, 95% CI: 1.1159–4.563).
Conclusions: MRI imaging is a promising method to 
assess the stromal activity in pancreatic cancer, thereby 
providing an important tool in the differential diagnosis and 
in the estimation of the prognosis of pancreatic cancer patients.
P0062P
PIGMENT EPITHELIUM-DERIVED 
FACTOR INCREASES NEUROPATHY AND 
FIBROSIS IN PANCREATIC CANCER
C. Reiser-Erkan, M. Erkan, T. Samkharadze, E. Demir, C. 
Michalski, H. Friess and J. Kleeff
Department of Surgery, Klinikum rechts der Isar, 
Technische Universität München, Munich, Germany
Background: Pigment Epithelium-Derived Factor (PEDF) 
is a noninhibitory member of the serine protease inhibitor 
gene family with neuroprotective, neuroproliferative, and 
anti-angiogenic functions. Its role in pancreatic fi brosis and 
neuropathy is unknown.
Materials and methods: The expression and localization of 
PEDF were assessed by quantitative RT-PCR, IHC, and 
quantitative image analysis and correlated with neural and 
microvessel density in the normal pancreas (n = 20) and 
pancreatic cancer (n = 55). Primary human pancreatic stellate 
cells (PSC), primary human Schwann cells, primary human 
endothelial cells and mouse neuroblastoma cells were used 
for functional experiments. The effect of hypoxia on PEDF 
production in cancer cell lines and immortalized pancreatic 
ductal epithelial cells was assessed by quantitative RT-PCR 
and ELISA. The effect of recombinant PEDF on PSC was 
assessed by immunoblot analysis.
Results: PEDF expression was homogenous in the normal 
pancreas. Higher expression was found in the activated 
stroma of pancreatic cancer. Recombinant PEDF-protein 
increased PSC activity by 275%, periostin and fi bronection 
secretions by 11-fold (p < 0.0001), and 5.6-fold (p < 0.0001), 
respectively. In pancreatic cancer, compared to the normal 
pancreas, there was a signifi cant increase in neuropathy (p = 
0.0251) and periacinar fi brosis with a concomitant loss of the 
fi ne periacinar innervation. In cancer cell lines and in human 
immortalized pancreatic ductal epithelial cells, hypoxia 
increased PEDF mRNA up to 132-fold without a surge in its 
protein expression. Higher expression of PEDF in cancer 
cells was signifi cantly correlated with better patient survival 
(median survival 22 mo vs. 17 mo, p = 0.043).
Conclusion: PEDF increases PSC activity, thereby contrib-
uting to the desmoplasia of pancreatic cancer. PSC over-
activation likely leads to periacinar fi brosis and degeneration 
of the fi ne acinar innervation. Increased focal PEDF expres-
sion in cancer cells correlates with neuropathic changes and 
better patient survival.
P0063P
SUCTION DRAINS ARE NOT 
NECESSARY AFTER LAPAROSCOPIC 
DISTAL PANCREATECTOMY
F. Rotellar1, F. Pardo1, A. Benito1, D. Casanova2, 
P. Martí-Cruchaga1 and G. Zozaya1
1Universty Clinic, Pamplona, Spain; 2Hospital Marqués de 
Valdecilla, Santander, Spain
Introduction: A controversial issue in recent years on pan-
creatic surgery is about the use of suction drains. Nevertheless, 
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there is scarce evidence about drainless distal pancreatec-
tomy or enucleation. This is probably due to the high risk of 
fi stula after these procedures.
Patients and methods: From December 2003 to June 2010 
we have performed in our institution 21 laparoscopic distal 
pancreatectomies:
– Distal pancreatectomy with splenectomy: 4.
– Warshaw procedure: 1.
– Distal pancreatectomy spleen and splenic vessels preser-
vation: 16.
Of these, aspirative drain was left only in two patients with 
a chronic pancreatitis and a diffi cult dissection (one distal 
pancreatectomy with splenic vessels preservation and one 
distal pancreatectomy with splenectomy). In the 19 remain-
ing patients no drain was left. The outcome of this group was 
prospectively recorded.
Results: No conversion or transfusion was needed in any 
case. Mean hospital stay was 4.3 (3–9) days. At 1–3 months 
ultrasound control, a fl uid collection was found in 10 (52.6%) 
patients. The size of the collection was variable (1–10 cm). 
However, all patients except one were asymptomatic. Only 
one (5%) patient referred back and shoulder pain that did 
not respond to conventional analgesia. She had a 9 cm 
collection and underwent uneventful transgastric drainage. 
The rest of the patients (95%) had no collections or if so, 
they were asymptomatic and disappeared in successive 
controls.
Conclusion: Suction drains may not be necessary after lapa-
roscopic distal pancreatectectomy. The fi stula rate with this 
strategy is, in some way, zero. In case a collection becomes 
symptomatic, it can be treated endoscopically without 
turning it into an external fi stula.
P0064P
RISK FACTORS FOR EARLY 
RECURRENCE AFTER 
PANCREATICODUODENECTOMY (PD) 
FOR DUCTAL ADENOCARCINOMA OF 
THE PANCREATIC HEAD
J-C. Vignal, C. Laurent, G. Belleannée, V. Vendrely, 
E. Terrebonne, D. Collet and A. S. Cunha
Chu Bordeaux, Bordeaux, France
Introduction: The purpose of this study was to identify risk 
factors for early recurrence following PD for ductal 
adenocarcinoma.
Methods: From January 2000 to December 2009, 130 
patients who underwent PD for adenocarcinoma were 
selected from a prospective database. Patients who relapsed 
before 1 year were compared to patients with relapsed or not 
after 1 year. Patients without recurrence and whose follow-
up was less than 1 year were excluded.
Results: Fifty-fi ve patients had relapsed before 1 year. 
Seventy fi ve had not relapsed before 1 year (46 have relapsed 
after, and 29 have not relapsed). In logistic regression, CA 
19–9 > 100 (p = 0.022), CA 19–9 level adjusted to bilirubin 
>100 (p = 0.017), lymph node ratio >0.2 (p < 0.001), pres-
ence of lymph node rupture (p = 0.006), more than one 
lymph node involvement (p < 0248), positive rétroportale 
margin (p = 0.023) were signifi cantly associated with early 
recurrence in univariate analysis. In multivariate analysis 
preoperative adjusted CA 19–9 > 100 (p < 0.002, OR 9.6) 
and presence on the histological analysis of lymph node 
ruptures (p = 0.0042, OR 13.7) were independently associ-
ated with early recurrence. Survival after early recurrence 
was signifi cantly worth than if it occurs after 1 year (5 VS 
9.5 month, p < 0.0001).
Conclusion: Adjusted CA 19–9 > 100 and the presence of 
nodes capsular break are independent prognostic factors of 
early recurrence following PD for ductal adenocarcinoma. 
They are evidence of aggressive disease and require probably 
more appropriate perioperative treatment.
P0065P
RUNX2 MRNA DETECTION IN SERUM 
OF PANCREATIC CANCER PATIENTS
F. Giovinazzo1,2, M. Valenti2,3, L. D. Carbonare2,3, 
G. Innamorati2, M. Zanatta3, G. Francia3, M. V. Davi3, 
A. Scarpa2,4, C. Bassi1,2 and R. Salvia1
1Department of Surgery, Endocrine and Pancreatic Unit, 
Hospital of ‘G.B.Rossi’, University of Verona, Verona, 
Italy; 2Pancreatic Diseases Research Group. University 
Laboratory for Medical Research-Verona (L.U.R.M), 
University of Verona, verona, Italy; 3Clinic of Internal 
Medicine D, Department of Medicine – University of 
Verona, Verona, Italy; 4ARC-NET Research Center, 
University of Verona, Verona, Italy
Introduction: circulating RNA detection from peripheral 
blood is an interesting biological challenge because mRNA 
transcript levels may represent potential biomarkers for a 
non-invasive technique in tumour diagnosis and monitoring. 
Over-expression of circulating mRNA was detected in 
patients affected by breast, hepatocellular and colorectal 
cancer cancer as well as other kinds of tumours. Additionally 
it was shown they were come from tumour tissues. The 
Runx2 gene is known as a key regulator in osteogenic dif-
ferentiation. In vitro studies, transgenic mice and human 
genetic disorders show as an excessive or insuffi cient levels 
of functional Runx2 have devastating consequences on 
osteoblasts and skeletal structures. Furthermore, recent data 
show that Runx2 promotes neoplastic development in cancer 
tissues.
The aim of this study was to test the Runx2 mRNA tran-
script levels in the serum of patients with pancreatic tumours 
by using Real-Time reverse transcription PCR.
Materials and methods: We selected 8 patients, consecu-
tively hospitalized in our Institute. All of the patients had 
diagnosis of Pancreatic Adenocarcinoma (PDAC) through 
fi ne needle aspiration (FNA). Patients included in the study 
were untreated. The results were compared with biological 
samples obtained by age-matched non-malignant donors. To 
compare relative Runx2 mRNA levels in serum from patients 
and non-malignant donors the gene expression was calcu-
lated after normalization against the housekeeping gene 
(beta-2-microglobulin (B2M)), using the relative fold expres-
sion differences.
Results: We obtained good quality of RNA from serum of 
patients and non-malignant donors as evaluated by ratio of 
the absorbance at 260 and 280 nm (ranging from 1.8 to 2.0). 
In addition, by RT Real-Time PCR, beta-2-microglobulin 
was positive in all samples (Ct < 30).
The Runx2 mRNA was over-expressed in 5 patients and 
the mean fold of expression with respect to non-malignant 
donors was 7.72 with ranks range 3.25–11.16.
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Conclusions: Our preliminary data demonstrate that Runx2 
mRNA is over-expressed in serum of pancreatic cancer 
patients and that it could be utilized as a useful cancer 
marker.
P0066P
CYTOKINES ASSAYS IN LIQUID FROM 
DRAINAGES AFTER PANCREATIC 
SURGERY: PRELIMINARY RESULTS OF 
FEASIBILITY STUDY
F. Giovinazzo1,2, M. Kidd3, R. Salvia1,2, G. Butturini1,2, 
D. Monsellato1,2, A. Pea1,2, G. Innamorati2, A. Scarpa2,4 and 
C. Bassi1,2
1Department of Surgery, Endocrine and Pancreatic Unit, 
Hospital of ‘G.B.Rossi’, University of Verona, Verona, 
Italy; 2Pancreatic Diseases Research Group. University 
Laboratory for Medical Research-Verona (L.U.R.M), 
University of Verona, Verona, Italy; 3Gastrointestinal 
Pathobiology Research Group, Yale University School of 
Medicine, New Haven, CT, United States; 4ARC-NET 
Research Center, University of Verona, Verona, Italy
Summary: Cytokines play multiple roles in infl ammatory, 
angiogenetic as well as tissue repair and growth infl uencing 
pathways in vitro anastomotic healing, cancer progression 
and metastasis, but their ‘in vivo’ roles, particularly during 
pancreatic cancer surgery remains unknown. Our aim was to 
quantitate Transforming growth factor beta (TGF-β), Insulin-
like growth factor-1 (IGFI), Epidermal growth factor (EGF) 
and Interleukin-6 (IL6) levels in drainage fl uid from patients 
that had undergone pancreatic surgery and evaluate how 
these altered during healing.
Methods: Fluid from the right and left drainage sites of 30 
patients who underwent pancreatic resection were collected 
in postoperative day 1st (POD 1), centrifuged at 15000 rpm 
for 20 minutes and the total proteins, TGF-β, IGFI, EGF, and 
IL6 concentration measured with Enzyme-linked immuno-
sorbent assay (ELISA) kits. The cytokines were normalized 
to the total protein concentration and correlated with amylase 
concentration (U/L), patient with or without complications, 
Ca 19.9 levels (cut-off less or more than 100 U/L) and pan-
creatic adenocarcinoma (PDAC) versus other conditions.
Results: Amylase values did not correlate with cytokine 
levels (TGF-β: p = 0.5, IGFI: p = 0.2, EGF: p = 0.8, IL6: p 
= 0.9 respectively). Comparing the groups with or without 
complications identifi ed that Amylase was signifi cantly cor-
related (p = 0.0006), while no signifi cance was identifi ed for 
cytokines (p = 0.08–0.9). A signifi cant association was iden-
tifi ed for IL6 using a Ca 19.9 cut-off less or more than 
100 U/L (p = 0.014) as well as for the analysis PDAC versus 
other conditions (p = 0.027). In addition, Amylase was sig-
nifi cantly elevated in PDAC versus other conditions (p = 
0.015), but no signifi cant association was identifi ed for the 
cytokines analyzed (p = 0.13–56).
Conclusion: To our knowledge, this is the fi rst study testing 
cytokine levels in drainage fl uid after pancreatic surgery. 
Despite the small number of patients, we confi rmed Amylase 
as a good marker of surgical complication, identifi ed that 
IL-6 was signifi cantly elevated in PDAC and that drainage 
fl uid may be a useful compartment to study.
P0067P
PANCREATIC CANCER. HOW TO 
OBTAIN BEST RESULTS
M. A. Secchi1, L. Rossi1,2, L. Quadrelli1, J. M. Torre1 and 
M. Cantaberta1
1IUNIR-Medical School-Hospital Italiano Garibaldi, 
Rosario, Argentina; 2Model Clinic, Rufi no, Argentina
Introduction: Pancreatic adenocarcinoma is usually diag-
nosed in the advanced setting, and only 10–15% of patients 
present with operable disease. About 85% of tumors are 
locally advanced and unresectable and the rest are 
metastatic.
Methods: Selective and combined non-invasive methods 
may be used for appropriate staging: clinical examination, 
tumor markers, US, CT, HCT, multislice CT, CT angio, MRI, 
MRCP, ERCP, MR – angio and PET- scan. Pretreatment 
assessment of resectable and borderline resectable pancreatic 
cancer was adapted to the Expert Consensus Statement (Mark 
P. Callery et al. Ann Surg Oncol 2009 16:1727–1733).
Patients and surgical treatment: Resection rate: 17% of 
678 evaluated patients in the last 20 years. Multimodal treat-
ment was performed according to each patient’s staging: 
surgery + chemotherapy + radiotherapy or palliative care. 
One hundred and nineteen patients underwent resection at 
the HIG and IUNIR centers: R0: 92 (77%), 88 by PD; R1: 
23 (19%), 11 by PD and R2: 4 (2%), 3 by PD.
Results: Morbidity was 40% (48 of 119 patients); 2 or more 
complications in 15 (12.6%), pancreatic fi stula in 22 (18%), 
re-laparotomy or laparoscopy in 20 (16%) for all complica-
tions. The operative mortality was 5.0% (6/119). Survival at 
5 years was 18% in (17 of 92) patients with R0 pancreatec-
tomy, 4% in (1 of 23) patients with R1 pancreatectomy, and 
0% in 4 patients with R2 pancreatectomy. The mean survival 
for pancreatic cancer was 29.2 months (R0), 11.1 months 
(R1), 6.2 months (R2).
Conclusion: Our results in the treatment of pancreatic ade-
nocarcinoma were obtained by curative R0 resection after 
appropriate staging, and personalized adjuvant chemoradio-
therapy. In the near future best results may be obtained using 
molecular biology: targeted molecular therapy and new gen-
eration of cancer drugs.
P0068P
MANAGEMENT OF POST-OPERATIVE 
PANCREATIC FISTULA AFTER 
PANCREATECTOMY FOR PANCREATIC 
CANCER
M. A. Secchi1, L. Quadrelli1, L. Rossi1,2, J. M. Torre1 and 
M. Cantaberta1
1IUNIR-Medical School-Hospital Italiano, Rosario, 
Argentina; 2Model Clinic, Rufi no, Austria
Introduction: The rate of post-operative and pancreatic 
fi stula (POPF) in pancreatic cancer is between 5% and 29%, 
depending on the type of pancreatic surgery.
An all-inclusive defi nition of POPF is a drain output of any 
measurable volume of fl uid on or after post-operative day 3, 
with amylase content greater than 3 times the serum amylase 
activity. Three different grades of POPF (grades A, B, C) are 
defi ned according to the clinical impact on the patient’s 
hospital course.
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Method: The aim of the treatment is to minimize the healing 
time. A multidisciplinary approach based on optimal patient 
management, nutrients, reduced loss of fl uid, reduced fi stula 
output with pharmacotherapy, reduced risk of intraabdominal 
infection and reoperation, improved quality of life for the 
patient and reduced (direct and indirect) costs to fi stula treat-
ment with a shorter hospital stay was used.
Patients and treatment: Our personal experience in POPF 
from 119 pancreatectomies for pancreatic cancer includes 22 
patients (18%). In 8 patients with grade A POPF, the use of 
somatostatin analogues was instituted exceptionally (8/22). 
The peripancreatic drains were always maintained in place. 
There was no mortality. Six patients with grade B POPF were 
kept NPO (nothing by mouth) and were supported with 
partial or total parenteral or enteral nutrition. The peripan-
creatic drains were always maintained in place, intravenous 
antibiotics were administered, and octeotride – a somatosta-
tin analogue – was often instituted. There was no mortality.
There were 8 patients with grade C POPF. All showed 
systemic infl ammatory response syndrome (SIRS) and 
required aggressive clinical intervention. Reoperation and 
SIVACO were used in 6 of 8 cases. Patients were kept on 
total parenteral nutrition or enteral (jejunal) nutrition, intra-
venous antibiotics, and octeotride was always instituted in 
an intensive care unit setting. Two (2) patients died (25%).
Conclusion: We had 22 POPF in 119 patients with pancre-
atectomy for cancer, that is, 18%, with a mortality rate of 
1.6% after management by this multidisciplinary approach.
P0069P
SURGICAL MANAGEMENT OF 
PANCREATIC NECROSIS IN ACUTE 
PANCREATITIS (AP)
M. A. Secchi1, L. Quadrelli1, L. Rossi1,2, E. Mateljan1,2 and 
J. M. Torre1
1IUNIR-Medical School-Hospital Italiano-HECA-HP, 
Rosario, Argentina; 2Model Clinic, Rufi no, Argentina
Pancreatic necrosis is a non viable area of pancreatic paren-
chyma, in a clinic context characterized by a marked early 
infl ammatory response followed by sepsis.
Patients: From April 1987 to July 2010 we have treated 
1343 patients with certifi cate AP. Dynamic CT Scan was the 
most common and reliable method to demonstrate the local 
involvement of the AP: 188 patients presented pancreatic 
necrosis.
Method: In severe AP and in necrosis we have initiated pre-
cocious ATB and jejunal nutrition (TEN). When infection is 
suspected, a percutaneous puncture must be performed. If the 
bacteriology is positive, necrosectomy will be performed. If 
the bacteriology is negative as in the hemoculture, the ATB 
will be rotated. If evolution is good, a causative treatment will 
be established. By contrast, if it is bad, necrosectomy will be 
performed in one or various steps by combined methods.
Results: 188 patients presented pancreatic necrosis; 96 men 
and 92 women with an average age of 44 years (22–78).
A) Out of which 75 were sterile necrosis, who had received 
ATB and TEN. Mortality was of 9.3%: 7 severe patients 
died before the second week with precausious systemic 
complications with negative percutaneous bacteriology.
B) The others 113 presented certifi cate infected pancreatic 
necrosis: 7 received exclusive ATP and TEN or TPN 
treatment, due to patient refusal surgical procedure or 
anesthetic contraindications (2 deaths). 5 patients had a 
percutaneous drainage and 101 patients were operated: 
32 with close and/or drainage method (10 by laparoscopy 
(3 retroperitoneal and 7 transperitoneal), out of which 7 
had to be re operated to complete the necrosectomy (3 
deaths) and 69 by means of open method in which the 
average of re-surgery before closure was of 4.5 (2–9) (12 
dead patients). All patients had positive bacteriology in 
different culture. Mortality of infected necrosis was of 
15% (17 of 113 patients).
In total the mortality was 24 of 188 patients: 12.7%.
Conclusion: In surgical management of infected necrosis 
with severe AP, the simple drainage and washing are insuf-
fi cient. Survival will depend to perform necrosectomy 
because it is there where the septic focus is placed. The 
combination of classics and news methods is a rational 
response to decrease mortality in this severe pathology.
P0070P
APPROPRIATE USE OF 
LAPAROROSCOPIC APPROACH IN 
MANAGEMENT OF LOCAL 
COMPLICATIONS IN ACUTE 
PANCREATITIS
M. A. Secchi1, L. Rossi1,2, L. Quadrelli1 and E. Mateljan1,2
1IUNIR Medical Scholl, HIG;HECA;PH, Rosario, 
Argentina; 2Model Clinic of Rufi no, Rufi no, Argentina
Background: In our experience local complications (LC) of 
acute pancreatitis (AP) are the major cause of death within 
the second week after the onset of the disease.
Design: Retrospective (1987–1997) and prospective (1998–
2010) study in 1343 patients, were performed at 4 surgicals 
centers: Hospitales Italiano, HECA, Provincial from Rosario 
and Model Clinic from Rufi no. (Argentina).
Method: esions and local complications were defi ned 
according to the Pancreas Club, República Argentina, 1998. 
All patients had AP of any etiology confi rmed by morpho-
logical methods. A CT Scan performed after the 4th. Day of 
the onset of AP showed an AP local involvement. The clinical 
therapy was to treat local lesion, and a combination of clini-
cal, percutaneous, laparoscopic (VLP) and/or conventional 
surgery was performed to treat local complications. 332 
patients developed local lesions and complications. Local 
lesions’ = 120: 45 had acute fl uid collections >5 cm. in 
diameter (10 underwent percutaneous punction and drain-
age), and 75 had pancreatic necrosis. Local complications 
n = 212: 35 abscesses, 58 acute pseudocyst, 6 infected acute 
pseudocyst: and 113 infected necrosis (and walled-off pan-
creatic necrosis WOPN: 8 of 113). Abscesses of any size and 
pseudocysts >5 cm of diameter were treated. Second surgical 
procedures for treating infected necrosis were not 
considered.
 Abstracts 131
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 2), 1–145
Results of treatment:
A.P. Local Complications Complic (n = 212) No Surgical Percutaneous Surgical (VLP: 33) Mortality (n = )
Abscesses  35  6 21 8 (7)  1
Acute pseudocyst  58 17  5 36 (15)  1
Infected acute pseudocyst 
(WOPN)
(Bacterology +)
 6  0  1 5 (1)  0
Infected necrosis and 
WOPN
113  7  5 101 (10) 17
none in Lap.
Laparoscopic approach were used in 33 cases for treated 
local complications of AP (15.5%), This technique is feasi-
ble, safety and apropiate for recurrent abscesses (n = 7), 
cystograstrostomy or assisted cystoyeyunostomy (n = 15) 
and focal infected necrosis or WOPN less than 30% of pan-
creas volume (n = 10). Effi cacy of Laparoscopic approach of 
LC in AP must be proved in prospective studies in larger 
series. As well percutaneous approach was used in 32 cases 
(15.0%) Mortality in patients with local complications was 
8.9% (19 of 212).
Conclusion: An appropriate, selective and multidisciplinary 
treatment, including percutaneous and laparoscopic, is man-
datory to obtain better results in LC of AP lower rates of L.C. 
Mortality with multidisciplinary treatment: was 1.4% 
(19/1343).
P0071P
INVASIVE MARKERS IDENTIFIED BY 
GENE EXPRESSION PROFILING IN 
PANCREATIC CANCER
M. Smith1, A. Rogers1, P. Doolan2, C. Clarke2, A. 
McDermott1, N. Swan1, P. Crotty1, P. Ridgway1 and 
K. Conlon1
1The Adelaide and Meath Hospital Incorporating the 
National Children’s Hospital, Tallaght, Dublin 24, Ireland; 
2The National Institute for Cellular Biotechnology, Dublin 
City University, Dublin 9, Ireland
Introduction: Molecular profi ling has proven utility as a 
diagnostic and predictive tool in clinical oncology. However, 
a clinically relevant gene expression profi le in pancreatic 
cancer remains elusive.
Methods: Primary and metastatic pancreatic cancer cell 
lines (BxPC-3 and AsPC-1), were stimulated with phorbol-
12-myristate 13-acetate (PMA), a known inducer of cell 
invasion. Affymetrix microarray analysis was performed, 
comparing gene expression to unstimulated controls. Signal 
values were calculated using gcRMA, signifi cance analysis 
was performed using an unpaired t-test. Bioinformatic analy-
sis was performed using ArrayAssist, Pathway Studio and 
GOstat. The derived gene expression signature was further 
validated in fresh frozen pancreatic tumour samples. A three 
gene signature was identifi ed and compared to clinicopatho-
logical variables.
Results: PMA induced n = 490 genes in AsPC-1 cells, and 
n = 751 genes in BxPC-3 cells, with a p-value of 0.02, and 
a fold change of >1.5 (GEO series numbers: GSE22973, 
GSE22973). Functional analysis of the expression changes 
of the BxPC-3 cells demonstated dysregulation of apoptosis, 
cell death, and transcription. Upregulated genes in AsPC-1 
cells were related to basement membrane function, indicat-
ing increasing invasiveness. Expression of three genes, con-
stituting a bespoke ‘invasive signature’ (uPA, MMP-1 and 
IL1-R1) was confi rmed in human pancreatic tumours, and 
was found to differentiate PDAC from other pancreatic neo-
plasms. Expression of MMP-1 was also associated with 
high-grade PDAC (p < 0.05, Wilcoxon rank sum).
Conclusion: We have identifi ed a three gene expression sig-
nature, which may differentiate PDAC from other pancreatic 
neoplasms. We found that one of the constituents of the sig-
nature, MMP-1, was associated with high grade tumours. This 
suggests the ‘invasive signature’ may have utility in the iden-
tifi cation of tumours with a more aggressive phenotype.
P0072P
LAPAROSCOPIC VERSUS OPEN DISTAL 
PANCREATECTOMY; A COST-
EFFECTIVENESS STUDY
M. F. Hamdan, F. Di Fabio, C. D. Johnson, M. Abu Hilal 
and P. Swan
Hepatobiliary-Pancreatic and Laparoscopic Surgical Unit, 
Southampton General Hospital, Southampton University 
Hospitals NHS Trust, Southampton, United Kingdom
Background: Minimally invasive distal pancreatectomy 
(DP) is being increasingly performed. Cost-effectiveness is 
a practical burden on all health institutes. This study com-
pares the costs and the outcomes of laparoscopic distal pan-
createctomy (LDP) and open distal pancreatectomy (ODP).
Methods: Between March 2000 and October 2010; 47 DP 
were performed in a major university teaching hospital, of 
which 30 were done laparoscopically. A retrospective cost 
analysis of prospectively collected data was performed. For 
this purpose, all intra- and post-operative data were com-
pared including; the cost of the procedure, blood transfu-
sions, postoperative hospitalization, complications and their 
management, readmission and return to theatre. The total 
cost for each patient was also calculated separately.
Results: Median operative time was 210 minutes (120–420) 
in LDP and 210 minutes (120–460) in ODP (P = 0.86). 
Median blood loss was 200 mL (50–700) in LDP and 388 mL 
(75–2000) in ODP (P = 0.0097). Median Hospital stay was 
7 days (3–25) in LDP versus 11 days (5–46) in ODP (P = 
0.0059); with a median of 0 days (0–7) (mean 0.241) stay in 
Intensive Therapy Unit in LDP versus 0 days (0–21) (mean 
2.88) in ODP (P = 0.043). Complication rate was 45% in 
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LDP versus 59% in ODP (P = 0.27). An average of 0.207 
interventional procedures (0–3) was needed in LDP and 
0.647 (0–5) in ODP (P = 0.13). The average operative, post 
operative and overall cost was £6104 (4276–9500), £4252 
(900–18927), £10356 (5998–24248) versus £5205 (3409–
9330), £11046 (2000–46516), £16251 (6544–55846) for the 
LDP and ODP groups respectively (P = 0.024, P = 0.014, 
P = 0.044).
Conclusion: Although theatre costs are more in the LDP 
group compared to the ODP group, the overall cost is sig-
nifi cantly less in the LDP group confi rming the cost effec-
tiveness of the minimally invasive approach.
P0073P
SLOWER RECOVERY FROM 
POSTOPERATIVE COMPLICATIONS 
DRAMATICALLY AFFECTS LENGTH OF 
STAY OF VERY ELDERLY PATIENTS 
UNDERGOING 
PANCREATICODUODENECTOMY
F. Di Fabio, S. Syed, M. Hamdan, D. Layfi eld, N. W. 
Pearce, C. D. Johnson, M. A. Hilal and P. Swan
Southampton University Hospitals NHS Trust, 
Southampton, Hampshire, United Kingdom
Background: The increased life expectancy of the general 
population and dramatic improvements in postoperative care 
have extended the indications to perform pancreaticoduode-
nectomy (PD) in the elderly. However, this remains an area 
of debate. The aim of this study is to critically analyse the 
impact of age on postoperative complications, recovery, and 
length of hospital stay (LoS).
Methods: We reviewed a database of patients undergoing 
PD between January 2007 and November 2009 (n = 174). 
We analysed the impact of age on postoperative complica-
tions (bile leak, pancreatic leak, delayed gastric empting 
[DGE], abdominal collection/abscess, chest infection), and 
LoS. Patients have been divided into three age-groups, 1) 
very elderly: more than 80 years (5%); 2) elderly: between 
70 and 80 years (35%); younger: less than 70 years (60%).
Results: Patients over 80 years (very elderly) showed a 
trend toward increased postoperative bile leak (p = 0.538), 
pancreatic leak (p = 0.684), abdominal collection/abscess (p 
= .203), chest infection (p = 0.428), and a signifi cantly higher 
rate of DGE (p = 0.002, chi-squared test) compared to the 
elderly and younger patients. Among patients who developed 
postoperative complications, recovery time as expressed by 
LoS was substantially longer in the very elderly patients 
compared with the elderly and younger patients having the 
same complications (50 vs. 29 vs. 27 days for bile leak; 47 
vs. 22 vs. 19 days for pancreatic leak; 44 vs. 16 vs. 17 days 
for DGE; 28 vs. 26 vs. 18 days for abdominal collection/
abscess; 36 vs. 21 vs. 18 days for chest infection). Multivariate 
analysis showed that age, DGE, abdominal collection/
abscess, and chest infection were independently associated 
with longer LoS.
Conclusion: A slower recovery from postoperative compli-
cations seems to considerably infl uence LoS after PD in the 
octogenarians. Not only complications rate but recovery time 
from complications should be considered in outcome analy-
sis after PD for a comprehensive risk-benefi t and cost-
effectiveness analysis.
P0074P
THE ROLE OF ENDOSCOPIC 
RETROGRADE PANCREATOGRAPHY IN 
THE TREATMENT OF LOCAL 
COMPLICATIONS OF PANCREATIC 
TRAUMA
D. Thomson, J. Krige, P. Bornman and J. Shaw
Department of Surgery, University of Cape Town Health 
Sciences Faculty, Cape Town, South Africa
Aim: This study reviewed the role of endoscopic retrograde 
pancreatography (ERP) and endoscopic intervention in 
the treatment of patients with complicated pancreatic 
trauma.
Methods: 359 patients who had pancreatic injuries between 
April 1983 and January 2010 were reviewed. Patients who 
had an ERP either pre- or postoperatively for complications 
of pancreatic trauma were included in the study. The indica-
tion for ERP, its timing in relation to the injury, fi ndings at 
ERP, therapeutic intervention performed and the need for 
further surgery were analysed.
Results: 48 patients (42 men, 6 women, mean age 29.6, 
range 15–68 years) who had blunt trauma (n = 26), gunshot 
(n = 15) or stab wounds (n = 7) to the pancreas underwent a 
total of 74 ERPs at a mean of 38 days (range 2–365 days) 
after their injury. The pancreatic injury involved the head of 
the pancreas (n = 12), neck (n = 4), body (n = 18) and tail 
(n = 8), 1 site was unknown. ERP was successful in 47 
patients. Twenty-four patients had a pancreatic fi stula, 12 
patients had a main pancreatic duct stricture and 10 patients 
had a pseudocyst. In one patient no pancreatic leak was 
demonstrated on ERP. Endoscopic intervention was success-
ful in 25 patients (pancreatic duct sphincterotomy n = 15, 
pancreatic duct stent n = 7, pseudocyst drainage n = 6). Ten 
patients required pancreatic surgery (distal resection n = 6, 
pancreaticojejunostomy n = 3, cystjejunostomy n = 1. Ten 
patients resolved on conservative treatment following ERP. 
In seven patients stented none proceeded to surgery. A total 
of 74 ERPs were performed on the patient group in total with 
an average delay from injury until ERP of 38 days.
Conclusion: Pancreatic duct injury is a major determinant 
of outcome after pancreatic trauma. ERP is an effective endo-
scopic option in the diagnosis and treatment of local compli-
cations of pancreatic trauma.
P0075P
THE STANDARDIZED MORTALITY 
RATIO IS NOT RELIABLE FOR THE 
ASSESSMENT OF QUALITY OF CARE 
FOR PATIENTS WITH PANCREATIC 
CANCER
Y. van Gestel1, V. Lemmens1 and I. de Hingh2
1Comprehensive Cancer Center South, Eindhoven, 
Netherlands; 2Catharina Hospital, Eindhoven, Netherlands
Background: Hospital Standardized Mortality Ratios 
(HSMRs) are increasingly used as indicators of quality of 
hospital care and will be disclosed to the general public in 
the Netherlands in the near future. The HSMR is constructed 
from Standardized Mortality Ratios (SMRs) from specifi c 
diseases. The SMR for pancreatic cancer appeared to be 
increased in our hospital. This is alarming since our hospital 
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serves as a regional referral center for these patients. The aim 
of this study was to re-examine the patients who died in the 
hospital.
Methods: During 2006 and 2008, 178 patients were admit-
ted to our hospital with pancreatic cancer as the primary 
diagnosis. The observed in-hospital mortality rate for pan-
creatic cancer was 15 patients while the predicted mortality 
rate was 12 patients. The 3 excess deaths resulted in an 
increased SMR of 128. The medical records of the 15 patients 
who died during the hospital stay were reviewed.
Results: In total, 84 patients underwent surgery for pancre-
atic cancer of whom 3 patients (3.6%) died in the postopera-
tive period. Furthermore, 1 cardiac compromised patient 
died due to complications after endoscopic retrograde 
cholangiopancreatography.
The remaining 11 pancreatic cancer patients who died in 
our hospital were all admitted with end-stage disease and 
severe symptoms to receive palliative care only.
Conclusions: The in-hospital mortality rate after pancreatic 
surgery is acceptable and in accordance with the (interna-
tional) literature. The increased SMR in our hospital appeared 
to be mainly caused by the admission of patients for pallia-
tive care. As the SMR model does not adjust for type of 
treatment (surgery, diagnostic, palliative), use of this measure 
is not appropriate to make a reliable comparison between 
hospitals for quality of care of pancreatic cancer. Publication 
of these results will have a signifi cant impact on the public 
confi dence and may lead to incorrect conclusions and 
decisions.
P0076P
VALUE OF FDG-PET/TC AS A 
PREOPERATIVE PROGNOSTIC TOOL IN 
PATIENTS WITH PANCREATIC 
ADENOCARCINOMA
H. Duran, E. Esteban, L. Garcia-Cañameque, M. Marcello, 
P. Galindo, E. Diaz-Reques, Y. Quijano, E. Vicente, 
A. Carbajo, M. Allona, I. Martinez, F. Lopez-Rios and 
J. De Dios Diaz
Hospital Madrid Norte Sanchinarro, Madrid, Spain
Introduction and objective: We wonder if FDG-PET-TC 
shows a prognostic value in pancreatic cancer.
Patients and method: Retrospective study on 28 patients 
who underwent R0 resection of pancreatic cancer.
Preoperative maximum SUV was compared to known 
bad-prognosis pathologic features
Results: 28 patients underwent resection: true positives 23, 
false positives 3 (chronic pancreatitis, lymphoplasmocytic 
pancreatitis and intraepitelial pancreatic neoplasm) and false 
negatives 2 (sensitivity 92%, positive predictive value 88%).
SUV study: Mean SUV was 5.57 (0–12.87). Mean SUV in 
well-differentiated tumors (8) was 3.63, in moderately-dif-
ferentiated tumors (15) was 6.14 and in poorly-differentiated 
(2) was 9.03 (p < 0.005). Mean SUV when vascular involve-
ment was found (16) was 5.41, versus 5.85 when not (9) 
(NS). Mean SUV when perineural invasion was present (23) 
was 5.49, versus 6.43 when not (2) (NS). SUV when tumor 
size was >4 cm (12) was 6.325, versus 4.87 when <4 cm (13) 
(mean size was 4, under a normal distribution) (NS). Mean 
SUV when invasion of SMV was confi rmed by pathologic 
exam (6) was 5.28, versus 5.66 when not (19). Similarly, 
SUV when SMA invasion was confi rmed by pathologic 
exam (1) was 5.19, versus 5.58 when not (24). T3N0 stage 
(4) showed a mean SUV of 5.85, T3N1 stage (15) showed 
mean SUV of 5.85, and T4N1 stage (3) showed a mean SUV 
of 6.33.
Conclusions: SUV of poorly-differentiated lesions was sta-
tistically higher than well-differentiated ones (p > 0.005). A 
SUV over the mean (5.57) correlates to lesions larger than 
4 cm. A linear progression was found between SUV and 
TNM stage in our series.
P0077P
25% OF OUR RESECTED PANCREATIC 
NEOPLASMS ARE NEUROENDOCRINE 
TYPE: ASPECTS CONCERNING THIS 
UNEXPECTED HIGH INCIDENCE
M. Marcello, H. Duran, E. Esteban, P. Galindo, 
E. Diaz-Reques, Y. Quijano, E. Vicente J. Roman, 
L. Cordoba, A. Muro, E. Garcia and J. De Dios Diaz
Hospital Madrid Norte Sanchinarro, Madrid, Spain
Introduction: Large series of neuroendocrine tumors of the 
pancreas (NETP) have not been reported We report our series 
of NETP.
Patients and methods: 18 out of 67 resected pancreatic 
neoplasms were NETP (26.8%).
Results: Clinical presentation:
a) Non-functioning NETP: 15 patients (84%). 4 patients 
with jaundice, 10 patients with unspecifi c abdominal 
pain, 1 asymptomatic patient.
b) Functioning NETP: 3 patients (16%). 2 patients with diar-
rhea (VIP-secreting tumors), 1 patient with MEN type I 
(symptomatic gastrinoma).
Median size of functioning vs. non-functioning tumors were 
1.6 cm vs. 4.4 cm (p < 0.05).
When PET-CT was positive, mean Ki-67 was 22% and 
tumor size was 4.5 cm. When PET-CT was negative and 
octreoscan was positive, mean Ki-67 was 11.6% and tumor 
size was 3.5 cm (almost statistically signifi cative, p < 0.1).
Surgery: 3 patients (16.6%, all of them non-functioning 
tumors) required SMV resection, 1 of them with associated 
left-lateral liver segmentectomy. 1 of the patients with SMV 
resection died postoperatively.
Overall survival and disease-free survival: Mean follow-
up was 14 months (range 4–34). All of the 17 patients are 
currently alive. 2 patients have shown a relapse after 7 
months (the patient with the associated liver resection) and 
10 months (the patient with Ki-67 54%).
Conclusions: Incidence of NEPT in our series (26.8%) is 
much higher than previously reported (1–5%). There are 
some arguments to support that a positive PET-CT is associ-
ated with a worse prognosis (larger size and higher Ki-67) 
than a positive octreoscan. Non-functioning NEPT, with a 
larger size, occasionally require challenging surgical proce-
dures, such as SMV resection.
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P0078P
CASE OF LONG TERM SURVIVAL IN 
PATIENT WITH PANCREATIC CANCER 
AFTER TOTAL 
DUODENOPANCREATOSPLENECTOMY
S. Zemskov1,2, O. Dronov1,2, I. Kovalska1, E. Kruchina1,2 
and M. Zemskova2
1Bogomolets National Medical University, Kiev, Ukraine; 
2Kiev Center for Hepatopancreatoboliary Surgery Named 
V.S. Zemskov, Kiev, Ukraine
Patient C. 46 years old, presented with chronic abdominal 
pain. CT revealed heterogenic pancreatic head with no 
regional lymphadenopathy or distant metastases. Endoscopy: 
prolapse of papilla Vateri. Biopsy: no malignancy. Patient 
recommended Whipple’s procedure. 29/05/2006 intraopera-
tively adenocarcinoma of pancreatic head identifi ed. After 
duodenopancreatectomy tumor invasion in remnant pancreas 
revealed. Resection of body of pancreas. Frozen section 
identifi ed malignancy at remnant main duct of hpancreas. 
Total duodenopancreatosplenectomy with Roux-en-Y hepat-
icojejuno- and gastrojejunoanstomosis and extended lymph-
adenectomy performed.
Diagnosis: Cancer of pancreas T3N0M1. G2. Total involve-
ment. Stage II. Tumor appeared to be CK7/CK20, CEA, 
CA19-9 and CDX2 positive at immunohistochemistry stain-
ing. Leakage of hepaticojejunoanastomosis and diffuse peri-
tonitis postoperatively. 13/06/06: relaparotomy, abdominal 
cavity sanitated and drained. Postoperatively: uncontrolled 
hyperglycemia with ketoacidosis occurred despite insulino-
therapy 70 Units per day. Glucose metabolism was regulated 
by Continious Glucose Monitoring System (CGMS) for 9 
days with insulin dose 24 units/day and glycemia fl uctuation 
5–10 mmol/l. 11/07/06 patient discharged in satisfactory 
condition. Adjuvant therapy: Gemcytabine in total dose 
10.8 g applied. September 2007 patient developed liver and 
vertebral metastases with mild pain syndrome. He refused 
further chemotherapy. Zoledronic acid 4 mg/month and NSC 
631570 (derivate of Chelidonium majus L. alkaloids 20 mg/
week I/V) used for further treatment. NSC 631570 is non-
specifi c immunomodulant having pronounced proapoptotic 
effect in tumor cells. 30 months disease remained stable, 
proved by CT scans. March 2010 patient presented weakness 
in his legs without increase in pain. Despite neurologic 
therapy lower paraparesis developed. Vertebral MRI: extra-
dural metastasis compressing spinal cord Th5 revealed. 
14/05/2010: laminectomy, tumor debulking, vertebropasty at 
Th5 and transpedicular fi xation performed. As for September 
2010 patient is in satisfactory condition he can stand and 
walk in walking frame. ECOG/WHO score 3 (still able for 
professional computer activity).
Conclusion: adequate substitute and palliative therapy 
makes long term survival in pancreatectomized cancer 
patients possible despite disease progression.
P0079P
VALIDATION STUDY OF REVISED 
ATLANTA CLASSIFICATION FOR ACUTE 
PANCREATITIS INCLUDING 
‘MODERATELY SEVERE ACUTE 
PANCREATITIS’: A MORTALITY 
ANALYSIS
F. Di Fabio, M. A. Hilal, M. Hamdan, C. D. Johnson and 
P. Swan
Southampton University Hospitals NHS Trust, 
Southampton, Hampshire, United Kingdom
Background: The Atlanta classifi cation of patients with 
acute pancreatitis into two broad categories of ‘mild’ and 
‘severe’ disease has been considered inadequate for predict-
ing outcome. Recently, a revised version to include a patient 
group with ‘moderately severe acute pancreatitis’ has been 
proposed. This new category includes patients with local 
complications but no organ failure. The aim of this study is 
to validate this revised classifi cation using an existing data 
set.
Methods: Data from a total of 290 patients were reviewed. 
Patients with predicted severe acute pancreatitis (APACHE-II 
>6) from 78 hospitals in the UK were previously studied in 
a trial of lexipafant. Organ failure was assessed daily for the 
fi rst week, and all clinically relevant local complications 
were recorded. The associations between early organ failure, 
local complications and in-hospital mortality were 
analysed.
Results: 165 (57%) patients had early organ failure of 
whom 55 (33%) had associated local complications. Sixteen 
patients (6%) had local complications without early organ 
failure. A total of 37 in-hospital deaths (13%) were due to 
acute pancreatitis. Thirty-four of the 37 deaths (92%) were 
in patients who had early organ failure. In-hospital mortality 
was 36% in patients with both early organ failure and local 
complications and 12% in patients with early organ failure 
without local complications. Among patients with local com-
plications without early organ failure, only one (6%) died 
in-hospital. In patients with neither early organ failure nor 
local complications (n = 105), two (2%) patients died.
Conclusion: A small group of patients with acute pancreati-
tis develop local complications in the absence of early organ 
failure. Patients with predicted severe acute pancreatitis and 
no early organ failure have a low mortality risk irrespective 
of local complications. Our data support the concept of 
‘moderately severe acute pancreatitis’ to describe patients 
with local complications without early organ failure.
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P0001T
CLINICAL IMPACT OF ARTERIAL 
INJURIES IN POST-MORTEM DONOR 
LIVERS WITH ABERRANT ANATOMY
F. Ausania, R. Al-Ghnaniem, N. V. Jamieson and 
R. K. Praseedom
Hepato-Pancreato-Biliary and Transplant Surgery, 
Addenbrooke’s Hospital, NIHR Comprehensive Biomedical 
Research Centre, Cambridge, United Kingdom
Hepatic artery retrieval injury is a rare complication of post-
mortem liver procurement. It is associated with higher inci-
dence of hepatic artery thrombosis (HAT) and it usually 
occurs when arterial anatomy is aberrant, therefore making 
more challenging the utilization of the graft. Arterial recon-
struction is also a risk factor for HAT: the aim of this study 
is to investigate whether arterial injury really increases the 
rate of HAT and biliary complications within 3 months from 
liver transplantation when anatomy is aberrant and therefore 
reconstruction is anyhow needed.
Out of 844 liver transplants performed between 1994 and 
2007 at our Unit, 87 (10%) grafts had aberrant anatomy 
which required more than one arterial anastomosis; only in 
79 cases the data collection was complete. Sixty-three grafts 
did not have any injury, whilst arterial injury was registered 
in 16 cases. HAT occurred in 6 cases (7%, 4 and 2 cases 
respectively). Biliary complications at 3 months occurred in 
9 cases (11%, 7 and 2 cases respectively). There was no 
statistically signifi cant difference in HAT and biliary compli-
cations rate between the two groups.
This is the fi rst study analysing the clinical impact of arte-
rial injury during liver procurement in case of aberrant 
anatomy requiring bench reconstruction. We conclude that in 
those cases when technically feasible, arterial injury repair 
should be carried out as does not add any additional risks.
P0002T
POTENTIAL AND ACTUAL LIVER 
DONORS: IS THE DIFFERENCE 
PREDICTABLE?
F. Ausania, R. Al-Ghnaniem, N. V. Jamieson and 
R. K. Praseedom
Hepato-Pancreato-Biliary and Transplant Surgery, 
Addenbrooke’s Hospital, NIHR Comprehensive Biomedical 
Research Centre, Cambridge, United Kingdom
The overall shortage of liver donors seems to be a persistent 
problem in United Kingdom despite a recent increase in both 
living and cadaveric non heart-beating donation. In order to 
make the best use of our resources in the future, we looked 
into factors that predisposed to livers not being used for 
transplantation. We reviewed data validated by UKT from 
2000 to 2008 for liver donors offered to our Centre 
(Addenbrooke’s Hospital, Cambridge). Age, gender, type of 
donor (cadaveric heart-beating [HB]; non heart-beating 
[NHB]), body mass index (BMI), blood group, cause of 
death, retrieval centre, outcome of organ donation and 
reasons for non-use of the organ were analysed. From 
January 2000 to December 2008, 1007 donors were regis-
tered, of which 822 were offered for whole liver donation to 
Cambridge. Only 128 were considered as discarded for clini-
cal reasons.
Univariate analysis revealed older age, blood group B, 
NHB donor, higher BMI and cause of death to be signifi -
cantly associated with non utilization of donor livers. 
However, NHB donor and age seemed to be excellent predic-
tors for discarding the liver (P < 0.000). This analysis was 
unfortunately limited by our inability to consider other sin-
gularly important factors such as liver function tests, alcohol 
consumption history, steatosis, perfusion of the liver and 
similar factors. We conclude that age and type of donor 
(NHB) strongly infl uence the decision to accept a liver for 
transplantation, although it would appear that discarding a 
liver graft remains a subjective choice depending on a 
number of variables that are considered at the time of organ 
procurement. Not only the donor factors but the recipient 
status and the transplanting centre play a determinant role in 
donor selection.
P0003T
INDUCTION OF DIFFERENT TYPES OF 
CELL DEATH AFTER NORMOTHERMIC 
LIVER ISCHEMIA-REPERFUSION
R. Cursio1,2, P. Colosetti1, M-C. Saint-Paul3, P. Gounon4, 
A. Iannelli2, P. Auberger1 and J. Gugenheim1
1INSERM U895, Equipe 2 C3M, IFR 50, Université de 
Nice Sophia Antipolis, Nice, France; 2Service de Chirurgie 
et Transplantation Hépatique, Hôpital l’Archet 2, 
Université de Nice Sophia Antipolis, Nice, France; 3Service 
d’Anatomo-pathologie, Hôpital Pasteur, Université de Nice 
Sophia Antipolis, Nice, France; 4Centre Commun de 
Microscopie Appliquée, Faculté des Sciences, Université 
de Nice Sophia Antipolis, Nice, France
Normothermic liver ischemia-reperfusion (I-R) may induce 
hepatocellular autophagy, apoptosis, and necrosis. The aim 
of this study was to investigate these three types of death in 
normothermic liver I-R in rats. A segmental normothermic 
ischemia of the liver was induced for 120 minutes. Liver 
autophagy was evaluated by transmission electron micros-
copy and LC3 immunohistochemical studies. Liver apopto-
sis was assessed by FLIVO and TUNEL assays. Liver 
necrosis was determined by optical microscopy examination. 
Autophagy was increased in ischemic liver lobes 6 h after 
reperfusion, compared with non-ischemic lobes. Fluorescence 
microscopy showed that in situ caspase −3 and −7 specifi c 
activity was increased in ischemic liver lobes after 6 h of 
reperfusion, compared to non-ischemic lobes. Quantitative 
analysis of apoptotic cells evaluated by TUNEL method 
showed a clear signifi cant increase in ischemic liver lobes 
3 h after reperfusion, compared with non-ischemic lobes. 
Necrotic cell death was signifi cantly increased in ischemic 
liver lobes 6 h after reperfusion, compared with non-isch-
emic lobes (p < 0.005). In conclusion, our fi ndings show that 
120 min normothermic liver I-R resulted in increased 
autophagic, apoptotic and necrotic cell death.
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P0004T
EFFICACY AND SAFETY OF 
CALCINEURIN-INHIBITOR-FREE 
DE-NOVO IMMUNOSUPPRESSION WITH 
EVEROLIMUS AFTER LIVER 
TRANSPLANTATION
F. Sacchetti1, G. L. Grazi2, M. Cescon1, E. Ponte1, P. D. 
Gioia1, G. Vetrone1 and A. D. Pinna1
1Liver and Multiorgan Transplant Unit, Policlinico S.
Orsola-Malpighi, University of Bologna, Bologna, Italy; 
2Hepato-Biliary-Pancreatic Surgery Unit, Regina Elena 
National Cancer Institute, Roma, Italy
Introduction: Immunosuppression with calcineurin inhibi-
tors (CNI) increases the risk of renal dysfunction after ortho-
topic liver transplantation (OLT). Based on this clinical data 
this study protocol was designed to assess the effi cacy and 
safety of calcineurin-inhibitor-free de-novo immunosuppres-
sion with mTOR inhibitor, Everolimus, after liver transplan-
tation for HCV-related cirrhosis.
Materials and methods: A prospective therapeutic study in 
a total of 45 liver transplant patients was designed to assess 
the safety and effi cacy of de-novo CNI-free immunosuppres-
sion with basiliximab, prednisolone and Everolimus in com-
parison with basiliximab, prednisolone and Tacrolimus. The 
primary endpoint were the rate of rejections and the rate of 
HCV infection recurrence. Secondary endpoints were the 
mortality up to 1 year after OLT, liver allograft function 
(assessed by measurement of AST, ALT, total bilirubin, 
AP, GGT), kidney function (assessed by measurement of 
serum creatinine and creatinine clearance) and overall inci-
dence of adverse events (infections rate, neurotoxicity, neph-
rotoxicity, incidence of de-novo-diabetes, hyperlipidemia 
and edema).
Results: Preliminary data show the substantial feasibility of 
this therapeutical approach for what concerns both the 
primary and secondary endpoints. Rejection rate was com-
parable (9.1% vs 0%, p = ns) as well as HCV recurrence 
(45.5% vs 43.5, p = ns). The most important collateral effect 
in the Everolimus study group was the onset of lower limbs 
edema (45.5% vs 8.7%, p = 0.005), whereas tacrolimus 
treated patients developed more frequently de-novo-diabetes 
(26.1% vs 4.5%, p = ns).
Discussion: If these data corroborate safety of de-novo 
CNI-free immunosuppressive regimen this should be con-
fi rmed in other randomized, prospective, controlled double-
blinded clinical trial.
P0005T
HIGH INCIDENCE OF HEPARIN-
INDUCED THROMBOCYTOPENIA IN 
LIVER TRANSPLANT RECIPIENTS
N. Hüser, V. Aßfalg, D. Reim, E. Matevossian, A. Novotny 
and H. Friess
Klinikum rechts der Isar der TU München, Munich, 
Germany
Aim: Factors associated with high incidence (30%) of 
Heparin-induced Thrombocytopenia (HIT) in 46 consecutive 
patients who underwent liver transplantation at our institu-
tion between June 2007 and September 2009 were 
investigated.
Methods: In 14 of 21 patients with suspected HIT the diag-
nosis could be confi rmed by HIPA-assay. 37 clinical vari-
ables were retrospectively analyzed for their association with 
the development of HIT after liver transplantation using the 
Mann-Whitney U-test, the Student t-test or the χ2-test where 
appropriate. Factors that were signifi cantly correlated to the 
development of HIT in univariate analysis were included in 
a multivariate model and binary logistic regression analysis 
was performed. For the factor that was found to be an inde-
pendent predictor of HIT in the multivariate model a cutoff 
was calculated using multiple χ2-testing.
Results: Patient’s age (p = 0.001), postoperative dialysis (p 
= 0.028) and postoperative hospital stay (p = 0.035) were the 
only parameters signifi cantly associated with the develop-
ment of HIT in univariate analysis. When the factors were 
analyzed for their independent association with HIT-
development, postoperative dialysis and postoperative hos-
pital stay turned out as epiphenomena of patient age, which 
was found to be the only independent predictor (0.021) of 
perioperative HIT-development in patients undergoing liver 
transplantation. By multiple χ2-testing a cutoff could be cal-
culated, separating the patient population into a high- and a 
low-risk group. Hereby patients younger than 59 years could 
be assigned to the low risk group, while patients of 59 years 
and older had an increased risk of developing HIT.
Conclusion: Apart from postoperative dialysis, the observed 
high incidence of perioperative HIT in liver-transplant candi-
dates was not associated with factors that could be imagined 
to induce thrombocyte activation, like the use of blood prod-
ucts or cell-saver use. Only patient age could be identifi ed as 
independent predictor of HIT development in these patients.
P0006T
LONG-TERM SURVIVAL IN PATIENTS 
WITH ADVANCED HCC IS DEPENDENT 
FROM 18-F-FDG TUMOR UPTAKE
A. Kornberg1, B. Küpper2, K. Thrum2, B. Krause3, H. 
Olaf3, F. Helmut3 and P. Büchler1
1TU Munich, Klinikum rechts der Isar, Department of 
Surgery, Munich, Germany; 2Department of Surgery, 
Klinikum Bad Berka, Bad Berka, Germany; 3Department of 
Surgery, University of Jena, Jena, Germany
Background: The implementation of the Milan criteria has 
signifi cantly increased the outcome after liver transplantation 
(LT) for hepatocellular carcinoma (HCC). However, there is 
increasing evidence that a subset of patients with HCC 
beyond the Milan criteria might benefi t from LT too. The aim 
of this trial was to analyze prognostic variables predicting 
long-term survival in these liver recipients.
Patients: A total of 91 liver transplant candidates with HCC 
were included in this trial. Indication for LT was based on 
Milan criteria. Signifi cant tumor progression during waiting 
time, such as macrovascular invasion and extrahepatic tumor 
spread, resulted in patient drop out. The impact of clinical 
(age, Child, MELD, immunosuppression, macromorpholp-
ogy) and biological (AFP-level, grading, microvascular inva-
sion, lymphoinvasion, 18F-FDG-uptake on PET) variables 
on tumor recurrence rate and long-term survival were deter-
mined by uni- and multivariate analysis.
Results: The mean follow-up post-LT was 65.1 ± 44.9 
months (range: 5–165 months). Final clinical (c) staging 
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pretransplantation demonstrated HCC within the Milan 
burden in 57 patients (Milan In; 62, 6%), while 34 liver 
transplant candidates revealed HCC beyond the Milan crite-
ria (Milan Out; 37, 4%). Five-year overall and recurrence-
free survival rates were 75, 5% and 72.7%, respectively. 
Tumor recurrence rates were 41, 2% in the (c) Milan Out 
population and 12, 3% in the (c) Milan In-patients (P < 
0.001). In the (c) Milan Out population, only 18F-FDG 
tumor uptake on PET (odds ratio 6.4) and poor tumor dif-
ferentiation (odds ratio 4.6) were identifi ed as independent 
variables predicting long-term outcome. Five-year recur-
rence-free survival rates in the (c)Milan Out subset were 
70% in patients with poor tumor differentiation (versus 0%; 
P < 0.001) and 81% in patients with 18-F-FDG nonavid HCC 
(versus 21%; P < 0.001).
Conclusions: Dependent from tumor biology, patients with 
advanced HCC may achieve excellent long-term survival 
after LT. For the fi rst time we were able to demonstrate that 
pretransplant assessment of 18F-FDG-uptake on PET helps 
identifying patients with HCC beyond the Milan criteria to 
profi t from LT.
P0007T
HEPATOPULMONARY SYNDROME IN 
CHILDREN UNDERGOING LIVER 
TRANSPLANTATION
L. Goddard1, W. Spearman2, M. McCulloch1, A. 
Numanoglu1, A. Millar1 and D. Kahn2
1Red Cross Children’s Hospital, Cape Town, South Africa; 
2Groote Schuur Hospital, Cape Town, South Africa
Background: Hepatopulmonary syndrome (HPS) occurs in 
15–20% of patients with cirrhosis. Liver transplantation is 
the only effective treatment for HPS.
Aim: To analyse the outcome of children with HPS who 
underwent liver transplantation.
Method: This was a retrospective study over the past 9 
years (April 2000 to April 2009). HPS was diagnosed using 
a technetium 99m-labeled macroaggregated albumin scan 
(MAA scan).
Results: During this period HPS was diagnosed by MAA 
scan in 3 patients who underwent liver transplantation. A 
total of 50 transplants were done in the unit over this time. 
The size of the shunts were 36%, 40% and 32% (normal <8% 
in systemic circulation). The perioperative and postoperative 
outcome was uneventful in 2 patients. The 3rd patient devel-
oped on ileal perforation on day 10. The patients received 
mechanical ventilation for a mean of 6 days (range 2 to 12 
days). Two patients received nitric oxide therapy whilst on 
ventilation. All 3 patients had repeated venesections in the 
fi rst 3 post-op weeks to prevent the haematocrit from rising 
above 40%. None of the patients received heparin prophy-
laxis. The 3 patients required prolonged (5, 7 and 10 months) 
home oxygen therapy. These patients are well and are leading 
productive lives 36, 53 and 72 months post transplantation.
Conclusion: HPS was reversible after OLT in all our 
patients. All patients with HPS who underwent Liver trans-
plantation are alive and well.
P0008T
THE LEFT LATERAL LOBE AS A GRAFT 
FOR THE MAJORITY OF RECIPIENTS- 
CAN WE INCREASE DONOR SAFETY 
WITHOUT IMPAIRING GRAFT 
SURVIVAL?
M. Schulze1, F. Barun1, M. Kohl2, M. Burdelski2 and 
D. Bröring1
1Department of Surgery, University of Schleswig Holstein 
Campus Kiel, Kiel, Germany; 2Department of Pediatrics, 
University of Schleswig Holstein, Campus Kiel, Kiel, 
Germany
Due to organ shortage living donation is increasing through-
out all transplant ceenters. The most important criteria in 
living related transplantation is donor safety, therefore the 
smallest operation i.e. the donation of the left lateral segment 
resembles the safest procedure. Some asian contries are cur-
rently mainly using the left lateral segment. We could dra-
matically increase the number of organs by usimg the left 
lateral lobe in split grafts as well
Methods: Between September 2006 and October 2010 we 
performed 62 pediatric liver transplantations in 59 children. 
The mean bodyweight was 14.3 kg (3.4 kg–50 kg).
In 49 cases we used the left lateral lobe, 41 were from a 
living donor. We used 4 full pediatric organs, 3 reduced size 
organs, 1 right lobe from a living donor and two full left 
lobes from a deceased donor. The mean graft weight of the 
left lateral segments was 335 g.
Results: Our overall patient survival and graft survival was 
100% and 96% respectively. We performed three re-trans-
plants, twice due to arterial thrombosis, once due to a portal 
vein thrombosis. Both cases of arterial thrombosis were in a 
left lateral lobe from a living donor. We only had one case 
of small for size syndrome in a recipient of 24.4 kg and a 
GWBW ratio of 0.6. Other cases with signifi cantly smaller 
GWBW ratios did not develop any clinical signs of small for 
size syndrome.
Conclusions: According to our experience we can increase 
the number of recipients for left lateral grafts, escpecially in 
good quality organs with a short cold ischemic time in living 
as well as cadaveric liver transplantation without impairing 
graft survival or increasing patient morbidity. By using spe-
cifi c surgical methods we can prevent or treat small for size 
syndrome. This however requires optimal pre-, intra-, and 
postoperative interdisciplinary management.
P0009T
EFFECTS OF EARLY ENTERAL 
NUTRITION TO THE LIVER 
TRANSPLANT PATIENTS
I. J. Yun
Konkuk University Hospital, Seoul, Korea
Background: Many surgeons think that nutritional support 
after liver transplantation surgery is unnecessary due to the 
early beginning of oral feeding and nutritional improving 
effect of transplantation itself. However, malnutrition more 
severe than moderate degree before transplantation is 
common and many damages related to transplantation 
surgery easily deteriorate the graft function, so nutritional 
therapy should be considered seriously in many cases. Even 
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enteral feeding (EN) is more physiologic and effective 
method, many regard ‘nil to mouth’ until gas-out is common 
sense and early application of EN before ‘gas out’ is not 
secure and safe.
Methods: From June 2006 to July 2008, total 19 patients 
received liver transplantation in Konkkuk University 
Hospital. Early EN is applied to all the transplants. Naso-
intestinal tube is inserted during operation and EN is started 
from fi rst postoperative day. L-tube is removed at fi rst post-
operative day. Feeding method is continuous infusion with 
20 hour per day and beginning with water and increasing 
concentration and amount. With oral diet, EN is ceased when 
the 80% purpose calorie is reached by oral diet.
Results: EN can be started 15 hours after extubation. On the 
third day of post-operation, EN feeding reaches to needed 
calories. Oral diet is beginning 4 days after transplantation. 
There is no complication including wound problems and 
postoperative infection. Antibiotics is used until 1~2 days 
after operation. No GI motility problem is provoked and all 
the scheduled EN can be performed successfully. Average 
stay in ICU is 9.37 days and for average postoperative hos-
pital stay, 39.6 days. No postoperative mortality is occurred.
Conclusions: Early EN after liver transplantation surgery is 
safe and effective. All the patients are tolerable to the early 
EN. No delayed wound healing and severe infectious com-
plications are occurred even for the more than moderate 
malnourished patients. Good outcomes may be closed related 
to the proper nutritional therapy. Early EN after liver trans-
plantation seems to be the safe and effective nutritional 
therapy and recommended to all the liver transplantation 
patients.
P0010T
HEPATICOJEJUNOSTOMY AS A 
METHOD OF TREATMENT OF POST 
LIVER TRANSPLANTATION BILIARY 
STRICTURES
K. Zieniewicz, W. Patkowski, T. Wroblewski and 
M. Krawczyk
Dept. of General, Transplant & Liver Surgery, Medical 
University of Warsaw, Warsaw, Poland
Biliary strictures, casts formation and concrements are the 
most common late biliary complications following liver 
transplantation, reaching 20% of cases. The early diagnosis 
and prompt treatment of biliary obstruction improve the 
long-term graft and patient survival. Endoscopic treatment, 
however effective, may not be the defi nitive method of cure. 
In selected cases the hepaticojejunostomy may become an 
alternative to multiple endoscopic or percutaneous interven-
tions. The aim of the study was to present the indications and 
results of hepaticojejunostomy in this group of patients in 
single center experience.
Patients and methods: Retrospective analysis of medical 
records of 810 adult liver transplant recipients in the period 
December 1994-August 2010 was carried out. Four patients 
(0.5%) underwent the hepaticojejunostomy for biliary 
obstruction after unsuccessful multiple procedures of ERCP 
and/or PTC with stenting: 3 women and 1 man, aged 21–55, 
mean 30 years. The indications to LTx were different: post-
alcoholic cirrhosis, Budd-Chiari syndrome in the course of 
osteomyelofi brosis, overlapping PSC/AIH and Wilson 
disease.
3 patients were transplanted with piggy back technique, 
one with classical one. 2 patients have choledocho-
choledochal end-to-end anastomosis, 2 – end-to-side hepati-
cojejunostomy Roux-en-Y. 1 patient underwent urgent reLTx 
for hyperacute rejection due to AB0 incompatibility of the 
fi rst graft transplanted in emergency settings. The median 
time from the transplantation to the onset of biliary stenosis 
symptoms was 6 months (the longest was 56 months). The 
median time from the onset of biliary symptoms to reopera-
tion – hepaticojejunostomy Roux-en-Y was 6 months, 
however in one case it was 1 month and in the other – 34 
months.
Results: There were no major complications after hepatico-
jejunostomy. All of the patients are alive and in good general 
condition, 3 of them – free of the cholestatic symptoms. 
Mean follow-up time is 24 months. In one patient, trans-
planted for PSC/AIH overalapping syndrome, relapsing 
cholangitis occurred 3 months after hepaticojejunostomy. 
The MRCP and liver biopsy revealed recently the recurrence 
of the underlying disease – PSC. The retransplantation was 
performed successfully.
Conclusion: Hepaticojejunostomy in the treatment of post-
transplant biliary strictures appears to be safe and attractive 
option, especially when repeated ERCP and/or PTC with 
stenting are unsuccessful.
